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RÉSUMÉ 
Une faible exposition à des stress tels qu'un choc thermique, du stress oxydatif ou 
des  radiations  peut induire une réponse  adaptative  qui  permet aux  cellules  et  aux 
organismes  qu'elles  constituent  de  continuer  à  fonctionner  normalement  lorsqu'ils 
sont  confrontés  à  un  stimulus  négatif.  Ces  réponses  adaptatives  impliquent  de 
nombreux changements dans l'expression de gènes et de protéines, dont l'induction de 
défenses cellulaires (an  ti oxydants, protéines de choc thermique (heat shock pro  teins 
(Hsps)), etc.)  qui  permettront à la cellule de survivre. Si  une réponse adaptative ne 
parvient pas à contrer les effets de l'exposition au stress, les cellules sont éliminés via 
des  processus  de  mort  cellulaire  comme l'apoptose  ou  la nécrose. Une  exposition 
préalable  à  des  températures  modérées,  de  l'ordre  de  40°C,  induit  une  réponse 
adaptative (la thermotolérance)  qui permet aux  cellules de résister à une agression 
toxique  ultérieure.  La  thermotolérance  induite  par  des  températures  modérées  de 
l'ordre de 39-40°C (ce qui correspond physiologiquement à un état fiévreux) a été peu 
étudiée et  est mal  comprise. Les  deux  objectifs  principaux  de  cette étude sont:  (i) 
d'évaluer si l'induction d'un système de défense par une température modérée et non-
létale (  40°C)  peut permettre de protéger la cellule contre l'activation de la cascade 
apoptotique par le stress oxydatif, et (ii) de comprendre  les mécanismes moléculaires 
détaillés  de l'apoptose induite par le stress oxydatif. L'apoptose est évaluée au niveau 
des voies de signalisation médiées par les mitochondries, des recepteurs de mort et le 
réticulum endoplasmique (RE) dans des cellules HeLa. 
L'objectif premier est de déterminer si un  choc thermique modéré peut induire un 
mécanisme de  défense cellulaire autre que les Hsps. En  effet, une thermotolérance 
modérée (  40°C,  3h)  induit une augmentation  du  taux  de  plusieurs  antioxydants  et 
protéines  de  stress  du  RE.  L'expression  protéique  et  l'activité  enzymatique  de  la 
manganèse superoxyde dismutase (MnSOD)  et de  la catalase sont augmentées dans 
les  cellules  thermotolérantes,  comparées  aux  contrôles  (37°C).  Les  niveaux 
intracellulaires  de  glutathion  et  de  y-glutamylcysteine  synthétase,  l'enzyme  qui 
synthétise  le  glutathion,  sont  aussi  augmentés.  Ceci  peut  être  expliqué  par 
l'augmentation  de la production  de  dérivés  réactifs  de  l'oxygène  (reactive  oxygen 
species, ROS) dans les cellules thermotolérantes. De plus, l'expression des protéines 
de stress du RE,  PERK, p-PERK, eiF2a et p-eiF2a, est accrue dans ces cellules. Cela 
démontre  que  la thermotolérance  modérée  accroit  les  effets  pro-survie  de  la voie 
PERK/eiF2a  de  réponse  aux  mauvais  repliements  de  protéines  (unfolded  protein 
response, UPR). 
Le second objectif a pour but de déterminer les mécanismes de l'apoptose induite 
par le stress oxydatif.  Lorsqu'elles sont exposées à du peroxyde d'hydrogène (H20 2) , 
les  cellules entrent en  apoptose via  les  voies des  mitochondries, des  recepteurs de xx 
mort et du RE. L'activation de la cascade mitochondriale de l'apoptose implique la 
translocation  de  Bax  à  la  mitochondrie,  la  dépolarisation  de  la  membrane 
mitochondriale, la libération du cytochrome c, l'activation des caspases -9  et -3  et la 
condensation de la chromatine du noyau. De plus, H20 2 cause l'activation de p53  et 
l'induction  de  sa protéine  cible PUMA,  ainsi  que  l'apoptose  caspase-indépendante 
impliquant  le  facteur  d'induction  de  l'apoptose  (AIF).  Ces  évènements  sont  tous 
inhibés dans les cellules thermotolérantes, ce qui suggère qu'une exposition préalable 
à  des  températures  modérées  et  physiologiques  peut  protéger  les  cellules  contre 
l'apoptose  mitochondriale  déclenchée  par  le  stress  oxydatif,  qu'elle  soit  caspase-
dépendante ou -indépendante. 
De plus, H20 2 active la voie d'apoptose du Fas recepteur de mort par l'induction du 
ligand  FasL,  le  recrutement  de  la protéine  F  ADD  à  la membrane  plasmique  et 
l'activation  des  caspases  -8  et  -2.  Ceci  mène  au  clivage  de  Bid  et  à  la  voie 
mitochondriale de l'apoptose.  Tous ces  évènements sont diminués dans  les  cellules 
thermotolérantes, ce qui démontre une fois  de plus le rôle anti-apoptotique de cette 
réponse  adaptative.  L'induction  de  FasL,  l'activation  des  caspases  -8  et  -2  et 
l'apoptose sont inhibées par pifithrin-a, un inhibiteur de p53, ce qui suggère que p53 
agit en amont dans l'activation de la voie des death receptors par H20 2. 
Une exposition courte (15  min) des  cellules au  H20 2 donne lieu à l'activation de 
l'UPR, comme le confirment l'augmentation de l'expression de p-PERK, p-eiF2a, p-
IRE 1  a  et du  clivage de  ATF6. Une exposition plus  longue (1-3  h)  au  H20 2 induit 
l'apoptose  liée  au  RE,  durant  laquelle  l'expression  de  CHOP  ainsi  que  l'activité 
enzymatique  de  la  calpaïne  et  des  caspase-7,  -4,  -12  et  -3  augmentent.  Tous  ces 
évènements pro-apoptotiques sont diminués dans  les  cellules thermotolérantes.  Il  a 
été  montré  que  le  calcium,  la  calpaïne  et  la  caspase-7  agissent  en  amont  de 
l'activation de l'apoptose liée au RE par H20 2.  De plus, la réponse adaptative (UPR) 
prédomine  lors  d'expositions  courtes  au  H20 2  (stress  léger)  tandis  que  lors 
d'expositions plus longues (stress  sévère), c'est l'apoptose liée au  RE qui est la plus 
fréquente. 
En  conclusion,  cette  étude permet  d'ajouter  aux  connaissances  sur  l'effet  anti-
apoptotique et protecteur de la réponse adaptative induite par un  stress modéré, tel 
une  fièvre,  sur  le  stress  oxydatif.  Cette  étude  améliore  également  notre 
compréhension  de  l'activation de  la  cascade apoptotique par le pro-oxydant H20 2, 
cascade qui  a d'importantes répercussions sur la santé humaine si  l'on  considère le 
rôle  des  ROS  dans  les  pathologies  majeures  que  sont  le  cancer,  le  diabète,  les 
maladies cardiovasculaires ou encore les maladies neurodégénératives. 1 ---
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ABSTRACT 
Low  dose exposure to  stresses  such as heat shock, oxidative stress and radiation 
can induce adaptive responses, which allow cells and organisms to  continue normal 
function in the face of adverse stimuli. Adaptive responses involve multiple changes 
in gene and protein expression, including induction of cellular defences (  antioxidants, 
heat shock proteins (Hsps), etc.) to  enable the cell to  survive. If an adaptive response 
cannot  counteract  an  adverse  stress  exposure,  then  cells  are  eliminated  by  death 
processes such as  apoptosis or necrosis.  Pre-exposure to  mild temperatures such  as 
40°C induces an adaptive response (thermotolerance), whereby cells resist subsequent 
exposure to  a toxic insult. The phenomenon of thermotolerance induced at moderate 
temperatures  such  as  39-40°C,  within  the  physiological  fever  range,  has  received 
little attention and is not well understood. The two main objectives of this study are: 
(i) To evaluate whether induction of  defense systems by a mild nonlethal temperature 
(  40°C)  can  afford cellular protection against activation of the  apoptotic cascade by 
oxidative  stress,  and  (ii)  To  understand  the  detailed  molecular  mechanisms  of 
apoptosis  induced  by  oxidative  stress.  Apoptosis  is  evaluated  at  the  levels  of 
signalling pathways mediated by mitochondria, death-receptors and the endoplasmic 
reticulum (ER) in HeLa cells. 
The first  objective determines whether mild heat shock can induce other cellular 
defences besides Hsps. Indeed, mild thermotolerance (  40°C,  3h) induced an increase 
in  levels  of several  antioxidants  and  ER  stress  proteins.  The  protein  expression 
pattern  and  enzymatic  activity of manganese  superoxide  dismutase  (MnSOD)  and 
catalase were increased in  thermotolerant cells,  compared to  controls (37°C).  There 
were  also  increases  in  levels  of intracellular  glutathione  and  y-glutamylcysteine 
synthetase, the glutathione synthesis enzyme, in these cells. This could be explained 
by increased  generation  of reactive oxygen  species  (ROS)  in  thermotolerant cells. 
Furthermore,  expression  of the  ER  stress  proteins  PERK, p-PERK,  eiF2a and  p-
eiF2a was  increased in thermotolerant cells.  This  shows that mild thermotolerance 
enhanced the pro-survival effects of the PERK/eiF2a branch of the unfolded protein 
response (UPR). 
The second objective was  to  determine the mechanisms of apoptosis induced by 
oxidative  stress.  When  exposed  to  hydrogen  peroxide  (H20 2) ,  cells  underwent 
apoptosis through the mitochondrial, death receptor and ER pathways. Activation of 
the mitochondrial cascade of apoptosis entailed translocation of Bax to mitochondria, 
mitochondrial  membrane  depolarisation,  cytochrome  c  release,  activation  of 
caspases-9  and  -3,  and  nuclear  chromatin  condensation.  In addition,  H20 2  caused 
activation  of p53  and  induction  of its  target  protein  PUMA,  as  well  as  caspase-
independent apoptosis involving apoptosis-inducing factor (AIF).  These events were XXll 
aU  inhibited  in  thermotolerant  ceUs,  which  suggests  that  pre-exposure  to  mild 
physiological  temperatures  can  protect  ceUs  against  both  caspase-dependent  and 
caspase-independent mitochondrial apoptosis triggered by oxidative stress. 
Moreover, H20 2 activated the Fas death receptor pathway of apoptosis, which was 
evident  by  induction  of death  ligand  FasL,  recruitment  of adaptor  protein  Fas-
associated  death  domain  (FADD)  to  the  plasma  membrane,  and  activation  of 
caspases-8 and  -2. This led  to  activation of the cross-talk pathway mediated by Bid 
cleavage, and activation of the mitochondrial apoptotic pathway. AU  of these events 
were  diminished  in  mild  thermotolerant  ceUs,  once  again  demonstrating  the 
antiapoptotic role of this adaptive response. FasL induction, activation of caspases-8 
and -2 and apoptosis were inhibited by p53 inhibitor pifithrin-a, implicating p53 as an 
upstream factor in activation of  the death receptor pathway by H20 2. 
A short exposure (15 min) of ceUs to H20 2 led to activation of the UPR, revealed 
by increased expression of p-PERK, p-eiF2a, p-IRE 1  a, and A  TF 6 cleavage.  Longer 
exposure  (1-3  h)  to  H20 2  induced  ER-mediated  apoptosis, whereby  expression of 
CHOP increased, as weU as activity of calpain, caspase-7, -4, -12 and -3.  AU of  these 
pro-apoptotic events were diminished in thermotolerant cells. Calcium, calpain and 
caspase-7  were  shown  to  be  upstream  factors  in  the  activation  of ER-mediated 
apoptosis  by  H20 2.  Moreover,  the  adaptive  response  (UPR)  dominates  at  shorter 
exposure  times  to  H20 2  (milder  stress),  whereas  ER-mediated  apoptosis  occurs  at 
longer exposure times (more severe stress). 
In  conclusion, this study advances knowledge about the protective anti-apoptotic 
effect of the adaptive response induced by exposure to  mild  stresses, such as  fever 
temperatures,  against  oxidative  stress.  Furthermore,  this  study  improves 
understanding  about  activation  of the  apoptotic  cascade  by the  pro-oxidant  H20 2, 
which has important repercussions for human health, given the role of ROS in major 
physiopathologies  such  as  cancer,  diabetes,  cardiovascular  diseases  and 
neurodegenerative disorders. CHAPTERI 
INTRODUCTION 
1.1 OXIDATIVE STRESS 
Oxygen plays a major role in the life of aerobic organisms. lt is used as  a terminal 
electron acceptor during the production of ATP in the mitochondria by a process known 
as  oxidative  phosphorylation.  This  process  results  in  the  generation  of bath reactive 
oxygen  and  nitrogen  species  (ROS, RNS).  The majority  of ROS  are  products  of the 
mitochondrial respiratory chain. The three major types  of ROS  include the superoxide 
anion (Oz.-), hydrogen peroxide (HzOz) and  the hydroxyl radical (OH} In most cases, 
Oz.- is  the  first  ROS  species  generated  in  living  cells. The  one-electron reduction  of 
molecular oxygen produces a relatively stable intermediate, the superoxide anion (Figure 
1.1) (Orrenius et al, 2007). Apart from  the mitochondrial respiratory chain, other sources 
of Oz.- include enzymes such as  cytochrome P450 in the endoplasmic reticulum  (ER), 
lipooxygenases, cyclooxygenases, xanthine oxidase and NADPH oxidase. DNA 
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Figure 1.1  The  mitochondrial  formation  of ROS  and  RNS.  Figure  adapted  from 
Bellance et al, 2009 (see text for details). 
The superoxide anion  acts  as  a  major precursor for the  generation of various other 
reactive  pro-oxidants,  where  dismutation  of  superoxide  anion  by  the  mitochondrial 
manganese-superoxide dismutase (MnSOD) produces hydrogen peroxide. 
Under stress conditions, an excess of superoxide releases "free iron" from iron-
containing molecules (Liochev et al, 1994). The released iron (Fe
2+) can participate in the 
Fenton reaction. Generation of the hydroxyl radical by the Fenton reaction takes place in 
two steps: 
(1) Fe (III)  + 0 2 .- Fe (II)  + 0 2 3 
Thus, under stress conditions, 0 2. - acts as an oxidant of iron-sulfur [  4Fe-4S]  cluster-
containing enzymes and  facilitates OH. production from  H20 2 by making Fe
2
+ available 
for the Fenton reaction. 
The highly reactive OH. radical can also be generated by the metal catalysed Haber-
Weiss reaction: 
Fe Il/Fe III 
Reactive nitrogen species (RNS) include •NO and their related species such as peroxy 
nitrite anion (ONOO -). Ni tric oxide is a reactive and transient radical molecule that can 
diffuse across the cell membrane. It is generated from  guanido nitrogen of L-arginine by 
three distinct isoforms ofnitric oxide synthase (NOS) in the cells (Pacher et al, 2007). 
0 2.- undergoes a reaction with •NO to  produce ONOO- (Figure  1.1). Peroxynitrite is 
relatively long-lived, stable molecule,  which  has  an  ability to  reach  critical  targets  of 
cells, as it is membrane permeable (Glebska and Koppenol, 2003). •NO related species in 
mitochondria including  ONOO-, N02,  N20 3  and  S-nitrosothiols  (from  •NO  and  thiol 
reaction) cause slow, nonselective, weak, but irreversible or slowly reversible inhibition 
of many mitochondrial components including proteins, lipids and  mt-DNA. Moreover, 
the inhibition observed in most cells in response to •NO or expression of inducible nitric 
oxide synthase (iNOS  or NOS2) appears to  be largely competitive with 0 2  (Brown and 
Borutaite, 2007). 4 
1)  L-arginine ~ 
NOS  --:.•NO 
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ROS  species can  also  interact with diverse macromolecules  such  as  proteins, lipids 
and  DNA, resulting in their damage (Figure  1.2)  (Ott et al,  2007).  Out of various  free 
radical-induced biochemical processes, lipid peroxidation is the most extensively studied 
pathway. The methylene (  -CH2-) groups of  polyunsaturated fatty acids (PUF  A) are highly 
susceptible  to  oxidation.  The  oxidation  of membrane  phospholipids  in  the  plasma 
membrane, as well as within internai organelle membranes such as mitochondria, leads to 
biophysical changes that disrupt membrane and  organelle function  (Valko et al, 2006). 
Lipid pero xi dation in tum yields additional reactive species (  e.g., 4-hydroxynonenal (  4-
HNE),  malonaldehyde),  which  may  contribute  to  toxicity  and/or  cellular  signaling 
(Franco and Cidlowski, 2009). 5 
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Figure 1.2 Damaging effects of ROS on key cell components. ROS  cause damage to 
cell  constituents, which include DNA, proteins and  lipids.  Depending on  the levels  of 
ROS, the cell either stimulates or inhibits cellular proliferation resulting in the initiation 
of  cell death processes. Figure adapted from Ott et al. 2007. 
1.2 ANTIOXIDANTS 
1.2.1 Enzymatic antioxidants 
Cells possess various defense mechanisms to prevent the damage caused by ROS. The 
major  defense  mechanisms  include  the  enzymatic  antioxidants  superoxide  dismutase 
(SOD), catalase and glutathione peroxidase (Figure 1.3). (1)  Cytoplasmic Copper/Zinc (Cu/Zn)-SOD, mitochondrial MnSOD, and extracellular 
SOD, catalyze conversion of 0 2"-to H20 2. H20 2 is lipid soluble and it can diffuse 
through membranes and generate the hydroxyl radical (OH") at localized Fe
2+- or 
Cu+- containing sites. It is also the precursor ofhypochlorous acid (HOCl), a 
powerful oxidizing agent that is produced by phagocytic cells. Leukocytes and 
macrophages release myeloperoxidase that converts H20 2 to HOCl (Klebanoff, 
1999). 
(2)  Catalase, present in peroxisomes, can neutralize hydrogen peroxide to water and 
oxygen (2 H20 2 -7 H20  + 02). 
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(3)  Glutathione peroxidase (Gpx) can reduce cytoplasmic hydrogen peroxide to water 
with the help ofreduced glutathione (GSH), which gets oxidized to glutathione di-
sulfide (GSSG). The later can be reconverted to the reduced form by the enzyme 
glutathione reductase using a molecule ofNADPH produced by the pentose 
phosphate pathway. 7 
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Figure 1.3 Role of enzymatic antioxidants in ROS detoxification. Generation of ROS 
can be triggered by various environmental factors (e.g. UV, IR radiations, and toxins) and 
by normal  metabolic processes. ROS are kept in  check by antioxidant defenses,  which 
include  detoxifying  enzymes  such  as  catalase,  GSH  peroxidase  and  SOD.  If  these 
antioxidant  defence  mechanisms  are  too  weak,  ROS-mediated  damage  to  cellular 
macromolecules will eventually lead to cell  death. 
1.2.2 Non-enzymatic antioxidants 
Non-enzymatic  antioxidants  like  glutathione  (GSH),  carotenoids,  flavonoids,  une 
acid, bilirubin, a-tocopherol (vitamin E),  ascorbic acid (vitamin C) and  retinol (vitamin 
A)  can prevent the oxidation of various cel!  components (e.g.  unsaturated fatty acids) by 
free radicals such as superoxide and hydrogen peroxide by acting in one of the following 
ways:  1) they directly neutralise ROS, 2) they act as a chelators of transition metals such 
as iron and  copper (e.g.  urie  acid)  to  decrease ROS  production, or 3)  they oppose the 
toxic actions of lipid peroxides and limit the amount of cellular lipid peroxide formation, 
and  they  also  help  by maintaining  membrane  integrity  and  homeostasis  by  repairing 
oxidative damaged lipid components (Valdo et al, 2007). 8 
The balance between the generation of ROS  and the cellular antioxidants determines 
the level  of oxidative stress.  When the intracellular oxidative activities overwhelm  the 
reducing  equivalents,  it  shifts  cells into  a condition of oxidative stress,  leading to  the 
activation  of  several  stress  signaling  pathways  (mitogen-activated  protein  kinases 
(MAPKs)/Extracellular signal-regulated kinases (ERK) pathway, stress-activated protein 
kinase (SAPK) pathways) and transcription factors  (eg:  NFKB, HSF-1, p53) that govem 
specifie gene expression patterns (reviewed by Martindale and  Holbrook, 2002;  Finkel 
and  Holbrook,  2000).  Although  the  molecular  mechanisms  by  which  ROS  initially 
activate these pathways are not yet clear, once activation occurs, these pathways lead to 
various  cellular  consequences,  including  proliferation,  growth  arrest,  senescence  and 
apoptosis. 
1.3 OVERVIEW OF APOPTOSIS AND CELL DEA  TH 
The term apoptosis was first introduced by Kerr and  colleagues in  1972  (Kerr et al., 
1972).  It was  named  after  an  ancient  Greek  word,  referring  to  the  process  of leaves 
falling from trees. Apoptosis is a genetically-controlled process of cell death, essential for 
the  development  and  life  of multicellular organisms  (Prindull,  1995). It is  an  active, 
complex  process  with  a  characteristic  set  of morphological  and  biochemical  features 
whereby cells undergo a cascade of self-destruction. Multicellular organisms often need 
to  discard  cells  that  are  superfluous  and  potentially  harmful,  having  accumulated 
mutations  or become  infected  by pathogens.  Thus,  proper  regulation  of apoptosis  is 
essential  for  maintaining  normal  cellular  homeostasis.  However,  the  deregulation  of 
apoptosis  is  an  underlying  factor  in  many  pathological  conditions  where  excessive 
apoptosis  of neurons  due  to  toxic  protein  aggregates  and  oxidative  stress  has  been 
implicated  in  Parkinson's  and  Alzheimer's  diseases,  and  failure  to  execute  apoptosis 
contributes to chronic inflammation, atherosclerosis and cancer (Thompson, 1995). Thus, 
it is highly important to  understand the molecular mechanisms behind the regulation of 
apoptosis and determine which proteins are involved in this process. 
-- ·---·------------------------------------------------------------------------9 
The  current classification of different types  of cell  death was reviewed recently by 
(Kroemer  and  Galluzzi  2009;  Galluzzi  et  al,  2007).  There  are  many  observable 
morphological  differences  between  the  cell  death  phenotypes  for  apoptosis,  necrosis, 
autophagy  and  mitotic  catastrophe  (Figure  1.4;  Table  1.1 ).  The  mechanism  (i.e. 
apoptosis, necrosis or autophagie cell death) by which a cell dies depends on  different 
exogenous factors, the severity and duration of stress, the cell type, as well as the ability 
of the  cell  to  handle  the  stress  exposure.  The  important  objective of this  study is  to 
understand the molecular mechanisms of apoptotic cell death induced by oxidative stress; 
hence it has been elaborated in detail. 
Cell death mode 
Apoptosis (Type  1) 
Autophagy (Type 2) 
Necrosis (oncosis)  (Type 3) 
\~itotic catastrophe 
Characteristic morphological aspects 
•  Rounding up of the cell 
•  Reduction of cellular and nuclear volume (pyknosis) 
e  Retraction of pseudopodes 
•  Nuclear fragmentation  {karyorrhexis) 
•  Little  modification of cytoplasmic organelles 
•  Plasma membrane blebbing 
•  Lack of chromatin condensation 
•  Massive vacuolization of the cytoplasm 
(double-membraned autophagie vacuoles) 
•  Cytoplasmic swelling 
•  Rupture o1  plasma membrane 
•  Swelling of  c~~top l asm i c organelles 
•  1/loderate chromatin condensation 
•  Micronucleation 
•  Multinucleation 
Table 1.1  Characteristic morphological features of distinct modalities of cell  death. 
Table adapted from Galluzzi et al, 2007. 10 
Figure  1.4  Different  modes  of cell  death.  Characteristic  morphological  features  of 
distinct  modes  of cell  death,  seen  by transmission  electron  microscopy.  (a)  H1975 
(human non-small celllung cancer) cell undergoing apoptotic cell death is represented by 
reduction of cellular and nuclear volume (pyknosis). (b) HeLa (human epithelial cancer) 
cell  undergoing autophagie  cell  death is  observed by the massive vacuolization of the 
cytoplasm  and  accumulation  of double-membraned  autophagie  vacuoles  (indicated  by 
arrows).  (c)  HCT116  (human colon carcinoma)  cell  responding to  a necrotic stimulus. 
The  nucleus  (N)  remains  intact  and  bas  clearly  defined  nucleoli,  while  the  plasma 
membrane  and  cytoplasm  are  extensively  damaged.  (d)  HCT116  cell  exhibiting 
hallmarks of mitotic catastrophe, including aberrant multipolar mitotic figures (AM) and 
multinucleation (M). Figure adapted from Galluzzi et al. 2007. 11 
Apoptosis can be triggered by a variety of exogenous factors  (Wyllie,  201 0).  These 
include death signais, which can be physiological messenger molecules (  e.g.  cytokines, 
hormones),  and  stress  induced  by  DNA  damaging  agents  (e.g.  UV  and  gamma 
irradiations), serum  deprivation,  ROS, reactive  nitrogen  species  (RNS),  hypoxia, heat 
shock, viral infection, as weil as chemical (e.g. pesticides, environmental pollutants) and 
pharmacological  agents  (  e.g.  chemotherapeutic  drugs  ).  Furthermore,  many  apoptotic 
stimuli  can  themselves  increase  generation  of ROS  and  RNS,  leading  to  oxidative 
damage  of cellular  constituents  and  eventually  cell  death  by apoptosis.  A  family  of 
enzymes known as caspases plays a major role in the induction of  apoptotic cell death. 
1.3.1 Caspases 
The  family  of cysteine proteases known  as  "Caspases"  (ç_ ysteinyl  ~spartate-~pecific 
nroteases), play  an  important role  in  apoptosis  and  inflammation  (Pop  and  Salvesen, 
2009).  "C" in  the term  caspase  stands for  cysteine protease and  "aspase" reflects their 
ability to  cleave  substrates  at  aspartic  acid  (Asp)  residues  (Lavrik  et  al,  2005)  in  the 
context of tetrapeptide motifs.  They are synthesized as  catalytically inactive zymogens. 
These proteases typically lie dormant in the healthy cell  and, in  response to  cell-death 
stimuli,  are  converted,  either  by  proteolytic  cleavage  or  by  recruitment  into  large 
complexes, into  active  enzymes.  The  constitutively  expressed  procaspases  consists  of 
three domains:  an  NH2-terminal pro-domain, a large  (~20 kDa)  and  a small  (~10 kDa) 
domain. The large 20  kDa domain  contains the active site cysteine within a conserved 
QACXG motif. The activation of caspases requires the cleavage of specifie aspartic acid 
residues, which separates the N-terminal prodomain, the plO domain and the p20 domain. 
When processed, the two subunits (pl 0 and p20) will associate and form  a heterodimer. 
The active form of caspase is a heterotetrameric enzyme consisting of two large and two 
small  subunits  (Figure  1.5)  with two  active  catalytic  sites per molecule (Kohler et  al, 
2002). plO 
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Nature Reviews 1 Microbiology 
12 
Figure  1.5  Caspase  activation  by  proteolysis.  Caspases  are  synthesized  as  inactive 
zymogens/procaspases  that  are  activated  by  proteolysis.  Caspase  activation  requires 
proteolytic processing (two cleavages) at specifie aspartic acid  (Asp)  residues. The first 
divides the proenzyme into large and small caspase subunits, and the second removes the 
N-terminal prodomain. The resulting functional caspase is  a tetramer of two large (p20) 
and two small (plO) subunits. Figure adapted from Clarke et al, 2009. 
Fourteen caspases have been identified so far, based on their homology in  amjno acid 
sequences  and  substrate  specificity;  these  caspases  can  be  classified  into  apoptotic 
(caspases-2, -3, -6, -7, -8, -9, -10) and pro-inflammatory (caspases-1, -4, -5,-11,-12,-13 
and  -14)  groups.  Apoptotic  caspases  can  be  subdivided  further  into  initiator  (apical, 
apoptosis  activator)  (caspases-8,  -9  and  -10)  and  effector  (executioner,  downstream) 
groups (caspases-3, -6 and -7) (Table 1.2). S  :~.bfam il!v 
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Table 1.2 Subfamilymembers ofthe caspase family. Table adapted from Fan et al, 2005. 
The  most  significant  structural  difference  regarding  caspases  involves  the  varying 
length of  the N-terminal prodomain. The initiator caspases such as caspase-8 and -9 have 
longer prodomains that allow  them to  interact with death  effector domains  (DEDs)  or 
caspase recruitment domains (CARDs) in adaptor proteins such as  Fas-associated death 
domain  (FADD)  protein  and  apoptotic protease-activating factor  -1  (Apaf-1).  Effector 
caspases  (such as  caspase-3)  contain short pro-domains and they function primarily to 
cause the morphological  features  of apoptosis  (Kohler et al, 2002).  In  response to  an 
apoptotic stimulus, initiator caspases are the first  to  be activated.  These active initiator 
caspases  in  tum  process  and  activate  effector  procaspases.  Once  activated,  they 
subsequent1y cleave many intracellular substrates, including structural proteins such  as 14 
lamin  A,  actin,  gelsolin  and  fodrin,  the  DNA  repmr  enzyme  poly  (ADP-ribose) 
polymerase (P ARP), cell cycle regulators such as p21, Rb and mdm2, and the inhibitor of 
caspase-activated  DNase  (ICAD)  (Figure  1.6)  (Fan  et  al,  2005).  Caspase-activated 
deoxyribonuclease (CAD) is one of  the key substrates for activated caspase-3. It normally 
exits as  an  inactive enzyme bound to  its inhibitor ICAD  (inhibitor of caspase-activated 
DNase). Active caspase-3  cleaves ICAD, thereby releasing CAD, which cleaves cellular 
DNA, resulting in DNA fragmentation. Another important target for activated caspase-3 
is  the nuclear protein P  ARP  (molecular mass  116  kDa).  P  ARP pla  ys  a key role in the 
maintenance of chromatin  structure as  well  as  DNA  repair.  Active  caspase-3  cleaves 
P  ARP  to  an  85  kDa fragment, which hinders  its  DNA-repairing  activity  (Wang  et  al, 
2005).  Cleavage  of ICAD,  nuclear  and  cytoskeletal  proteins  leads  to  characteristic 
morphological  hallmarks  of apoptosis  such  as  chromatin  condensation,  nucleosomal 
DNA  fragmentation,  nuclear  membrane  breakdown,  extemalization  of 
phosphatidylserine, and the formation of apoptotic bodies (Hengartner 2000). Apoptotic 
bodies are removed by phagocytic or neighbouring cells  without releasing intracellular 
contents  into  surrounding  tissue,  thus  avoiding  induction  of inflammatory  responses. 
Addition  to  their  function  in  cell  death  recent  publications  also  provide  increasing 
evidence  that  apoptotic  caspases  also  participate  in  several  non-apoptotic  cellular 
processes  such  as  cell  proliferation,  differentiation, shaping  and  migration  (Kuranaga, 
2011; Kuranaga and Miura, 2007). 
The  other  important  family  of cysteine  proteases  that  is  calpains  also  plays  an 
important role in initiation, regulation and execution of cell death (Harwood et al, 2005), 
but their role is not as well characterized as that for the caspases. Calpains are also known 
to  cleave many important regulators of apoptosis and to  crosstalk with caspase cascades. 
All the ab  ove mentioned intracellular pro  teins, su ch as lamins, actins, fodrin, and P  ARP, 
also act as substrates for active calpains and thus play an important ro1e in the execution 
of apoptosis (reviewed by Lopatniuk and Witkowski, 2011 ). 
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Figure  1.6  Downstream  substrates  that are  targeted  by  active  effector  caspases, 
resulting  in  the  execution  of characteristic  morphological  features  of apoptosis. 
Figure adapted from Fan et al, 2005. 
1.3.2 Signaling pathways of Apoptosis 
Cells undergo apoptosis mediated by three major signaling pathways, involving death 
receptors  (  extrinsic pathway), mitochondria (intrinsic pathway),  and more recently, the 
endoplasmic reticulum (ER) (intrinsic) (Strasser et al, 2009; Fulda et al,  201 0;  Du  prez et 
al, 2009). 16 
1.3.2.1 Mitochondrial (intrinsic) pathway 
Mitochondria  are  important  intracellular  organelles  for  the  production  of A  TP  by 
oxidative  phosphorylation,  which  supplies  energy  for  various  cellular  functions.  In 
addition  to  supplying  energy,  mitochondria  play  a  critical  role  in  the  initiation  and 
regulation  of apoptosis.  A  variety  of stress-inducing  agents  such  as  aldehydes  (e.g. 
acrolein), chemotherapeutic agents, UV and gamma irradiations, heat shock and growth 
factor withdrawal can trigger apoptosis through the mitochondrial pathway  (Jin et al., 
2005; Tanel and Averill-Bates, 2005; Bettaieb and Averill-Bates, 2005). 
A cri ti cal cellular target of ROS is mitochondrial DNA (mtDNA), which could lead to 
lethal cell injury by disrupting electron transport, mitochondrial membrane potential and 
ATP generation (Ott et al, 2007). Therefore, ROS  can cause mitochondrial dysfunction, 
leading to  activation of the mitochondrial pathway of apoptosis (Orrenius  et  al, 2007). 
Induction of the mitochondrial  permeability transition  (MPT)  and  mitochondrial  outer 
membrane permeabilization are  important features  of apoptosis.  A consequence of the 
MPT is swelling of the matrix and  rupture of the outer mitochondrial membrane. These 
changes  lead  to  the  release  of  cytochrome  c  (Cyt  c),  and  other  pro-apoptotic 
mitochondrial  proteins  such  as  DIABLO/SMAC,  Omi/Htr2,  apoptosis  inducing  factor 
(AIF)  and  endonuclease G (Endo G)  into the cytoplasm, resulting in  cell death by both 
caspase-dependent and caspase-independent mechanisms (Figure 1.  7). 17 
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Figure  1.7  Caspase-dependent and  -independent pathways  of apoptotic  cell  death. 
Various apoptotic stimuli (e.g., ROS) cause permeabilization of the mitochondrial  outer 
membrane and the release of proapoptotic proteins. In the cytosol, cytochrome c,  Apaf-1 
and dATP form the apoptosome complex, to which initiator procaspase-9 is recruited and 
activated. Caspase-9-catalyzed activation of effector caspase-3 executes the final steps of 
apoptosis. Caspase activation is  further enhanced by neutralization of caspase inhibitors 
by  apoptogenic  proteins  such  as  Srnac/Diablo  and  Orni/HtrA2  that  are  released  from 
mitochondria.  In  addition,  rnitochondrial  proteins  such  as  AIF  and  Endo  G  prornote 
caspase-independent apoptosis through nuclear translocation and by mediating genornic 
DNA fragmentation. Figure adapted from Jin et al., 2002 (modified). 1 
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The  haemoprotein  cytochrome  c  plays  an  important  role  in  caspase-dependent 
apoptosis.  Under  normal  conditions,  cytochrome  c  is  a  component of the  respiratory 
chain and is attached to  the outer surface of the inner mitochondrial membrane (IMM), 
mainly in association with the anionic phospholipid cardiolipin (CL)  (Ott et al., 2007). 
The oxidation of cardiolipin by ROS decreases cytochrome c binding and increases the 
level of soluble cytochrome c in the intermembrane space (Orrenius et al., 2007) (Figure 
1.8).  Once  released,  cytochrome  c  binds  to  Apaf-1  and  procaspase-9,  generating  an 
intracellular  disc-like  complex  known  as  the  "apoptosome".  This  leads  to  the  auto-
activation of caspase-9, which can subsequently activate the executioner caspases such as 
caspase-3, -6 and -7, resulting in the ultimate demise ofthe cell. 19 
Figure 1.8 Effects of ROS on cardiolipin oxidation and cytochrome c release into the 
cytosol. Normally cytochrome c (Cyt c)  is bound to  the mitochondrial inner membrane 
by an interaction with the anionic phospholipid cardiolipin (CL). Oxidation of cardiolipin 
by  mitochondrial  ROS  (H20 2)  decreases  its  binding affinity  for  cytochrome c,  which 
results  in  cytochrome c  detachment.  Oxidized  cardiolipin,  together  with  pro-apoptotic 
proteins  (e.g.  Bid  and  Bax),  forms  a  megapore  channel  within  the  mitochondrial 
outermembrane, which enables cytochrome c release from mitochondria into the cytosol. 
In the cytosol, cytochrome c interacts with Apaf-1, procaspase-9 and dA  TP, forming the 
apoptosome complex, resulting in  caspase-9 activation.  Figure adapted from Circu  and 
Aw 2010. 20 
The pro-apoptotic proteins second mitochondrial activator of caspases (SMAC)/ direct 
inhibitor  of apoptosis-binding  protein  with  low  pl  (DIABLO),  and  high-temperature 
requirement  A2  serine  protease  (HtrA2/0mi),  which  are  released  from  mitochondria 
during  apoptosis,  facilitate  caspase  activation by binding to  and  neutralizing the  anti-
apoptotic  activity of inhibitors of apoptosis  proteins  (lAPs), which  are potent  caspase 
inhibitors (Figure 1. 7). 
Once  released  from  mitochondria,  AIF  and  Endo  G  are  involved  in  caspase-
independent apoptosis (Figure 1.7). These proteins can bind directly to  DNA, which can 
stimulate their DNAse activity, leading to  chromatin condensation and  large-scale DNA 
fragmentation.  AIF  appears  to  play a  role  in  mediating  cell  death  in  severa}  human 
disease  states,  including  ischemia-reperfusion  injury,  neurodegenerative  disorders  and 
certain types of  cancers (Norberg et al, 201 0). 
1.3.2.2 Death receptor (extrinsic) pathway 
The  extrinsic  pathway  involves  the  binding  of extemal  ligands  to  death  receptors 
located  at  the plasma membrane.  These death  receptors  belong to  the  tumor necrosis 
factor  receptor  (TNF-R)  super  family  and  generally  have  several  cellular  functions 
including inflammation and apoptosis (Baud  and  Karin, 2001).  The death receptors that 
are involved in apoptosis possess an intracellular death domain (DD). They include TNF 
receptor 1 (TNFR1  (also known as death receptor 1 (DR1)), Fas receptor (DR2, CD95 or 
AP0-1), DR3  (AP0-3 or TRAMP), TNF-Related Apoptosis-Inducing Ligand  (TRAIL) 
receptor 1 (TRAIL-R1; also called DR4), TRAIL receptor 2 (TRAIL-R2; also called DR5 
or KILLER) and DR6 (Russo et al, 2010). 
The Fas ligand (FasL)/Fas system is the most widely studied system in death-receptor-
mediated apoptosis. Fas-mediated apoptosis is  activated by the binding of  FasL to  its 
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specifie  receptor  Fas.  This  interaction  results  in  clustering  and  trimerization  of the 
receptor, which is required for formation of the DISC at the plasma membrane. The DD 
ofthe receptor interacts with the DD ofFADD, while the DED ofFADD interacts with 
the DED domains of procaspase-8 or procaspase-1 O.  The association of procaspase-8 or 
procaspase-10 at the DISC leads to their auto-activation (Elrod et al, 2008). A significant 
level of  caspase-8 activation directly activates effector caspases such as caspase-3, -6 and 
-7,  whereas  low  caspase-8  activation  mediates  caspase-3  activation  through  an 
amplification loop  involving  mitochondria (Figure  1.9).  Thus,  the  death  receptor  and 
mitochondrial  pathways  can  be  linked  through  caspase-8-mediated  cleavage  of pro-
apoptotic  Bcl-2  family  protein Bid.  The  cleaved  fragment,  t-Bid,  then  translocates  to 
mitochondria ap.d  induces  outer mitochondrial  membrane  permeabilization  through  its 
interaction with Bcl-2 family proteins such as Bax and Bak. This interaction results in the 
release of cytochrome c into the cytosol, which is a key step required for the induction of 
mitochondrial-mediated apoptosis (Y  oule and Strasser, 2008) (Figure 1.9). 
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Figure 1.9  Fas- mediated death receptor pathway of apoptosis. Figure adapted from 
Zhaoyu et al 2005 (see text for details). 23 
Fas  can  also  mediate  apoptosis  via  death  domain  associated  protein  (Daxx  (also 
known  as  Death-associated protein  6)), with subsequent activation of apoptosis  signal-
regulating kinase  1 (ASK-1)  and  c-Jun  N-terminal  kinase  (JNK)  (Dorion  et  al, 2002; 
Salomoni and Khelifi, 2006; Fujisawa et al, 2007). During apoptosis, Daxx translocates 
from the nucleus to  the plasma membrane and specifically binds to  the death domain of 
Fas.  Although  Daxx  does  not  contain  a death  domain, it plays  a  central  role  in  Fas-
mediated apoptosis through activation of ASK-1.  ASK-1 is an upstream regulator of the 
JNK and  p38  mitogen-activated protein kinases  (MAPKs)  during  exposure to  stressful 
stimuli such as hyperosmotic shock, oxidative stress, cold shock, UV irradiation, TNF-a 
and interleukin-1  (Fusijawa et al, 2007). JNK activation was shown to promote apoptosis 
by reducing the anti-apoptotic activity of Bcl-2 by causing its phosphorylation (Liu and 
Lin, 2005). 
The induction of apoptosis by TRAIL is similar to that of Fas (Russo et  al, 201 0; Jin 
and  El-Deiry,  2005). The binding of TRAIL-R1  and -R2 to  their respective receptors, 
DR4 and DR5, triggers formation ofthe DISC by recruiting FADD and procaspase-8, or-
10,  followed  by  activation  of  caspase-3.  TRAIL-induced  apoptosis  also  involves 
amplification through the mitochondrial pathway, similar to Fas-induced apoptosis. 
Unlike  Fas  and  TRAIL  signaling, the  cytokine  TNF-a  does  not  induce  cell  death 
spontaneously. TNF-R1-mediated intracellular signaling is more complex than that of Fas 
or TRAIL-R1  and - R2 since it can activate both apoptotic and survival signais (Russo et 
al, 201 0). Upon activation by TNF-a, trimerization ofTNF-R1 is followed by recruitment 
of the  adaptor  protein  TNFR-associated  protein  with  death  domain  (TRADD).  This 
results in the formation  of two  complexes that activate distinct downstream survival  or 
apoptotic  signaling  pathways.  TRADD  recruits  signaling  proteins  like  F  ADD,  TNF-
associated factor-2 (TRAF-2), and  receptor-interacting protein (RIP).  In complex  I, the 
interaction  of TNF-R1  with  TRADD,  RIP  and  TRAF-2  leads  to  the  activation  of 24 
transcription  factors  such  as  nuclear  factor  kappa  B  (NF-KB)  and  JNK,  which  can 
promote cell survival and the activation of immune and inflammatory responses (Deng et 
al, 2003; Beyaert Ret al, 2002). Activation ofNF-KB by TNF-a up-regulates several anti-
apoptotic  factors,  including  c-FLIP,  Bel-XL,  MnSOD,  X-linked  inhibitor of apoptosis 
protein (XIAP), and c-lAP 1 and 2. 
Complex II is comprised ofTNF-Rl, TRADD, FADD and procaspase-8 and promotes 
apoptosis through the direct activation of effector caspases such as caspase-3 (Russo et al, 
2010)  (Figure  1.10). The  cellular balance between FLIPL and  RIPl  appears  to  be an 
important  factor  in  determining  whether  TNF-Rl  activation  results  in  apoptosis  or 
survival  signalling.  High  concentrations  of FLIPL  inhibit  procaspase-8  binding  at 
complex II  and prevent DISC formation, whereas caspase-8 mediated cleavage of RIPl 
dissembles complex I and promotes the formation of complex II that mediates apoptosis 
(Circu and Aw, 2010). '·  ROS 
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Figure 1.10 Apoptosis-mediated by the death receptors. Stimulation of death receptors 
such as  Fas/FasL, TNF-Rl/TNFa, and TRAlL-Rl/TRAIL results in  receptor aggregation 
and  recruitment  of adaptor  molecules  FADD/TRADD  and  caspase-8.  Once  recruited, 
caspase-8  becomes  activated  and  initiates  apoptosis by direct cleavage  of downstream 
effector caspases.  The mitochondrial pathway is  initiated  by stress  signais through  the 
release  of  apoptogenic  factors  such  as  cytochrome  c,  AIF,  or  Smac/DIABLO. 
Cytochrome c release into the cytosol triggers caspase-3 activation through formation of 
the apoptosome complex. Smac/DlABLO promotes caspase activation by neutralizing the 
inhibitory effects of lAPs,  whereas AIF causes DNA condensation. The receptor and the 
mitochondrial  pathways  can  be  interconnected,  for  example,  by  Bid,  which  causes 
cytochrome c release upon cleavage by caspase-8.  Activation  of caspases is negatively 
regulated  at  the  receptor  level  by  FLIP,  which  blocks  caspase-8  activation,  at  the 
mitochondria by Bcl-2 family proteins,  and  by lAPs. Activation of the NF-KB  survival 
pathway enhances transcription of antiapoptotic proteins such as  FLIPL or MnSOD and 
apoptosis blockade. At high ROS levels, failure to activate NF-KB  promotes ASKl/JNK 
activation that triggers apoptosis. Figure adapted from Circu and Aw, 201 O. 26 
Despite  the  early  discovery  of caspase-2,  its  physiological  role  remams  unclear 
(Krumschnabel et al, 2009). Caspase-2 appears to  have multiple roles in processes such 
as  apoptosis,  DNA  repair  and  tumor  suppression.  Caspase-2  activation  has  been 
demonstrated  in  apoptosis  induced  by  different  systems  such  as  anti-Fas,  cytokine 
deprivation, B-amyloid, etoposide  and  other stress  stimuli  (Zhivotovsky  and  Orrenius, 
2005).  Several  studies  have  reported  p53-mediated  activation  of caspase-2  by  the 
PIDDosome,  in response to  DNA damage (Maiuri  et  al,  2007;  Tinel  et  al,  2007).  The 
PIDDosome is  a temary complex that is  composed of p53-induced  protein  with  death 
domain  (PIDD),  RIP-associated  Ich-1/Ced-3-homologue  protein  with  a  death  domain 
(RAIDD) and procaspase-2. However, it was also shown that recruitment of caspase-8 to 
the  DISC  can  lead  to  caspase-2  activation  in  the  absence  of PIDDosome  formation 
(Lavrik et  al, 2006;  Manzl  et  al, 2009; Olsson et al, 2009).  Thus,  there exist different 
routes by which caspase-2 can be activated.  Once activated, caspase-2 can trigger Bid-
mediated activation of  the mitochondrial pathway of  apoptosis (Lavrik et al, 2006). 
1.3.2.3 Endoplasmic reticulum (ER) stress (intrinsic) pathway 
The  ER  is  an  organelle  that  is  involved  in  lipid  synthesis,  protein  folding  and 
maturation (Breckenridge et al, 2003). Membrane and secretory proteins undergo folding 
and  modification into  their mature conformation in  the ER and  then are transported to 
lysosomes, Golgi and the cell membrane. Protein chaperones such as Bip/glucose-related 
protein  78  (GRP78),  GRP94,  GRP170,  calnexin,  calreticulin  and  the  oxidoreductase 
protein  disulphide isomerase  (PDI)  are present in  the  ER  to  assure  correct folding  of 
newly synthesized proteins (Figure 1.11 ). Uf"R ~nsd ..:en: 
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Figure  1.11  Fonctions  of ER.  Nascent  proteins  are  translocated  into  the  ER  lumen, 
through  protein  channels  in  the  ER  membrane  called  translocons.  Proper  folding  of 
nascent  proteins  is  facilitated  by ER chaperones  including  Bip,  calnexin  and  protein 
disulphide  isomerise  (PDI).  These  chaperones  facilitate  proper  folding  of the  nascent 
protein  by preventing  aggregation,  and  by  maintaining  polypeptides  in  appropriate 
conformations for folding and subunit assembly. During stress conditions, changes in the 
ER  environment  shift  the  balance  from  normal  to  improper  folding,  leading  to 
accumulation of unfolded proteins in the ER lumen. This results in activation of the ER 
stress response pathway.  Figure adapted from Faitova et al, 2006 (modified). 28 
1.3.2.3.1  ER Stress 
A  variety  of  conditions  including  glucose  deprivation,  inhibition  of  protein 
glycolysation, disturbance of calcium homeostasis, hypoxia and excess ROS can perturb 
ER function  leading  to  accumulation  of unfolded  proteins  in  the  ER  (Schroder  and 
Kaufman, 2005; Fulda et al,  201 0).  This phenomenon is known as  ER stress. ER stress 
activates several signaling pathways, including the unfolded protein response (UPR) and 
ER-associated protein degradation  (ERAD).  The UPR is  generally a  survival response 
that aims to recover normal cellular function in the face of adverse conditions. However, 
if protein damage is too severe, ER stress pla  ys  an important role in elimination of the 
damaged  cell by apoptosis  and/or autophagy (Schleicher  et  al,  2010;  Verfaillie et  al, 
2010). 
The ER stress response involves 3 distinct mechanisms: (i) translational attenuation to 
decrease the synthesis  of new proteins;  (ii)  transcriptional  activation of genes  for  ER 
chaperones (  eg: Bip, GRP94), ERAD molecules and antioxidants; and (iii) ERAD, which 
involves translocation of misfolded or aggregated ER proteins to  the cytoplasm, where 
they are tagged by ubiquitin for proteosomal degradation (Shroder and Kaufman, 2005; 
Verfaillie et al, 2010). 
The activation of the UPR is mediated by three distinct ER stress sensors:  Inositol-
requiring protein-1(IRE1),  activating  transcription  factor-6  (ATF6)  and  protein kinase 
RNA (PKR)-like ER kinase (PERK)  (Figure 1.12).  In  non-stressed cells, these sensors 
are retained in the ER lumen by interactions with Bip/GRP78  (Shroder and Kaufman, 
2005). During ER stress, Bip releases these 3 sensors, leading to their activation, and then 
binds  to  unfolded  proteins.  PERK  and  IRE1  undergo  homo-oligomerization  and 
autophosphorylation during activation (Figure 1.12). 29 
Figure  1.12  Signaling  the  ER  stress  response  (UPR)  pathway.  Accumulation  of 
unfolded proteins in  the  ER leads to  activation of three ER stress  sensors PERK, IREl 
and A  TF6.  Activation of these sensors is triggered by dissociation of Bip from their ER 
luminal domains.  Once activated,  PERK phosphorylates the translation initiation factor 
eiF2a to  prevent further accumulation of unfolded proteins.  Phosphorylation of NF-E2-
related  factor  2  (Nrf2)  by  PERK,  promotes  its  dissociation  from  Kelch-like  Ech-
asspciated protein 1 (Keap1), leading to nuclear accumulation of Nrf2. Nrf2 binds to the 
antioxidant  response  element  (ARE)  to  activate  transcription  of  genes  encoding 
detoxifying enzymes (antioxidants). Activated IRE1  splices the mRNA for XBP-1, which 
allows the translation of mature XBP-1 protein, a transcription factor, responsible for the 
upregulation  of genes  involved in  ERAD,  ER  quality  control  and  redox  homeostasis. 
ATF6 is  activated by a two-step cleavage by site-1  and site-2 proteases (S 1P  and S2P). 
The cleaved  fragment  (p50)  forms  an  active  transcription  factor  that  mainly  mediates 
expression of severa!  components for ERAD and ER homeostasis. When functions of the 
ER  are  severely  impaired,  apoptosis  is  induced  by  the  transcriptional  induction  of 
CCAAT/-enhancer-binding  protein  homologous  protein  (CHOP),  which  can  be  up-
regulated by XBPl, ATF6 and PERK, and can mediate transcription of the pro-apoptotic 
BH3-only protein Bim.  Figure adapted from Verfaillie et al, 2010. 
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Activated PERK then phosphorylates the eukaryotic initiation factor 2 (eiF2a), which 
inhibits  general  protein  translation,  thus  preventing  the  accumulation  of  newly 
synthesized proteins in the ER under conditions where protein folding is  compromised. 
The PERK-eiF2a pathway causes translation of ATF4, which activates transcription  of 
chaperones such as Bip and GRP94. IRE1  catalyzes the alternative splicing of the X-Box 
binding protein (XBP-1) mRNA, leading to  expression of the active XBP1  transcription 
factor that stimulates transcription of ER chaperone genes (Calfon et al, 2002). The up-
regulation  of ER  chaperone  genes  is  also  mediated by the  A  TF6  pathway. ER  stress 
causes  translocation  of ATF6  from  the  ER  to  Golgi,  where  it  is  processed  by 2-step 
cleavage, by Site-1  protease  (S1P)  and  Site-2  protease  (S2P).  The cleaved  active  N-
terminal fragment of  A  TF6 (p50) is th en transported to the nucleus, where it functions as 
a transcriptional activator for ER stress-related genes (Breckenridge et al, 2003). If UPR 
activation  is  not able to  rescue cells  from  ER  stress  and  correct the defects  in  protein 
folding, then  cells generally undergo  ER stress-induced cell  death  (Breckenridge et  al, 
2003; Fulda et al, 201 0; Malhotra and Kaufrnan, 2007a; Rasheva and Domingos, 2009). 
1.3.2.3.2  ER Stress-mediated apoptosis 
Cells  undergo  ER-mediated  apoptosis by several  different pathways, which  can  be 
mitochondria-independent or -dependent: 
(1)  The caspase-12/caspase-4 pathway; (2) IRE 1-mediated activation of apoptosis signal-
regulating kinase  1 (ASK1)/JNK; (3)  Bax/Bak-regulated calcium  release  from  the ER 
(Figure  1.13);  (4)  PERK/ATF6/IRE1-dependent  transcriptional  induction  of the  pro-
apoptotic transcription factor CHOP; and (5) Cleavage oftransmembrane ER protein Bcl-
2-associated protein-31 (BAP31) by active caspase-8. JtlK 
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Figure 1.13 Mechanism of the ER mediated a  po  ptosis. Figure adapted from 
Breckenridge et al, 2003. 
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(1) Caspase-12 (mice)  and -4 (human) have been proposed as  caspases that initiate 
ER stress-induced apoptosis (Fulda et al, 201 0; Malhotra and Kaufman, 2007a). 
Procaspase-12 is localized at the cytosolic side of the ER membrane and can be 
activated  through  severa}  mechanisms,  including  cleavage  by  the  calcium-
dependent  cysteine protease m-calpain  (Boyce  and Yuan,  2006)  (Figure  1.13). 
Therefore,  calcium released from the ER can trigger apoptosis through calcium-
mediated  calpain  activation  and  crosstalk  between  the  calpain  and  caspase 
families. Caspase-12 can also be cleaved by caspase-7, which is recruited to  the 
ER during ER stress (Boyce and Yuan, 2006). Caspase-7 forms a complex with 
caspase-12  and  Bip,  resulting  in  caspase-7-mediated  cleavage  of caspase-12. 32 
Furthermore,  caspase-12  appears  to  form  a  complex  with  IRE 1  and  TRAF2, 
which provides a scaffold for caspase-12 processing during ER stress (Y oneda et 
al, 2001) (Figure 1.13). Once activated, caspase-12 can activate caspase-9, which 
in tum activates  caspase-3,  in  a manner that is  independent of the cytochrome 
c/Apaf-1  pathway (Szegezdi et al, 2003). However, the role of caspase-12 in ER 
stress-induced  apoptosis  is  controversial,  since  most  of the  human  population 
does not possess the complete functional gene product of caspase 12  (Boyce and 
Yuan, 2006).  Instead, caspase-4 has been suggested to be the human counterpart 
ofmurine caspase-12. 
(2)  ER stress-induced apoptosis can be mediated by interaction between IRE1  and the 
adaptor  protein  TRAF2  (Malhotra  and  Kaufmann,  2007a;  Boyce  and  Yuan, 
2006).  IREl  and  TRAF2  then  interact with  ASK1,  which  phosphorylates  and 
activates  JNK  (Figure  1.12).  Once  activated,  JNK  can  phosphorylate  and 
inactivate  the  anti-apoptotic protein  Bcl-2  at  the  ER  membrane  leading  to  its 
proteasomal degradation. Consequently, phosphorylated Bcl-2 is unable to inhibit 
pro-apoptotic BH3-only proteins (Bax and  Bak)  and  loses its  ability to  regulate 
ER  Ca
2+ fluxes  (Bassik  et  al,  2004).  Phosphorylated  Bcl-2  enhances  calcium 
efflux from the ER, which leads to  calcium uptake by mitochondria. In addition, 
JNK can  phosphorylate the  BH3-only protein  Bim  (Figure  1.12)  (Putcha et  al, 
2003). Under normal conditions, the pro-apoptotic activity of Bim is inhibited by 
binding to  dynein motor complexes. Phosphorylation by JNK releases Bim from 
these complexes  and  allows  activation of the Bax-dependent apoptotic cascade 
(Figure 1.14). Resting conditions  ER s lre88 
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Figure  1.14  Role  of  Bcl-2  family  proteins  in  ER-mediated  apoptosis.  Under 
physiological  conditions,  the  pro-apoptotic  proteins  Bax  and  Bak are  antagonized  by 
antiapoptotic  members  such  as  Bcl-2,  both  at  the  mitochondrial  and  endoplasmic 
reticulum (ER) membranes. The BH3 only member, Bim is  kept inactive by binding to 
cytoskeletal dynein (BH3 in  the figure represents Bim). During ER stress,  induction of 
transcription factor CHOP, and activation of JNK antagonize Bcl-2 and render it inactive 
by phosphorylation. Activation of JNK also Jeads  to phosphorylation of Bim, leading to 
its activation. Activated Bim prevents anti-apoptotic Bcl-2 from inhibiting pro-apoptotic 
Bax and Bak.  Consequently, Bax and  Bak undergo conformational  changes  Jeading  to 
their oligomerization and insertion into the mitochondrial membrane, f01·ming  pores  and 
causing release of proteins such as  cytochrome c  into the cytosol, which contributes to 
formation  of the apoptosome and subsequent activation of the  caspase  cascade.  Figure 
adapted from Szegezdi et al, 2006. 34 
(3)  ER stress can activate pro-apoptotic Bcl-2 family proteins including Bim, Bik and 
Puma (Boyce and Yuan, 2006; Szegezdi et al,  2009). Bax and Bak co-localize to 
the  ER membrane  and  undergo  oligomerization,  which  leads  to  release  of ER 
calcium  into  the  cytoplasm,  thus  depleting  ER  calcium  stores  (Schroder  and 
Kaufman,  2005)  (Figure  1.14).  The  increase  in  cytosolic  levels  of calcium 
activates the protease m-calpain, which can  activate caspase-12  (Nakagawa and 
Yuan, 2000) (Figure 1.13). Thus, Bax and Bak play a role in  ER stress-induced 
apoptosis  through  regulation  of calcium  fluxes  and  amplification  of apoptosis 
through the mitochondrial pathway. 
(  4)  CHOP,  also  known  as  growth  arrest- and  DNA  damage-inducible  gene  153 
(GADD153), is  a bZIP transcription factor that is  induced downstream from  the 
PERK and ATF6 pathways (Oyadomari and  Mori, 2004). CHOP sensitizes cells 
to  ER stress-induced apoptosis mainly through clown-regulation of Bcl-2, which 
leads to  increased oxidant injury and  apoptosis (Malhotra and  Kaufman, 2007a) 
(Figure  1.14).  CHOP  also  induces  expression  of Bim  (Shroder  and  Kaufman, 
2005)  and  can  promote  activation  and  mitochondrial  translocation  of  Bax 
(Szegezdi et al,  2006).  Induction of CHOP  appears to  perturb the cellular redox 
equilibrium by causing glutathione depletion  and  enhanced production  of ROS 
(McCullough  et  al,  2001).  CHOP  is  also  regulated  post-translationally by p38 
MAPK phosphorylation, which increases its activity (Szegezdi et al, 2006). p38 is 
a substrate of ASK1, which is recruited to  the IRE1-TRAF2 complex during ER 
stress. 
(5)  The ER membrane protein B-cell receptor associated protein 31  (BAP31) contains 
a pseudo-death effector domain and serves as an activation platform for caspase-8 
(Ng  et  al,  1997).  After  binding  and  activation,  caspase-8  cleaves  a  20  kDa 
fragment  (Bap20)  from  Bap31.  This  p20  apoptosis  inducer  fragment  causes 35 
calcium-dependent  mitochondrial  fission;  outer  mitochondrial  membrane 
permeabilization and  cytochrome c release (Nguyen et al,  2000).  Bcl-2 and Bel-
xL  can  bind to  BAP31, thus preventing caspase-8  activation,  generation of the 
p20  fragment, and ultimately,  transmission of the death  signal  to  mitochondria. 
Bap31, calnexin and caspase-12 also form  a complex that appears to be involved 
in ER stress-induced apoptosis, through unkown mechanisms (Groenendyk et al, 
2006). 
A  common  factor  in  all  three  of the  major  pathways  of apoptosis  is  the  tumor 
suppressor protein p53.  DNA  damage, induced by stresses  such  as  ROS, can  activate 
p53,  which plays an important role in regulation of apoptosis, at both the transcription-
and transcription-independent levels. 
1.4 THE ROLE OF P53 IN APOPTOSIS 
1.4.1 Induction of apoptosis by p53 
The role of the tumor suppressor p53  as  a transcriptional factor has been extensively 
described. p53  plays an important role in critical cellular functions  such as  DNA repair, 
cell  cycle  arrest,  senescence  and  apoptosis  (Figure  1.15)  (Y oshida  and  Miki,  201 0; 
Schuler and  Green,  2001).  The p53  gene is  one of the most frequent  sites  for  genetic 
alterations  in  human  solid  cancers  and  is  mutated  in  more  than  50%  of cancer cases 
(Hollstein et al,  1991). In unstressed cells, p53  has a short half-life and is  maintained at 
low  levels  by the  protein  Mdm2  (Hdm2  in  humans)  (Figure  1.15).  Mdm2  inhibits 
transcriptional activity of p53  and promotes its degradation by the proteasome (Haupt et 
al, 1997). @ 
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Figure  1.15  Activation  of p53  and  cellular  response.  Activation  of cellular  stress 
pathways leads to post-translational modifications and  tetramerization of p53, stabilizing 
the protein and leading toits accumulation in  the nucleus. Transcriptionally, p53 induces 
the activation of its target genes that are implicated in  various cellular functions such as 
apoptosis, cell-cycle arrest or DNA repair. When p53 is  no longer needed, it is targeted 
for ubiquitylation by Mdm2 and  moved out of the  nucleus  to  be degraded by  the  26S 
proteasome. Figure adapted from Bode et al, 2004. 37 
p53 protein levels increase rapidly in response to different stress signais, and when the 
genomic integrity of a cell is threatened by metabolic or genetic disorders. These factors 
include DNA damage, ROS, nucleotide depletion, hypoxia and oncogene activation (Liu 
et al, 2008). p53  becomes stabilized and transformed into an  active form, mainly due to 
post-translational modifications including phosphorylation, acetylation and  methylation. 
DNA  damage  causes  p53  stabilization  through  activation  of the  Ataxia-telangiectasia 
mutated  kinase  (A TM)/checkpoint  kinase  2  (Chk2)  pathway.  Under  normal 
circumstances  Chk2  is  kept  inactive  by  binding  to  protein  phosphatase  2  (PP2A). 
Phosphorylation of Chk2  by A  TM  results  in  its  dissociation  from  PP2A leading to  its 
activation.  The  fully  active  Chk2  in  tum  phosphorylates  and  stabilizes  p53.  The 
activation  of these upstream kinases  is  opposed  by  an  inhibitory phosphatase, Wip  1, 
which  is  induced by stabilized p53  (Lu  et  al,  2008).  This  mode of negative  feedback 
functions in addition to that provided by the ubiquitin ligase Mdm2. Thus, these feedback 
loops  maintain  low  levels  of p53  in  undamaged  cells,  and  can  attenuate  signais  once 
lesions are repaired. Thus, modulated DNA damage signais cause the cyclical activation 
and deactivation of  p53  (Batchelor et al, 2008) (Figure 1.16). 38 
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Figure 1.16 Regulation of p53. Mdm2 (human analogue, Hdm2) negative! y regulates p53 
through  ubiquitin-mediated  proteolysis  that  subsequently  degrades  p53.  DNA  damage 
caused by ionizing radiation leads  to  activation of the ATM-Chk2 pathway.  Upstream 
signais  lead  to  dissociation  of p53  from  the  ubiquitin  ligase  Hdm2  and  thereby  p53 
becomes  stabilized.  The  ATM-Chk2  pathway  is  in  tum  regulated  by  the  protein 
phosphatase, Wip 1, which is induced by stabilized p53. Together, these feedback circuits 
keep levels of p53  low in undamaged cells, and  can attenuate signais once lesions  are 
repaired. Figure adapted from Freeman et al, 2010 (modi:fied). 39 
Cell  cycle  arrest  and  apoptosis  are  two  of the most  studied  p53-mediated  cellular 
responses that reflect the choice of p53  to  determine a cell's ultimate fate, life or death 
(Yoshida and Miki, 2010). However, the signais that determine cell fate remain unclear. 
1.4.2 Choice of response-Life or Death: The two faces of p53 
The  decision  between  life  and  death  is  dependent  on  the  balance  between  the 
availability of cellular factors as well as extracellular signaling events. The type of stress 
versus  the  extent of damage that  triggers  p53  activation is  an  important factor, which 
indicates whether or not the injury is  worth repairing.  If damage is  not too  severe, p53 
acts by causing cell cycle arrest to  allow the cell to repair the damage, before continuing 
through the cell cycle. If damage is too extensive, then the damaged cell is eliminated by 
apoptosis  to  maintain  genomic  fidelity.  Thus,  p53  is  known  as  the  <<guardian of the 
genome>> (Lane,  1992). There are numerous targets of p53  that participate in different 
cellular processes  and  the actions  of these  targets  ultimately decide  the  fate  of a cell 
subjected to stress. 
1.4.3 Role of p53 in apoptosis 
At the transcriptionallevel, phosphorylated p53 induces transcription ofpro-apoptotic 
proteins  such  as  Bax,  Bid,  Puma and  Noxa,  and  it  suppresses  the  activity  of anti-
apoptotic  proteins  such  as  Bcl-2  and  lAPs  (Figure  1.17)  (Schuler  and  Green,  2001; 
Yoshida and  Miki, 2010;  Miyashita and  Reed, 1995; Yu  and  Zhang,  2008).  Puma can 
antagonize mitochondrial Bcl-2 proteins, thus promoting mitochondrial translocation and 
multimerization of Bax (Yu and Zhang, 2008). Noxa is induced by p53 in response to X-
ray irradiation (Oda et  al,  2000).  It contributes to  p53-mediated apoptosis in  a similar 
manner to Puma and Bax.  Other apoptotic proteins induced by p53 include p53-inducible 
genes  (PIG),  p53-induced  protein  with  death  domain  (PIDD),  p53-apoptosis  effector 
related  to  PMP-22  (PERP),  Scotin,  and  p53-regulated  apoptosis-inducing  protein  1 
(p53AIP1). The p53  target, p53AIPI can regulate mitochondrial membrane potential and 40 
trigger the release of Cyt c by interacting with Bcl-2 (Matsuda et al,  2002). Many of the 
PIG  genes  encode  for  redox  active  proteins,  including  two  ROS-generating  enzymes, 
human  NAD(P)H:quinone  oxidoreductase  (NQOl)  and  proline  oxidase  (POX,  PIG6) 
(Liu et al, 2008). In  the extrinsic pathway, p53  induces expression of the death receptors 
Fas and DR5, along with the death ligands FasL and TRAIL (Schuler and Green, 2001; 
Yoshida  and  Miki,  2010)  (Figure  1.17).  p53  may  also  induce  apoptosis  via  an  ER-
dependent mechanism by transactivating the expression of Scotin, a protein  located in the 
ER and at the nuclear membrane (Bourdon et al, 2002). 
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Figure 1.17  p53-apoptotic pathways.  In  response  to  cellular stress,  p53  transactivates 
pro-apoptotic genes that activate the ( 1) death receptor pathway (CD95/Fas, Bid) and (2) 
the mitochondrial pathway (Bax, Noxa,  Puma). Figure adapted from Bai et al, 2006. 
Further  to  its  activity  at  the  transcriptional  level,  p53  protein  cao  also  promote 
apoptosis  through  severa!  transcription-independent  mechanisms  (Vaseva  and  Moll, 
2009). The first mechanism established that p53 rapidly translocates to the mitochondrial 41 
membrane.  Wild  type  p53  is  able  to  interact  physically  and  functionally  with  anti-
apoptotic proteins such  as  Bel-2, Bel-XL and Mel-1  at the mitochondrial membrane,  to 
displace previously sequestered pro-apoptotic proteins such as Bax, Bak and t-Bid. p53 is 
able to displace t-Bid and Bax from inhibitory complexes formed with Bel-XL (Chipuk et 
al, 2004). Furthermore, p53 interacts with Bak and liberates it from its inhibitory complex 
with Mel-1  (Vaseva and Moll, 2009). p53 can also induce Bax and Bak oligomerization, 
which  facilitates  cytochrome c release  after mitochondrial  membrane permeabilization 
(Mihara et al, 2003; Chipuk et al, 2004). 
In a  parallel  transcription-independent  pathway,  p53  protein  is  sequestered  in  the 
cytoplasm in an  inactive complex by Bel-XL in  non-stressed cells  (Chipuk et al, 2005) 
(Figure  1.18).  During  genotoxic  stress,  nuelear  p53  induces  Puma,  which  liberates 
cytoplasmic  p53  from  Bel-XL,  thus  allowing  p53  to  translocate  to  mitochondria  and 
activate  Bax,  thus  directly  inducing  apoptosis  in  a  transcription-independent  manner. 
Puma can therefore couple the nuelear and cytoplasmic apoptotic functions of  p53. Hcalthy  Sires~ 
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Figure 1.18 p53 and Bcl-2 family proteins at the level of mitochondria. p53 protein is 
sequestered  in  the  cytoplasm in  an  inactive  complex  by  Bel-XL  in  non-stressed  cells. 
Activation of p53 by stress induces Puma, which liberates cytoplasrnic p53 from Bel-XL, 
thus allowing p53 to translocate to rnitochondria and activate Bax, thus directly inducing 
apoptosis in a transcription-independent manner. Figure adapted from Moll et al, 2006. 
Genotoxic stress can result in  p53-mediated activation of caspase-2. The binding of 
p53 to death domain-containing adaptor proteins,  PIDD and RAIDD leads to  recruitment 
of procaspase-2. The resulting ternary  complex leads to  caspase-2 activation.  Activated 
caspase-2 can trigger Bid-mediated activation of the rnitochondrial pathway of apoptosis 
(Lavrik et  al,  2006)  (Figure  1.19). Thus,  tumor suppressor p53  can  regulate  apoptosis 
both  transcription-dependent  and  -independent  mechanisms.  Mutations  in  the  DNA-
binding site of p53  in  human tumors impairs both the transcriptional and mitochondria 
pro-apoptotic functions of p53 (Mihara et al, 2003). Box 21  Caspase-dependent and caspase-independent routes to cell death 
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Figure 1.19 p53-associated pathways involved in apoptotic cell death. In  response to 
DNA  damage,  p53  activates  cell  death  by  up-regulating  BH3-only  proteins  such  as 
PUMA  and  NOXA,  which  promotes Bax  or Bak  activation, leading  to  mitochondrial 
outer  membrane  permeabilization  (MOMP),  cyt  c  release,  apoptosome  formation, 
caspase-9  activation,  and  the  caspase-dependent  cascade.  In  an  alternative  pathway, 
caspase-2 acts upstream of MOMP and is possibly activated by different complexes, such 
as  the PIDDosome or DISC (through caspase-8). Once activated caspase-2 cleaves and 
activates Bid, which causes MOMP and cyt c release. Figure adapted from Maiuri et al., 
2007. 44 
1.4.4 p53 and oxidative stress 
A complex relationship exists between p53  and  levels of ROS. Low  levels of DNA 
damage caused by oxidative stress  can be repaired, whereas  extensive damage usually 
results in cell death. p53 contributes to both outcomes by stimulating expression of either 
pro- or antioxidant genes (Figure 1.20). 
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Figure 1.20 Levels of ROS regula  te p53 fonction. Figure adapted from Liu et al, 2009. 
During extensive cellular stress, p53 levels increase and induce the  expression of  pro-
oxidant  genes, which  elevate  ROS  levels,  leading  to  cell  death  by  apoptosis.  Under 
normal conditions, levels of ROS are low and cells experience only mild oxidative stress. 
In  such  situations,  p53  enhances  cell  protective  mechanisms  by  up-regulating  the 
expression of several antioxidant genes, including Gpx, MnSOD, and mammalian sestrin 45 
homologs  SESNl  and  SESN2,  which  are  involved  in  the  regeneration  of oxidized 
peroxiredoxins  (Figure  1.20).  This  differentiai  control  of redox  levels  within  a cell  is 
attributed to  the levels of p53  itself.  Thus,  low  levels of p53  suppress ROS  within the 
cell, while higher levels ofp53 promote ROS accumulation (Liu et al, 2008). 
1.5 PROTECTIVE/ADAPTIVE MECHANISMS AGAINST STRESS-INDUCED 
APOPTOSIS 
Cellular stress signais can contribute to evasion of apoptosis by activating a group of 
powerful  anti-apoptotic  genes.  This  includes  activationlup-regulation  of  mitogenic 
signaling pathways (e.g.  Akt pathway), anti-apoptotic proteins (lAPs, FLIP, Bcl-2), ROS 
scavengers (antioxidants), and heat shock proteins (Hsps) (Figure 1.21 ). / 
Anti-apoptotic 
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Figure 1.21 Figure depicting the role of anti-apoptotic proteins (Akt, lAPs, FLTP, Bcl-
2, Bel-XL, ROS scavengers and Hsps) in  the regulation of major pathways of apoptosis. 
Figure adapted from Portt et al, 2011. 47 
1.5.1 The serine/threonine protein kinase Akt 
Growth factor stimulation of phosphoinositide 3-kinase (PBK) activity leads to  Akt 
activation.  The  mechanism  by  which  Alet  protects  cells  from  death  is  likely  to  be 
multifactorial, because Alet directly phosphorylates severa! components of the cell- death 
machinery. The pro-apoptotic protein, Bad is one of the targets of Akt activation. In the 
unphosphorylated  state, Bad is targeted to  the mitochondria where it forms  a complex 
with Bcl-2 or  BclXL,  inhibiting their anti-apoptotic activity.  Phosphorylation of Bad by 
Alet inhibits its pro-apoptotic effect (Figure 1.21) (Datta et al, 1997; Harvey and  Lonial, 
2007). Alet also regulates cell death by inhibiting caspase-9 activation by phosphorylation 
(Cardone  et  al,  1998).  Akt  can  also  activate  the transcription  of anti-apoptotic  genes 
through activation of the transcription factor NFKB  (Figure  1.21 ).  NFKB  is  kept inactive 
in the cytoplasm by binding to its inhibitor IKB. Akt can phosphorylate and activate IKB 
kinase (IKK), a kinase that induces proteosomal degradation of  IKB. This allows NFKB to 
translocate to  the nucleus and activate transcription of a variety of substrates including 
anti-apoptotic genes such as c-lAPI and 2 ( Gagnon et al, 2003; Chen et al, 2006). 
1.5.2 Inhibitor of Apoptosis Proteins (lAPs) 
Caspase  activity  can  be regulated  by a family  of proteins  known  as  lAPs  (Figure 
1.21). These proteins bind to procaspases under physiological conditions and thus prevent 
their activation. In mammals, the members of the IAP  family include X-linked inhibitor 
of apoptosis protein (XIAP), cellular inhibitor of  apoptosis protein 1, 2 (  clAP-1, ciAP-2), 
neuronal  apoptosis  inhibitory  protein  (NAIP),  and  survivin.  These  proteins  are 
characterized by the presence of 1-3 baculoviral IAP repeats (BIR) (Figure 1.22) (Altieri, 
2010). 48 
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Figure  1.22  Schematic  representation  of domain  structure  in  representative  lAPs. 
The presence of at least one BIR domain is the defining characteristic of the IAP family. 
Along with the BIR domains,  severa!  lAPs contain  a  RING-zinc finger domain  at the 
carboxy terminus. e-lAPs (112)  both possess a caspase recruitment domain (CARD) in 
the Jinker region between the BIR domains and the RING domain. Figure adapted from 
AJtieri, 2010. 
lAPs function as direct inhibitors of both initiator and effector caspases. lAPs such as 
XIAP,  clAP-1  and  c-IAP-2  were  shown  to  bind  directJy  to  caspase-3,  -7  and  -9  and 
inhibit their activity (Shiozaki et al,  2003;  Scott et aJ,  2005). In  addition,  clAP-1  and 
clAP-2 can bind to  TRAF2 by means of their BIR domain and  thus negatively regulate 
death receptor-mediated apoptosis by promoting the activation of cell survivaJ factor NF-
KB  (Chu et aJ,  1997; Hunter et al,  2007).  The activity of lAPs in  turn  is regulated by 
mitochondriaJ pro-apoptotic proteins, SMAC/DIABLO, and HtrA2/0mi (Figure 1.21). 49 
1.5.3 FLIP 
The death receptors (DISC)- mediated apoptotic pathway can be regulated by FLICE-
like inhibitory protein (c-FLIP) (Figure 1.21). It is a cytosolic caspase-8/FLICE inhibitor, 
which  exists  in  two  different  forms:  long  form  (c-FLIPL)  and  short  form  (c-FLIP5). 
Because of  its sequence homology to caspase-8, it competes with caspase-8 for binding to 
the death  effector domain (DED)  of adaptor protein F  ADD.  The interaction of c-FLIP 
with  FADD  prevents  DISC-mediated  processing  and  activation  of  caspase-8 
(Zimmermann et al, 2001 ; Ghavami et al, 2009). 
Thus,  lAPs  and  FLIP  play  an  important  role  in  regulation  of caspase-dependent 
apoptosis (Figure 1.21 ). 
1.5.4 Bcl-2 Family proteins 
The mitochondrial pathway of apoptosis is  regulated by a balance between the pro-
apoptotic and  anti-apoptotic members of the B-cell  lymphoma protein  2 (Bel-2)  super 
families  of proteins.  The  anti-apoptotic  (Bel-2,  Bel-XL,  Bcl-w,  Al  and  Mel-1)  and 
proapoptotic (Bax,  Bak, Bad, Bim, Bid,  Bik, Bmf, Hrk, p53-upregulated modulator of 
apoptosis (Puma) and Noxa) proteins play a major role in mitochondrial outer membrane 
permeabilization and susceptibility to apoptosis (Y oule and Strasser, 2008). Proteins such 
as Bad, Bik, Bid, Bim, Hrk, Puma and Noxa have a conserved Bcl-2 homology domain 3 
(BH3)  that  can  bind  and  regulate  the  anti-apoptotic  Bcl-2  proteins,  thus  promoting 
apoptosis. The pro-apoptotic member Bak and the anti-apoptotic members Bel-2 and Bel-
XL  are  integral membrane proteins that  are present mainly in  the outer mitochondrial 
membrane.  The  anti-apoptotic  Bel-2  family  members  (Bel-2  and  Bel-XL)  inhibit 
apoptosis by binding Bax and Bak (Figure 1.21), sequestering truncated Bid (t-Bid) and 
Apaf-1,  and  th  us  preventing  the  release  of  pro teins  such  as  cytochrome  c  and 
Smac/Diablo from mitochondria (Figure 1.23). Normal 
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Figure 1.23 Diagram depicting the state of Bcl-2 family proteins during normal and 
apoptotic conditions. Under normal  conditions, pro-apoptotic proteins (Bax, Bak, and 
Bid)  are  kept  inactive  by  the  anti-apoptotic  proteins  Bel-2  and  Bel-XL.  During  an 
apoptotic  stimulus,  the  activation  of BH3-only  proteins  (e.g.  Bad)  antagonizes  anti-
apoptotic proteins Bel-2 and Bel-XL. This allows the activation of Bax and Bak, release 
of cyt  c,  activation  of caspase-9  and  caspase-3,  and  execution  of apoptosis.  Figure 
adapted from Schoemaker and Moshage 2004. 
Under normal conditions, pro-apoptotic proteins such as Bax, Bid and Bad are located 
in the cytosol. Upon an apoptotic stimulus, Bid can be eleaved by caspase-8, -10, or -2 to 
form  t-Bid, whereas  Bax undergoes  oligomerization.  Bad  is  released  from  the  adaptor 
molecule 14-3-3 by dephosphorylation (Figure 1.23). These events lead to translocation 
of t-Bid,  Bax  and  Bad  to  the  outer  mitochondrial  membrane.  At  the  mitochondrial 
membrane, Bad interacts with and  antagonizes the anti-apoptotic proteins Bel-2  and/or 
Bel-XL (Figure  1.21),  whereas  Bak  and  Bax  require  an  interaction with  t-Bid  to  form 
pores in the mitochondrial membrane, which allow the release of cytochrome c. The pro-
apoptotic  proteins  Puma and  Noxa are  induced  by p53  in  response  to  DNA  damage 51 
(Y oule and  Strasser, 2008). Puma mainly acts indirectly by activating Bax and/or Bak, 
and by blocking the inhibition of these proteins by anti-apoptotic proteins such as Bcl-2, 
Bel-XL  (Figure  1.21)  (Yu  and  Zhang,  2008).  It appears  that  Puma  can  also  trigger 
apoptosis by directly activating Bax. 
Thus, mitochondrial anti-apoptotic Bcl-2 family proteins, such  as  Bcl-2 and  Bel-XL 
protect the mitochondria by inhibiting Bax activation and  its  subsequent mitochondrial 
translocation (Chao et al, 1995), thus preventing Bax from disrupting outer mitochondrial 
membrane integrity. Therefore, the release of cytochrome c and  subsequent pro-caspase 
activation are inhibited, favoring cell survival (Yang et al, 1997). 
1.5.5 Thermotolerance (beat pre-conditioning) 
Thermotolerance can be defined as the ability of the body and its cellular structures to 
withstand  severe  destructive  heat  stress.  Exposure  of ce11s  to  transient,  non-lethal 
elevations  in  temperature  activates  cellular  stress  reponses  and  induces  a  state  of 
thermotolerance,  which renders  the  cells  resistant to  subsequent lethal  insults  such  as 
those  induced by heat shock,  oxidative  stress,  chemotherapeutic  agents,  radiation  and 
environmental stressors (Ritcher et al, 2010; Martindale et al,  2002; Kregel et al,  2002). 
Thermotolerance can be developed  fo11owing  shorter exposures (  e.g.  30  min)  to  lethal 
temperatures  (42-45  °C)  or  during  continous  heating  (e.g.  3-24  h)  at  non-lethal 
temperatures  (39.5-41.5  °C)  (Landry  et  al,  1982;  Przybytkowski  et  al,  1986).  It  is  a 
transient process  and  usua1ly  declines  within  several  days.  The adaptive role of mild 
thermotolerance  against  apoptotic  pathways  is  relatively  unknown  in  humans.  It is 
associated with the synthesis and cellular accumulation of a family of highly conserved 
proteins referred to  as  heat shock proteins (Hsps)  (Figure  1.21), which bind to  various 
molecules to pro vide cell protection (Review Ritcher et al, 201  0). 52 
1.5.5.1 Heat shock proteins 
Hsps,  also  called  stress  proteins,  are  synthesized  by  all  orgamsms,  not  only  m 
response  to  increased  temperatures  but  also  to  a  diverse  array  of stresses,  such  as 
oxidative stress, toxic metals, anoxia and radiation. Increased gene transcription occurs in 
response  to  all  conditions  that contribute to  denatured  or  abnormally  folded  proteins. 
These conditions can result from  environmental stress, which includes exposure of cells 
to  heavy  metals,  amino  acid  analogues,  or  oxidative  stress  (Scharf et  al,  1998)  or 
pathophysiological  stress,  including  pathogen  infection,  inflammation  or  fever 
(Morimoto,  2008).  Non-stressful  events  or  components  associated  with  increased 
expression of Hsps include development and differentiation of cells, growth factors and 
oncogenes, or prooncogenes (Georgopoulis and Welch, 1993) (Figure 1.24). CELL STRESS RESPONSE 
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Figure  1.24  Diagram  illustrating different stress  conditions  that induce  the  heat 
shock response.  (Figure adapted from Morimoto 2008). 
A set of transcription factors,  known  as  heat shock factors (HSF), are responsible for 
the  induction  of  protective  genes  which  in  turn  induce  the  expression  of the  Hsps 
(Pirkkala et al, 2001 ; Shabtay et al, 2006).  HSFl is implicated in  the heat shock response 
and  developmental  process  because  mice  lacking  HSF 1  were  unable  to  develop 
thermotolerance or induce heat responsive genes upon heat shock (Mcmillan et al, 1998; 
Zhang et al, 2002), confirming that HSF1  in  particular is responsib1e for the heat shock 
response. Normal 
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Figure  1.25 Induction of Hsps  inhibits apoptosis and  promotes cell  survival. Stress-
inducing agents, such as heat, oxidants, toxins and heavy metals, initiate trimerization of 
HSF-1  monomers in the cytoplasm. These trimers translocate into the nucleus and induce 
the transcription of Hsp genes  such as  Hsp27  and  Hsp70.  These Hsps regulate  various 
events of the apoptotic pathways and promote cel!  survival.  Figure adapted from Fulda et 
al, 2010. 55 
Inactive HSF-1  is  maintained in  a monomeric form  through interaction with Hsp90 
and  cochaperones in the cytosol (Figure 1.25). During stress, accumulation of unfolded 
proteins  competes  with HSF1  for  binding to  Hsp90.  Thus, release of HSF1  from  the 
complex results in its transition from  a monomer to  a homotrimer, which translocates to 
the nucleus and binds to  DNA, leading to the expression of heat shock proteins (Figure 
1.25). These proteins play a central role in the development of  thermotolerance. 
Hsps  are  generally classified into two  groups  according to  their size:  high  and  low 
molecular weight Hsps. The larger Hsps are subdivided into three major families, Hsp60, 
Hsp70 and Hsp90, which function as ATP-dependent chaperones. The smaller Hsp group 
is comprised mainly of the ATP-independent chaperone Hsp27 (Sreedhar and Csermely, 
2004).  Many members of these Hsp families  are present constitutively in  cells and  are 
involved in  the regulation of normal homeostasis.  However, sorne  Hsps  are  expressed 
only after stress. These inducible Hsps help cells to  cope and recover from  the stressful 
situation.  Among the different Hsps, Hsp27  and  Hsp70  are  the most strongly induced 
after stresses su ch as  an ti cancer drugs, oxidative stress and irradiation .  The inducible as 
well  as  the  constitutively  expressed  members  of the  Hsp  families,  are  known  as 
molecular chaperones, which i) help in normal folding of various polypeptides, ii) assist 
mis-folded proteins to  attain or regain their native states, iii) regulate protein degradation 
and/or iv)  help in translocation of proteins to  different cellular compartments (reviewed 
in Ritcher et al, 201 0; Hartl and Hayer-Hartl 2002). The above functions imply that these 
proteins  interact  with  a  large  variety  of cellular  proteins  and  thus  are  important 
components of cellular networks. The cytoprotective function of these proteins is mainly 
explained by their anti-apoptotic function. 56 
1.3.2.4 Hsps: Role in apoptosis 
Data accumulated in  the last  10  years  clearly demonstrate that  these proteins have 
essential  anti-apoptotic  properties.  They  can  combine  with  key  stress  signalling  and 
apoptotic molecules, thereby blocking cell death and promoting survival, proliferation or 
differentiation.  These  proteins  can  block  the  apoptotic  pathways  (both  intrinsic  and 
extrinsic)  through the  interaction with key proteins  at  three  levels:  1)  upstream  of the 
mitochondria,  thereby  modulating  signaling  pathways;  2)  at  the  mitochondrial  level, 
controlling the release of  apoptogenic molecules; 3) and at the post-mitochondriallevel. 
Studies show that increased expression ofHsp27, Hsp70 or Hsp90 can protect against 
apoptosis induced by different stimuli, including hyperthermia, oxidative stress, ligation 
ofthe Fas death receptor, staurosporine, or anti-cancer drugs (Garrido et al, 1997; Mehlen 
et  al,  1996).  The  most  important  anti-apoptotic  role  of Hsp27  involves  its  ability  to 
reduce cellular ROS levels by enhancing the antioxidant defense of  the cell (Preville et al, 
1999). Thus, Hsp27 regulates both redox homeostasis and mitochondrial stability of the 
cell. Also, Hsp27 can bind to both cytochrome c and procaspase-3 in the cytoplasm, thus 
preventing apoptotic events taking place downstream of the mitochondria (Concannon et 
al,  2001 ).  Hsp27  can  interact  with  DAXX  and  also  regulate  caspase-independent 
apoptosis (Charrette et al, 2000). 
Hsp70 has been shown to  inhibit the  apoptotic pathways at  different levels  (Figure 
1.26). At the mitochondriallevel, it inhibits Bax translocation and insertion into the outer 
mitochondrial membrane, thus  preventing mitochondrial  cytochrome  c release. At  the 
post-mitochondrial level, it can interact with Apaf-1, thereby preventing the recruitment 
of procaspase-9 to  the apoptosorne and  subsequent activation of caspase-9 (Beere et  al, 
2000). Hsp70 was also shown to regulate caspase-independent cell  death by interacting 
with AIF, which neutralizes its DNase activity (Ravagnan et al, 2001; Gurbuxani et  al, 
2003).  Hsp70  inhibits  TNF-induced  cytochrome  c  release  by suppressing  caspase-8-57 
mediated cleavage of Bid and its activation (Gabai et al, 2002; Paul et al, 2002). A very 
recent  study  showed  that  Hsp72  protects  cells  from  ER  stress-induced  apoptosis  via 
enhancement ofiRE1a-XBP-1 signaling (Gupta et al, 2010). 
Hsp90 can interfere with apoptosome formation by sequestering Apaf-1  and thereby 
preventing caspase-9 activation (Pandey et al,  2000). Hsp90 can bind directly with Akt 
and  protect it from  protein phosphatase 2A  (PP2A)-mediated  dephosphorylation.  This 
enables  phosphorylated  Akt  to  phosphorylate  Bad,  thereby  leading  to  caspase-9 
inactivation and cell survival (Basso et al, 2002; Cardone et al, 1998; Datta et al, 1997). 
Therefore, Hsps play a major role in the regulation of the three major pathways  of 
apoptosis, but it is still unclear wh ether the anti-apoptotic influence of thermotolerance is 
caused by Hsps alone or if  other defense proteins such as anti-oxidants and anti-apoptotic 
proteins are also implicated in the adaptive survival role of  this phenomenon. Heat Shock, Hypoxia, 
radiation, Serum 
deprevation, ROS, 
Chemothera  utic 
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Figure  1.26  Events  regulated  by  Hsps  in  the  intrinsic  (mitochondrial)  and 
extrinsic  (death  receptor)  pathways  of apoptosis.  Hsps  intervene  at  multiple 
points both upstream and downstream of mitochondria. Hsp27 inhibits apoptosis by 
preventing the mitochondrial release of cytochrome c into the cytoplas, as well as by 
sequestering  procaspase-3  in  the  cytosol,  thus  preventing  its  activation.  Hsp70 
regulates death receptor induced apoptosis by preventing recruitment of procaspase-
8 to the death complex. lt also prevents the cleavage and activation of Bid. It further 
acts  downstream  by  preventing  cytochrome  c  release  into  the  cytosol  and 
sequestering  Apaf-1,  inhibiting  apoptosome  formation,  as  well  as  activation  of 
caspase-3 by  sequestering cytosolic procaspase-3.  Hsp70 can  also regulate caspase-
independent cell death through suppression of AIF activity. Hsp90 sequesters Apaf-1 
and thereby prevents apoptosome formation.  Hsp27  and  Hsp70 can regulate stress 
mediated by the JNK pathway, by inhibiting the recruitment of DAXX and ASK1 to 
the Fas signalling complex. 1 
l  __ _ 
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1.6 PRESENTATION OF PROJECT 
Cancer is  one of the  major diseases  affecting  people all  over the  world.  Several 
treatment  strategies  (  e.g.  chemotherapy,  radiotherapy,  immunotherapy  and  surgery) 
were developed for treating cancer. Hyperthermia is one of  the most innovative methods 
of treating cancer, mainly used as  an adjuvant to  radiotherapy and  chemotherapy. The 
scientific basis for the use ofhyperthermia as an adjunct for the treatment of  cancer rests 
on four main observations: 
1)  Tumor cells are more sensitive to the effects ofincreased temperature (42-45 °C) 
compared to the normal cells. 
2)  The combination of chemotherapeutic drugs and hyperthermia produces additive 
and synergetic killing effects on tumor cells. These effects appear more dramatic 
at low pH. 
3)  Hyperthermia produces changes in the tumor blood flow and oxygen. 
4)  Hyperthermia  augments  the  immune responses  of the  patient  toward  tumors. 
These would in elude effects on  macrophages, natural killer (NK)  cells, and T-
cell cytotoxic effector functions. 
Hyperthermia  has  the  potential  to  mcrease  cytotoxic  effects  of radiation  or 
chemotherapeutic agents  within the tumor volume, without increasing normal  tissue 
toxicity.  In  the  clinic,  this  technique  is  applied  in  combination  with  radiation  and 
cytotoxic agents by localized heating of the tumor region at higher temperatures such 
as 42-43°C for 1-2 h or by milder heating of  the body at 39.5-41 o c for longer times. 
An ex po  sure to mi1d heat shock in  duces the development of thermotolerance, which 
is accompanied by the transcriptional activation and accumulation of a group ofhighly 
conserved proteins called heat shock proteins (Hsps). These proteins can protect cells 
against damage caused by different stresses by preventing protein denaturation and by 
repairing denatured proteins in order to restore their biological activity. The heat shock 60 
response has been largely studied at relatively high, lethal temperatures such as  42  to 
45°C. However, the heat shock response at low non-lethal temperatures such as  39-
400C within the physiological fever range has received little attention and is not clearly 
understood. 
Cancer  patients  undergoing  high  dose  chemotherapy  often  experience  recurrent 
fevers  during periods of neutrophil deprevation.  It has not been  determined  in  vivo 
whether  these  febrile  temperatures  could  induce  thermotolerance  and  Hsps,  which 
could  attenuate tumor responses  to  cytotoxic treatments  such  as  chemotherapy,  and 
radiotherapy, which aim to destroy tumor cells by apoptotic cell death. 
1.6.1 Hypothesis 
The  hypothesis  is  that  "Mild  thermotolerance  induced  at  non-lethal  temperatures 
(e.g.  39-40°C) is an  adaptive physiological response that can increase cellular defenses 
and protect cells against different stresses such as oxidative stress and heat shock." 
1.6.2 General objectives 
The  general  objectives  of the  project  are  to  1mprove  understanding  of adaptive 
cellular stress responses. This thesis will evaluate whether induction of cellular defense 
systems at a mild non-lethal temperature can afford protection against activation of the 
apoptotic cascade induced by the pro-oxidant hydrogen peroxide. 61 
1.6.3 Specifie objectives 
1)  Objective  1:  To  determine  whether  mild  thermotolerance  (40°C,  3h)  leads  to 
induction  of cellular  deferrees  such  as  antioxidants  and  anti-apoptosis  proteins  and 
protects cells against activation of the mitochondrial pathway of apoptosis by hydrogen 
peroxide in human cervical carcinoma cells (HeLa). 
2) Objective 2:  To  evaluate the protective role of mild thermotolerance, developed at 
40°C,  against  activation  of the  death  receptor-mediated  apoptotic  cascade  by pro-
oxidant hydrogen peroxide in HeLa cells. 
3) Objective 3: To investigate whether mild thermotolerance can alter the induction of 
ER-mediated stress and apoptosis in cells exposed to hydrogen peroxide. 62 
CHAPTERII 
EXPERIMENTAL RESULTS 
(THREE ARTICLES) 
2.1 PREFACE 
This section includes three scientific articles describing the experimental results of 
this project which 1 have carried out during my doctorate studies in the laboratory of Dr. 
Diana Averill-Bates. 
The  first  article  entitled:  "Mild  thermotolerance  induced  at  40°C  increases 
antioxidants and protects HeLa cells against mitochondrial apoptosis induced by 
hydrogen peroxide: role of p53" by Pallepati P and  Averill-Bates DA. This article is 
published  in the journal Archives of Biochemistry and Biophysics 495  (2):  97-111, 
2010. Experiments were carried out by me and the manuscript was composed by myself 
and revised by Dr. Diana Averill-Bates. 
The second  article entitled:  "Mild thermotolerance induced at 40°C  protects HeLa 
cells  against  activation  of  death  receptor  mediated  apoptosis  by  hydrogen 
peroxide" by Pallepati P and Averill-Bates DA.  This article is published in the journal 
Free Radical Biology and Medicine 50  (6):  667-79, 2011. Experiments were carried 
out  by me  and  the  manuscript  was  composed  by  myself and  revised  by Dr.  Diana 
Averill-Bates. 
A third article entitled: "Activation of ER stress and apoptosis by hydrogen peroxide 
in HeLa cells: protective role of mild heat preconditioning at 40°C" by Pallepati P 
and Averill-Bates DA.  This article is published in the journal Biochimica Biophysica 
Acta  - Molecular  Cell  Research  1813  (12):  1987-1999,  2011.  Experiments  were 63 
carried out by me and the manuscript was composed by myself and revised by Dr. Diana 
A  verill-Bates. 
Book Chapter: Pallepati  P,  Averill-Bates  DA.  "Reactive oxygen  species,  cell  death 
signaling  and  apoptosis".  Invited  book  chapter.  Principles  of  Free  Radical 
Biomedicine.  Kostas  Pantopoulos  and  Hyman  Schipper,  eds.,  Nova  Sciences 
Publishers, loc., Hauppauga, New York, In press 2011. The following contents of  the 
book chapter, Overview of apoptosis and  cell  death, Signaling pathways of apoptosis, 
Role of calcium in  ROS-mediated  apoptosis, ROS  and  p53-mediated  apoptosis,  were 
written by myself and revised by Dr. Diana Averill-Bates. Sorne of these contents were 
included as a part of  the Introduction section of  this thesis. 
Other Contributions:  (i)  "Acrolein  induces  a  cellular stress  response and triggers 
mitochondrial apoptosis in A549  cells" by Roy J, Pallepati P,  Bettaieb A, Tanel  A, 
Averill-Bates DA.  My contribution in this article is  that I helped Julie Roy (MSc)  in 
repeating sorne of her experiments so  that statistically significant data was obtained.  I 
also carried out new experiments that were required by the evaluators in order to  accept 
the manuscript. The manuscript was revised by Dr. Diana Averill-Bates. The article was 
published in  the journal Chemico-Biological Interactions 181  (2):154-67, 2009.  See 
Appendix A. 
(ii) "Acrolein induces apoptosis through the death receptor pathway in A549 lung 
cells:  role of p53" by Roy J, Pallepati P,  Bettaieb A, Tanel A, Averill-Bates DA.  My 
contribution in this  article is  that I helped Julie Roy (MSc)  in  repeating sorne of her 
experiments  so  that statistically significant data was  obtained.  I also  carried out new 
experiments that were required by the evaluators in order to accept the manuscript. The 
manuscript was  revised by Dr.  Diana Averill-Bates.  The article was published in the 
journal Canadian Journal of Physiology and Pharmacology 88 (3):353-68, 2010. See 
Appendix B 64 
(iii) "Acrolein causes ER stress and apoptosis in  A549 lung cells" by Andre Tan  el, 
Pragathi  Pallepati,  Patrick  Morin,  Yulia  Zilber  and  Diana  A.  Averill-Bates.  My 
contribution in this article is that I wrote the material and methods and results sections 
whereas  the  Introduction  and  Discussion  sections  were  written  by  Andre  Tanel. 
Experiments were carried out by Yulia Zilber and I supervised experiments carried out 
by Patrick Morin. The manuscript is under revision by Dr. Diana Averill-Bates. ------------ - - ---
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RÉSUMÉ 
L'exposition  des  cellules  à  des  températures  modérées  (  40°C)  induit  la  tolérance 
thermique,  ce  qui  rend  les  cellules  résistantes  ultérieurement  aux  stress  toxiques.  La 
tolérance thermique est habituellement associée  à l'accumulation de protéines de choc 
thermique.  Cette  étude  détermine  si  la tolérance  thermique modérée  (40°C,  3h)  peut 
induire d'autres protéines de défense (par exemple des antioxydants, des protéines anti-
apoptotiques)  et protéger les  cellules  HeLa contre  l'apoptose  déclenche  par le  H20 2. 
L'expression des protéines MnSOD  et catalase ainsi que leur activité enzymatique sont 
augmentées dans les cellules tolérantes à la chaleur. De plus, les niveaux intracellulaires 
de  glutathion  et  l'expression  de  la  y-glutamylcystéine  synthétase  sont  également 
augmentés. En outre, les niveaux d'espèces réactives d'oxygène (ROS) ont été augmentés 
dans les cellules tolérantes à la chaleur,  ce qui cause l'hyperpolarisation de la membrane 
mitochondriale.  La  tolérance  thermique  modérée  inhibe  l'activation  de  la  cascade 
apoptotique  via  la  mitochondrie  induite  par  le  H20 2.  Cette  inhibition  entraîne  une 
translocation de Bax mitochondrial, une dépolarisation de la membrane mitochondriale, 
la  sortie  du  cytochrome  c,  l'activation  des  caspases-9/-3  et  la  condensation  de  la 
chromatine. La tolérance thermique inhibe l'apoptose indépendante des caspases induite 
par le H20 2, impliquant  le AIF, l'activation de p53 et l'expression accrue de sa protéine 
cible PUMA. La tolérance thermique induite aux températures physiologiques modérées 
protège les cellules tant contre l'apoptose dépendante des caspases que contre l'apoptose 
indépendante des caspases déclenche par le stress oxydatif. 
Mot-clé: Stress oxydatif; Peroxyde d'hydrogène; Tolérance thermique; protéine de choc 
thermique; Apoptose; Caspases; Antioxydant; Mitochondrie; protéine p53 ------------------
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ABSTRACT 
Ex  po sure of cells to mild temperatures (  40°C) in  duces thermotolerance, which rend  ers 
cells  resistant to  subsequent toxic  insults.  Thermotolerance  is  usually  associated  with 
accumulation  of  heat  shock  proteins.  This  study  determines  whether  mild 
thermotolerance  (40°C,  3h)  can  induce other defense proteins  (e.g.  antioxidants, anti-
apoptosis proteins), and protect HeLa cells against apoptosis triggered by H20 2.  Protein 
expression  and  enzymatic  activity  of  MnSOD  and  catalase  were  increased  in 
thermotolerant  cells,  as  well  as  intracellular glutathione  levels  and  y-glutamylcysteine 
synthetase  expression.  Furthermore,  levels  of reactive  oxygen  species  (ROS)  were 
increased  in  thermotolerant  cells,  which  caused  mitochondrial  membrane 
hyperpolarisation. Mild thermotolerance inhibited activation of  the mitochondrial cascade 
of apoptosis  by  H20 2•  This  entailed  inhibition  of mitochondrial  Bax  translocation, 
mitochondrial membrane depolarisation, cytochrome c release, activation of caspases-9/-
3  and  chromatin  condensation.  Thermotolerance  inhibited  H20 2-induced  caspase-
independent  apoptosis  involving  apoptosis-inducing  factor,  and  activation  of p53  and 
increased  expression  of its  target  protein  PUMA.  Thermotolerance  induced  at  mild 
physiological  temperatures  protects  cells  against both  caspase-dependent  and  caspase-
independent apoptosis triggered by oxidative stress. 
Keywords: Oxidative stress; Hydrogen peroxide; Thermotolerance; Heat shock protein; 
Apoptosis; Caspases; Antioxidant; Mitochondria; p53 protein 68 
INTRODUCTION 
Reactive oxygen species (ROS) include partially reduced metabolites of oxygen such 
as  superoxide anion (02"-),  hydrogen peroxide (H20 2)  and hydroxyl radical (OH").  These 
species,  whether  generated  as  byproducts  of  mitochondrial  respiration  or  as  a 
consequence  of exposure  to  environmental  factors  (  e.g.  ionising  radiation,  UV  rays, 
heavy  metals,  cigarette  smoke,  pollutants,  pesticides  and  anticancer  drugs),  pose  a 
constant threat to  cells  and  tissues  living in  an  aerobic  environment and  can  be taxie 
when present at higher doses  [Thannickal  et al, 2000].  Cells cope with the toxicity of 
ROS by using a range of non-enzymatic (  e.g. glutathione, vitamin E, ascorbate, pyruvate, 
flavonoids,  and  carotenoids)  and  enzymatic  antioxidants  that  in  elude  superoxide 
dismutase  (SOD),  catalase,  and  glutathione  peroxidase  (Gpx).  These  antioxidants 
function  by either scavenging ROS  or by repairing ROS-induced damage.  Superoxide 
radicals produced by the mitochondrial respiratory chain are dismutated by mitochondrial 
SOD  (MnSOD)  [Fridovich,  1997], leading to  the production of H20 2, which  is  further 
detoxified to water, either by catalase or glutathione peroxidase (GPx) [Radi et al, 1991; 
Chance et  al,  1979]  These antioxidants  counteract and  regulate overall  ROS  levels  to 
maintain physiological homeostasis. Oxidative stress occurs when this critical balance is 
disrupted,  which  can  result from  excess ROS  production, depletion of antioxidants, or 
both.  Oxidative  stress  has  been  implicated  in  the  etiology  of wide  array  of human 
diseases such  as  atherosclerosis, cancer, diabetes, arthritis, neurodegenerative disorders 
and aging [Finkel and Holbrook, 2000]. lt is therefore important to  clarify the underlying 
mechanisms  in  arder  to  elucidate  successful  preventive  and/or  protective  measures 
against ROS in disease processes as well as in environmental exposures. 
H20 2 is considered to be a key ROS  because of its involvement in cellular signaling 
cascades. Although  the  mode of  action  of H20 2  has been  widely  studied, the precise 
molecular mechanisms involved in apoptosis are not entirely characterized and the role of 69 
H20 2 in cellular signalling remains unclear. At nontoxic submicromolar levels, H20 2 has 
been  implicated  in  cellular  functions  such  as  growth, proliferation  and  differentiation 
[Burdon, 1995]. However, at higher micromolar to millimolar concentrations, depending 
on  the  cell  type,  Hz02  can  cause  oxidation,  such  as  lipid  peroxidation  and  protein 
oxidation,  as  well  as  depletion  of levels  of ATP,  reduced  glutathione  and  NADPH. 
Eventually, irreversible damage to cellular targets leads to cell death by processes such as 
apoptosis  or  necrosis  [Chandra  et  al,  2000;  Groeger  et  al,  2009].  In  general,  higher 
concentrations  of hydrogen  peroxide  induce  necrosis,  whereas  lower  concentrations 
induce apoptosis [Troyano et al, 2003]. During apoptosis,  cells become fragmented into 
apoptotic bodies that are recognized and engulfed by macrophages, thereby avoiding an 
inflammatory  response  in  surrounding  tissues,  which  clearly  distinguishes  it  from 
necrotic cell death [Savill and Fadok, 2000]. During necrosis, due to swelling, disruption 
of organelles,  and  the  loss  of membrane  integrity,  the  cellular  contents  are  released 
uncontrolled into the extracellular  environment, resulting in damage to surrounding cells 
and tissue, and a strong inflammatory response [Leist and J aattela, 2001]. 
Hyperthermia (42-47°C) is among the recent and innovative methods of  cancer 
treatment [Horsman and Overgaard, 2007].  Although temperatures  exceeding 42°C are 
cytotoxic  to  cells,  hyperthermia  is  mainly  used  as  an  adjuvant  to  radiation  and 
chemotherapy.  Localised  heating  allows  targeting  of  radiation  and  chemotherapy 
treatments  to  the  tumor  region.  Hyperthermia  is  one  of the  most  effective  radiation 
sensitizers  known  and  can  eliminate  radio-resistant  tumor  cells.  It  can  enhance  the 
cytotoxic effects of  certain anticancer drugs including bleomycin, Adriamycin, melphalan 
and platinum derivatives. However, the preconditioning of cells at elevated temperatures 
induces  a  stress  response  known  as  thermotolerance,  which  renders  cells  resistant  to 
subsequent lethal  insults such as heat shock, oxidative stress, chemotherapeutic agents, 
radiation and environmental stressors [Gill et al, 1998; Martindale and Holbrook, 2002; 
Kregel, 2002). Thermotolerance can be developed following shorter exposures  (e.g.  30 70 
min) to lethal temperatures (  42-45°C), or during continuous heating (  e.g.  3-24h) at non-
lethal temperatures (39.5-41.5°C) [Wiese et al, 1995; Landry et al, 1982]. 
Thermotolerance is transient and usually declines within several days, thus there is no 
interference  with  clinical  use  of hyperthermia.  Most  studies  have  investigated  the 
induction of thermotolerance at higher lethal temperatures such as  42  to  45°C, whereas 
induction by lower temperatures has received little attention. Mild temperatures such as 
40°C are physiological and occur during fevers.  Thermotolerance is generally associated 
with the synthesis and  accumulation of heat shock proteins (Hsp)  [Landry et  al,  1982; 
Przybytkowski et al, 1986; Landry et al, 1989]. 
Thermotolerance could also  induce ether cellular defenses  such  as  antioxidants and 
anti-apoptosis  proteins.  Therefore,  this  study determines whether mild thermotolerance 
developed at 40°C can induce major antioxidants such as  SOD, catalase and glutathione, 
and  anti-apoptosis  factors  such  as  Bcl-2  family  proteins  and  inhibitor  of apoptosis 
proteins (lAPs). Furthermore, the ability ofmild thermotolerance to protect cells against 
activation  of apoptosis  is  not  well  understood.  This  study  also  evaluates  whether 
thermotolerance developed at 40°C can afford protection against H20 2-induced activation 
of mitochondrial apoptosis in human cervical carcinoma (HeLa) cells. The role of  p53 is 
also  considered,  along  with  the  protective  role  of mild  thermotolerance  against  both 
caspase and caspase-independent cell death processes mediated by H20 2. 71 
MATERIALS AND METHODS 
Cell culture 
HeLa  cells  (ATCC#CCL-2)  were  grown  in  monolayer  in  Dulbecco's  modified 
Eagle's  medium  (Invitrogen  Canada,  Burlington,  ON,  Canada)  containing  10%  fetal 
bovine  serum  (FBS)  (Invitrogen),  in  tissue  culture  flasks  (Sarstedt,  St  Laurent,  QC, 
Canada)  at 37°C in a humidified atmosphere of 5% C02  in  a water jacketed incubator 
[Bettaieb and Averill-Bates, 2008]. Medium was replaced with fresh medium 24h before 
experiments. To  induce thermotolerance, cells were transferred to  an  identical incubator 
for 3h  at 40°C (± 0.1 °C),  following  a period of 20  min to  allow the temperature of the 
culture medium to reach 40°C [Przybytkowski et al,  1986]. The cells were grown to near 
confluence and  then harvested using 0.25% (w/v)  trypsin-0.02% (w/v)  EDTA solution, 
and washed by centrifugation (1000 x g,  3 min).  There was  no  loss of viability in cells 
heated at 40°C for 3h, evaluated by trypan blue exclusion (data not shown). 
Treatment with H20 2 and inhibitors 
Confluent  cells in  monolayer were pretreated  or  not  with  the  following  inhibitors: 
pifithrin-a (10 !-LM,  1h), a reversible inhibitor ofp53-mediated apoptosis (Calbiochem, La 
Jolla,  CA,  USA),  polyethylene  glycol-catalase  (PEG-catalase)  (300  U/ml,  3h)  (cell 
permeable H20 2  scavenger)  (Sigma-Aldrich Canada)  and  L-buthionine sulfoximine (L-
BSO)  (1  mM, 3h (Sigma-Aldrich Canada)). Freshly harvested thermotolerant and  non-
thermotolerant  HeLa  cells  were  then  resuspended  in  D-MEM  plus  10%  FBS  and 
incubated  at  constant  cell  density  (1 x  10
6 /ml)  with  25  to  100  !-LM  of H20 2,  in  a final 
volume of 1.0 ml at 37°C for lhor 3h, relative to untreated controls. Cells were washed 
by centrifugation (1 000 x g, 3 min) to remove H20 2, and then analysed for mitochondrial 
apoptosis and clonogenic cell survival. 72 
Flow cytometric analysis of mitochondrial membrane potential 
The collapse of electrochemical gradient across the mitochondrial membrane is one of 
the  early events  during  cellular apoptosis. The mitochondrial  membrane potential was 
detected using 5,5' ,6,6' -tetrachloro-1 ,1  ',3,3'tetraethylbenzimidazolcarbocyanine 
(JC-1 ; Molecular Probes, Eugene, OR, USA). JC-1  forms  red fluorescent aggregates in 
energized  mitochondria  with  high  membrane  potential,  whereas  it  dissociates  to 
monomers with green fluorescence at low membrane potential. The aggregate red forrn 
bas  absorption/emission  maxima  of  585/590nm.  The  green  monomeric  form  bas 
absorption/emission maxima of 510/527  nm.  Healthy, apoptotic, and  necrotic cells can 
be  analysed  simultaneously  by  flow  cytometry  using  different  detectors.  Following 
treatrnent with H20 2, thermotolerant (3h, 40°C) and non-thermotolerant (3h, 37°C) HeLa 
cells (1  x 1  0
6
)  were rinsed once with complete culture medium and incubated with 10 J.!M 
of JC-1  for 30 min at 37°C.  Cells were washed twice and resuspended in 500  J.!l  of cold 
PBS. Cells were analysed with a F  ACScan flow  cytometer (Ex. 488  nm)  equipped with 
an argon laser (Becton Dickinson, Oxford, UK)  [Bettaieb and Averill-Bates, 2008]. Data 
was  acquired  and  analysed  using  Lysis  II  software  (Becton  Dickinson).  The  mean 
fluorescence intensity of 10,000  cells was  calculated for  each  sample and corrected for 
auto fluorescence obtained from samples of  unlabelled cells. The ratio of red fluorescence 
(  detected by FL-2 detector) to  green fluorescence (FL-1  detector) was considered as  the 
relative  6. 'l'rn  value.  The  chemical  uncoupler  p-trifluoromethoxy-phenyl-hydrazone 
(FCCP, 25 J.!M, 30 min) was used as a positive control for the 6. 'l'rn decrease. 
ROS generation 
Cells were harvested after 3h at 37°C or 40°C, and then 10  J.!M  2'7'-dihydrodichloro-
fluorescein  diacetate (H2DCFDA)  or 20  J.!M  dihydroethidium (DHE)  was  added for  30 
mm.  H2DCFDA  measures  steady  state  levels  of  pro-oxidants  (presumably 
hydroperoxides), whereas DHE estimates intracellular superoxide levels.  Levels of ROS 73 
were determined in 10 000 cells by flow cytometry using the FL-1  detector and corrected 
for autofluorescence from unlabelled cells [Bettaieb and Averill-Bates, 2008]. 
Preparation of wh  ole celllysates 
For analysis  of total  SOD  activity,  and  protein  expression  of MnSOD,  CuZnSOD, 
catalase,  gamma-glutamyl  cysteine  synthetase  (y-GCSc),  Bcl-2,  c-Flip,  C-IAP1/2, 
survivin,  Bax, Bid,  Bad  and  Bip,  cells were harvested after 3h  at  37°C or 40°C.  For 
detection  of  p53,  PUMA,  ICAD,  and  PARP  proteins,  thermotolerant  and  non-
thermotolerant cells were harvested and incubated with hydrogen peroxide at 37°C for the 
required time periods. Cells were washed by centrifugation (1 000 x g,  3min) in buffer A 
(100  mM  sucrose,  1 mM EGTA,  20  mM  MOPS,  pH  7.4)  [21].  The  supematant was 
discarded, pelleted cells were resuspended in lysis buffer B [buffer A plus 5%  Percoll, 
0.01% digitonin and  a cocktail of protease inhibitors:  10  11M  aprotinin, 10  11M pepstatin 
A,  10  11M leupeptin, 25  11M cal pain inhibitor 1 and  1 mM phenylmethylsulfonyl fluoride 
(PMSF)] and incubated on ice for 1h.  Then, by a 10 min centrifugation step at 2500 x g 
to  remove nuclei and unbroken cells, the proteins of whole cell lysates were isolated in 
the supematant [Bettaieb and Averill-Bates, 2008]  for immunodetection of proteins and 
detection oftotal SOD activity. 
Preparation of subcellular fractions 
Cells were pretreated with or without 10  11M  pifithrin-a for 3 h and  th en  exposed to 
H20 2.  Subcellular fractions  were  then  prepared  as  previously described  [Bettaieb  and 
Averill-Bates, 2008;  Samali  et  al,  1999].  Thermotolerant  and  non-thermotolerant cells 
were washed in buffer A and resuspended in buffer B containing 0.1  mM dithiothreitol 
(DTT).  Lysates  were homogenised  using  a  dounce  homogeniser  (50  strokes/sample). 
After  a  30  min  incubation  on  ice,  unbroken  cells  and  nuclei  were  pelleted  by 
centifugation at 2500 x g for 1  0 min. The nuclear fraction was puri fied and isolated from 
the cellular debris, and was used for the detection of  apoptosis inducing factor (AIF). The 74 
supemantant was centrifuged further at 15,000 x g for 15  min. The pellet containing the 
mitochondrial fraction was then resuspended in buffer C (300 mM sucrose, 1 mM EGTA, 
20 mM MOPS, 0.1  mM DTT, 100 !ll/10 ml of  cocktail ofprotease inhibitors, pH 7.4) and 
used for detection of Bax and AIF. The supematant was further centrifuged at 100 000 x 
g for  1h. The resulting supematant was designated as  the cytosolic fraction which was 
used for  detection of Bax,  cytochrome c,  and  AIF.  Purity of nuclear (89%),  cytosolic 
(98%)  and  mitochondrial  (97%)  fractions  was  determined  by Western  blotting  using 
lamin B, glutathione S-transferase (GST  -n1) and cytochrome oxidase, respectively. 
Immunodetection 
Pro  teins  (  40  !lg)  were quantified  according to  Bradford  [Bradford,  197  6]  and  th  en 
solubilised  in  Laemmli  sample  buffer  [Laemmli,  1970].  SDS-polyacrylamide  gel 
electrophoresis (SDS-PAGE) (8%  for PARP;  10% for  AIF,  catalase, y-GCSc and  Bip; 
15% for  CuZnSOD,  MnSOD,  Gpx, Bid, Bcl-2,  C-Flip,  Survivin,  Bax,  Cytochrome  c, 
p53  and  PUMA) of cellular proteins was  carried  out at  a  constant voltage of 125  V. 
Cellular proteins were transferred to a polyvinylidene difluoride (PVDF) membrane using 
a MilliBlot Graphite Electroblotter I apparatus (Milli-pore, Bedford, MA, USA)  [Tanel 
and Averill-Bates, 2007].  The blots were probed with the following primary antibodies 
(1 :  1  000):  anti-PARP, anti-AIF,  anti-catalase, anti-y-GCSc, anti-Gpx, anti-Bcl-2, anti-C-
Flip, anti-Survivin, anti-Bax, anti-Bad, anti-cytochrome c,  anti-PUMA, anti-GAPDH (1: 
5000)  (Santa  Cruz  Biotechnology,  Santa  Cruz,  CA,  USA),  and  anti-CuZnSOD,  anti-
MnSOD,  and  anti-p53  Ser
15
'
46P  (Stressgen,  San  Diego,  CA,  USA),  anti-Bip  (BD 
Biosciences  Canada,  Mississauga,  ON,  Canada)  in  Tris-buffered  saline  (50  mM Tris 
base,  150 mM NaCl,  0.1% Tween-20)  (TBS-T)  containing  1% bovine serum  albumin 
(BSA)  for  1 h  at room temperature.  Membranes were washed and incubated for  1h at 
room  temperature  with  horseradish  peroxidase  (HRP)-conjugated  goat  anti-mouse,  or 
anti-rabbit, IgG (1: 1  000) (Biosource, Camarillo, CA, USA) diluted in TBS-T containing 
5% milk powder.  Proteins were detected using the ECL plus chemiluminescence kit 75 
(PerkinElmer, Boston, MA,  USA).  Protein expression was  analysed using a scanning 
laser  densitometer  (Alpha  Innotech  Corp.,  San  Leandro,  CA,  USA)  and  Fluorchem 
software, relative to GAPDH. 
Caspase activity by fluorescence spectroscopy 
Following  treatment  with  H20 2  (0,  25-100  f-LM)  for  3h,  freshly  harvested 
thermotolerant and non-thermotolerant HeLa cells were washed twice with cold PBS by 
centrifugation (1 000 x g,  3 min at 4 °C)  and resuspended in 7  5 f.ll  of reaction buffer (20 
mM piperazine-N,N'-bis(2-ethanesulfonic acid) (PIPES), 100 mM NaCl, 10 mM DTT, 1 
mM  EDTA,  0.1%  3-[  (3-cholamidopropyl)-dimethylammonio  ]-2-hydroxy-1-propane-
sulfonic acid  (CHAPS),  10%  sucrose,  pH  7.2)  [Tanel  and  Averill-Bates,  2007].  Cells 
were lysed  at  -80°C for  30 min.  The kinetic reaction was followed  for  30  min after 
addition of the appropriate caspase substrate at a final  concentration of 50  ).lM,  at 37°C 
using a  Spectra Max  Gemini  spectrofluorimeter (Molecular Deviees,  Sunnyvale,  CA). 
Caspase-9  activity was measured by cleavage of the fluorogenic peptide substrate Ac-
Leu-Glu-His-Asp-amino-4-trifluoromethylcoumarin  (Ac-LEHD-AFC  (Calbiochem,  La 
Jolla,  CA,  USA)  to  produce  7-amino-4-trifluoromethylcoumarin  (AFC)  with  Àmax 
excitation at 400nm and Àmax  emission at 505nm. For caspase-3, the substrate was Ac-
Asp-Glu-Val-Asp-AMC (Ac-DEVD-AMC) with  Àmax  excitation at  380 nm  and  Àmax 
emissiOn  at  460nm.  Activities  of caspases  are  represented  as  Vmax  of the  kinetic 
reaction. 
Catalase activity 
Freshly harvested thermotolerant and non-thermotolerant HeLa cells (  5 x  1  0
6
), were 
lysed via sonication (twice for 20 s) (Vibra Cell, Sonics &  Materials, Inc., Danbury, CT) 
in 50 mM potassium phosphate buffer (pH 7.0) and centrifuged (14,000 rpm, 15 min) to 
obtain  a  clear  extract  [Lord-Fontaine  and  Averill-Bates,  1999;  Claibome,  1985].  The 
dosage was  performed using  a  solution of 19  mM H20 2  containing the  clear cellular 76 
extract in  a final  volume of 3 ml  of phopshate buffer.  Catalase activity in the cellular 
extract  was  measured  as  hydrogen  peroxide  consumptionlmin  [Claibome,  1985],  by 
detecting the decrease in absorbance at  240  nm  during  120  s and recording over  15-s 
intervals, using a DU-62 spectrophotometer (Beckman). One unit was defined as  J.lmol  of 
peroxide consumed/min/1  0
6 cells, obtained using the intial velocity from the linear slope 
of the  curve.  Catalase  activity  was  normalized  to  controls  and  displayed  as  fold 
difference. 
Glutathione peroxidase enzymatic activity 
Glutathione peroxidase activity was measured by following the oxidation of NAD PH 
spectrophotometrically at 340nm [Lord-Fontaine and Averill-Bates, 1999; Lawrence and 
Burk, 1976]. Cells were resuspended in 500  J.lL of PBS, sonicated twice for 20 sec and 
then  centrifuged (10,000  x g,  15  min). Cell  extracts were added  to  50  mM  potassium 
phosphate  buffer  (pH  7.0)  containing  1  mM  EDTA,  1  mM  sodium  azide,  0.2  mM 
NADPH,  1  mM  GSH  and  glutathione  reductase  (1.3  E.U./mL).  The  mixture  was 
0 
incubated for  10 min at 25  C before the addition of 0.25 mM H20 2.  The kinetic reaction 
was followed  at  340  nm  at  15-s intervals for  5 min.  One unit was defined  as  J.lmOl  of 
peroxide consumed/min/1 0
6 cells, obtained using the intial velocity from  the linear slope 
of the curve. GPx activity was normalized to controls and displayed as fold difference. 
Enzymatic activity of SOD by zymography 
Whole  cell  lysates  were prepared  (see  2.5  above)  and  used  to  measure total  SOD 
activity  in  thermotolerant  and  non-thermotolerant  HeLa  cells.  Total  SOD  activity 
(absence of cyanide) was investigated by zymography as  described by Beauchamp and 
Fridovich [Beauchamp and Fridovich, 1971], using riboflavin as  a reducing agent. Equal 
amounts of  protein (30  ).lg) were electrophoresed on 12% non-denaturing polyacrylamide 
gels.  After  electrophoresis,  gels  were  stained  in  the  dark  for  15  min  with  nitroblue 
tetrazolium  (NBT),  in  the  presence  of TEMED  and  riboflavin.  The  gels  were  then 77 
exposed to  light  for  approximately 30 min.  SOD  activity was  observed  as  discoloured 
bands on a purple colored background. Densitometric analyses were performed and band 
densities were compared estimating the relative enzymatic activities. 
Measurement of total glutathione 
Freshly harvested thermotolerant (40°C, 3h) and non-thermotolerant (37°C, 3h) HeLa 
cells  (1  x  1  0
6
)  were  used  for  the  detection  of glutathione.  Total  glutathione  was 
determined according to the user's manual for the ApoGSHTM Glutathione Colorimetrie 
Detection Kit (BioVision). Briefly, cells (5  x 10
5 cells) were centrifuged at 700 x g for 5 
min at 4°C  and  the supernatants removed. The pellets were washed with ice-cold PBS, 
lysed in 80  ).ll  of ice-cold Glutathione Buffer and incubated on ice for  10 min. Then the 
samples were dissolved  with  5%  5-sulfosalicylic acid  (SSA,  20  J..ll)  and  centrifuged  at 
8000 x g for  10 min. The supernatants (20  Ill)  were incubated in 160  Ill  of the Reaction 
Mix at room temperature for  10  min and  Substrate solution (20  ).ll)  was  added  and  the 
mixture was incubated for a further 1  0 min. Absorbance was measured at 415nm using a 
micro plate reader. The standard curve was obtained from absorbance of the diluted GSH 
Standard that was incubated in the mixture as in samples. 
Boechst 33258 staining 
To  visualize  nuclear  morphology  and  chromatin  condensation  by  fluorescence 
following treatment with H20 2,  :freshly harvested thermotolerant and non-thermotolerant 
cells (lx10
6/ml) were washed twice with PBS and Hoechst 33258  (1  mg/ml) (blue-green 
fluorescence) (Sigma Chemical Co.), which binds to  condensed chromatin in the nucleus 
of apoptotic cells, was added for  15  min at 3  7°C  [Tan el and A  verill-Bates, 2007]. Cells 
were washed with PBS  and propidium iodide (red fluorescence)  (Sigma Chemical Co.) 
(1mg/ml)  was  added  subsequently to  stain  necrotic  cells.  Observations  were made  by 
fluorescence  microscopy  (Carl  Zeiss  Canada  Ltd.,  St.  Laurent,  QC,  Canada)  and 
photographs  were  taken  by  digital  camera  (camera  3CCD,  Sony  DXC-950P,  Empix 78 
imaging Inc, Mississauga, ON). Images were analyzed using Northem Eclipse software. 
Cells were classified using the following criteria: (1) Live cells with normal nuclei, pale 
blue/green  chromatin  with  organized  structure);  (2)  Apoptotic  cells  with  bright  blue 
/green condensed or fragmented chromatin) (3) Necrotic cells (red, enlarged nuclei with 
smooth normal structure [Tanel and Averill-Bates, 2007]. The fractions of apoptotic and 
necrotic  cells  were  determined  relative  to  total  cells  (  obtained  using  bright  field 
illumination). A minimum of300 cells was counted per sample. 
Clonogenic cell survival assay 
Clonogenic cell  survival  measures  the  ability of cells  to  undergo  cell  proliferation 
following a toxic insult. Non-thermotolerant cells, with and without pifithrin-a (1 ÜIJ.M, 
3h), and thermotolerant (  40°C, 3h) cells were exposed to H20 2 (0-1 00  11M) for 2h at 3  7°C 
in a final volume of 1.0 ml, in D-MEM containing 10% FBS. After the appropriate time, 
the  cells  were  washed  three  times  by  centrifugation  (1 000  x  g,  2  min)  to  stop  the 
incubation  [Lord-Fontaine  and  Averill-Bates,  1999].  The  cells  were  resuspended  in 
culture  medium,  diluted  to  the  appropriate  concentration  and  plated  in  tissue  culture 
dishes (60 mm x  15  mm), which were incubated at 37°C incubator in an atmosphere of 
5% COz for 10 da  ys. The dishes were th en washed with PBS, fixed with 95% ethanol and 
stained  with  methylene  blue  before  counting  macroscopic  colonies  (>50  cells). 
Cytotoxicity was expressed as the mean number of  colonies obtained relative to the mean 
number of colonies obtained in the control. Two hundred cells were seeded in the control 
plates, but where there was a loss of cell survival, cells were plated at severa! different 
densities  to  ensure  that  countable  colonies  would  be  obtained,  and  the  results  were 
corrected accordingly.  We have previously demonstrated that, in  this  system,  there  is 
linearity between the number of  cells plated and colonies formed over the range of 10-10
4 
[Lord-Fon  taine and A verill-Ba  tes, 1999]. 79 
Statistics 
Data represent means  ±  SEM  from  at  least 3  independent  experiments.  When  not 
shown, error bars lie within symbols.  Comparisons of mean values with the control were 
analysed by  the  Student's bilateral  t  test.  The Bonferroni-Holmes  stepwise adjustment 
was  used  to  control  for  the  Family-wise  error  rate  at  a  desired  level  (a=5%). 
Comparisons among multiple groups were made by one-way ANOV  A,  which measures 
the linear contrast ofmeans, with Dunnett adjustment.  Software used was JMP Statistical 
Discovery 4.0 (SAS Institute Inc., Cary, NC). For significant differences, p<0.05. 
RESULTS 
Mild  thermotolerance  developed  at  40°C  increases  the  expression  of  major 
antioxidants 
The development of thermotolerance at a mild temperature of 40°C for 3h was shown 
to  induce the protein expression of six major Hsps of 27,  32,  60,  72,  90  and  110  kDa 
[Bettaieb  and  Averill-Bates,  2008].  The present study determines whether exposure  of 
cells to  a fever temperature of 40°C for 3h could induce the expression of other cellular 
defense proteins,  such  as  antioxidants  or anti-apoptosis proteins.  Antioxidants  such  as 
SOD, catalase, GPx and glutathione play a major role in ROS regulation and hence, their 
levels were compared between thermotolerant and non-thermotolerant HeLa cells (Figs. 
1-3). The enzymatic activities of SOD (Fig.  lA and  lB) and catalase (Fig. 2A) in whole 
cell lysates were increased significantly by 38  and  49%, respectively, in thermotolerant 
cells  compared  to  control  cells. Mild  thermotolerance  also  significantly  increased  the 
protein expression of MnSOD  (41 %)  (Fig.  lC and  ID) and  catalase (46%)  (Figure 2B 
and 2C). At 40°C, there was a small increase in CuZnSOD expression (5%) (Fig.  lE and 
IF).  Furthermore,  intracellular  glutathione  levels  were  three  times  higher  in 
thermotolerant cells, compared to  non-thermotolerant cells  (Fig.  3A).  Since y-glutamyl 
cysteine  synthetase  (yGCS)  is  the  rate-limiting  enzyme  in  glutathione  synthesis,  we 80 
determined whether mild thermotolerance could alter its expression.  Indeed, the protein 
expression of y-GCS increased by 40% in thermotolerant cells compared to controls (Fig. 
3B  and  3C). However, there was no  change in the activity and  expression of GPx,  the 
other  peroxide  detoxifying  antioxidant  (Fig.  3D-3F).  These  results  show  that  mild 
thermotolerance induces  not only the  expression of Hsps,  but also  the  expression  and 
enzymatic activity of  several major antioxidants. 
Subsequently, the expression of anti-apoptosis proteins was verified in thermotolerant 
cells.  However, mild  thermotolerance  (3h, 40°C)  did  not alter the  expression  of anti-
apoptotic proteins  such  as  Bcl-2, Bip, c-FLIP,  clAPl/2 and  survivin, or pro-apoptotic 
proteins such as Bax, Bid and Bad, from controllevels (data not shown). 
Cellular levels of ROS are increased during mild thermotolerance (40°C) 
The induction of antioxidants during thermotolerance suggests that exposure to mild 
heat shock at 40°C for 3h could increase ROS  generation. Consequent! y,  levels  of ROS 
were compared in thermotolerant and non-thermotolerant cells (Fig. 4). Indeed, there was 
a 53% increase in H2DCFDA fluorescence in thermotolerant cells, relative to controls at 
37°C (Fig. 4A and 4B). Pretreatrnent of cells with PEG-catalase (300 U/ml, 3h) inhibited 
the  increase  in  H2DCFDA  fluorescence,  which  suggests  that  mild  heating  at  40°C 
increased levels of H20 2.  PEG-catalase increased intracellular catalase activity by 47% 
(Fig. 4C).  However,  there  was  no  difference  in  levels  of DHE  fluorescence  between 
thermotolerant and normal cells (Fig. 4D). 
Mild thermotolerance developed at 40°C protects HeLa cells against H20 2-induced 
mitochondrial changes 
Subsequent! y,  the  ability  of mild  thermotolerance  (  40°C)  to  protect  cells  against 
oxidative  stress-induced  apoptosis  was  investigated.  ROS  and  a  number  of stimuli, 
including  chemotherapeutic  agents,  UV  radiation  and  growth  factor  withdrawal,  can 81 
mediate  apoptosis  v1a  the  «stress-activated»  mitochondrial  pathway  [Chandra  et  al, 
2000].  An earl y event in  this pathway is  the translocation of pro-apoptotic protein Bax 
from  the  cytosol  to  mitochondria.  This  leads  to  Bax  oligomerisation  and  membrane 
insertion, which alters mitochondrial membrane potential by forming Bax pores [Lalier et 
al,  2007).  Indeed,  exposure  of HeLa  cells  to  H20 2  (2S-100  11M)  for  1h  caused  a 
significant dose-dependent increase  (30-80%) in Bax levels at mitochondria, relative to 
untreated  control  cells  (Fig.  SA,SB).  There  was  a corresponding decrease in cytosolic 
levels of Bax (data not shawn). However, when thermotolerant (40°C)  cells were treated 
with H20 2,  Bax translocation to mitochondria was diminished significantly (Fig. SA and 
SB).  This suggests that mild thermotolerance developed at 40°C inhibited H20 2-induced 
Bax translocation to  mitochondria. The purity of mitochondrial  and  cytosolic fractions 
was 97 and 98%, respectively (Fig. SC). 
To determine whether Bax translocation is associated with disruption ofmitochondrial 
transmembrane potential (6 'l'rn), HeLa cells were loaded with the cationic fluorochrome 
J C-1 . The 6  'l'rn decreased as a function of dose in cells treated with H20 2 (2S-1 00  11M) 
for lh (Fig. SD). FCCP was used as  a positive control and caused a decrease in 6  'l'rn by 
80%. 6  'l'rn was higher in thermotolerant cells compared to  normal cells (Fig.  SD), and 
this  appeared to  represent a protective effect against the decrease in  6 'l'rn induced by 
H20 2  in  non-thermotolerant  cells.  Membrane  hyperpolarization  occurred  in  untreated 
thermotolerant  control  cells,  but there was  a dose  dependent  decrease in  6  'l'rn when 
these cells were exposed to  H20 2  (Fig.  SD).  Several  studies have linked mitochondrial 
membrane hyperpolarisation with ROS generation [Russell et al, 2002; Park et al, 200S; 
Roy et al, 2009]. Indeed, the increase in mitochondrial membrane potential observed in 
untreated thermotolerant cells was  inhibited by PEG-catalase (Fig. SE), suggesting that 
the increased ROS production detected in thermotolerant cells (Fig. 4A and 4B) could be 
responsible for this effect. 82 
Once  the  mitochondrial  membrane  potential  is  altered,  proteins  located  within 
mitochondria, such as  cytochrome c and AIF, can gain access to the cytosol [Chandra et 
al,  2000].  When  HeLa cells  were treated  with H20 2  (25-1 00  11M)  for  2h, there  was  a 
significant  dose-dependent  increase  in  cytosolic  levels  of cytochrome  c,  relative  to 
unteated controls  (Fig.  6A and 6B).  Mild thermotolerance developed at 40°C inhibited 
H20 2-induced cytochrome c release from mitochondria (Fig. 6A and 6B). 
Once released into the cytosol, cytochrome c interacts with dATP, apoptosis protease 
activating factor  (Apafl) and pro-caspase-9,  forming  the  apoptosome complex.  Within 
the  apoptosome,  pro-caspase-9  is  converted  to  active  caspase-9,  which  subsequently 
causes proteolytic activation of effector caspases such as caspase-3 [Chandra et al, 2000]. 
Exposure of HeLa cells to  H20 2  (25-1 00  !lM) for 3h caused significant dose-dependent 
activation of initiator caspase-9  (Fig.  7  A)  and  caspase-3,  relative to  untreated  controls 
(Fig.  7B).  Activity  of these  caspases  decreased  significantly  in  thermotolerant  cells, 
compared  to  non-thermotolerant  cells  (Fig.  7  A  and  7B).  These  results  show  that 
preconditioning of  cells with mild heat shock attenuates H20 2-induced caspase activation. 
Mild  thermotolerance  (40°C)  protects  HeLa  cells  against  pro-oxidant-induced 
activation of the execution phase of apoptosis 
Caspase-3, once activated, plays a central role in  execution of the apoptotic pro gram 
and can  cleave certain cytoplasmic, cytoskeletal  and  nuclear protein substrates such as 
lamins, fodrin and polyADP-ribose polymerase (PARP). PARP is a DNA repair enzyme 
that catalyzes the pol y (ADP-ribosyl) ation of a variety of nuclear proteins with NAD as 
substrate,  and  is  activated  by DNA  strand  breaks  [Germain  et  al,  1999].  Cleavage of 
P  ARP by effector caspases inactivates the enzyme, which destroys its ability to respond 
to  DNA strand breaks. The cell then exhibits the characteristic hallmark features  of the 
execution phase of apoptosis such  as  chromatin condensation and  DNA fragmentation. 
Subsequently,  we  determined  if mild  thermotolerance  could  inhibit  activation  of the 83 
execution  phase of apoptosis  by H20 2.  Protein  levels  of the  85kDa P ARP  cleavage 
fragment increased significantly in HeLa cells during exposure to H20 2 for 3h (Fig.  8A 
and  8B).  Nevertheless, P  ARP cleavage was  diminished significantly in  thermotolerant 
cells. 
Nuclear  changes  of the  execution  phase  were  detected  using  the  fluorescent  dye 
Hoechst  33258  (blue-green),  which  stains  condensed  chromatin  in  the  nucleus  of 
apoptotic cells. PI (red fluorescence) was used as  a counter stain for necrosis. H20 2 (25-
100  )lM, 3h) induced apoptosis  (11-34%) in  a dose-dependent manner (Fig.  9A2-9A5, 
9C),  relative  to  control  cells  (Fig.  9A1).  It should  be noted  that  at  higher  peroxide 
concentrations (75  and 100 )lM), there was an  increase in necrosis (Fig. 9A4, 9A5, 9D), 
indicating a graduai switch in the mode of  cell death from apoptosis to necrosis. Levels of 
apoptosis  and  necrosis  were reduced  in  thermotolerant  cells  (Fig.  9B 1-9B5,  9C,  9D), 
indicating that mild thermotolerance (  40°C)  protects against induction of apoptotic and 
necrotic  cell  death  by H20 2.  The  induction  of apoptosis  by H20 2 was  significantly 
attenuated by pretreatment of cells with 300 U/ml of PEG-catalase (Fig. 9E and 9F), a 
ROS scavenger that detoxifies H20 2. 
Inhibition  of  glutathione  synthesis  during  thermotolerance  partially  decreases 
development of resistance to H20 2-induced P  ARP cleavage 
Together,  the  above  results  show  that  mild  thermotolerance  (40°C)  protects  cells 
against induction of mitochondria-mediated apoptosis by H20 2. To  confirm the role of 
antioxidant induction by mild heat at  40°C in the development of resistance to  H20 2-
induced apoptosis, cells were treated with L-BSO, an  inhibitor of y-GCS.  L-BSO was 
present during the 3h heating period at 40°C, to prevent any new synthesis of glutathione 
during the development of  thermotolerance. P  ARP cleavage mediated by H20 2-treatment 
was  evaluated, being a  late stage  event of apoptosis.  Indeed,  the inhibition of H202-
induced P  ARP cleavage in thermotolerant cells was partially reversed wh  en cells were 84 
treated with L-BSO (Figure 1  0). This was seen as an increase in expression of the PARP 
cleavage  fragment  (85  kDa)  in  L-BSO-treated  thermotolerant  cells,  compared  to 
thermotolerant cells al one. In contrast, treatment of non-thermotolerant cells with L-BSO 
for 3h at 3  7°C did not increase H20 2-induced P  ARP cleavage (Figure 1  0).  In fact,  P  ARP 
cleavage by the higher dose of H20 2 75  (f.!M) was decreased with L-BSO. L-BSO did not 
affect levels of  P  ARP fragment in untreated (no H20 2)  controls during 3h at 3  7 or 40°C. 
These data indicate that the antioxidant glutathione contributes partially to the protective 
effect of mild ~hermotolerance against H20 2-induced apoptosis. However, we cannot rule 
out the contribution of other antioxidants such as MnSOD and catalase in this protective 
effect. 
H20 2  activates  caspase-independent  apoptosis  involving  AIF:  protective  effect  of 
mild thermotolerance induced at 40°C 
Apoptosis can proceed through pathways that involve the fYSteinyl  .ê,Spartate-~pecific 
.Qroteases (caspases), or through caspase-independent pathways [Leist and Jaattela; 2001]. 
AIF,  located  within  the  mitochondrial  inner  membrane, plays  a  key role  in  caspase-
independent cell death processes, when released  from  mitochondria and  translocated to 
the nucleus [Modjtahedi et al, 2006; Cregan et al, 2004]. AIF can bind directly to  DNA, 
which stimulates its DNAse activity, leading to  chromatin condensation and large-scale 
DNA fragmentation. Thus, mitochondrial proteins, once released, can trigger at least two 
different  death-signaling  pathways,  by  caspase-dependent  and  caspase-independent 
mechanisms.  To  determine  the  protective  role  of mild  thermotolerance  against  this 
caspase-independent pathway in H20 2-treated HeLa cells, the translocation of AIF from 
mitochondria  to  the  cytosol  and  nucleus  was  analyzed  by Western  blot.  Effectively, 
exposure to H20 2 (25-100  J.!M)  for  lh caused significant dose-dependent translocation of 
AIF  to  the  nucleus  (Fig.  llC  and  llD)  via  the  cytosol  (Fig.  liA  and  liB).  In 
thermotolerant  cells,  AIF  translocation  to  the  nucleus  was  decreased  significantly 
compared  to  their  non-thermotolerant  counterparts  (Fig.  11A-11D).  These  findings 85 
indicate  that  mild  thermotolerance  affords  protection  against  caspase-independent  cell 
death triggered by ROS. 
Role of p53 in H20 2-induced apoptosis 
The role of p53  as  a transcription factor has been extensively described.  lt plays  an 
important role in a wide variety of cellular functions  like DNA repair,  cell  cycle arrest 
and apoptosis [Schuler and Green, 2001]. p53  is activated by different stress conditions, 
which  include  ROS,  DNA  damage,  nucleotide  depletion,  hypoxia  and  oncogene 
activation. Post-translational modifications such as phosphorylation and  acetylation play 
a key role  in  its  pro-apoptotic activity.  As  a  transcription  factor,  phosphorylated p53 
induces transcription of pro-apoptotic proteins such as  Bax and  the BH3-only proteins 
Noxa and PUMA, and it suppresses the activity of anti-apoptotic proteins such as  Bcl-2 
[Miyashita and Reed, 1995; Yu et al, 2003]. We therefore determined whether induction 
of apoptosis by H20 2 in HeLa cells could be mediated by p53. The activation ofp53 was 
assessed  by  looking  at  its  phosphorylation  status  using  phospho-specific  antibodies. 
Exposure  of cells  to  H20 2  (50  )lM)  for  lh caused  significant p53  phosphorylation  at 
Ser46  and  Ser15  (Fig.l2A-12C). Mild thermotolerance (40°C, 3h)  exerted  a protective 
effect  by  decreasing  the  level  of p53  phosphorylation  (Fig.  12A-12C).  There  was  no 
change in the expression of p53  protein in non-thermotolerant and  thermotolerant HeLa 
cells, with or without peroxide treatment (Fig.  12A and  12D).  In  order to  clarify further 
the role of p53  in  H20 2-induced  apoptosis  in  HeLa cells,  we  studied  the downstream 
targets of p53  such as  PUMA and  Bax.  Indeed, H20 2  induced upregulation of the p53 
target protein PUMA (Fig.  13A-13B), as well as  Bax translocation to mitochondria (Fig. 
SA and SB,  13C and  13D). The role of p53  was  confirmed by significant inhibition of 
these  events  by  a  p53  inhibitor,  pifithrin-a  (Fig.  13A-13D).  Furthermore,  PUMA 
upregulation  and  Bax  translocation  were  inhibited  in  thermotolerant  cells  (Fig.  13A-
13D). Treatment with pifithrin-a also  diminished significantly H20 2-induced chromatin 
condensation  (Fig.  14A  and  14B). These  results  show  that  p53  is  an  upstream  factor 86 
leading  to  PUMA  upregulation  and  mitochondrial  Bax  translocation,  which  favor 
mitochondria-mediated apoptosis in H20 2-treated HeLa cells. 
Protective effect of mild thermotolerance against H20 2-induced cytotoxicity 
We  next  determined  whether  mild  thermotolerance  could  protect  cells  against 
clonogenic cell killing (  cytotoxicity) under conditions where mild hyperthermia afforded 
resistance  to  H20 2-induced  apoptosis.  Exposure to  H20 2  (0-150~-LM) caused  a marked 
decline in clonogenic cell  survival, and  in thermotolerant cells, there was  a significant 
protective effect (p=0.0002) (Fig. 14C). Subsequently, we evaluated whether inhibition of 
p53  with pifithrin-a could protect against H20 2-induced  clonogenic cell  killing.  There 
was  a  tendency  for  a  small  protective  effect  against  cytotoxicity  induced  by higher 
concentrations  of H20 2  (1 00-150  11M)  in  cells  that  were  treated  with  p53  inhibitor 
pifithrin-a (Fig. 14C). 
DISCUSSION 
Mild thermotolerance induced at 40°C increases ROS generation and expression of 
major antioxidants in HeLa cells 
The present study shows that protein expression and enzymatic activity of two major 
antioxidants,  MnSOD  and  catalase,  were  increased  in  HeLa  cells  following  the 
development  of thermotolerance  at  a  non-lethal,  fever  temperature  of 40°C  for  3h. 
Intracellular levels  of glutathione were  also  increased  in  thermotolerant  cells  and  this 
could be explained by increased expression of yGCSc. The exposure of rat myocardium 
to who le body hyperthermia (  42°C,  15 min) led to a delayed increase in MnSOD content, 
which was revealed 24 to 72h after the beat treatment [Y amashita et al, 1998]. 
The induction of antioxidants, such  as  catalase, MnSOD and glutathione, during the 
development of  thermotolerance suggests that ex  po sure to mild beat shock at 40°C for 3h 87 
could  increase  ROS  generation.  Indeed,  ROS  levels  (H2DCFDA  fluorescence)  were 
increased at 40°C in HeLa cells. An interesting point is that the 45% increase in catalase 
activity  observed  after  exposure  to  40°C  for  3h  was  not  enough  to  fully  prevent  the 
increased  peroxide  formation  (H2DCFDA  fluorescence),  while  an  additional  47%  of 
catalase activity achieved by incubation with PEG-catalase was effective. However, the 
increase  in  catalase  activity  is  probably  a  consequence  of increased  H20 2  formation 
during the  heat  treatment  at  40°C.  This  situation  could  be also  explained  in  terms  of 
intracellular compartments. Catalase is localised in peroxisomes, but it is not clear where 
PEG-catalase would be localised once inside the  cell.  This could be in  the cytosol,  or 
other  compartments,  since  PEG  allows  catalase  to  cross  biological  membranes.  ln 
addition,  the intracellular site(s)  of increased  generation of ROS  by heat is  unknown, 
although mitochondria would be a likely source. 
The  increased  ROS  levels  at  40°C  in  HeLa  cells  in  tum  led  to  mitochondrial 
membrane hyperpolarisation.  The mechanisms involved in membrane hyperpolarisation 
are  currently unknown.  Severa}  studies reported  that exposure to  heat shock at  higher 
temperatures, such as 42 to 45°C for 20 to  60 min, led to increased free radical electron 
paramagnetic  resonance  (EPR)  signais  [Flanagan  et  al,  1998]  and  oxidative  stress 
[Bettaieb  and  Averill-Bates,  2008;  Lord-Fontaine  and  Averill-Bates,  1999;  Li  and 
Oberley, 1997;  Lord-Fontaine and  Averill-Bates,  2002;  Spitz  and  Li, 1990;  Shin  et  al, 
2008].  Hyperthermia  is  able  to  activate  redox-sensitive  signaling  and  transcription 
factors,  where the initial  cellular response is  primarily mediated by heat  shock factors 
(HSF)  [Gius  et  al,  2004].  Oxidative  stress  and  heat  exposure  can  induce  common 
alterations in early response genes such as p53, p21, AP-l, NF-KB,  etc., which suggests 
that  heat  shock  could  have  similarities  to  other  environmental  stresses  that  induce 
oxidative  stress  [Gius  et  al,  2004].  Furthermore,  there  is  considerable  overlap  in 
signalling pathways, such as Ras and mitogen activated protein kinases (MAPK), which 
are induced by oxidative stress and heat shock. 88 
Low dose exposure to different stresses can lead to adaptive responses that allow cells 
and organisms to continue normal function in the face of an adverse stimulus [Holsapple 
and  Wallace,  2008].  Adaptive  responses  often  involve  changes  in  gene  and  protein 
expression,  including  the  induction  of cellular  defenses  to  enable  the  cell  to  survive 
[Davies, 2000]. Organisms have developed an intricate system of  defense molecules (e.g. 
Hsps,  antioxidants,  lAPs,  etc.)  to  protect  themselves  against  diverse  toxic  and 
environmental stresses. If  the adaptive response cannot protect the cell against an adverse 
stress  exposure,  then  the cell  will  be eliminated by death  processes  such  as  apoptosis 
[Davies,  2000].  It is  well  established  that  thermotolerance  developed  at  both  lethal 
(>42°C)  [Landry  et  al,  1982;  Landry  et  al,  1989]  and  non-lethal  (39.5-41.5°C) 
temperatures  [Przybytkowski  et  al,  1986;  Bettaieb  and  Averill-Bates, 2008;  Field  and 
Anderson, 1982] is associated with increased expression of Hsps. A novel finding in this 
study is  that,  in addition to  Hsps,  preconditioning of HeLa cells  with mild heat shock 
(  40°C) can also induce several major antioxidants. 
Mild thermotolerance developed at 40°C protects HeLa cells against H20 2-induced 
mitochondrial apoptosis 
Subsequently,  our  results  show  that  mild  thermotolerance  (  40°C)  inhibited  the 
molecular events  involved  in  the mitochondrial  cascade  of apoptosis  induced  by pro-
oxidant H20 2 in HeLa cells. This entailed inhibition of Bax translocation to mitochondria, 
loss of mitochondrial membrane potential, cytochrome c release, activation of caspase-9 
and  -3,  PARP  cleavage  and  nuclear  chromatin  condensation.  The  induction  of 
mitochondrial apoptosis by H20 2 has been reported in several cellular models [Chandra et 
al,  2000;  Barbouti  et  al,  2002;  Antunes  and  Cadenas,  2001],  although  the  signalling 
mechanisms involved are not completely understood. Furthermore, thermotolerant cells 
were able to  maintain reproductive integrity following an H20 2 insult.  These results  are 
potentially  significant  to  the  ability  of cancer  cells  to  exhibit  heat-induced  cross 89 
resistance to  therapeutic agents,  such  as  radiation and  oxidant-generating drugs,  which 
kill cancer cells via oxidative stress. 
The protective effects of  mild thermotolerance against peroxide-induced apoptosis and 
necrosis  in  HeLa cells  could  be attributed  to  both  Hsps  and  antioxidants  (Scheme  1  ). 
Hsps  seem  to  have  a  complex  role  in  regulation  of apoptosis  [Beere,  2004].  Hsp70 
appears  to  inhibit  apoptosis  by  interfering  with  events  upstream  of mitochondrial 
membrane  permeabilization  that  ultimately  decrease  Bax  activation  and  block 
cytochrome c release [Steel et al, 2004; Stankiewicz et al, 2005]. Hsp70 can  also protect 
against oxidative injury [Musch et al, 1996; Chen et al, 1999a; Komatsuda et al, 1999]. 
Hsp27 can block mitochondrial ROS generation, thus suppressing the loss of membrane 
potential  and  cytochrome  c  release  [Samali  et  al,  2001].  In  addition,  Hsp27  can 
upregulate glutathione levels, which helps in  maintaining the cellular redox equilibrium 
[Mehlen et al, 1996]. Hsp27, Hsp70 and Hsp90 can inhibit apoptosome formation, thus 
preventing caspase-9 activation [Beere, 2004]. Hsp72 inhibited procaspase-3 processing 
and  P  ARP  cleavage induced by heat-shock, thus  preventing the executionary events of 
the apoptotic process [Buzzard et al, 1998]. 
The mitochondrial  antioxidant defense  systems  appear to  play a critical  role in  the 
regulation of apoptosis [Ott et al, 2007]. The intracellular sites of  ROS generation during 
mild heat stress are not presently known. Mitochondria are a likely candidate given that 
the respiratory chain is  a major cellular source of ROS, mainly at  Complexes I and  III 
[Ott et al, 2007].  Increased content of cellular defense proteins such as  MnSOD could 
thus  play  a protective  role  against  apoptosis  in  H20 2-treated  thermotolerant  cells  by 
buffering  mitochondrial  ROS  production.  Upregulation  of  MnSOD  protected 
adenocarcinoma and  neuronal  cells  against apoptosis  induced by stresses  su ch  as  UV, 
doxorubicin  and  tumor  necrosis  factor-a  [Delhalle  et  al,  2002;  Sompol  et  al,  2006]. 
Furthermore,  overexpression  of MnSOD  attenuated  cytochrome  c  release,  caspase-9 90 
activation and  apoptotic cell death in mice after focal  cerebral ischemia [Noshita et al, 
2001].  The  overexpression  of the  antioxidant  enzymes  MnSOD,  CuZnSOD  and  Gpx 
protected  cells  against  ionizing  radiation  injury  [Sun  et  al,  1998].  The  influence  of 
catalase activity on apoptosis is less clear and both anti-apoptotic and pro-apoptotic roles 
have been found [Kahl et al,  2004].  The GSH redox status, particularly in mitochondria, 
appears to  be a central player in apoptosis [Circu, 2008].  Opening of the mitochondrial 
transition pore (MTP) is redox-dependent. Depletion of GSH leads to MTP opening and 
mitochondrial apoptosis. The antioxidant N-acetylcysteine, which increases intracellular 
GSH  levels,  protected  CHO  cells  against  acrolein-induced  mitochondrial  apoptosis 
[Tanel  and  Averill-Bates,  2007].  Therefore,  increased  levels  of  GSH  during 
thermotolerance could protect cells against the loss of mitochondrial membrane potential 
during peroxide-induced apoptosis. Our findings suggest that upregulation of  antioxidants 
by mild temperatures such as  40°C could scavenge mitochondrial ROS  and thus play a 
role in regulation of  apoptosis induced by pro-oxidant stresses (Scheme 1  ). 
H20 2  activates  caspase-independent  apoptosis  involving  AIF:  protective  effect  of 
mild thermotolerance induced at 40°C 
This  study  shows  that  H20 2  can  induce  both  caspase-dependent  and  caspase-
independent  pathways  of apoptosis  in  HeLa  cells.  Interestingly,  AIF  release  into  the 
cytosol and its translocation to the nucleus occurred rapidly after a 1h exposure to H20 2, 
whereas caspase activation occurred later,  after 3h. The cytosolic and  nuclear levels of 
AIF  were  considerably  lower  in  thermotolerant  cells,  compared  to  their  non-
thermotolerant counterparts, indicating that mild temperatures could also protect against 
caspase-independent  cell  death  mediated  by H20 2.  Hsp70,  which  is  induced  by mild 
thermotolerance, can neutralize AIF, either by inhibiting its release from  mitochondria 
and/or sequestering it once leaked into the cytosol [Ravagnan et al, 2001 ; Ruchalski et al, 
2003]. Apart from  its  pro-apoptotic role, recent  studies  show  that  AIF  plays  an  anti-
apoptotic role by maintaining integrity of components (Complex I)  of the mitochondrial 91 
electron transport chain and by regulating mitochondrial ROS production via its putative 
oxidoreductase and peroxide scavenging activities [Modjtahedi et al,  2006; Cregan et al, 
2004]. Thus, low levels of AIF in cytosolic and nuclear fractions indicate that AIF could 
play a cytoprotective role by ensuring proper mitochondrial  function  in thermotolerant 
cells.  Interestingly,  continuous rather than  bolus  addition  of H20 2  caused  nuclear AIF 
translocation and caspase-independent apoptosis in Jurkat cells, under conditions where 
caspase-dependent  apoptosis  was  inhibited  through  an  iron-dependent  mechanism 
[Barbouti et al, 2007). AIF appears to be a safeguard death mechanism under conditions 
where there  is  ineffective activation of caspases  [Cregan  et  al, 2004,  Ravagnan  et  al, 
2001]. 
Protective effect of mild thermotolerance against H20 2-induced p53 activation 
Finally, our findings using pifithrin-a indicate that p53 is an upstream factor leading to 
increased  expression  of PUMA  and  Bax  translocation  to  mitochondrial, during  H20 2-
induced  apoptosis  in  HeLa  cells.  p53,  as  a  transcription  factor,  is  able  to  induce 
transcription of PUMA, whose expression can  antagonize mitochondrial Bcl-2 proteins, 
thus  promoting  mitochondrial  translocation  and  multimerization  of Bax  [Schuler  and 
Green, 2001; Miyashita and Reed, 1995; Yu et al, 2003). Apoptosis induced by H20 2  (1 
mM, 24h) in glioma cells was associated with increased p53 protein expression [Datta et 
al, 2002]. In rat neural AF5 cells, H20 2 (800 11M, 24h) increased the protein expression of 
p53, p53-Ser15 phosphorylation, PUMA, Noxa and Bax [McNeill-Blue et al, 2006). 
Mild thermotolerance decreased  H20 2-induced p53  activation,  and  induction  of the 
target proteins PUMA and Bax, in HeLa cells. This protective effect could be attributed 
to  both  Hsps  and  antioxidants.  However,  regulation  of the  p53  pathway  by Hsps  is 
complex  and  not well  understood.  Hsp70  is  involved  in  suppression  of p53-induced 
senescence signaling in transformed cells, which indicates that Hsp70 plays  an  essential 
role in maintaining cell growth upon activation of oncogenic signalling pathways [Gabai 92 
et al,  2009].  Pre-treatment with thermal  stress  (  42°C, 4h)  protected  HepG2  cells  from 
UVC-induced apoptosis [Chen et al,  1999b  ].  The anti-apoptotic effect of thermal stress 
appeared  to  be due  to  formation  of a  HSP70-p53  complex,  thus  allowing  increased 
stability and  DNA binding activity of p53. Consequently,  p53  could perform  its  anti-
apoptotic effect by activating p53-dependent genes  such  as  p21  and  GADD45  that are 
involved in DNA repair.  Hsp70, in  co-operation with Hsp40, can inhibit mitochondrial 
Bax translocation  [Beere, 2004].  Interactions between Hsps and  PUMA have not been 
reported. 
Interactions between p53, ROS and antioxidants are complex and not weil understood 
[Liu et al, 2008]. p53 is able to regulate apoptosis by protein interactions at mitochondria 
and at the transcriptional lev  el in the nucleus [Siee et al, 2004]. During apoptosis induced 
by tumor promoter 12-0 tetradecanoylphorbol-13-acetate, p53 underwent translocation to 
mitochondria, where it directly bound to  and inhibited MnSOD [Zhao et al,  2005]. p53-
mediated MnSOD inactivation led to subsequent activation of  p53  transcriptional activity 
and  induction  of pro-apoptotic target  genes  such  as  Bax. Translocation  of p53  to  the 
nucleus and induction of Bax protein was blocked by a SOD mimetic (MnTE-2-PyP
5+). 
This indicates that overexpression of MnSOD during mild thermotolerance could inhibit 
H202-mediated  activation  of p53.  Furthermore,  overexpression  of catalase  protected 
HepG2 cells against apoptosis induced by DNA-damaging agents  [Bai  and  Cederbaum, 
2003].  The  protective  effect  was  associated  with  decreased  p53  phosphorylation  and 
accelerated proteasomal degradation of p53  protein. p53  is a redox-sensitive protein that 
undergoes oxidation at cysteine residues that contain redox-sensitive thiol groups [Liu et 
al,  2008].  During  oxidative  stress,  p53  undergoes  S-glutathionylation,  which  inhibits 
DNA binding activity ofp53. This process was reversed when GSH levels were increased 
by  N-acetylcysteine.  During  mild  thermotolerance,  increased  cellular  levels  of 
glutathione  could  also  affect  the  S-glutathionylation  status  and  function  of p53. 
Furthermore, increased binding of p53  to  GSH  could  occur, which would prevent p53 93 
binding and inactivation of MnSOD, thus maintaining mitochondrial antioxidant activity. 
It appears that each of the antioxidants that are increased during mild thermotolerance 
(40°C) is capable ofregulating the pro-apoptotic activity ofp53. 
CONCLUSION 
This  study  shows  that  febrile  temperatures  such  as  40°C  can  induce  mild 
thermotolerance and upregulation of the expression of antioxidants, in addition to  Hsps. 
Preconditioning with mild  heat stress  is  an  adaptive stress response that  could  protect 
cells  and  tissues  against  damage  caused  by  diverse  environmental  stresses  (e.g. 
pesticides, radiation, pharmaceutical drugs  and  hypoxia) whose toxicity is  mediated by 
ROS.  Adaptive  stress  responses  favour  survival  responses  by  counteracting  stress-
induced  damage  to  lipids,  proteins  and  DNA,  increasing  cellular  tolerance  to  such 
damage, or by inhibiting pro-apoptotic signaling pathways (e.g. p53). If the stress is too 
severe,  then  damaged  cells  are  eliminated  by  apoptosis.  Improved  knowledge  about 
mechanisms of adaptation to  stressful and  extreme environments provides the basis for 
understanding environmental health problems, performing toxicological risk assessment, 
and  in  clinical  applications  against  many  disease  states  that  involve  ROS,  such  as 
neurodegenerative and respiratory disorders, atherosclerosis and cancer. 
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Figure  1  A  mild  temperature  of 40  °C  induces  enzymatic  activity  and  protein 
expression of antioxidant MnSOD. (A)  Enzymatic activity of SOD  was  analysed by 
zymography. SOD activity in thermotolerant (3h, 40°C)  ( o) and non-thermotolerant (3h, 
3  7°C) ( D) HeLa cells was revealed as discoloured bands on a purple colored background 
after staining with NBT. (B) Enzymatic activity was quantified by densitometry relative 
to non-thermotolerant control cells at 37°C (1 00 %).  (C-F) Protein expression of  MnSOD 
and CuZnSOD was detected by Western blot using GAPDH (36 kDa) as loading control. 
Representative blots from  three independent experiments  are  shown  for  expression  of 
MnSOD (25  kDa)  (D)  and CuZnSOD (23  kDa)  (F).  Protein levels of MnSOD (C), and 
CuZnSOD (E)  were analysed by densitometry and expressed relative to  control cells at 
37°C (1 00%). For levels/activity of SOD at 40°C relative to controls at 37°C: P<0.05  (*), 
P<O.Ol  (**). B 
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Figure 2 Mild beat treatment at 40 °C  increases activity and protein expression of 
H20 2  scavenger  catalase.  (A)  Enzymatic  activity  and  (B,  C)  protein  expression  of 
catalase were analysed in whole cell lysates  of thermotolerant (3h, 40°C)  ( o) and  non-
thermotolerant (3h, 37°C)  ( o) HeLa cells.  (A)  Catalase activity increased from  3.71  ± 
0.67  to  6.20  ±  0.30  11mol/min/1 0
6  cells.  Mean  and  SEM  from  three  independent 
experiments.  (B)  Representative  blots  for  expression  of  catalase  are  from  three 
independent  experiments.  (C)  Densitometric  analyses  of  catalase  expression  in 
thermotolerant cells are relative to  non-thermotolerant control  (37°C)  cells  (1 00%).  For 
levels/activity of catalase at 40°C relative to controls at 37°C: P<O .OS  (*), P<0.01  (**). A 
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Figure 3 Mild thermotolerance at 40 °C increases intracellular levels of antioxidant 
glutathione and yGCS. (A)  Intracellular glutathione content and (D)  GPx activity were 
determined in thermotolerant (3h, 40°C) (D) and non-thermotolerant (3h, 37°C) (D) HeLa 
cells.  Representative  blats from  three independent  experiments  are  shawn  for  protein 
expression  of (B)  yGCS  (73  kDa)  and  (E)  GPx  (22  kDa), using  GAPDH  (37kDa)  as 
loading control. Densitometric analyses of the expression of (C) yGCS  and (F)  Gpx are 
relative to  non-thermotolerant control (37°C)  cells, designated as  100%. For glutathione 
and yGCS levels at 40C relative to controls at 37°C: P<0.05 (*), P<O.Ol  (**). .....------ -
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Figure  4  ROS  generation  increases  during  induction  of mild  thermotolerance at 
40 °C. (A) A representative FacsScan plot from three independent experiments is shown 
for  H2DCFDA  fluorescence  in  thermotolerant  (3h,  40°C)  (black  line)  and  non-
thermotolerant  (3h,  37°C)  (red  line)  HeLa  cells. Where  indicated,  thermotolerant  cells 
were  pretreated  with  300  U/rnJ  PEG-catalase  for  3h  (green  line).  Data  for  relative 
fluorescence intensity for (B) H2DCFDA and  (D) DHE represent means and  SEM from 
three  independent  experiments  and  are  relative  to  the  untreated  control  (100%).  (C) 
Catalase activity was  determined in  cells (5 x  10
6
)  following incubation with 300 U/mJ 
PEG-catalase  for 3h, relative to contrais.  For catalase activity  and  ROS  levels  at  40°C 
relative to contrais at 37°C: P<0.05 (*), P<O.Ol  (**). A  Bax (21  kDa) 
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Figure 5 Thermotolerance developed  at 40  °C  protects cells  against H20 2-induced 
mitochondrial  Bax  translocation  and  mitochondrial  membrane  depolarization. 
Thermotolerant (3h, 40°C)  ( o) and non-thermotolerant (3h, 3  7°C)  ( o) HeLa cells were 
incubated for 60  min at 37°C with H20 2  (0-100  iJ.M)  in D-MEM containing  10% FBS. 
(A)  Representative blots  are  shown for  Bax  (21  kDa)  protein  levels  in  mitochondrial 
fractions.  (B)  Densitometric analysis of mitochondrial Bax expression is relative to non-
thermotolerant control cells at 37°C (100%). Means and SEM are from  four independent 
experiments. (C) A representative blot is shown for purity of subcellular fractions, using 
lamin  A, glutathione  S-transferase  (GST-nl)  and  cytochrome oxidase for  nuclear (N), 
cytosolic (C)  and mitochondrial (M) fractions, respectively. (D) Thermotolerant (D) and 
non-thermotolerant ( o) control cells at 37°C (100%) were analyzed by flow  cytometry 
for  JC-1  fluorescence, (E)  with or without PEG-catalase. FCCP (25  iJ.M)  was  added to 
non-thermotolerant  (  t!l  )  and  thermotolerant  (  rn )  cells  as  a  positive  control  for 
mitochondrial  membrane  depolarization.  Data  represent  means  and  SEM  of relative 
fluorescence intensity from three independent experiments. P<O.OS  (*,&)or P<0.01  (**, 
&&) indicates a statistically significant difference between treatment with H20 2  and the 
respective untreated control, for thermotolerant (&)or non-thermotolerant (*) cells. (B,C) 
For comparison of curves for Bax expression and membrane potential in thermotolerant 
versus normal cells, P<O.OOOl. A 
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Figure 6 H20 2-induced release of cytochrome c from mitochondria is  decreased by 
mild thermotolerance (40 °C). Thermotolerant (3  h, 40°C) ( o ) and non-thermotolerant 
(3h, 3  7°C)  (  o ) HeLa cells were incubated with H20 2 (0-1 00 JlM)  at 3  7°C for 2h.  (A) 
Representative b1ots are shown for cytosolic expression of cytochrome c (11  kDa) using 
GAPDH (37 kDa) as  loading control.  (B) Protein levels were analysed by densitometry 
and expressed relative to control cells at 3 7°C (1 00%).  Data are mean and SEM of three 
independent experiments.  P<0.05  (*,  &)  or P<0.01  (**,  &&)  indicates  a  statistically 
significant difference between treatment with H20 2  and the respective untreated control, 
for  thermotolerant  (&)  or  non-thermotolerant  (*)  cells.  P<0.05  (#),  P<0.01  (##)  or 
P<O.OOl  (###)  indicates  a  statistically  significant  difference  for  cytochrome  c  levels 
between thermotolerant and non-thermotolerant cells. 100 
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Figure 7 Mild thermotolerance (40 °C) inhibits activation of caspase-9 and caspase-3 
by H 20 2• Thermotolerant (3  h, 40°C)  ( o) and non-thermotolerant (3h, 3  7°C)  ( D ) HeLa 
cells were incubated with H20 2  (0-1  00  JlM)  at 3  7°C for  3h. Enzymatic activities of (A) 
caspase-9  and  (B)  caspase-3  were  determined  by  spectrofluorimetry  and  expressed 
relative to  non-thermotolerant control  (3 7°C)  cells, designated as  100%.  Data represent 
mean and SEM from  three independent experiments performed with multiple estimations 
per point.  P<0.05  (*, &), or P<O.Ol  (**, &&), or P<0.001  (***) indicates a statistically 
significant  difference  for  +/- H20 2,  for  thermotolerant or non-thermtolerant  cells.  For 
comparison of curves for caspase-9 and caspase-3  activity in thermotolerant versus non-
thermotolerant cells, P<0.0001  and P=0.0004, respectively. 101 
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Figure  8  Mild  thermotolerance  diminishes  H20 2-induced  P  ARP  cleavage. 
Thermotolerant (3h, 40°C)  ( o) and non-thermotolerant (3h, 3  7°C)  ( o) HeLa cells were 
incubated for  3h at 37°C with H20 2  (0-100  11M)  in D-MEM containing 10% FBS. (A) 
Immunodetection of native PARP (116 kDa) and cleaved PARP (85  kDa) in whole cell 
lysates was carried out by Western blotting, using GAPDH (37 kDa) as  loading control. 
(B) Densitometric analysis of cleaved P  ARP expression is relative to non-thermotolerant 
control  (37°C)  cells,  designated  as  100%.  Data represent means  and  SEM from  four 
independent experiments performed with multiple estimations per point. P<0.05  (*, &)or 
P<0.01  (**, &&)  indicates a statistically significant difference between treatment with 
H20 2  and the respective untreated control, for thermotolerant (&) or non-thermotolerant 
(*)  cells.  P<0.05  (#),  P<0.01  (##)  or P<0.001  (###)  indicates a  statistically significant 
difference for cleaved P  ARP between normal and thermotolerant cells. 102 
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Figure 9 Mild  thermotolerance at 40 °C  protects against HzOz-induced  chromatin 
condensation and necrosis. Thermotolerant (3h, 40°C (B 1-B5))  and  non-thermotolerant 
(3h, 37°C (A l-AS)) HeLa cells were incubated with H20 2 (0-100 f.i.M)  for 3h. (E, F) Cells 
were  pre-incubated  for  3h  with  300 U/ml  of PEG-catalase  before  addition  of 50  f.i.M 
H20 2.  Nuclear  morphology  was  assessed  by  fluorescence  microscopy  using  Hoechst 
33258  to  detect  blue-green  apoptotic  cells  and  PI  to  detect  red  necrotic  cells 
(Magnification 320X). The fractions of apoptotic (C, E) and necrotic (D) cells are relative 
to  total  cells.  (A,  B, F)  Photographs are representative of three individual experiments. 
P<O.OS  (*,  &),  P<O.Ol  (**,  &&),  or  P<O.OOl  (***,  &&&)  indicates  a  statistically 
significant difference between treatment with H20 2 and the respective control.  (E) P<O.Ol 
(##) or P<O.OOl  (###) indicates a statistically significant difference for apoptosis in  cells 
+1- PEG-catalase. 103 
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Figure  10  Inhibition  of  glutathione  synthesis  during  thermotolerance  partially 
decreases the development of resistance to H20 2-induced PARP cleavage. HeLa cells 
were pretreated for  3h at 37°C  (non-thermotolerant)  or 40°C  (thermotolerant), with  or 
without BSO (lmM), and then exposed to H20 2 (0, 50, 75JlM) for 3h at 37°C in D-MEM 
containing 10% FBS. A) Immunodetection of  native PARP (116 kDa) and cleaved P  ARP 
(85  kDa) in whole cell lysates was carried out by Western blotting, using GAPDH (37 
kDa)  as  loading  control.  (B)  Densitometric  analysis  of cleaved  P  ARP  expression  is 
relative to non-thermotolerant controls (3 7°C), designated as 100%. Data represent means 
and  SEM from  four independent experiments performed with multiple estimations per 
point.  P<O.Ol  (##)  indicates  a  statistically  significant  difference  for  cleaved  PARP 
between normal and thermotolerant cells, or normal versus L-BSO treated cells. 104 
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Figure 21 Thermotolerance induced at 40 °C inhibits H20 2-induced translocation of 
AIF from  mitochondria to  the nucleus.  Thermotolerant  (3h,  40°C)  ( o  )  and  non-
thermotolerant (3h, 37°C)  ( D) HeLa cells were incubated for lh at 37°C with H20 2  (0-
1  00  )lM)  in  D-MEM  containing  10%  FBS.  Representative  blots  for  expression  of 
cytosolic (B), mitochondrial (data not shown), and nuclear (D) AIF (57 kDa) are shown, 
using  GAPDH  (37  kDa)  as  loading control  for  the  cytosolic fraction.  Densitometric 
analyses of  the expression of (A) cytosolic AIF and (C) nuclear AIF are shown relative to 
control  cells  at  37°C  (100%).  Data represents mean and  SEM from  three independent 
experiments.  P<0.05  (*,  & )  indicates  a  statistically  significant  difference  between 
treatment with  H20 2  and  the respective untreated  control.  P<0.05  (#)  or P<O.Ol  (##) 
indicates a statistically significant difference for AIF between normal and thermotolerant 
cells. 
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Figure 3 H20 2-induces phosphorylation of p53 at ser 15 and ser 46. Thermotolerant 
(3h, 40°C)  ( o) and non-thermotolerant (3h, 37°C)  ( o) HeLa cells were incubated with 
H20 2  (0,  50  J.lM)  for  lh and  then immunodetection of p53, p-p53  (Ser15), and p-p53 
(Ser46)  was  carried  out.  (A)  Representative  blots  are  shown  from  three  independent 
experiments. Densitometric analyses of  the expression ofp53 (D), p-p53 (Ser46) (B), and 
p-p53  (Ser15) (C)  are relative to  non-thermotolerant control (37°C)  cells, designated as 
100%,  using  GAPDH  as  loading  control.  Data represents  mean  and  SEM  from  three 
independent experiments performed with multiple estimations per point. P<0.05 (*, &)or 
P<O.OOl  (***,  &&&)  indicates  a  statistically significant difference between treatment 
with H20 2  and the respective control.  P<O.OOl  (###) indicates a statistically significant 
difference for p53 between normal and thermotolerant cells. A 
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Figure 13  Inhibition of p53 by pifithrin-a decreases induction of PUMA and Bax 
translocation by H20 2• Normal and thermotolerant cells were pretreated for 3h at 37°C 
with  or  without  10  11M  pifithrin-a  and  th en  exposed  to  H20 2  (0-50  11M)  for  1  h. 
Representative blots from  three individual experiments are shown for expression of (B) 
PUMA  (25  kDa)  and  (C)  Bax  (21  kDa)  in  mitochondrial  fractions,  with  or without 
pifithrin-a.  Densitometric analyses  of (A)  PUMA and  (D)  Bax  expression  are  shown 
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RÉSUMÉ 
L'exposition  des  cellules  à  des  températures  modérées  de  40°C  induit  une 
thermotolérance  leur  permettant  de résister  à  des  expositions  toxiques  subséquentes. 
Cette  recherche  étudie  les  mécanismes  impliqués  dans  les  effets  protecteurs  d'une 
thermotolérance  modérée  (  40°C,  3h)  contre  1' activation  de  la  voie  extrinsèque  de 
l'apoptose  induite  par  le  peroxyde  d'hydrogène  (H20 2)  chez  les  cellules  HeLa.  Le 
peroxyde d'hydrogène (5-50  )lM)  entraîne une activation rapide (1-3h)  de la voie des 
récepteurs  de la mort activée par Fas,  ce  qui  est mis en  évidence par une régulation 
positive de FasL et le recrutement de sa molécule adaptatrice F  ADD  (Fas  Associated 
Death Domain) au  niveau de la membrane plasmique. Ceci résulte en l'activation de  la 
caspase 8 et de la caspase 2, lesquelles conduisent à l'activation de la voie impliquant le 
clivage de Bid, la translocation de tBid à la mitochondrie et l'activation de la caspase 9. 
Les  cellules  thermotolérantes  montrent  toutes  une  diminution  de  ces  effets.  La 
thermotolérance  modérée  protège  à  la  fois  contre  la  cytotoxicité  du  peroxyde 
d'hydrogène (H20 2) ,  l'activation de la caspase  3  et la condensation de  la  chromatine. 
L'antioxydant PEG-catalase (polyéthylène glycol catalase) inhibe l'induction de FasL et 
l'activation de la caspase 8 causées par le  peroxyde d'hydrogène. La régulation positive 
de FasL, l'activation des caspases 2-3-8-9 et la condensation de la chromatine ont toutes 
été diminuées par la présence d'un inhibiteur de p53, la pifithrine-a, impliquant que p53 
agit comme un facteur en amont dans l'activation de l'apoptose médiée par la voie des 
récepteurs  de  la mort en présence  de  peroxyde  d'hydrogène.  Cette  étude  propose  un 
avancement des connaissances à propos des effets protecteurs aux réponses adaptatives 
induites par des  stress  modérées,  telle que la température causée par la fièvre,  contre 
l'induction de l'apoptose liée au stress oxydatif. 
Mots  clé :  stress  oxydatif,  peroxyde  d'hydrogène,  apoptose,  thermotolérance,  réponse 
adaptative, récepteur de la mort, protéine p53, protéines de choc thermique, antioxydant, 
radicaux libres. 111 
ABSTRACT 
Preexposure to  mild temperatures  such as  40  °C induces thermotolerance, whereby 
cells resist subsequent exposure to  a toxic insult.  This study investigates the protective 
effect of mild thermotolerance (3h, 40 °C)  against activation of death receptor-mediated 
apoptosis by H20 2 in HeLa cells. H20 2  (5-50  11M)  caused rapid activation (1-3h) of the 
Fas  death receptor pathway of apoptosis, which  was  evident by up-regulation of death 
ligand  FasL  and  recruitment  of adaptor  protein  Fas-associated  death  domain  to  the 
plasmamembrane.  This resulted in  activation of caspase-8  and  caspase-2, which led  to 
activation  of the  cross-talk  pathway  involving  Bid  cleavage,  tBid  translocation  to 
mitochondria  and  caspase-9  activation.  These  changes  were  all  diminished  in 
thermotolerant  cells.  Mild  thermotolerance  also  protected  cells  against  cytotoxicity of 
H20 2  as  well  as  execution phase events of apoptosis  such  as  caspase-3  activation  and 
chromatin  condensation.  The  antioxidant  polyethylene  glycol-catalase  abolished  FasL 
induction  and  caspase-8  activation  due  to  H20 2.  FasL  up-regulation;  activation  of 
caspases-8, -2, -9  and  -3  activation; andchromatin condensation were decreased by p53 
inhibitor pifithrin-a, implicating p53 as an upstream factor in activation of  death receptor-
mediated apoptosis by H20 2. This study advances knowledge about the protective effect 
of adaptive  responses  induced  by mild  stresses,  such  as  fever  temperatures,  against 
induction of  apoptosis by oxidative stress. 
Key words: Oxidative stress, Hydrogen peroxide, Apoptosis, Thermotolerance, Adaptive 
response, Death receptor, p53  protein, Caspase, Heat shock protein,  Antioxidant,  Free 
radical s. 112 
INTRODUCTION 
Reactive oxygen species (ROS) are involved in various normal cellular functions such 
as  proliferation,  signalling  pathways  and  apoptosis  [Circu  and  Aw,  2010].  Cells  and 
tissues are equipped with a wide range of antioxidant defense systems that approximately 
balance  the  production  of ROS  under  normal  conditions  [Halliwell  and  Gutteridge, 
2007]. Superoxide, for example, is catalytically removed by superoxide dismutase (SOD) 
and  hydrogen  peroxide  (H20 2)  by catalase  and  glutathione  peroxidase.  However,  the 
generation of ROS  can be increased by various conditions of stress, including ionising 
radiation,  chemotherapeutic  drugs,  environmental  pollutants  and  herbicides.  Increased 
levels  of ROS  in  cells  and  tissues  can  cause  an  imbalance  in  the  redox  equilibrium 
between  pro-oxidants  and  antioxidants  [Halliwell  and  Gutteridge,  2007;  Chen  et  al, 
2007]. A redox imbalance can lead to oxidative damage to essential macromolecules such 
as proteins, lipids and nucleic acids [Circu and Aw, 2010]. Oxidative cellular damage can 
result in senescence, in which cells are no longer able to divide, or in cell death processes 
such as apoptosis and necrosis. Milder conditions of stress generally lead to apoptotic cell 
death, whereas more severe stress leads to cell death by necrosis [Kroemer et al, 1998]. 
Apoptosis  is  a  highly  regulated  cell  death  process,  which  plays  an  important  ro1e 
during  embryonic  development  and  tissue homeostasis, by removing  excess, infected, 
transformed or damaged cells [Roya and Mauro, 2004]. Deregulation of this pro cess can 
lead  to  development  of various  pathophysiological  conditions,  including  cancer  and 
neurodegenerative disorders. Characteristic hallmarks of apoptosis  include exposure of 
phosphatidylserine  at  the  extracellular  surface,  DNA  fragmentation,  cytoplasmic  and 
nuclear condensation, and  the formation  of membrane-bound apoptotic bodies that are 
phagocytosed by macrophages  [Elmore, 2007].  The apoptotic process can take place by 
three different pathways that involve death receptors (extrinsic), mitochondria (intrinsic) 
and the endoplasmic reticulum (intrinsic). Induction of apoptosis via death receptors such 113 
as Fas receptor (Fas), tumor necrosis factor receptor (TNFR) and TNF-related apoptosis-
inducing ligand (TRAIL) [Lavrik et al, 2005] results in the activation ofinitiator caspases 
such as caspase-8 or caspase-1  0, which in tum leads to activation of the effector caspases 
-3,  -6  and  -7.  The  effector  caspases  are  responsible  for  the  cleavage  of key  cellular 
proteins, leading to  the typical morphological changes observed in  apoptotic cells. The 
death receptor pathway can be interconnected with the mitochondrial pathway through a 
crosstalk  pathway mediated  by cleavage  of Bcl-2  family  protein  Bid  [Strasser  et  al, 
2009]. 
Hyperthermia  (42-47°C)  is  among  the  recent  and  innovative  methods  of cancer 
treatment [Horsman and Overgaard, 2007] and is mainly used as an adjuvant to radiation 
and  chemotherapy.  A  major  advantage  is  that  localised  heating  allows  increased 
cytotoxicity  and  the  targeting  of radiation  and  chemotherapy treatments  to  the  tumor 
region. Indeed, hyperthermia is one of the most effective radiation sensitizers known and 
can  eliminate radioresistant tumor  cells. Significant improvements in  clinical  outcome 
were reported using a combination of hyperthermia with radiotherapy, chemotherapy, or 
both,  for  tumours  of the head  and  neck, breast, brain,  bladder,  cervix,  rectum,  lung, 
oesophagus, for melanoma and sarcoma [Van der Zee, 2002; Issels et al, 2006; Van der 
Zee  and  Erasmus,  2007].  Despite  such  promising  progress  at  the  clinical  level,  the 
mechanisms  involved  in  hyperthermia-induced  cell  death  are  not  clearly  understood 
[Milleron and Bratton, 2007]. 
The  exposure  of cells  and  tissues  to  elevated  temperatures  (39-45°C)  induces  the 
expression  of beat  shock  pro  teins  (Hsp)  and  the  phenomenon  of thermotolerance 
[Calderwood et al, 2006; Field and Anderson, 1982; Landry et al,  1989; Przybytkowski et 
al,  1986].  Thermotolerance  is  a  transient  adaptive  response  where  by  cells  become 
resistant to a subsequent lethal insult such as that induced by beat shock, oxidative stress, 
anticancer drugs, radiation and environmental stressors [Gill  et al, 1998; Martindale and 114 
Holbrook, 2002; Kregel, 2002]. It usually disappears within several days, and therefore, 
does not interfere with clinical use of hyperthermia. Thermotolerance can be developed 
after shorter exposures (  e.g.  30 min) to higher, lethal temperatures (  42-45°C),  or during 
continuous  heating  (e.g.  3-24h)  at  lower,  nonlethal  temperatures  (39.5-41.5°C) 
[Przybytkowski  et  al,  1986;  Landry  et  al,  1982].  Most  studies  have  investigated 
thermotolerance  developed  at  higher,  lethal  temperatures,  whereas  thermotolerance 
developed at  mild physiological temperatures (39-41 °C),  which  occur during fevers,  is 
poorly understood. 
W  e reported that mild thermotolerance developed at 40°C in  creas es the production of 
ROS, as well as the expression/activity of several major antioxidants such as manganese 
superoxide dismutase  (MnSOD),  catalase  and  glutathione  as  well  as  its  key synthesis 
enzyme, y-glutamylcysteine synthetase [Pallepati and Averill-Bates, 201 0]. However, the 
ability of mild thermotolerance to protect cells against the activation of apoptosis is not 
well  understood.  This  study  evaluated  the  protective  role  of mild  thermotolerance, 
developed  at  40°C,  against  activation  of death  receptor-mediated  apoptosis  by pro-
oxidant H20 2 in human cervical carcinoma (HeLa) cells. This study also aimed to provide 
new  insights  into  activation  of the  death  receptor  signaling  pathway of apoptosis  by 
H20 2, including the roles ofp53, Fas and caspase-2. 115 
MATERIALS AND METHODS 
Cell culture 
HeLa cells  (ATCC  No. CCL-2)  were  grown in  monolayer in Dulbecco's modified 
Eagle's  medium  (Invitrogen  Canada,  Burlington,  ON,  Canada)  containing  10%  fetal 
bovine serum  (FBS)  (Invitrogen, Canada), in tissue culture flasks  (Sarstedt, St Laurent, 
QC,  Canada)  at  37°C  in  a  humidified  atmosphere  of 5%  C02  in  a  water  jacketed 
incubator  [Bettaieb  and  Averill-Bates, 2005].  Cell  culture  medium  was  replaced  with 
fresh medium 24h before experiments. To induce thermotolerance, cells were transferred 
to  an identical incubator for 3h at 40°C (± 0.1 °C), following a period of 20min to  allow 
the temperature of the culture medium to reach 40°C [Pallepati and Averill-Bates, 201 0]. 
The cells were grown to  near confluence and then harvested using 0.25% (w/v)  trypsin-
0.02% (w/v)  EDTA solution, and washed by centrifugation (1 000  g, 3 min).  There was 
no loss of  cell viability, using trypan blue, in cells heated at 40°C for 3h. 
Treatment with H20 2 and inhibitors 
Confluent  cells  in  monolayer were pretreated, where indicated, with  the  following 
inhibitors: Fas  antagonist Kp7-6 (1  mM,  1 h), caspase-8 (Z-IETD-FMK, 20  11M, 2 h), 
caspase-2 (Z-VDVAD-FMK, 25  11M, 1 h), pifithrin-a (10  11M, 1 h) a reversible inhibitor 
of p53-mediated  apoptosis  (Calbiochem, La Jolla, CA, USA), or polyethylene  glycol-
catalase (PEG-catalase) (300 U/ml, 3h) (cell permeable H20 2 scavenger) (Sigma-Aldrich 
Canada). Freshly harvested thermotolerant and non-thermotolerant HeLa cells were then 
resuspended in D-MEM plus 10% FBS and incubated at constant cell density (lx10
6/ml) 
with 25  to  100 11M of H20 2,  in a final volume of 1.0 ml at 3  7°C for 1 or 3 h, along with 
untreated controls. Cells were washed by centrifugation (1 000 g, 3 min) to rem ove H20 2, 
and then analysed for Fas  ligand (FasL)  expression, caspase-8,  -2,  -9 and -3 activation; 
Bid cleavage; and chromatin condensation. 
Flow cytometric analysis ofFasL expression 116 
After treatment with H20 2,  thermotolerant (3  h, 40 °C) and non-thermotolerant (3  h, 
37  °C)  HeLa  cells  (1 0
6
)  were  incubated  with  20  J...lg/ml  of (PE)-labelled  anti-FasL 
[Kayagaki et al,  1995]  (Caltag Laboratories, Burlingame, CA, USA) for 30 min at 22°C 
in  the  dark  [Filion  et  al,  2004].  Cells  (1 0,000)  were  washed  and  analysed  using  a 
F  ACScan flow cytometer equipped with an argon laser (Ex. 488 nm). Data were analysed 
using  Cell  Quest  software  (Becton  Dickinson,  Oxford,  UK).  The  mean  fluorescence 
intensity  of  10,000  cells  was  calculated  for  each  sample  and  corrected  for 
autofluorescence obtained from  samples of unlabeled cells. The extracellular expression 
ofFasL was compared with untreated cells. 
Immunodetection of total protein expression 
For  detection  of procaspase-8  and  inhibitor  of caspase-activated  DNase  (ICAD), 
thermotolerant and nonthermotolerant cells were harvested and incubated with H20 2  at 
37°C  for  the required times.  Cells  were  washed  by  centrifugation  (1 000  g,  3  min)  in 
buffer A (100 mM sucrose, 1 mM EGTA, 20 mM MOPS, pH 7.4) [Samali et al,  1999]. 
The supematant was discarded, pelleted cells were resuspended in lysis buffer B [buffer 
A  plus  5%  Percoll,  0.01%  digitonin  and  a  cocktail  of protease  inhibitors:  10  J...LM 
aprotinin,  1  0  J...lM  pepstatin A,  1  0  11M  leupeptin, 25  11M  cal  pain inhibitor I and  1 mM 
phenylmethylsulfonyl fluoride (PMSF)] and incubated on ice for  lh. Then, by a 10 min 
centrifugation step at 2500 g to remove nuclei and unbroken cells, the proteins of who  le 
celllysates were isolated in the supematant [Tanel and Averill-Bates, 2005]. Proteins (30 
J...lg)  [Bradford,  1976]  were  separated  by  SDS-polyacrylamide  gel  electrophoresis 
[Laemmli, 1970] and transferred to polyvinyl difluoride membranes, which were probed 
with  the  primary  antibodies  (1: 1  000):  ICAD,  caspase-8  or  GAPDH  (Santa  Cruz 
Biotechnology Inc.). Secondary antibodies  (1 :5000)  were goat horse-radish peroxidase 
(HRP)-conjugated  polyclonal  anti-mouse  IgG  or HRP-conjugated rat  MAb-anti-rabbit 
IgG  (Biosource,  Camarillo,  CA).  Membranes  were  incubated  in  ECL-Plus 
chemiluminescence reagent  (Amersham  Biosciences  Corp,  Piscataway,  NJ)  and  films 117 
were scanned with a Laser Scanning Densitometer (Alpha Innotech Corp,  San Leandro, 
CA).  Total  protein  expression  was  analysed  using  IPGEL  software  (BD  Biosciences 
Bioimaging, Rockville, MD) and normalized to GAPDH as loading control. 
Immunodetection of proteins in subcellular fractionations 
Subcellular fractions were prepared as described previously [Samali et al,  1999; Tanel 
and  Averill-Bates,  2005].  Thermotolerant and  nonthermotolerant cells  were  washed  in 
buffer A and resuspended in buffer B containing 0.1  mM dithiothreitol (DTT).  Lysates 
were  homogenised  using  a Dounce homogeniser (50  strokes/sample).  After  a 30  min 
incubation on ice, unbroken cells and nuclei were pelleted by centrifugation at 2500 g for 
10  min.  The  supemantant was  centrifuged  further  at  15,000  g for  15  min.  The  pellet 
containing  the  mitochondrial  fraction  was  then  resuspended  in  buffer  C  (300  mM 
sucrose, 1 mM EGTA, 20 mM MOPS, 0.1  mM DTT, 100 !J.l/10 ml of cocktail ofprotease 
inhibitors,  pH  7.4)  and  used  for  detection  of Bid/tBid.  The  supematant  was  further 
centrifuged at  100 000 g for  1 h.  The resulting supematant (  cytosolic fraction) was used 
for  detection ofF  ADD  and  Bid/tBid.  The pellet was resuspended in 1ysis  buffer B and 
designated  as  the  microsomal  fraction,  which  was  used  to  detect  F  ADD  and  FasL. 
Microsomal extracts contain plasma membranes [Gomez-Angelats and Cidlowski, 2001]. 
Subcellular distribution of proteins (3Ü!J.g)  (F ADD, Bid/tBid, FasL,  1:1 000) (Santa Cruz 
Biotechnology Inc.)  was  analyzed  by SDS-PAGE  and  Western blotting  [Bettaieb  and 
Averill-Bates,  2005].  Protein  expression  was  analysed  relative  to  GAPDH  using  a 
scanning  laser  densitometer.  Purity  of  microsomal  (92%),  cytosolic  (98%)  and 
mitochondrial  (97%)  fractions  was  determined  by  Western  blotting  using  calnexin, 
glutathione S-transferase (GST-nl) and cytochrome oxidase, respectively. 118 
Caspase activity 
After treatment with H20 2 (0, 25-50  J..LM),  thermotolerant and nonthermotolerant cells 
were harvested, and cell  lysates were prepared at -80°C for  30 min and  then incubated 
with the following caspase substrates (50  J..LM)  [Tanel and Averill-Bates, 2005): Ac-Asp-
Glu-Val-Asp-amino-4-methylcoumarin  (Ac-DEVD-AMC)  for  caspase-3,  Ac-Leu-Glu-
His-Asp-7-amino-4-trifluoromethylcoumarin (Ac-LEHD-AFC) for  caspase-9, Z-Ile-Glu-
Thr-Asp-AFC  (Z-IETD-AFC)  for  caspase-8,  and  Z-Val-Asp-Val-Ala-Asp-AFC  (Z-
VDV  AD-AFC) for caspase-2 (Calbiochem). Caspase substrate cleavage to generate AFC 
(Àmax  excitation at 400nm, Àmax  emission at 505nm) or AMC (Àmax  excitation at 380 
nm, Àmax emission at 460nm) was measured by spectrofluorimetry (SpectraMax Gemini, 
Molecular Deviees, Sunnyvale, CA) at appropriate excitation and emission wavelengths. 
Caspase activities are represented as Vmax of  the 30 min kinetic reaction. 
Morphological analysis of apoptosis 
Thermotolerant  and  nonthermotolerant  cells  (1 0
6/ml)  were  labelled  with  Hoechst 
33258  (50  f..tg/ml)  (blue-green  fluorescence)  (Sigma  Chemical  Co.),  which  binds  to 
condensed nuclear chromatin of apoptotic cells  [Tanel  and  Averill-Bates, 2005].  Cells 
were washed with PBS and then propidium iodide (PI) (50 ).lg/ml) was added to visualize 
necrotic cells  (red  fluorescence).  Observations were made by fluorescence microscopy 
(model  IM,  Carl  Zeiss Canada Ltd, St.  Laurent,  QC)  and  photographs  were  taken  by 
digital camera (camera 3CCD, Sony DXC-950P, Empix imaging Inc, Mississauga, ON). 
Images  were  analyzed  using Northem  Eclipse  software  (Empix  Imaging).  Cells  were 
classified using the following criteria:  (1)  live cells with normal nuclei, pale blue/green 
chromatin with organized structure); (2) apoptotic cells with bright blue /green condensed 
or fragmented  chromatin);  (3)  necrotic cells  (red, enlarged nuclei  with smooth normal 
structure). Fractions of apoptotic or necrotic cells were calculated relative to  total cells. 
For each condition, 300 cells were counted. 119 
Statistics 
Data represent means ± SEM from  at least three independent experiments performed 
in  duplicate.  When  not  shown,  error  bars  lie  within  symbols.  Comparisons  among 
multiple groups were made by one-way ANOV  A, which measures the linear contrast of 
means. The Bonferroni-Holmes adjustment was used to control for the family-wise error 
rate  at  a desired  level  (a=5%).  The  software used  was  JMP  Statistical  Discovery 4.0 
(SAS Institute Inc., Cary, NC, USA). For significant differences, P< 0.05. 
RESULTS 
Mild  thermotolerance  developed  at  40°C  protects  cells  against  H20 2-induced 
cytotoxicity and apoptosis 
The  pretreatment of HeLa  cells  at  a mild  temperature  of 40°C  for  3h  led  to  the 
development of thermotolerance, which was seen as  subsequent resistance to toxicity of 
the pro-oxidant H20 2 (25-50  )lM)  (Figure 1  ). The loss of clonogenic cell  survival  (Fig. 
lA) and induction of apoptosis (Fig.  lB-F) by H20 2 were diminished in thermotolerant 
cells compared to controls (maintained at 37 °C for 3 h).  Apoptosis was evaluated by the 
condensation of nuclear chromatin (Fig.  1  B and  C), activation of effector caspase-3 (Fig. 
ID) and cleavage of ICAD (Figs.  lE and F), which are late-stage events occurring in the 
execution phase.  Very few (<5%) necrotic cells were seen under these conditions (Fig. 
lB). 
H20 2 induces up-regulation of the Fas death ligand (FasL): protective effect of mild 
thermotolerance 
Subsequent!  y,  the  ability  of mild  thermotolerance  (  40 °C)  to  protect  cells  against 
H20 2-induced  apoptosis  was  investigated.  The  role  of H20 2 in  the  activation  of the 
mitochondrial  pathway of apoptosis  is  well-established  [Chandra et al,  2000], whereas 
activation of death receptor-mediated apoptosis  by H20 2 is  not completely understood 120 
[Circu  and  Aw,  2010].  Apoptosis involving the  death  receptor Fas  is  activated by the 
binding of FasL to  its receptor. To  determine the role of H20 2 in the activation of death 
receptor  signalling,  we  evaluated  the  extracellular  expression  of  FasL  in  both 
thermotolerant and non-thermotolerant HeLa cells by flow  cytometry. Exposure of cells 
to 5-25 11M H20 2 for 1 h caused an increase in FasL expression by 31-48% (Figs. 2A and 
B). Next, to  confirm  the role of H20 2  in  the induction of FasL expression,  cells were 
treated  with  the  cell-permeative  H20 2  scavenger,  polyethylene  glycol  (PEG)-catalase. 
The  induction  of FasL  expression  by 5  11M  H20 2  was  completely inhibited by PEG-
catalase (Figs.  2B  and C).  Treatment of HeLa cells with PEG-catalase (300 U/ml, 3 h) 
increased  catalase  activity  by  46.1  ±  11.6%,  compared  to  untreated  controls. 
Interestingly, mild thermotolerance completely inhibited the peroxide-induced increase in 
FasL expression (Figs. 2A and B), which is an early event in the death receptor pathway. 
Protective effect of mild thermotolerance against H20rinduced FADD translocation 
to the plasma membrane 
The ligation of FasL to its receptor Fas changes the conformation of the receptor and 
results  in  clustering  as  well  as  trimerization  of the  receptor,  which  is  required  for 
formation of  the death-inducing signalling complex (DISC) at the plasma membrane. The 
components of the  DISC  include oligomerized Fas,  the adaptor protein  Fas-associated 
death  domain  (FADD)  and  procaspase-8.  Activation  of Fas  triggers  translocation  of 
F  ADD from the cytosol to the plasma membrane. When HeLa cells treated with H202 for 
1h, there was an increase in the expression ofmicrosomal FADD (Figs. 3A and B), along 
with  a  corresponding  decrease  in  cytosolic  levels  of F  ADD  (Figs.  3C  and  D).  In 
thermotolerant cells, the H20 2-induced increase  in microsomal  F  ADD  expression  was 
significantly reduced (Figs. 3A and B)  and cytosolic levels ofF  ADD  were higher (Figs. 
3C and D), compared to normal (non-thermotolerant) cells. The purity of  microsomal and 
cytosolic fractions was 92 and 98%, respectively (Fig. 3E). 121 
Caspase-8 and caspase-2 play important roles in H20 2-induced apoptosis: protective 
effect of mild thermotolerance 
Auto-proteolytic cleavage of  procaspase-8 at the DISC results in activation of  initiator 
caspase-8.  Exposure of HeLa cells  to  H20 2  (0-SO)..lM)  for  1 h caused procaspase-8  (55 
kDa) cleavage and a marked increase in levels of the 20 kDa cleavage fragment (Figs. 4A 
and B). The activation of caspase-8 by H20 2 was confirmed by an  enzymatic assay (Fig. 
4C).  Caspase-8  activation  was  completely  inhibited  by  PEG-catalase  (Fig.  4D), 
confirming  the  role  of H20 2  in  caspase-8  activation.  Mild  thermotolerance  (  40°C) 
markedly decreased levels of the caspase-8  cleavage fragment and caspase-8  activation, 
compared to control cells (Figs. 4A, B, and C). Recent studies showed that recruitment of 
caspase-8 to the DISC can also lead to activation of caspase-2 [Olsson et al, 2009; Manzl 
et al, 2009]. H20 2 also caused enzymatic activation of caspase-2 in HeLa cells (Fig. SA). 
Accordingly, H20 2-induced caspase-2 activation was  decreased partially by a caspase-8 
inhibitor,  Z-IETD-FMK  (Fig.  SB).  Caspase-2  activation  by  H20 2  was  inhibited  in 
thermotolerant cells (Fig. SA). 
The roles of caspase-8 and caspase-2 in apoptosis induced by H20 2 were investigated 
using inhibitors of caspase-8  and  caspase-2.  Indeed, the induction of nuclear chromatin 
condensation by H20 2 was decreased partially by inhibitors of caspase-8 (Figs. 4E and F) 
and caspase-2, (Figs. SC and D), Z-IETD-FMK and Z-VDVAD-FMK, respectively. 
H20 2 activates the cross-talk pathway mediated by Bid cleavage: inhibition by mild 
thermotolerance 
Once activated, caspase-8 and  caspase-2 can induce downstream events of apoptosis 
by two  distinct mechanisms.  One  is  by direct  cleavage  of effector  caspase-3  and  the 
second is by means of  cross-talk between the death receptor and mitochondrial pathways, 
through cleavage of the pro-apoptotic protein Bid.  The cleaved fragment t-Bid can then 
translocate to mitochondria and activate mitochondrial apoptosis. Exposure of  HeLa cells 122 
to  H20 2  (0-50  J..LM)  for  1  h  caused  cleavage  of Bid  and  translocation  of t-Bid  to 
mitochondria (Fig. 6).  Cytosolic levels ofBid decreased (Figs. 6A and B) while levels of 
t-Bid  increased  in  the  mitochondrial  fraction  (Figs.  6C  and  D).  The  purity  of the 
mitochondrial fraction was 97% (Fig. 3E). Thermotolerance developed at 40°C  afforded 
protection  against  H20 2-induced  Bid  cleavage  and  t-Bid  translocation  (Fig.  6).  The 
inhibition of Bid cleavage (Figs. 7  A and B)  and mitochondrial t-Bid translocation (Figs. 
7C  and  D)  by inhibitors  of caspase-8  and  caspase-2  confirmed  the  role  of these  two 
caspases in H20 2-induced Bid cleavage. 
Translocation  of t-Bid  to  mitochondria  leads  to  activation  of the  mitochondrial 
pathway of apoptosis involving initiator caspase-9 [Strasser et al, 2009]. Indeed, H20 2 (0-
50  J..LM)  caused  caspase-9  activation, which  was  diminished  partially by inhibitors  of 
caspase-8  and  caspase-2  (Fig.  8A).  Furthermore,  H20 2-induced  activation  of effector 
caspase-3 was also inhibited by the caspase-8 inhibitor (Fig. 8B). 
Role of the Fas in H20 2-mediated death receptor apoptosis 
To  further  confirm  the role  of FasL in  apoptosis  induced by H20 2, we  determined 
whether inhibition of Fas  activation  could block H20rinduced apoptosis.  Kp7-6  is  an 
irreversible inhibitor of Fas  activation.  It acts by binding with both the Fas  and  FasL, 
therefore  preventing  FasL  from  forming  a stable  complex  with  Fas  [Hasegawa  et  al, 
2004]. We therefore evaluated whether Kp7-6 could inhibit H20 2-induced apoptosis. Pre-
treatment  of cells  with  Kp7-6  effectively  inhibited  H20 2-induced  nuclear  chromatin 
condensation by about 50% (Figs. 9A and 9B). Moreover, Kp7-6 inhibited H20 2-induced 
activation  of caspase-8  (Fig.  1  OA),  caspase-2  (Fig.  1  OB)  and  caspase-9  (Fig.  1  OC). 
Together,  these findings  show  that  H20 2  can  activate  apoptosis  through  the  Fas  death 
receptor  in  HeLa  cells.  Furthermore,  the  mitochondrial  pathway  of apoptosis  was 
activated, at least in part, by the death receptor pathway through the cross-talk pathway. -------------------------------------------------------------
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Role of p53 as  an  upstream factor in activation of the death  receptor pathway by 
H202 
The tumor suppressor protein p53  can be activated by various DNA damaging agents 
[Yoshida and Miki, 2010], including the pro-oxidant H20 2 [Pallepati and Averill-Bates, 
2010;  Liu  et  al,  2008].  At  the  transcriptional  level,  activated  p53  can  induce  the 
expression of pro-apoptotic proteins such as  Bax, FasL, Puma and  Noxa, and  suppress 
anti-apoptotic proteins such as  Bcl-2 [Yoshida and Miki, 2010].  To  determine whether 
induction of FasL expression by H20 2 requires upstream p53  activation, cells were pre-
treated  with  a p53  inhibitor,  pifithrin-a.  Indeed, pifithrin-a inhibited  the  induction  of 
FasL expression by H202 (1 0-25  ~-tM) (Figs.  1  OD  and  E).  Furthermore, H20 2-induced 
caspase-8  activation was markedly reduced by pifithrin-a (Fig. 1  OA).  The activation of 
caspase-2  by H20 2 was  decreased  partially  by  pifithrin-a  (Fig.  1  OB).  These  results 
suggest  that p53  is  an  upstream  factor  in  H20 2-mediated  activation  of death  receptor 
signalling, leading to induction of  FasL and caspase-8 activation, which, in tum, activates 
initiator caspase-2. However, activation of caspase-9 in the mitochondrial pathway was 
not  inhibited  by  pifithrin-a  (Fig  1  OC).  This  shows  that  H20 2  can  activate  the 
mitochondrial pathway directly, or by altemate mechanisms that are independent of p53 
activation. 
The activation of execution phase events of apoptosis by H20 2  was also dependent on 
p53. Caspase-3 activation (Fig.  11A) and nuclear chromatin condensation (Figs. llB and 
C) were inhibited partially by pifithrin-a. 
DISCUSSION 
The findings of this study contribute to knowledge about adaptive responses, in that 
mild thermotolerance developed at  40°C protects cells  against H20 2-induced apoptosis 
through the death receptor signalling pathway.  Moreover,  they improve understanding 124 
about activation of death receptor-mediated apoptosis by H20 2 in HeLa cells. Activation 
of  the death receptor pathway, upon exposure to 5-50 !lM H20 2 for lh to 3h, was evident 
by  increased  expression  of FasL  and  recruitment  of F  ADD  and  procaspase-8  to  the 
plasma  membrane.  Once  activated,  caspase-8  processed  caspase-2,  which  is  a  novel 
finding  in  this  study.  The  conditions  (25-50  !lM  H20 2)  that  induced  apoptosis  also 
decreased clonogenic cell survival, which represents loss of  cell proliferation. 
Role of caspase-2 in H20 2-induced apoptosis 
This  study is  the first  to  show  the role of caspase-2  in  apoptosis  induced by H20 2, 
where  a  caspase-2  inhibitor reduced  pro-oxidant-induced  Bid  cleavage,  mitochondrial 
tBid translocation and chromatin condensation. Despite the early discovery of caspase-2, 
its physiological role still remains a puzzle [Krumschnabel et al, 2009]. Caspase-2 seems 
to have multiple roles in processes such as apoptosis, DNA repair and tumor suppression. 
Activation of caspase-2 has been reported during apoptosis induced by anti-Fas, cytokine 
deprivation,  ~-amyloid, etoposide  and  other  stress  stimuli  [Zhivotovsky  and  Orrenius, 
2005].  Caspase-2  can  be activated  by the  PIDDosome  in  response  to  DNA  damage 
[Maiuri et al, 2007; Tinel  et al,  2007]. However, recruitment of caspase-8 to  the DISC 
can lead to  caspase-2 activation in  the absence of PIDDosome formation  [Olsson et al, 
2009; Manzl  et al, 2009].  Thus,  there exist different routes by which caspase-2 can be 
activated. 
Activation of the cross-talk pathway during H20rinduced apoptosis 
The cross-talk pathway that connects the mitochondrial and death receptor pathways 
was  activated  by  H20 2  in  HeLa  cells.  Cleavage  of Bid  and  mitochondrial  t-bid 
translocation were completely suppressed by caspase-8  and -2  inhibitors. This suggests 
that  both  caspase-8  and  caspase-2  can  process  Bid  and  contribute  to  mitochondrial 
amplification  of cell  death  by  apoptosis  (Scheme  1  ).  However,  post-mitochondrial 
caspase-9 activation by H20 2 was only partially decreased by inhibitors of caspase-8  and 125 
-2. This indicates that H20 2 can activate the mitochondrial pathway in part through the 
death  receptor  pathway,  and  by altemate  mechanisms  that  are  independent  of death 
receptor activation. Indeed, direct activation of  mitochondrial apoptosis by H20 2 has been 
reported  in  several  cell  types  [Pallepati  and  Averill-Bates,  2010;  Chandra et al,  2000; 
Singh and Singh, 2008]. 
Role of Fas in H20rinduced dea th receptor apoptosis 
The Fas  signalling pathway plays a critical role in  regulation of homeostasis in  the 
immune system, and is  also  involved in stress-induced apoptosis [Strasser et al,  2009]. 
Our findings show that H20 2 can induce FasL expression (Scheme 1). The role of Fas in 
H20 2-induced  death  receptor  apoptosis  is  confirmed  by  inhibition  of  caspase-8/-2 
activation and chromatin condensation by the Fas/FasL antagonist Kp7-6. 
In  other studies, H20 2 induced apoptosis through death receptors, but often at higher 
concentrations and longer exposure times than those in HeLa cells.  In  murine intestinal 
epithelial cells, H20 2  (50-200 11M, 4-6h) increased mRNA 1evels for FasL and  Fas after 
18h  [Denning  et  al, 2002].  H20 2  (200-1 000  11M, 24h)  caused  up-regulation  of Fas  in 
HUVEC cells [Suhara et al,  1998]. A more rapid response occurred in HL-60 cells where 
50  11M  H20 2  (2h)  activated  caspase-8  and  caspase-3  [Zhuang  et  al,  2000].  However, 
H20 2  (50-100  11M, 12h)  induced apoptosis by a Fas-independent mechanism involving 
mitochondria in a humanT cellline (CEM C7) [Dumont et al,  1999]. The mechanisms of 
H20 2-induced apoptosis are clearly dependent on cell type. 
Role of p53 as an upstream factor in H20rinduced dea th receptor apoptosis 
This study shows that pifithrin-a decreased FasL up-regulation, activation of caspase-
8 and caspase-2, and execution phase events, confirming that p53 is an upstream factor in 
death receptor activation during H20 2-induced apoptosis (Scheme 1).  p53  also played a 
role in mitochondrial apoptosis by causing induction of Puma and translocation of  Bax to 126 
mitochondria  [Pallepati  and  Averill-Bates,  2010].  Apoptosis  was  associated  with 
increased p53  protein expression in several cell types including rat neural AFS  (800  1-!M 
H20 2,  24h), glioma (1  mM H20 2,  24h) and HeLa cells (50  f.!.M  H20 2,  1h)  [Pallepati and 
Averill-Bates, 2010; Datta et al, 2002; McNeill-Blue et al, 2006]. 
Mild thermotolerance developed at 40°C protects HeLa cells against H20 2-induced 
death receptor apoptosis 
The  dose-response  relationship  is  a  key  factor  in  determining  whether  a  certain 
compound or stress  causes  an  adverse  effect.  Low dose, chronic exposure to  different 
stresses  such  as  heat  shock, ROS  and  radiation  can  induce adaptive responses,  which 
allow  cells  and  organisms  to  continue  normal  function  in  the  face  of a  stimulus 
[Holsapple and Wallace, 2008]. Pre-exposure of cells to low doses of H20 2 or heat shock 
(  45 min at 45°C) was shown to in duce subsequent resistance to H20 2  [Spitz et al, 1987]. 
Adaptive  responses  often  involve  multiple  changes  in  gene  and  protein  expression, 
including the induction of cellular defenses (e.g.  Hsps, antioxidants,  etc.) to  enable the 
cell  to  survive [Davies, 2000].  Hsp27  appears  to  be involved in mediating an  adaptive 
response  to  ROS-generating  agents  such  as  carcinogens,  anticancer  drugs  and  other 
xenobiotics  [Huot et  al,  1996].  Mild thermotolerance developed  at  40°C increased the 
expression of6 Hsps (27, 32, 60, 70,90 and 110 kDa) [Bettaieb and Averill-Bates, 2008]. 
The  induction  of antioxidants  during  development  of thermotolerance  could  be  an 
adaptive response resulting from  increased  ROS  generation  during  mild  heat  shock  at 
40°C [Pallepati  and  Averill-Bates, 2010].  If an  adaptive response cannot counteract an 
adverse  stress  exposure,  then  cells  will  be  eliminated  by  death  processes  such  as 
apoptosis or necrosis [Davies, 2000]. 
Our findings  show that mild thermotolerance induced at 40°C created an  apoptosis-
resistant  phenotype;  activation  of the  death  receptor  signalling  pathway  (FasL  up-
regulation,  caspase  activation,  Bid  cleavage)  was  inhibited in  HeLa  cells  treated  with 127 
H20 2. This apoptosis-resistant phenotype could be conferred by increased levels of both 
Hsps and antioxidants. Fas-mediated induction of apoptosis was regulated by Hsp70 and 
Hsp27  [Liossis  et  al,  1997;  Mehlen  et  al,  1996;  Schett et al,  1999; Zhao  et  al, 2007]. 
Hsp27 and Hsp70 regulated the death receptor pathway by preventing t-bid translocation 
to mitochondria, which in  tum inhibits cytochrome c release [Gabai et al, 2002; Paul et 
al,  2002].  Hsp90-a  was  shown  to  be  a  negative  regulator  of caspase-2  activation 
[Bouchier-Hayes et al, 2009]. Furthermore, Hsp70 and phosphorylated Hsp27 can protect 
cells against oxidative stress. [Huot et  al,  1996; Musch  et  al, 1996;  Chen  et  al, 1999; 
Komatsuda et  al, 1999]. Hsp27, Hsp70  and  Hsp90  can  attenuate apoptosis upstream of 
mitochondria [Steel et al, 2004], as well as interfering with apoptosome formation, post-
mitochondrial events and  caspase activation [Beere, 2004].  Thus, Hsps play a complex 
role in the regulation of apoptosis. Scheme 2 summarises the protective role of different 
Hsps against activation of  death receptor-mediated apoptosis by H20 2. 
CONCLUSION 
This  study  advances  knowledge  about  the  protective  effect  of adaptive  responses 
induced  by  exposure  to  mild  stresses,  such  as  fever  temperatures,  against  ROS. 
Furthermore, new insights are provided about activation of the death receptor pathway of 
apoptosis by the pro-oxidant H20 2,  which has important repercussions for human health, 
given  the  role  of  ROS  in  major  physiopathologies  such  as  cancer,  diabetes, 
cardiovascular diseases and neurodegenerative disorders. 
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Figure 1 Protective effect of mild thermotolerance against H20 2-induced chromatin 
condensation and cytotoxicity. Thermotolerant (3h, 40°C) and  nonthermotolerant HeLa 
cells  (3  h,  37  °C),  were  treated  with  H20 2  (0-150f!M)  for  (A)  2  h or (B-F)  3  h.  (A) 
Cytotoxicity of H20 2 in thermotolerant versus normal cells was assessed by a clonogenic 
cell  survival assay.  The control value represents  10
5  cells and was normalized to  100% 
cell  survival.  For  curve  analysis  of  thermotolerant  versus  non-thermotolerant  cells, 
p=0.0002.  (B)  Nuclear  morphology  was  assessed  by  fluorescence  rnicroscopy  using 129 
Hoechst 33258  to  detect blue-green  apoptotic cells  and  propidium iodide to  detect red 
necrotic  cells  (magnification  320  X).  Images  are  representative  of a  minimum  of 3 
independent experiments. (C)  The fractions of apoptotic cells are given relative to  total 
cells. (D) Enzymatic activity of caspase-3 was measured in celllysates using fluorogenic 
substrate (Ac-DEVD-AMC), and was expressed relative to  the control at  37°C (100%). 
(E) Immunodetection ofiCAD (45 kDa) in whole celllysates was carried out by Western 
blotting, using GAPDH (36 kDa) as loading control. A representative blot is shown from 
three independent experiments. (F) ICAD protein expression from densitometric analyses 
is relative to  the control  at 37°C.  (A, C, D, F)  Data represent means and  SEM from  a 
minimum ofthree independent experiments. P<0.05 (*, &), P<O.Ol  (**, &&)or P<O.OOl 
(***, &&&) indicates a statistically significant difference between treatment with H20 2 
and  the  respective untreated  control,  for  thermotolerant  (&)  or non-thermotolerant (*) 
cells.  P<0.05  (#),  P<O.Ol  (##)  or  P<O.OOl  (###)  indicates  a  statistically  significant 
difference between treatments (± thermotolerance), for a given concentration ofH20 2. 130 
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Figure  2  Mild  thermotolerance  protects  cells  against  induction  of  Fas  ligand 
expression by H20 2• (A)  Thermotolerant (3  h,  40 °C)  and nonthermotolerant HeLa cells 
were treated  with  H20 2  (0-25  f.,lM)  for  1 h.  (B,  C)  Nonthermotolerant cells  were  pre-
incubated for 3 h with or without PEG-catalase and then treated with H20 2 (0-5  f.,lM)  for 
1  h.  FasL  expression  was  determined  by  flow  cytornetry  and  is  shown  relative  to 
untreated controls (no H20 2)  at 37°C, designated as  100%. Data represents rneans ±SEM 
from five independent experiments. (B) The histograrn plots are representative results of 
FasL expression in control cells (no HzOz,  grey line), and cells treated with 5[!M H20 2 
(green  line),  with  PEG-catalase  (no  H20 2,  pink line), or with  PEG-catalase  and  H20 2 
(blue  line).  (A,  C)  P<O.Ol  (**)  indicates  a  statistically  significant difference  between 
treatment  with  H20 2  and  the  control.  Significant differences  between  PEG-treated,  or 
thermotolerant cells, and untreated controls (37°C), for a given concentration of H20 2, are 
represented by P < 0.01 (##). Microsomal FADO 
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Figure  3  H20 2  causes  translocation of  the  adaptor protein FADD  to  the  plasma 
membrane: abrogation by mild thermotolerance developed  at 40 °C. After H20 2  (0-
50 11M) treatment for 1 h, F  ADD protein was immunodetected in thermotolerant (3  h, 40 
0C)  and  nonthermotolerant  (3  h,  3  7  °C)  HeLa cells. A  representative blot from  three 
independent experiments is shown for F  ADD (30 kDa) expression (A) in microsomal and 
(C)  cytosolic  fractions,  using  GAPDH  (36  kDa)  as  loading  control  for  the  cytosolic 
fraction.  Densitometric  analyses  for  expression  of (B)  microsomal  and  (D)  cytosolic 
F  ADD are relative to  non-thermotolerant controls at 3  7°C (1 00%  ). (E) A representative 
blot is shown for purity of subcellular fractions, using calnexin, glutathione S-transferase 
(GST-nl) and cytochrome oxidase for microsomal (rn), cytosolic (C) and mitochondrial 
(M)  fractions,  respectively.  P  <  0.05  (*)  or  P  <  0.01  (**)  indicates  a  statistically 
significant difference between H20 2  treatment and the control.  P<0.05  (#) indicates a 
significant difference between treatments (± thermotolerance), for 25 11M H20 2. 0  5  10  25  50 
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Figure 4 Caspase-8 plays a key role in H20 z-induced apoptosis: abrogation by mild 
thermotolerance. Thermotolerant cells (3  h,  40 °C)  and nonthermotolerant (3  h,  37  °C) 
cells (pretreated with PEG-catalase, caspase-8 inhibitor, or no inhibitor), were incubated 
with H20 2 (0-50  ~M) at 37 °C  for  1 h (caspase-8) or 3 h (chromatin condensation). (A) 
Representative Immunoblots are shown from  five  independent experiments for levels of 
procaspase-8 (p55) and the p20 cleavage fragment.  (B)  Protein Jevels  were analyzed by 
densitometry and expressed relative to  non-thermotolerant cells at 37 oc (100%).  (C, D) 
Activity  of caspase-8  (lh) in  (C)  thermotolerant  and  nonthermotolerant  cells,  or  (D) 
normal cells with or without PEG-catalase, were expressed relative to untreated contrais 
(no  H20 2)  at  37°C  (100% ).  (E)  Chromatin condensation was  visualized using Hoechst 
33258 (magnification 320x). (F) The fraction of apoptotic cells following treatment with 
H20 2 for 3 his given relative to total cells. P < 0.05 (*),  P < 0.01  (**) or P<O.OOl  (***) 
indicates  a  statistically  significant  difference  between  treatment  with  H20 2  and  the 
control (&& is  relative to control for caspase-8 inhibitor). P<O.Ol  (##) or P<O.OOl  (###) 
indicates  a statistically significant difference between treatments  (± thermotolerance, ± 
inhibitors), for a given concentration of H20 2. A 
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Figure 5 Mild  thermotolerance  (  40°C)  inhibits  H20 2-induced  caspase-2 activation. 
Thermotolerant  (3  h,  40  °C)  and  nonthermotolerant  (3  h,  37  °C)  HeLa  cells  were 
incubated  at  37  °C  with  H20 2  (0-50  [lM)  in  D-MEM  containing  10%  FBS.  (A,  B) 
Caspase-2 activity (1  h)  was measured in  cell lysates using the fluorescent substrate (Z-
VDV  AD-AFC).  Activity  of caspase-2  in  (A)  thermotolerant  and  non-thermotolerant 
cells, or (B)  normal cells with or without caspase-8 inhibitor (B), was expressed relative 
to  controls  at  37°C  (1 00%  ).  Data  represent  mean  ±  SEM  from  se ven  in  dependent 
experiments. (C,  D)  Cells were pretreated with a caspase-2 inhibitor (Z-VDV  AD-FMK, 
25  [lmol/L,  1 h)  before exposure to  25  [lM  H20 2  for  3 h.  (C)  Cells were stained  with 
Hoechst and  PI and  visualized by fluorescence  microscopy (magnification 320 X).  (D) 
The fraction of apoptotic cells following treatment is given relative to total cells. P < 0.01 
(**)  or P<0.001  (***)  indicates a  statistically significant difference between treatment 
with  H202 and  the  untreated  control  (for  &  and  &&&, relative  to  inhibitor control). 
P<O.Ol  (##)  or  P<O.OOl  (###)  indicates  a  statistically  significant  difference  between 
treatments (± thermotolerance, ± caspase-8 or -2  inhibitor), for a given concentration of 
H202. 8 
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Figure  6  H202-acivates  the  Bid-mediated  cross-talk  pathway:  protection  by 
thermotolerance at 40  °C.  Thermotolerant  (3  h,  40  °C)  and  nonthermotolerant  (3  h, 
37°C) HeLa cells were incubated for 1 hat 37 °C with H20 2  (0-50  f.!.M).  Representative 
Immunoblots from  five individual experiments are shown for the expression of Bid (23 
kDa) in cytosolic fractions (A)  and t-Bid (14 kDa) in mitochondrial fractions (C), using 
GAPDH  as  loading control  for  cytosolic fractions.  (B,  D)  Densitometric  analyses  are 
shown  for  Bid  (B)  and  t-Bid  (D)  protein  expression  in  thermotolerant  and  non-
thermotolerant cells,  relative to  control  cells  at  37°C  (100  %). P<0.05  (*)  indicates  a 
statistically significant difference between H20 2 treatrnent and the control.  P<O.OS  (#), 
P<0.01  (##)  or P<0.001  (###)  indicates  a  statistically  significant  difference  between 
treatrnents (± thermotolerance), for a given concentration ofH20 2. DNormal 
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Figure 7 Roles of caspase-8 and caspase-2 in H20 2-mediated cleavage of Bid. HeLa 
cells (nonthermotolerant) were pretreated with inhibitors of caspase-8 or caspase-2, or no 
inhibitor, and  then incubated with H20 2  (0,  25~-LM) for  1 h.  Densitometric analyses of 
expression of (A) cytosolic Bid and (D) mitochondrial t-Bid are relative to control cells at 
3  7°C (1 00%  ).  Representative immunoblots from three individual experiments are shown 
for (B) cytosolic Bid (23  kDa) and (C) t-Bid (14 kDa). Purity of cytosolic fractions was 
determined using glutathione S-transferase (GST-nl) and mitochondrial fractions using 
cytochrome c oxidase (see Fig. 3E). P<O.Ol  (**)or P<O.OOl  (***) indicates a statistically 
significant difference between H20 2  treatment and the control.  P<0.05  (#)  or P<O.OOl 
(###)  indicates  a  statistically  significant  difference  between  treatments  (±  caspase 
inhibitors) for 25 11M H20 2. A 
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Figure 8 Caspase-9 activation by H 20 2 is mediated by the cross-talk pathway. HeLa 
cells (nonthermotolerant) were pretreated with inhibitors of caspase-8 or caspase-2, or no 
inhibitor, and then incubated with H20 2  (0-50  11M)  for 3 h. Enzymatic activities of (A) 
caspase-9  or (B)  caspase-3,  were detected using the fluorescent  substrates  Ac-LEHD-
AFC or Ac-DEVD-AMC, respectively,  and  expressed relative to  control cells (100%). 
Data represent  mean  and  SEM  from  three  independent  experiments  performed  with 
multiple estimations per point P < 0.05  (*), P < 0.01  (**) or P<O.OOl(***)  indicates a 
statistically significant difference between treatment with H20 2  and the control  (for &, 
relative  to  respective  inhibitor  control).  P<O.Ol  (##)  or  P<O.OOl  (###)  indicates  a 
statistically significant difference between treatments (±  caspase inhibitor)  for a  given 
concentration ofHzOz. 8 
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Figure  9  Role  of  the  Fas  in  apoptosis  mediated  by  HzOz.  HeLa  cells  (non-
thermotolerant)  were  preincubated  with  (B4-B6)  or  without  (B l-B3)  l mM  Kp7-6 
(Fas/FasL antagonist) for  l h and then incubated with H20 2 (0-50 f!M)  for 3 h.  Cells were 
stained with Hoechst 33258 and PI (magnification 320 X).  (A) The fraction of apoptotic 
cells (blue-green fluorescence) is  given relative to total cells.  Data represent means and 
SEM from four independent experiments. Significant differences between H20 2-treated 
cells and controls are represented by P < 0.05  (*) and P < 0.001  (***) (for&, relative to 
Kp7-6  control).  P<O.Ol  (##)  indicates  a  statistically  significant  difference  between 
treatments (± Kp7-6) for a given concentration of H20 2. 138 
0 Nonnal 
A  1;!1 Nom1al +  'Kp7·6 (Fas antagonis ) 
D Nonnal + Pifithnn-« 
0  Normal  0  Normal 
B  ~ No rm al~ KpH IF  as antagon1 st)  C  ~ Normal •  p7-6 (Fas antagomst) 
200 
160 
120 
'. 
' .  .. 
0  +'  . ...:a::Y"'-.,.-"""',.,_._-=-, 
D 
Microsomal Fasl 
(40 kDa) 
1  JNormal 
t= j  = =======! !Normal+ 
.___ ____  ____, ptftth nn "<X 
0  10  25 
EJ Normal •  Pifi hon-«  0  Normal •  P1 f1thnn~ 
g ~ 120 
:>  c:  ...  0 
0  (,)  80  - : ~  "' .s  9  ::: 
(!)  (!)  ·'  '.  V>  :>  40  -. ..  rn  · .;::;  :·  0.. <0  "'..,.  ·::"  "'  ~ 
(.) ~  0 
0  25  50 
H202  [IJM] 
E 
...J  160 
Ill~ 
('t:!-
LI..  0  120  ...  - .... 
(!!  c 
E o  80  0  () 
Ill~ 
0  0 
40  ...  0 
.~~ 
:ilE  0 
0  10  25 
H20 2 [IJM] 
Figure  10  Role  of p53  as  an  upstream factor  in  H20 2-mediated  death  receptor 
apoptosis. HeLa cells (nonthermotolerant) were pretreated with pifithrin-a or Kp7-6 or 
no inhibitor for 1 h and then incubated with H20 2  (0-50 !lM) for 1 h (A, B, D, E) or 3 h 
(C). (A-C) Activities of caspase-8 (A), caspase-2 (B) and caspase-9 (C) in cells, with or 
without Kp7-6 or pifithrin-a, were expressed relative to untreated controls (100%). (D) A 
representative blot from  three independent experiments for  FasL protein expression in 
microsomal fractions is shown. (E)  Densitometric analysis of FasL expression is shown 
relative to  untreated  controls  (100%).  P<O.Ol  (**)  indicates  a  statistically  significant 
difference  between treatment  with  H20 2  and  the  control  (for  &,  relative  to  inhibitor 
control). P < 0.05  (#), P<O.Ol  (##)  or P<O.OOl  (###) indicates a statistically significant 
difference between treatments (± pifithrin-a, ± Kp7-6) for a given concentration ofH20 2. 139 
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Figure  11  p53  inhibition  decreases  execution-phase  events  of  H20 2-induced 
apoptosis. HeLa cells (nonthermotolerant) were pretreated with or without pifithrin-a for 
1 h and then incubated with H20 2 (0-50 ~M)  for 3 h. (A) Enzymatic activity of caspase-3 
was measured in  cel!  lysates using Ac-DEVD-AMC, and was expressed relative to  the 
control  ( 100%  ).  (B)  Cells  were  stained  with  Hoechst  and  PI  and  visualized  by 
fluorescence microscopy (magnification 320 X). Images are representative of a minimum 
of 3 independent experiments. (C) The fraction of apoptotic cells following treatment is 
given  relative  to  total  cells.  Significant  differences  between  H20 2-treated  cells  and 
untreated contrais are represented by P < 0.05  (*) and  P < 0.01  (**) (for &, relative to 
pifithrin-cx  control).  P<O.OS  (#)  and  P<O.OOl  (###)  indicates  a  statistically  significant 
difference between treatments (± pifithrin-cx) for a given concentration of H20 2. 140 
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Scheme 2 Summary of the protective role of mild  thermotolerance developed at 40 °C in 
the regulation of the death receptor pathway of apoptosis induced by hydrogen peroxide. 2.4 ARTICLE III 
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RÉSUMÉ 
Le  stress  oxydatif peut  interférer  avec  le  repliement  des  protéines,  ce  qui  peut 
conduire  à  une  accumulation  de  protéines  à  la  structure  secondaire  inexacte  dans  le 
réticulum endoplasmique (RE). Ce phénomène va activer la voie de réponse aux mauvais 
repliements  de  protéines  (unfolded  protein  response,  UPR)  de  façon  à  restaurer 
l'homéostasie du RE. Dans les cas où cette réponse adaptative ne parvient pas à empêcher 
les cellules de subir des dommages, celles-ci entrent en apoptose via leur RE.  Le but de 
cette  étude est d'examiner si  la thermotolérance induite à une température modérée  et 
non-létale (40°C) peut altérer l'induction par le peroxyde d'hydrogène (H20 2)  de stress et 
d'apoptose  liés  au  RE  dans  des  cellules  HeLa.  L'expression  des  protéines  PERK,  p-
PERK,  eiF2a  et  p-eiF2a  est  augmentée  dans  des  cellules  thermotolérantes  par 
comparaison avec des cellules non-thermotolérantes. Ce résultat constitue une preuve de 
l'augmentation  des  effets  pro-survie  de  la  voie  PERK/eiF2a  de  l'UPR  par  une 
thermotolérance  modérée.  Une  exposition  courte  (15  min)  des  cellules  à  un  stress 
oxydatif (15-50  ).lM  H20 2)  donne  lieu  à l'activation  de  l'UPR,  comme  le  confirment 
l'augmentation de l'expression de p-PERK, p-eiF2a, p-IREla et du clivage de ATF6. Une 
exposition  plus  longue  (1-3h)  au  H20 2  induit  l'apoptose  liée  au  RE,  durant  laquelle 
l'expression de CHOP ainsi que l'activité enzymatique de la calpaïne et des caspase-7, -4, 
-12 et -3  augmentent. Tous ces évènements pro-apoptotiques et liés à la mort de cellules 
clonogéniques sont diminués dans les cellules thermotolérantes. L'activation des caspases 
-4  et  -12  est  diminuée  par  le  chélateur  de  calcium  BAPTA-AM  ainsi  que  par  des 
inhibiteurs de la calpaïne et de la caspase-7, ce qui confirme les rôles du calcium, de la 
calpaïne et de la caspase-7 dans l'activation par H20 2  de l'apoptose liée au RE.  Dans les 
cellules  thermotolérantes  présentant  un  niveau  de  PERK  diminué  par  siARN,  la 
résistance  à  l'apoptose  induite  par  H20 2  est  partiellement  inversée.  Ceci  prouve 
l'existence d'un lien de cause à effet entre le stress du RE et la résistance des cellules à 
l'apoptose induite par H20 2.  Ces résultats montrent qu'une thermotolérance modérée joue 
un rôle protecteur et anti-apoptotique en augmentant le seuil d'induction de l'apoptose liée 
au  RE  par le  stress  oxydatif.  De  plus,  la  réponse  adaptative  (UPR)  prédomine  lors 
d'expositions au H20 2 courtes (stress modéré) tandis que lors d'expositions plus longues 
(stress sévère), c'est l'apoptose liée au RE qui est la plus fréquente. La compréhension des 
mécanismes  moléculaires  de  la  réponse  adaptative  à  un  environnement  stressant  ou 
extrême  pose  les  bases  de  la  compréhension  des  problèmes  de  santé  liés  à 
l'environnement et de l'identification de mécanismes de protection. 
Mots clés: H20 2, apoptose, UPR, réticulum endoplasmique, caspase, CHOP. 144 
ABSTRACT 
The accumulation of misfolded proteins in the endoplasmic reticulum  (ER)  during 
stress  conditions  causes  activation  of the  unfolded  protein  response  (UPR).  If this 
adaptive response cannot restore ER homeostasis, cells undergo ER-mediated apoptosis. 
This study determines whether thermotolerance developed at a mild temperature (  40°C) 
can alter induction of ER-mediated stress and apoptosis by H202 in HeLa cells. Protein 
expression  of PERK,  p-PERK,  eiF2a  and  p-eiF2a was  increased  in  thermotolerant 
compared  to  non-thermotolerant  cells.  Thus,  mild  thermotolerance  enhanced  pro-
survival effects of the PERK/eiF2a branch of the UPR. A  short exposure (15  min) of 
cells to  H20 2 (15-50  J..LM)  activated the UPR:  expression of p-PERK, p-eiF2a and p-
IRE1a  increased,  and  ATF6  cleavage  occurred.  Longer  exposure  (1-3h)  to  H20 2 
induced ER-mediated apoptosis, whereby CHOP expression increased, and  enzymatic 
activity of calpain, caspase-7, -4, -12 and -9  also increased. These pro-apoptotic events 
and  clonogenic cell  killing were all  diminished in thermotolerant cells. Activation of 
caspases-4/-12 was decreased by the calcium chelator BAPTA-AM and by inhibitors of 
cal  pain  and  caspase-7,  confirming  the  roles  of calcium,  cal  pain  and  caspase-7  in 
activation of ER-mediated apoptosis by H20 2. In  thermotolerant cells with decreased 
levels  of PERK by siRNA,  there  was partial  reversai of resistance to  H20 2-induced 
apoptosis.  Bence,  a  causal  connection  exists  between  the  ER  stress  response  and 
resistance to  H20 2-induced  apoptosis.  Mild  thermotolerance plays  a  protective,  anti-
apoptotic role by increasing the threshold  for  induction of ER-mediated apoptosis by 
H20 2. Moreover, the adaptive response (UPR)  dominates  during milder H20 2 stress, 
whereas ER-mediated apoptosis occurs during more severe stress. 
Keywords: H20 2, apoptosis, unfolded protein response, endoplasmic reticulum, 
caspase, calpain 145 
INTRODUCTION 
Reactive oxygen species (ROS) such as superoxide and hydrogen peroxide (H20 2)  are 
recognized  as  critical  signaling molecules  that  take part in  different  cellular functions 
such as  development, proliferation and  differentiation [Circu and  Aw, 2010].  ROS  can 
trigger  cellular  dysfunction  by  damaging  bio-molecules  such  as  lipids,  proteins, 
carbohydrates and nucleic acids [Ott et al, 2007]. Levels of ROS are tightly controlled by 
scavenging  enzymes  (e.g. catalase and  superoxide  dismutase  (SOD))  and  antioxidants 
(  e.g. glutathione  and  vitamin  E)  that  can  detoxify  them. Wh en  levels  of pro-oxidants 
overwhelm  the  antioxidant  defenses,  disturbance  of the  redox  equilibrium  occurs, 
resulting in oxidative stress. This can lead to the activation of stress signaling pathways 
and transcription factors [Circu and Aw, 2010, Fulda et al, 2010]. Although the molecular 
mechanisms by which ROS activate these pathways are unclear, their activation can lead 
to  different  consequences, including growth  arrest,  senescence, up-regulation  of death 
proteins, and cell death by apoptosis or necrosis. 
Cells undergo  apoptosis by three pathways involving death receptors, mitochondria 
and  the  endoplasmic  reticulum  (ER). Protein  chaperones  such  as  Bip/glucose-related 
protein  78  (GRP78), GRP94, calnexin  and  protein  disulphide  isomerase  (PDI)  assure 
correct folding of newly-synthesized proteins in the ER [Faitova et al, 2006]. A variety 
of  conditions  including  glucose  deprivation,  hypoxia,  disturbance  of  calcium 
homeostasis,  and  excess  ROS  can  perturb  ER  function,  leading  to  accumulation  of 
unfolded  pro  teins  in  the  ER  [Fulda et  al,  201 0;  Schrôder  and  Kaufman, 2005].  This 
phenomenon, known  as  ER stress, activates  signaling pathways such as  the unfolded 
protein response (UPR)  and  ER-associated protein degradation (ERAD). The UPR is a 
survival response that aims  to recover normal  cellular function  in  the face of adverse 
conditions. However, if UPR activation is  not able to rescue cells  from  ER  stress and 
correct the defects in protein folding, then cells are generally eliminated by ER-mediated 146 
apoptosis  [Fulda et al,  2010;  Breckenridge et al,  2003;  Malhotra and  Kaufi.nan, 2007; 
Rasheva and Domingos, 2009). The ER stress response involves 3 distinct mechanisms: 
(i) translational attenuation to decrease the synthesis of new proteins; (ii) transcriptional 
activation of genes  for  ER chaperones  and  ERAD  molecules; and  (iii)  ERAD, which 
involves translocation of misfolded or aggregated ER proteins to  the cytoplasm, where 
they undergo proteosomal degradation [Schrôder and Kaufi.nan, 2005]. The activation of 
the UPR is mediated by three distinct ER stress sensors: protein kinase RNA (PKR)-like 
ER  kinase  (PERK),  activating  transcription  factor-6  (ATF6)  and  inositol-requiring 
protein-1  (IRE1).  In  non-stressed  cells, these sensors  are retained in  the ER lumen by 
interactions with Bip/GRP78. During ER stress, Bip releases these three sensors, leading 
to their activation [Schrôder and Kaufi.nan, 2005). 
To counteract the multitude ofprocesses that can trigger death, cells have developed a 
wide variety of survival strategies that can prevent inappropriate death [Portt et al, 2011]. 
The  pre-exposure  to  sub-lethal  doses  of different  stresses  (e.g.  ROS,  beat  shock, 
ischemia/reperfusion (IR)) can lead to adaptive responses that allow cells and organisms 
to  continue  normal  function  in  the  face  of an  adverse  stimulus  [Portt  et  al,  2011; 
Przybytkowski et al,  1986; Wiese et al, 1995; Kregel, 2002; Bettaieb and Averill-Bates, 
2005; Holsapple and  Wallace,  2008).  Adaptive responses  appear to  be mediated by a 
group  of anti-apoptotic genes  and  their products  (e.g.  Hsps, antioxidants)  that protect 
cells  against diverse toxic and  environmental stresses. If the adaptive response cannot 
protect the cell against an adverse exposure, then the damaged cell will be eliminated by 
apoptosis or necrosis [Portt et al, 2011; Holsapple and Wallace, 2008]. Thermotolerance 
is an adaptive survival response induced by beat preconditioning whereby cells become 
resistant  to  a  subsequent  lethal  insult  such  as  that  triggered by  beat  shock,  ROS  or 
environmental  stressors  [Landry  et  al,  1982;  Martindale  and  Holbrook,  2002).  This 
phenomenon is generally associated with the accumulation ofheat shock proteins (Hsp) 
[Landry et  al, 1982; Richter et  al, 2010;  Landry et  al, 1989).  Thermotolerance can be 147 
developed following  shorter exposures  (  e.g. 30  min)  to  lethal  temperatures  (  42-45°C) 
[15], or during continuous heating (e.g. 3-24 h) at non-lethal temperatures (39.5-41.5°C) 
[Przybytkowski  et  al,  1986].  The induction of thermotolerance by  lower,  fever-range 
temperatures such as 40°C has received little attention. 
We recently reported  that, besides  Hsps  [Bettaieb  and  Averill-Bates,  2005],  mild 
thermotolerance  (  40°C)  can  induce several  antioxidants  in human  cervical  carcinoma 
(HeLa) cells [Pallepati and Averill-Bates, 2010]. The present work determines whether 
mild thermotolerance can induce other adaptive survival responses such as  the UPR in 
HeLa cells. This study also investigates the role of the ER in H20 2-induced cell death, 
and whether mild thermotolerance (  40°C)  can alter the induction of ER stress by H20 2 
and protect cells against ER-mediated apoptosis. 148 
MATERIAL AND METHODS 
Cell culture 
HeLa  cells  (ATCC  #CCL-2)  were  grown  in  monolayer  in  Dulbecco's  modified 
Eagle's  medium  (Invitrogen  Canada, Burlington,  ON,  Canada)  containing  10%  fetal 
bovine serum  (FBS)  (Invitrogen Canada), in  tissue culture flasks  (Sarstedt, St.  Laurent, 
QC,  Canada)  at  37  o c in  a humidified  atmosphere  of 5%  C02  in  a  water jacketed 
incubator [Bettaieb  and  Averill-Bates, 2008].  Culture medium was replaced with fresh 
medium 24 h before experiments. To  induce thermotolerance, cells were transferred to 
an identical incubator for 3 h at 40 °C (± 0.1  °C), following a period of 20 min to  allow 
the temperature of the culture medium to  reach 40 °C IPrzybytkowski et al, 1986}. The 
cells  were  grown  to  near  confluence  and  then  harvested  using  0.25%  (w/v)  trypsin-
0.02% (w/v) EDTA solution, and washed by centrifugation (1 000 x g, 3 min). There was 
no  loss of viability in cells heated at 40 o c for 3 h, evaluated by trypan blue exclusion 
(data not shown). 
Treatment with H20 2 
Cells  (10
6/ml)  were incubated with H20 2  (Sigma-Aldrich, Canada,  ON, Canada)  (0, 
15-50  1-1M) in DMEM containing 10% FBS at pH 7.4 for different times ranging from  15 
min to 3 hat 37°C [Pallepati and Averill-Bates, 2010}.  Cells were pretreated for 1 h with 
50  1-1M  calcium  chelator BAPTA-AM (Sigma-Aldrich), 20  1-1M  calpain inhibitor I (Ac-
LLnL-CHO)  (Sigma-Aldrich),  50  1-1M  caspase-7/3  inhibitor  I  (5-[(S)-(+)-2-
(methoxymethyl)pyrrolidino ]sulfonylisatin)  (Calbiochem), 20  1-1M  caspase-4 inhibitor I, 
(LEVD-CHO)  (Calbiochem)  or  10  1-1M  caspase-12  inhibitor  (Z-ATAD- fluoromethyl 
ketone (FMK)) (MBL International Corporation), where indicated. Cells were washed by 
centrifugation (1 000 x g, 3min) to rem ove inhibitors and H20 2,  and then analyzed for the 
UPR response and ER apoptotic signaling. 149 
Morphological analysis of apoptosis 
Thermotolerant  and  non-thermotolerant  cells  (1 0
6 /ml)  were  labeled  with  Hoechst 
33258  (50  )lg/ml)  (blue-green  fluorescence)  (Sigma  Chemical  Co.),  which  binds  to 
condensed nuclear chromatin of apoptotic cells  [Tanel  and  Averill-Bates; 2005].  Cells 
were washed with PBS and then propidium iodide (PI) (50 )lg/ml) was added to visualize 
necrotic cells  (red  fluorescence).  Observations were made by fluorescence microscopy 
(model  IM,  Carl  Zeiss  Canada Ltd,  St.  Laurent,  QC)  and photographs  were taken by 
digital camera (camera 3CCD, Sony DXC-950P, Empix imaging Inc, Mississauga, ON). 
Images  were  analyzed  using Northem Eclipse  software  (Empix  Imaging).  Cells  were 
classified using the following criteria: (1)  Live cells with normal nuclei, pale blue/green 
chromatin  with  organized  structure);  (2)  Apoptotic  cells  with  bright  blue  /green 
condensed or fragmented chromatin); (3) Necrotic cells (red, enlarged nuclei with smooth 
normal structure). Fractions of apoptotic or necrotic cells were calculated relative to total 
cells. For each condition, 300 cells were counted. 
Clonogenic cell survival assay 
Clonogenic cell  survival  measures  the  ability of cells  to  undergo  cell  proliferation 
following  a toxic insult.  Non-thermotolerant cells  and  thermotolerant (  40°C,  3h)  cells 
were exposed to H20 2 (0-150 )lM) for 2 hat 37°C in a final volume of 1.0 ml, in D-MEM 
containing 10% FBS. After the appropriate time, the cells were washed three times by 
centrifugation  (1000  x  g,  2  min)  to  stop  the  incubation  [Pallepati  and  Averill-Bates, 
201 0].  The  cells  were  resuspended  in  culture  medium,  diluted  to  the  appropriate 
concentration and plated in tissue culture dishes (60 mm x 15 mm), which were incubated 
at 37°C incubator in an atmosphere of 5% C02 for 10 days. The dishes were then washed 
with  PBS,  fixed  with  95%  ethanol  and  stained  with  methylene blue before  counting 
macroscopic colonies  (>50  cells). Cytotoxicity was  expressed  as  the mean number of 
colonies obtained relative to the mean number of colonies obtained in the control. Two 
hundred  cells  were  seeded  in  the  control  plates,  but where  there  was  a  loss  of cell 
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survival, cells were plated at several different densities to ensure that countable colonies 
would  be  obtained,  and  the  results  were  corrected  accordingly.  We  have  previously 
demonstrated that,  in this  system,  there is  linearity between the number of cells plated 
and colonies formed over the range of 10-10
4
. 
Preparation of wh  ole celllysates 
For analysis  of protein expression of PERK, p-PERK, eiF2a, p-eiF2a, ATF6,  Bip, 
IRE1a and  p-IRE1a, non-thermotolerant (37 °C,  3 h)  and  thermotolerant (40 °C,  3 h) 
cells  were harvested  and  then  exposed  to  H20 2  for  15  min.  For detection  of CHOP, 
calpastatin, caspase-4 and caspase-12, thermotolerant and non-thermotolerant cells were 
harvested  and  incubated  with  H20 2  at  37 °C  for  1  or  2  h.  Cells  were  washed  by 
centrifugation (1000 x g, 3 min) in buffer A (100 mM sucrose, 1 mM EGTA, 20 mM 3-
(N-morpholino)  propanesulfonic  acid  (MOPS),  pH  7.4)  [Samali  et  al,  1999].  The 
supematant was discarded, pelleted cells were resuspended in  lysis buffer B [buffer A 
plus 5% Percoll, 0.01% digitonin and a cocktail of protease inhibitors:  10 ).LM  aprotinin, 
10  ).LM  pepstatin  A,  10  ).LM  leupeptin,  25  ).LM  cal pain  inhibitor  I  and  1 mM 
phenylmethylsulfonyl fluoride (PMSF)] and incubated on ice for 1 h.  Then, the proteins 
of who le cell lysates were isolated in the supematant, by a 1  0 min centrifugation step at 
2500 x g to  remove nuclei and unbroken cells  [Bettaieb and  Averill-Bates, 2008], and 
used for detection of  pro teins by Western blotting. 
Preparation of subcellular fractions 
Cells  were  treated  with  H20 2  and  then  subcellular  fractions  were  prepared  as 
described  previously  [Pallepati  and  Averill-Bates,  2010;  Bettaieb  and  Averill-Bates, 
2008].  Thermotolerant  and  non-thermotolerant  cells  were  washed  in  buffer  A  and 
resuspended  in  buffer  B  containing  0.1  mM  dithiothreitol  (DIT).  Lysates  were 
homogenized  using  a  dounce  homogenizer  (50  strokes/sample).  After  a  30  min 
incubation on ice, unbroken cells and nuclei were pelleted by centrifugation at 2500 x g 151 
for  10 min. The supernatant was centrifuged further at  15,000 x g for  15 min to  separate 
the mitochondrial fraction.  The supernatant was further centrifuged at 1  00 000 x g for 1 
h. The resulting supernatant (  cytosolic fraction) as well as the pellet (resuspended in lysis 
buffer B and designated as  the microsomal fraction), were used for protein detection of 
cal pain. 
Immunodetection 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) of cellular proteins was carried 
out according  to  Laemmli  (10%:  PERK, p-PERK, IRE1a, p-IREla, Bip, calpain and 
ca1pastatin; 15%: eiF2a, p-eiF2a, ATF6, CHOP, caspase-4 and -12)  [Laemmli,  1970]. 
Proteins  (40  )lg)  were  quantified  according  to  Bradford  [Bradford,  1976]  and  then 
solubilized  in  Laemmli  sample buffer.  Electrophoresis  was  carried  out  at  a constant 
voltage  of 125  V.  Cellular  proteins  were  transferred  to  a  polyvinylidene  difluoride 
(PVDF)  membrane  using  a  MilliBlot  Graphite  Electroblotter  I apparatus  (Milli-pore, 
Bedford, MA, USA) [Tanel and Averill-Bates, 2005].  The membranes were probed with 
primary antibodies  (see above proteins)  and  anti-GAPDH  (Santa Cruz  Biotechnology, 
Santa Cruz, CA, USA), in  Tris-buffered saline (50 mM Tris base, 150 mM NaCl, 0.1% 
Tween-20)  (TBS-T)  containing  1%  bovine  serum  albumin  (BSA)  for  1  h  at  room 
temperature.  Membranes were washed and incubated for  1 hat room temperature with 
horseradish  peroxidase  (HRP)-conjugated  anti-mouse,  anti-rabbit,  or  anti-goat  IgG 
(Biosource,  Camarilla,  CA,  USA)  diluted  in  TBS-T  containing  5%  milk  powder. 
Proteins were detected using the ECL plus chemiluminescence kit (PerkinElmer, Boston, 
MA,  USA).  Protein  expression  was  analyzed  using  a  scanning  laser  densitometer 
(Molecular Dynamics, Sunnyvale, CA, USA), relative to GAPDH. 
Determination of caspase or calpain activity by fluorescence spectroscopy 
Cells were pretreated with or without calcium che1ator BAPTA-AM, or inhibitors of 
cal  pain,  caspase-7,  caspase-4  and  caspase-12,  and  th  en  exposed  to  H20 2•  After  the 152 
incubation,  cells were washed,  resuspended and  then lysed  at -80°C for  30  min.  The 
kinetic  reaction  was  followed  for  30  min  after  addition of the  appropriate  caspase  or 
calpain substrates at 37°C using a Quadruple Monochromator Microplate Reader (Infinite 
Ml 000, Tecan US, NC, USA). Caspase or cal pain activities were measured by cleavage 
of the  following  fluorogenic peptide substrates:  Suc-LY-AMC for  calpain, Ac-DEVD-
AMC  for  caspase-3,  Ac-LEVD-AFC  for  caspase-4,  MCA-Val-Asp-Gln-Val-Gly-Trp-
Lys-(DNP)-NH2  for  caspase-7,  Ac-ATAD-AFC  for  caspase-12  and  Ac-LEHD-AFC for 
caspase-9  (Calbiochem)  [Tanel  and  Averill-Bates,  2005].  Activities  of caspases  or 
calpain  are represented  as  relative  cumulative fluorescence  of the kinetic reaction  and 
compared to untreated controls. 
Small interfering RNAs (siRNAs) 
HeLa cells  (0.25  x  1  0
6
)  were seeded in  6-well plates  and  allowed  to  reach 60-80% 
confluence on  the day of transfection.  The small  interfering RNA  (siRNA)  constructs, 
PERK  siRNA  (sc-36213),  the  non-targeting  siRNA  control  (sc-37007)  and  control 
siRNA-FITC  conjugate  A  (sc-36869)  were  obtained  from  Santa  Cruz.  Cells  were 
transfected  for  48  h  with  50  pmol  of  each  siRNA  construct,  according  to  the 
manufacturer's  protocol.  Transfection  efficiency  (80%)  was  determined  by  counting 
FliC-positive cells by flow cytometry. Protein expression was determined in whole cell 
lysates  (section  2.5)  of transfected  cells  by  10%  SDS-PAGE  and  Western  blotting 
(section 2.7)  using  anti-PERK antibody (1:1000)  (Santa  Cruz).  Transfected  cells  were 
made  thermotolerant  or  non-thermotolerant  and  then  analysed  for  H202-induced 
apoptosis. 
Statistics 
Data represent means ± SEM from  at least 3 independent experiments performed in 
duplicate. When not shown, error bars lie within symbols. Comparisons among multiple 
groups were made by one-way ANOV  A, which measures the linear contrast of means. 153 
The Bonferroni-Holmes adjustment was used to  control for the Family-wise error rate at 
a desired level  (a=5%). Software used was JMP Statistical Discovery 4.0 (SAS  Institute 
Inc., Cary, NC). For significant differences, P < 0.05. 
RESULTS 
Mild thermotolerance developed at 40°C protects HeLa cells against H20rinduced 
apoptosis and clonogenic cell killing 
Morphological  analysis  of nuclear  chromatin  condensation  shows  that  exposure  of 
cells to  H20 2 (25  and 50  )lM)  for 3 h induced cell death by apoptosis (Figure lAb-lAc, 
lB), compared to the untreated control (Fig.  la, lB). Very few (<5%) necrotic cells were 
seen under these conditions. The treatment of HeLa cells at a mild temperature of 40°C 
for  3  h  caused  thermotolerance,  which  afforded  significant  protection  against  H20 2-
induced  apoptosis  (Figure  lAe-lAf,  lB).  Thermotolerant  cells  were  also  resistant  to 
H20 2-induced clonogenic cell killing (Figure 1  C). 
Mild thermotolerance (40°C) induces the UPR in HeLa cells 
Mild  thermotolerance  developed  at  40°C  in  HeLa  cells  induced  severa}  Hsps  and 
antioxidants [Bettaieb and Averill-Bates, 2005; Pallepati and Averill-Bates, 2010]. These 
defense proteins  could  be involved  in  the protective  effect  of thermotolerance against 
H20 z-induced  apoptosis  [Pallepati  and  Averill-Bates, 2010].  In  addition, the  ability of 
mild thermotolerance (40°C)  to  evade H20 2-induced apoptosis might be associated with 
the  activation/up-regulation  of other survival  responses  such  as  ER  stress. This  study 
therefore  determines  wh ether  mild  thermotolerance  (  40°C)  can  induce  the  expression 
and/or  activation  of adaptive  proteins  of the  UPR  such  as  PERK, IRE 1  a  and  A  TF6. 
Activation of PERK by oligomerization  and  autophosphorylation to  its  active form  p-
PERK,  in  tum  phosphorylates  eukaryotic  initiation  factor  2  (eiF2a),  attenuating  the 
translational process to  reduce the load of newly synthesized proteins in the ER lumen 154 
[Harding et  al, 2000].  Indeed,  the  exposure of HeLa cells  to  mild heat  (40°C)  for  3 h 
caused significant activation (phosphorylation) of PERK (Fig. 2A, 2B)  and  eiF2a (Fig. 
3A,  3B),  compared  to  non-thermotolerant control  cells.  The  levels  of p-PERK and  p-
eiF2a were increased by 2.4- and 1.5-fold, respectively. In addition, protein expression of 
PERK  (Fig.  2C,  2D)  and  eiF2a  (Fig.  3C,  3D)  increased  by  1.4- and  1.2-fold, 
respectively.  There  was  a  small  1.2-fold  increase  in  protein  expression  of the  ER 
chaperone Bip, compared to  the non-thermotolerant control (Fig. 4A, 4B).  The levels of 
p-IRE1a, IRE1a (Fig.  7C), ATF6 and cleaved ATF6 (Fig.  8A, 8D) and were unchanged 
in  mild  thermotolerant  cells.  Together,  these  results  show  that  mild  thermotolerance 
enhanced the pro-survival effects of  the PERK/eiF2a branch of  the UPR. 
Activation of the UPR by H20 2 in HeLa cells: role of mild thermotolerance 
The  exposure  to  milder  conditions  of stress  can  often  induce  cellular  defenses  to 
enable the cell to survive. Therefore, the ability of H20 2 to  activate the UPR, under mild 
conditions, was evaluated in non-thermotolerant HeLa cells. The activation status of the 
ER  stress  sensors  PERK, ATF6  and  IREla was  evaluated,  as  well  as  expression  of 
chaperone  Bip  (Figs.  5-9).  The  treatment  of cells  with  H20 2  (15-50  )lM)  for  15  min 
caused significant and  dose-dependent activation (phosphorylation) of PERK (Fig.  SA, 
5B), eiF2a (Fig. 6A, 6B)  and  IRE 1  a (Fig.  7  A, 7B), relative to  untreated controls. H20 2 
caused  cleavage of ATF6, which is  shown by a decrease in protein expression of its  90 
kDa native form  (Fig.  8A, 8B) and an increase in its 36 kDa cleavage fragment (Fig.  8C, 
8E), relative to untreated controls. H20 2 induced protein expression of Bip after 15  min 
(Fig. 9A, 9C). These early ER stress responses were essentially lost after a longer 30 min 
treatment with H20 2 (data not shown). Together, these results show that exposure to mild 
stress induced by H20 2 activates the 3 branches of the UPR in HeLa cells. 
Subsequent! y, the ability of mild thermotolerance (  40°C,  3 h)  to  modulate activation 
of the UPR by H20 2 was determined (Figs 5-9). As mentioned above (section 3.2), non-155 
phosphorylated  and  phosphorylated  forms  of PERK  (Fig. 2)  and  eiF2a (Fig.  3)  were 
higher in thermotolerant versus non-thermotolerant cells. However, when thermotolerant 
cells were treated with H20 2, there were no significant changes in levels of p-PERK (Fig. 
5B  5C), PERK (Fig. 5C, 5D), p-eiF2a (Fig. 6B, 6C) and eiF2a (Fig. 6C, 6D), compared 
to untreated non-thermotolerant controls. In general, levels of these proteins were higher 
in  H20 2-treated thermotolerant cells  compared to  their non-thermotolerant counterparts 
(Fig.  5B, 5D, 6B,  6D), except for PERK expression at  50  !lM H20 2.  For IRE1a, H20 2-
induced  increases  in  expression  of p-IRE1a and  IRE1a  (Fig.  7A)  were  inhibited  in 
thermotolerant cells (Fig. 7B, 7C, 7D). For ATF6, there was a dose-dependent increase in 
expression of the 90 kDa form  when thermotolerant cells were treated with  15-50  !lM 
H20 2  (Fig.  8A,  8B).  Levels  of  A  TF6  were  significantly  higher  in  H20 2-treated 
thermotolerant cells, compared to non-thermotolerant cells. The generation of the cleaved 
form of A  TF6 (36 kDa) by H20 2 (Fig. 8C) was partially decreased in thermotolerant cells 
(Fig.  8D, 8E).  Levels of Bip increased slightly in H20 2-treated thermotolerant cells (Fig. 
9B, 9C).  Together, these results show that the PERK/eiF2a branch of the UPR remains 
activated  in  H20 2-treated thermotolerant cells.  In  addition, protein levels of ATF6  (90 
kDa)  were  induced  by H20 2  in  thermotolerant  cells,  whereas  cleavage  of ATF6  and 
activation ofiRE1 a by the oxidant were decreased. 
H20 2 induces ER-mediated apoptosis in HeLa cells 
H20 2 up-regulates pro-apoptotic factor CHOP: effect of mild thermotolerance 
Severe and prolonged ER stress generally results in cell death via apoptosis. The pro-
apoptotic  transcription  factor  CHOP  (also  known  as  growth-arrest  and  DNA-damage-
inducible gene 153  (GADD 153)) is strongly induced in response to ER stress [Malhotra 
and  Kaufman, 2007].  Exposure of HeLa cells  to  pro-oxidant H20 2  (25, 50  !lM)  for  a 
longer  time  of 2  h  caused  a  significant  1.2  to  1.6-fold  increase  in  CHOP  expression 
compared  to  untreated  control  cells  (Fig.  1  OA,  1  OB).  Mild  thermotolerance  (  40°C) 
completely inhibited the induction of CHOP expression by H20 2. -------------------
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Activation of calpain by H20 2: role of mild thermotolerance 
The  alteration  of ER  calcium  homeostasis  can  result  in  activation  of cytosolic 
proteases  known  as  calpains.  They  play  a  major  role  in  ER-mediated  apoptosis  by 
processing  and  activating  the  ER initiators  caspase-12  and  caspase-4  [Nakagawa  and 
Yuan, 2000; Tan et al,  2006].  We therefore determined if calpains are  involved in  ER-
mediated apoptosis during exposure of HeLa cells to  H20 2• Calpain activity is regulated 
by  its  endogenous  inhibitor,  calpastatin.  Treatment  of cells  with  H20 2  resulted  in 
calpastatin cleavage (Fig.  11). Levels of the 110 kDa cleaved fragment increased by 1.45 
to  1.8-fold as a function of H20 2 concentration, compared to untreated control cells (Fig. 
11A,  11B).  Calpastatin  cleavage  by  H20 2  was  significantly  attenuated  in  mild 
thermotolerant cells (Fig.  liA, liB). As a consequence, there was a significant increase 
in enzymatic activity of calpains upon treatment with H20 2  (Fig. 12A). Active calpains 
are  found  predominantly at  the plasma membrane. Indeed, increased protein levels  of 
calpain  were  detected  in  microsomal  fractions  (Fig.  12B,  12C)  of H20 2-treated  cells, 
along with a corresponding decrease in levels in cytosolic fractions (Fig. 12D, 12E). Mild 
thermotolerance  significantly  diminished  H20 2-induced  calpain  activation  (Fig.  12A), 
and its translocation to the plasma membrane (Fig. 12B-12E). 
Roles  of calcium,  calpain  and  caspase-7  in  activation  of ER caspases-4  and  -12 
during exposure to H20 2: protective role of mild thermotolerance 
Caspase-12  (mice)  and  -4  (human) have been proposed as  caspases that initiate ER 
stress-induced apoptosis [Fulda et al, 201 0; Przybytkowski et al, 1986]. Pro-caspase-12 is 
localized at the cytosolic side of the ER membrane and can be activated through several 
mechanisms,  including  cleavage  by m-calpain  and  by  caspase-7  [Breckenridge  et  al, 
2003; Nakagawa and Yuan, 2000; Tan et al, 2006; Boyce and Yuan, 2006]. Treatment of 
HeLa cells  with  H20 2  for  2 h  led  to  a  significant increase in  enzymatic  activities  of 
caspase-4 (Fig.  13A)  and caspase-12  (Fig. 13B). H20 2  caused  a significant increase in 
levels  of the  active  cleavage  fragments  of  caspase-4  (20  kDa)  (Fig.  13C,  13D)  and 157 
caspase-12 (33  kDa) (Fig. 13E, 13F). The activation of caspases-4 and -12 was inhibited 
in mild thermotolerant (40°C) cells (Fig. 13A-13F). 
Subsequently,  the upstream  factors  responsible for  activation  of ER  caspases  were 
determined. During ER stress,  caspase-7 associates with procaspase-12  and  can cleave 
the pro-domain to  initiate the processing of caspase-12 [Fan  et al, 2005].  A significant 
increase in enzymatic activity of caspase-7 activation was seen in HeLa cells exposed to 
H20 2  for 2 h (Fig.  14A). No activity was detected after a shorter 1 h exposure to  HzOz. 
Mild thermotolerance  significantly  attenuated  H20 2-induced  caspase-7  activation  (Fig. 
14A). The activation ofcaspase-4 (Fig. 14B) and caspase-12 (Fig.  14C) was significantly 
inhibited by a calcium chelator (BAPTA-AM), and by inhibitors of calpain and caspase-
7.  This confirms the roles of calcium, cal pain and caspase-7 as  activating factors of the 
ER caspases-4 and -12. 
Once activated, caspase-12 can activate caspase-9, which in tum can catalyze cleavage 
of procaspase-3  [Morishima et al,  2002]. The ro1es  of caspase-12  and  caspase-4 in  the 
activation of caspase-9 and caspase-3 in  H20 2-treated cells were evaluated by means of 
inhibitors  of caspase-4  and  caspase-12.  The  activation  of caspase-9  was  decreased 
partially, but not completely, by inhibitors of caspase-4 and caspase-12 (Fig. 15A). These 
results  suggest  th at  caspase-12  and  -4  can  directly  activate  caspase-9,  without  the 
involvement of cytochrome  c  and  mitochondria,  during  H20 2-induced  apoptosis.  In  a 
similar manner, the inhibitors of caspase-4 and  -12  partially inhibited the activation of 
executioner caspase-3  by H20 2  (Fig.  15B).  Furthermore, BAPTA-AM and  the  calpain 
inhibitor also caused partial inhibition of caspase-3 activation by H20 2  (Fig. 15B). HzOz-
induced  apoptosis  (chromatin  condensation)  was  also  partially decreased  by BAPTA-
AM, and inhibitors  of calpain and  caspases-7,  -4 and -12  (Figure  15C).  These findings 
suggest  that  the  activation  of caspase-3  and  the  induction  of apoptosis  by HzOz  are 158 
dependent, in  part, on the disruption of calcium homeostasis and apoptosis mediated by 
the ER. 
Role of the ER stress response in resistance to H20 2-induced apoptosis 
We  subsequently  determined  if a  causal  connection  exists  between  the  ER  stress 
response  and  resistance  to  H20 2-induced  apoptosis.  Therefore,  levels  of PERK were 
decreased to  evaluate whether the resistance to  H20 2-induced apoptosis  seen  following 
exposure to  mild hyperthermia could be inhibited.  Transfection of cells with  a siRNA 
targeted  against PERK led to  a decrease in protein levels of PERK to  60%  of control 
levels (Fig. 16A, 16B).  Cells with control or decreased levels of PERK were then made 
thermotolerant or non-thermotolerant, and exposed to 50  11M H20 2 for 3 h.  Knock down 
of PERK  had  little  effect  on  H20 2-induced  apoptosis  in  non-thermotolerant  cells. 
However,  in  thermotolerant  cells  with  decreased  levels  of PERK,  there  was  partial 
reversai  of resistance H20 2-induced apoptosis, compared  to  scrambled siRNA controls 
(Fig.  16C, 16D). This shows that the ER stress response plays a partial role in resistance 
to H20 2-induced apoptosis following mild beat preconditioning. 
DISCUSSION 
Induction of the UPR by mild thermotolerance (40°C) in HeLa cells 
This study shows that mild thermotolerance developed at 40°C can elicit the ER stress 
response. Mild heat stress enhanced the pro-survival effects of the PERK/eiF2a branch of 
the UPR. Adaptive responses induced by pre-exposure of cells and  tissues to  low levels 
of stresses  often  induce  cellular  defenses  including  stress  proteins  such  as  Hsps, 
antioxidants  (SOD, catalase), anti-apoptosis proteins  (e.g.  Bcl-2, inhibitor of apoptosis 
proteins (lAPs), cellular FLICE-inhibitory protein (cFLIP)) and damage repair molecules, 
as  well  as  survival  signaling  pathways  involving  extracellular  regulated  kinases  1/2 
(ERKl/2) and phosphatidylinositol 3-kinase (PI3-K)/Akt [Fulda et al, 201 0;  Portt et al, 159 
2011;  Davies, 2000). In  addition, the ER plays a role as  an  adaptive survival response 
mediated by three ER membrane receptors PERK, A  TF6 and IRE 1  a [Faitova et al, 2006). 
In HeLa cells, mild heat stress  (  40°C,  3 h)  triggered the induction of Hsps [Bettaieb 
and  Averill-Bates,  2008]  and  antioxidants  (SOD,  catalase,  glutathione)  [Pallepati  and 
Averill-Bates,  2010).  This  study  shows  further  that  mild  thermotolerance  (40°C)  can 
activate  another  cell  survival  mechanism,  the  PERK/eiF2a  branch  of the  UPR.  The 
phosphorylation of eiF2a allows translation of ATF4, which induces the transcription of 
survival genes involved in amino acid metabolism, redox reactions, the stress response, 
and protein secretion [Szegezdi et al, 2006). Once activated, PERK can mediate an  anti-
apoptotic response by phosphorylating nuclear factor (erythroid-derived 2)-like 2 (Nrf2), 
a transcription factor that promotes cell survival in response to ER stress [Cullinan et al, 
2003).  The  phosphorylation of Nrf2 by PERK activates the transcription of protective 
genes  containing antioxidant responsive elements  (AREs)  such  as  NAD  (P)H:quinone 
oxidoreductase  1,  herne  oxygenase  1,  glutathione  S-transferase  and  the  rate  limiting 
enzyme in glutathione biosynthesis, y-glutamylcysteine synthetase (y-GCS)  [Venugopal 
and Jaiswal,  1998; Wild et al,  1999; He et al, 2001; Nguyen et  al, 2005).  Interestingly, 
mild  thermotolerance increased protein expression of y-GCS  and  glutathione levels  in 
HeLa cells [Pallepati and Averill-Bates, 2010], which could be a consequence of PERK 
activation.  Enhanced  GSH  content  observed  in  thermotolerant  cells  could  scavenge 
mitochondrial ROS and prevent the opening of the mitochondrial permeability transition 
pore, cytochrome c release and caspase-9 activation (Franco and Cidlowski, 2009). 
Lower doses of H20 2 activate the UPR while higher doses cause apoptosis through 
the ER 
ROS cause protein damage, which could lead to accumulation of  misfolded pro teins in 
the ER lumen.  Mild oxidative stress (H20 2 (15-50  J..LM,  15  min)  activated the three ER 
stress  sensors, PERK, IRE1a and ATF6 in  HeLa cells. The activation of these  sensors 160 
increases the protein folding capacity of the cell by promoting gene transcription for ER 
chaperones and ER-associated degradation of damaged proteins [Malhotra and Kaufinan, 
2007;  Rasheva  and  Domingos,  2009].  H20 2  (50  to  500  ~M ,  24  h)  caused  ER  stress 
(induction of GRP78/Bip, p-PERK and p-eiF2a) in  human oral  keratinocytes  and  oral 
cancer cells  [Min et  al,  2008].  In  mesenchymal  stem  cells, H20 2  (120  ~M ,  6 to  24  h) 
caused an increase in the expression of  Bip [Wei et al, 201 0]. 
This  study  shows  that the  ER  stress  survival  response  predominates  under milder 
exposure  conditions  (15  min)  to  H20 2  (15-50  ~M) ,  whereas  apoptosis  predominates 
during more severe oxidative stress  (1-3 h).  ER-mediated apoptosis involved increased 
expression of CHOP, cleavage of calpastatin, and  activation of cal pain, caspase-4 and -
12. Caspase-4 cleavage and up-regulation of CHOP was induced by peroxide (200 to 500 
~M, 24 h) in human oral keratinocytes and oral cancer cells [Min et al, 2008]. H20 2  (1 20 
~M ,  6 to 24 h)  caused cleavage of procaspase-12 in mesenchymal stem cells [Wei et al, 
201 0].  The  pro-oxidant  tert-butylhydroperoxide  (tBOOH)  caused  calpain-mediated 
cleavage of procaspase-12 at the ER and its translocation to the nucleus, where increased 
caspase-12 activity was found, in rat hepatocytes [Haidara et al, 2008]. 
The exact mechanisms that regulate apoptosis through the ER are not well understood. 
Several  different  pathways  have  been  implicated  including  the  caspase-12/caspase-4 
pathway, CHOP, and IRE1-JNK pathways [Fulda et al, 2010]. Although caspases-12 and 
-4  have been implicated in ER stress-induced apoptosis, the events responsible for their 
activation remain ill-defined. This  study shows that calcium, calpain and  caspase-7  are 
among  the  initiating  factors  for  the  caspase-12/caspase-4  pathway  in  H20 2-induced 
apoptosis through the ER in HeLa cells. 
The  role  of  caspase-12  in  ER-mediated  apoptosis  IS  well  established  in  m1ce 
[Nakagawa et  al, 2000].  However,  its role in  apoptosis  of human  cells  is  unresolved, 161 
since the human caspase-12 gene contains several inactivating mutations [Fischer et  al, 
2002). Despite this, caspase-12 activation has been detected in  several human cell lines, 
including  retinal  pigment  epithelial  (ARPE-19)  [Luthra  et  al, 2006],  adenocarcinomic 
alveolar basal epithelial (A549)  [Bitko and Barik, 2001], branchial epithelial [Kerbiriou 
et al, 2009], embryonic kidney (HEK293T) [Yoneda et al, 2001] and HeLa cells [Won et 
al,  201 0;  Hu  et  al, 2005).  Our results  are  in  concordance  with  these  studies.  Once 
activated, caspase-12 causes cytochrome c-independent caspase-9 activation, followed by 
caspase-3 activation [Morishima et al, 2002; Rao et al, 2004). The partial attenuation of 
caspase-9 activation by a caspase-12 inhibitor suggests that caspase-9 can be activated by 
alternative  pathways  in  H20 2-treated  HeLa  cells.  Indeed,  H20 2  caused  caspase-9 
activation through release of cytochrome c from  mitochondria in HeLa cells  [Pallepati 
and Averill-Bates, 2010].  In mesenchymal  stem  cells, H20 2  induced  apoptosis through 
both mitochondrial and ER pathways [Wei et al, 2010). 
Caspase-4 is considered to fulfill the function of caspase-12 in human cells [Hitomi et 
al, 2004; Kim  et  al, 2006].  The  activation of caspase-4  was  mediated by calcium  and 
calpain  during  ER  stress  caused  by tunicamycin  and  thapsigargin  in  SK-N-SH  cells 
[Matsuzaki et al, 201 0).  However, little information is available about putative caspase-4 
substrates. lt was reported that caspase-4 can cleave actin, ataxin and the 65 kDa subunit 
of splicing factor U2AF [Agard et al, 201 0).  The inhibition of caspase-9 activation by a 
caspase-4  inhibitor  in  our  study  suggests  that  caspase-4  cleaved  caspase-9  in  a 
cytochrome  c-independent  manner,  similar  to  caspase-12.  The  over-expression  of 
caspase-4 in COS-7 cells resulted in caspase-9 cleavage in the absence of cytochrome c 
release from mitochondria [Yukioka et al, 2008). 
The  transcription  of CHOP  can  be  induced  by  the  three  ER  sensors,  but  the 
PERK/eiF2a  branch  of the  UPR  is  required  for  up-regulation  of  CHOP  protein 
expression [Malhotra and Kaufrnan,  2007; Szegezdi et al, 2006). However, the details of 162 
the apoptosis pathway downstream of CHOP are not well understood. CHOP appears  to 
be linked to apoptosis by down-regulating Bcl-2 expression [McCullough et al, 2001] and 
inducing the expression of BH3-only protein Bim [Puthalakath et al, 2007]. Transfection 
studies  done  in  HeLa  cells  show  that,  CHOP  downregulates  Bcl-2  expression  by 
inhibiting bcl2 transcription (McCullough et al, 2001). 
Mild thermotolerance as an adaptive apoptosis-resistant phenotype 
This study shows that mild thermotolerance developed at 40°C inhibited all of  the pro-
apoptotic  events  induced  by H20 2  at  the  level  of the  ER,  as  weil  as  clonogenic  cell 
killing.  Furthermore,  the  PERK/eiF2a branch  of the  UPR  contributes  in  part  to  this 
apoptosis-resistant  phenotype  in  HeLa  cells.  However,  other  mechanisms  must  also 
contribute to  the apoptosis-resistant phenotype and  these could involve increased levels 
ofHsps and antioxidants [Pallepati and Averill-Bates, 2010; Bettaieb and Averill-Bates, 
2008].  Mild  hyperthermia  induces  catalase  and  peroxidase  pathways  that  metabolize 
H20 2  [Pallepati  and  Averill-Bates,  201 0].  These  pathways  could  account  for  the 
resistance to H20 2  following mild hyperthermia, independent of the ER  stress response. 
The  ability of Hsps  to  inhibit apoptosis  through  the  mitochondrial  and  death  receptor 
pathways has been weil characterized [Beere, 2004]. Hsp72 was shown to bind to IRE1a, 
allowing PC-12 cells to  adapt to  ER stress by enhancing the pro-survival effects of the 
IRE1a/XBP1  branch  of the  UPR  [Gupta  et  al,  2010].  Hsp27  and  Hsp70  can  both 
maintain cellular redox homeostasis. Hsp27 is able to  increase glutathione levels [Arrigo 
et  al,  2005], reduce cytosolic ROS  levels [Wyttenbach et al,  2002], increase glucose 6-
phosphate dehydrogenase activity [Préville et al, 1999] and/or decrease intracellular iron 
levels [Arrigo et al, 2005]. ,-- - - -- -
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CONCLUSION 
This study improves understanding about the activation of ER stress and ER-mediated 
apoptosis by oxidative stress. Moreover, the adaptive response (UPR) dominates during 
milder oxidative stress, whereas ER-mediated apoptosis occurs during more severe stress. 
Furthermore, it  advances  knowledge  about the protective effect of adaptive responses 
induced by mild stresses, such as  fever temperatures, against the induction of apoptosis 
by oxidative stress through the ER. 
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Figure  1  Mild  heat  pretreatment  at  40°C  causes  resistance  to  H20 2-induced 
apoptosis and clonogenic cell killing. (A) (a toc) Normal (non-thermotolerant) (37°C, 3 
h)  and (d  to f)  thermotolerant (40°C, 3 h)  HeLa cells (10
6/ml) were incubated with H20 2 
concentrations of 0  !-LM  (a, d), 25  !-LM  (b, e), and  50 !-LM  (c, f)  for  3 h. (B) The fractions 
of  apoptotic  (Hoechst  33258)  cells  are  given  relative  to  the  total  number  of  cells 
(magnification 320 X).  Necrotic cells, stained with PI, were < 5%.  (C) Clonogenic cell 
survival is shown for H20 2-treated thermotolerant versus normal cells. The control value 
represents  10
5  cells and was normalized to  represent 100% cell survival.  Data represent 
means  and  SEM  from  three  independent  experiments  performed  with  multiple 
estimations per point. ***P<O.OOl  indicates a statistically significant difference between 
treatment  with  H20 2 and  the  untreated  control.  ##P<O.Ol  or ###P<O.OOl  indicates  a 
statistically  significant  difference between  treatments  (±  thermotolerance)  for  a  given 
concentration of H20 2. 165 
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Figure 2 Induction and activation of PERK in cells at a mild temperature of 40°C. 
Western  blot  analysis  of (A)  p-PERK and  (C)  PERK in  whole  cell  lysates  of non-
thennotolerant  (3 7°C,  3  h)  and  thennotolerant (  40°C,  3 h)  HeLa ce1ls.  Representative 
blots are from four individual experiments. Densitometric analyses for expression of (B) 
p-PERK and  (D)  PERK are relative to  untreated  controls, designated  as  100%,  using 
GAPDH  as  loading  control.  Data  represent  means  and  SEM  from  four  independent 
experiments  performed  with  multiple  estimations  per  point.  **P<O.O 1:  statistically 
significant difference compared to the untreated control. A 
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Figure 3 Mild thermal stress (40°C) causes induction and phosphorylation of eiF2a. 
Immunodetection  of  (A)  p-eiF2a  and  (C)  eiF2a,  in  whole  cell  lysates  of  non-
thermotolerant  and  thermotolerant  cells,  using  GAPDH  as  loading  control. 
Representative blots are  from  three individual  experiments.  Densitometric analyses  for 
expression  of (B)  p-eiF2a  and  (D)  eiF2a  (±SEM)  are  relative  to  untreated  controls 
(100%). *P<0.05: statistically significant difference compared to the untreated control. 167 
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Figure  4  Protein  expression  of  chaperone  protein  Bip  (GRP78)  in  non-
thermotolerant (37°C, 3 h) and thermotolerant (40°C, 3 h) cells. (A) Levels of Bip (78 
kDa) in whole cell  lysates  were analyzed by Western  blotting.  A representative blot is 
shown from three individual experiments.  (B) Densitometric analysis for Bip expression 
(±SEM) is relative to the untreated control (1 00%). A 
8 
3JCC, 15 min  3JCC  40°C, 15 min 
~ 
0  15  25  50  [H202]  (J.JM)  o  o  15  25  50 
1  1  p-PERK 1251<Dal 
1  1 GAPDH 37 KDaE  P== _ ~~====="'===~ 
1---- 1  PERK1251<Da 1 
1 - _._,_1  GAPDH 37 kDa  ~~======~ 
0 3715min 
~  ffi  300  o 40 15 min  ;;;;. 
~Loo  ~  ~  j~ 
c8  ;  rf , 
o  .... 
ëii  0  100  1 
~~  c..- 0  ~  Iii  ~ 
x  w 
IIi 
50 
o  3715min 
~  o 4015 min 
w- 200  Jl 
~  ~ 150  ~ #1 r  • 
c  0  rf ,  rf 
0  (..)  100  ·- .... 
~ 0 
~ ~  50 
c..-
><  w 
D 
*!~ 
50 
168 
c 
Figure  5  H20 2  causes  activation  of PERK:  role  of mild  thermotolerance.  Non-
thermotolerant (37°C, 3 h)  and thermotolerant (40°C, 3 h) HeLa cells were incubated for 
15  min at 37°C with H20 2 (0-50  ).lM)  in D-MEM containing 10% FBS.  Representative 
Western blats are for p-PERK (n=4) and PERK (n=3) in (A) non-thermotolerant and (C) 
thermotolerant  cells  (+  normal  control  at  37°C),  using  GAPDH  as  loading  control. 
Densitometric analyses for expression of (B) p-PERK and (D) PERK (±SEM) are relative 
to  the  untreated  non-thermotolerant  contrais  at  37°C  (100%).  *P<0.05  or  **P<O.Ol : 
statistically significant difference between treatment with H20 2 and the untreated control. 
#P<0.05,  ##P<O.Ol,  or  ###P<O.OOl:  statistically  significant  difference  between 
treatments (± thermotolerance) for a given concentration ofH20 2. 40°C, 15 min 
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Figure 6 H20 2 causes eiF2a phosphorylation: role of thermotolerance at 40°C. Non-
thermotolerant (3 7°C, 3 h) and thermotolerant (  40°C, 3 h) cells were incubated for 15 min 
at  37°C  with  H20 2 (0-50  J..LM).  Representative  Western  blots  from  three  individual 
experiments are for p-eiF2a and eiF2a in (A) non-thermotolerant and (B) thermotolerant 
cells  (+  normal  control  at  37°C),  using  GAPDH  as  loading  control.  Densitometric 
analyses  for  expression  of (B)  p-eiF2a  and  (D)  eiF2a  (±SEM)  are  relative  to  the 
untreated non-thermotolerant controls at 37°C (100%).  *P<0.05:  statistically signifi.cant 
difference between treatment with H20 2 and the untreated control. #P<0.05:  statistically 
significant difference between treatments (± thermotolerance) for  a given concentration 
ofH20 2. A 
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Figure 7  H20 2  causes IREla activation:  inhibition  in  thermotolerant cells.  Non-
thermotolerant (3 7°C, 3 h) and thermotolerant (  40°C, 3 h) cells were exposed to H20 2  (0-
50 !-lM)  for  15  min.  Representative Western blots for p-IREla and IREla in  (A) non-
thermotolerant and  (C)  thermotolerant cells (+ normal  control  at  37°C) are from  three 
individual  experiments,  using  GAPDH  as  loading  control.  Densitometric analyses  for 
expression  of (B)  p-IREla  and  (D)  IREla  (±SEM)  are  relative  to  untreated  non-
thermotolerant  controls  at  37°C  (1 00%).  **P<O.Ol:  statistically  significant  difference 
between treatment with H20 2  and the untreated control. #P<0.05: statistically significant 
difference between treatments (± thermotolerance) for a given concentration ofH20 2. c 
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Figure 8 H20 2 causes cleavage of ATF6: role of mild thermotolerance. (A, C) Non-
thermotolerant (37°C, 3 h) and (A, D) thermotolerant (40°C, 3 h) cells were incubated for 
15  min at 37°C with H20 2 (0-50  f.!M)  in D-MEM containing 10% FBS.  Representative 
Western blots for (A) ATF6 (90 kDa) and (C, D) cleaved ATF6 (36 kDa) are from three 
independent experiments, using GAPDH as  loading control. Densitometric analyses for 
expression of (B) ATF6 (90 kDa) and (E) cleaved ATF6 (36 kDa) (±SEM) are relative to 
the  untreated  non-thermotolerant  controls  at  37°C  (100%).  #P<0.05  or  ##P<O.Ol: 
statistically significant  difference  between treatrnents  (± thermotolerance)  for  a  given 
concentration of Hz  Oz. A  37°C, 15 min 
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Figure 9 Effect of H20 2 on expression of Bip. HeLa cells were incubated with H202 (0-
50  )..LM)  for  15  min.  Representative  Western  blots  for  Bip  (78  kDa)  in  (A)  non-
thermotolerant and  (B)  thermotolerant cells  (+  normal  control  at  37°C)  are from  three 
individual  experiments,  relative  to  GAPDH.  (C)  Densitometric  analysis  for  Bip 
expression (±SEM)  is relative to the untreated non-thermotolerant control (1 00%). A 
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Figure  10  H20 2  increases  CHOP  expression  in  HeLa  cells:  protective  role  of 
thermotolerance (40°C). Non-thermotolerant and thermotolerant cells were treated with 
H20 2 (0-50 JlM)  for 2 h.  (A) A representative Western blot is shown for CHOP (28 kDa) 
expression  from  four  independent  experiments, using GAPDH  as  loading  control.  (B) 
Densitometric  analysis  for  CHOP  expression  (±SEM)  is  relative to  the  untreated non-
thermotolerant  control  (100%).  *P<0.05:  statistically  significant  difference  between 
treatment  with  H20 2  and  the  untreated  control.  #P<0.05:  statistically  significant 
difference between treatments (± thermotolerance) for a given concentration ofH20 2. 174 
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Figure 11  H20 2  causes  calpastatin cleavage:  inhibition  by  mild  thermotolerance. 
Non-thermotolerant  (37°C,  3 h)  and thermotolerant (  40°C,  3 h)  cells  were  exposed  to 
H20 2 (0-50  J.!M)  for  1 h at 37°C in  D-MEM containing 10% FBS.  (A)  A representative 
Western blot for  calpastatin (126  kDa)  and  its  cleavage fragment  (11 0 kDa)  is  shown 
from  three  independent  experiments. (B)  Densitometric analysis  for  expression of the 
cleaved  calpastatin  fragment  (11 0  kDa)  (±SEM)  is  relative  to  the  untreated  non-
thermotolerant  control  at  37°C  (100%).  **P<O.Ol:  statistically  significant  difference 
between treatment with H20 2 and the untreated control. #P<0.05:  statistically significant 
difference between treatments (± thermotolerance) for a given concentration ofH20 2. A  ONormal 
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Figure  12  H20 2  induces  calpain  activation  and  translocation  to  the  plasma 
membrane:  abrogation  by  mild  thermotolerance.  Non-thermotolerant  and 
thermotolerant HeLa cells were exposed to  H20 2 (0-50 11M)  for  1 h at 37°C in D-MEM 
containing 10% FBS. (A) Calpain activity in cell lysates is relative to the untreated non-
thermotolerant control at 3  7°C (1 00% ).  Western blots for 11-calpain expression (80 kDa) 
in  (B)  microsomal  and  (D)  cytosolic  fractions  are  representative  of four  independent 
experiments. Calpain expression (±SEM) in microsomal (C) and  cytosolic (E)  fractions 
was analyzed by densitometry and is relative to untreated non-thermotolerant controls at 
37°C (1 00%). *P<O.OS  or **P<0.01 : statistically significant difference between treatment 
with  H20 2  and  the  untreated  control.  #P<O.OS,  ##P<0.01,  or ###P<0.001:  statistically 
significant difference between treatments (± thermotolerance) for  a given concentration 
ofHzOz. A 
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Figure  13  Activation  of caspase-4  and  caspase-12  by  HzOz;  inhibition  by  mild 
thermotolerance. Non-thermotolerant (37°C,  3 h)  and thermotolerant (  40°C, 3 h)  HeLa 
cells were exposed to  H20 2 (0-50  !lM) for  (A, B)  1 h or (A-F)  2 h at  37°C.  Enzymatic 
activities  of  (A)  caspase-4  and  (B)  caspase-12  are  relative  to  untreated  non-
thermotolerant  controls  at  3  7°C  (1 00%  ).  Data  represent  means  and  S.E.  from  three 
independent experiments. Representative Western blots for  expression of (C)  caspase-4 
and  (E)  caspase-12  are  from  three  independent  experiments,  relative  to  GAPDH. 
Densitometric analyses for expression of the cleavage fragments of (D)  caspase-4 (p20) 
and  (F)  caspase-12  (p33)  (±SEM)  are  given  relative  to  untreated  non-thermotolerant 
controls  at  37°C  (100%).  *P<0.05  or  **P<O.Ol:  statistically  significant  difference 
between treatment with H20 2 and the untreated control. ##P<0.01: statistically significant 
difference between treatments (± thermotolerance) for a given concentration ofHzOz. A 
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Figure 14  Roles  of calcium,  calpain and caspase-7 in H20 2-induced activation  of 
caspase-4 and caspase-12. Non-thermotolerant (37°C,  3h)  and thermotolerant (40°C,  3 
h)  HeLa cells  (1  x  10
6/ml) were exposed to  H20 2 (0-50  11M)  for  1 or 2 h at 37°C.  (A) 
Caspase-7 activity in celllysates is relative to the untreated non-thermotolerant control at 
37°C (100%). Non-thermotolerant (37°C, 3 h)  and thermotolerant (40°C, 3 h)  cells, with 
or without pretreatment (1  h) with inhibitors of cal  pain (20 11M), caspase-7 (50  j.tM), or a 
calcium  chelator  (BAPTA-AM,  50  11M),  were  exposed  to  H20 2  (0-50  11M)  for  2  h. 
Enzymatic activities of (B) caspase-4 and  (C) caspase-12 are given relative to untreated 
non-thermotolerant controls at 37°C  (1 00%).  Data represent means and SEM from  three 
independent  experiments  performed  with  multiple  estimations  per  point.  **P<O.O 1: 
statistically significant difference between treatment with H20 2 and the untreated control. 
#P<0.05,  ##P<O.Ol  or  ###P<0.001:  statistical  difference  between  treatments  (A) 
(±thermotolerance) or (B, C) (± inhibitor) for a given concentration ofH20 2. 178 
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Figure  15  H20 rinduced  activation  of  caspase-9,  caspase-3  and  apoptosis  is 
diminished  by  apoptotic  protease  inhibitors.  Normal  HeLa  cells  (37°C),  with  or 
without pretreatment (1  h)  with inhibitors of caspase-4  (20  f-LM), caspase-12  (1 0  f-LM), 
caspase-7  (50  f-LM)  or calpain (20  f-LM),  or a calcium  chelator (BAPTA-AM,  50  f-LM), 
were exposed to H20 2 (0-50 f-LM)  for 2 h (caspases) or 3 h (apoptosis) at 37°C. Enzymatic 
activities  of (A)  caspase-9  and  (B)  caspase-3  are  given  relative  to  untreated  non-
thermotolerant controls at 37°C (1 00%). (C) The fractions of apoptotic (Hoechst 33258) 
cells are given relative to the total number of cells. Data represent means and SEM from 
three  independent  experiments.  **P<O.Ol  or  ***P<O .OOl  indicates  a  statistically 
significant difference between treatment with H20 2 and the untreated control. #P<0.05, 
##P<O.Ol,  or  ###P<O.OOl:  statistically  significant  difference  between  treatments  (± 
inhibitor) for a given concentration ofH20 2. A  Ctrl  PERK 
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Figure 16 Knock down of PERK by siRNA causes partial reve1·sal of resistance to 
H202-induced apoptosis following mild heat preconditioning. Cells were transfected 
with a siRNA scrambled control  (Ctrl  scr) and  a siRNA directed against PERK (Santa 
Cruz) for 48  h. Non-transfected control cells are  also shawn. (A)  Protein expression of 
PERK was evaluated by Western blotting and  (B)  analyzed by densitometry, relative to 
GAPDH.  ***P<O.OOl.  (C,  D)  Cells  were  transfected  with  siRNA  PERK  or  siRNA 
scrambled  control  for  48  h  and  then  rendered  thermotolerant  (  40°C,  3  h)  or  non-
thermotolerant (37°C, 3 h).  Cells were treated with or without H20 2 (50 f!M)  for 3 h.  (C) 
Apoptosis  was  detected  by Hoechst  staining  and  (D)  the  fraction  of apoptotic  cells  is 
given. ###P<O.OOl  for scrambled siRNA control versus siRNA PERK at 40°C for 50 f!M 
H20 2.  &&&P<O.OOl  represents  a  statistically significant difference between  treatments 
(± thermotolerance) for 50 f!M H20 2. 180 
CHAPTERIII 
DISCUSSION AND CONCLUSION 
The generation of  oxidative stress is a common denominator for several types of  stress 
including  IR,  drugs,  pollutants,  herbicides,  and  heat  shock.  Several  chemotherapeutic 
drugs (  e.g., doxorubicin, cisplatin, and etoposide) indu  ce tumour cell death by generating 
oxidative  stress  within  the  tumour  environment  although  the mode of action  of these 
durgs is different (Siddik, 2003; Bromberg et al, 2003; Fomari et al,  1994; Maanen et al, 
1988), but the exact molecular mechanisms by which these cells undergo cell death are 
not  completely understood. Mild physiological  temperatures  (39.5-41 °C)  occur during 
fevers.  The heat shock response and thermotolerance induced at low temperatures are not 
well  understood.  Therefore,  this  project  aimed  to  investigate  the  detailed  molecular 
mechanisms  of apoptosis  induced  by oxidative  stress  using  H20 2  as  a  representative 
ROS,  and  simultaneously the protective role of mild thermotolerance against oxidative 
stress-induced apoptosis. 
This  study  show  that  exposure  of HeLa  cells  to  the  pro-oxidant  H20 2  resulted  in 
activation  of all  the  three  major pathways  of apoptosis.  H20 2  induced  both  caspase-
dependent  and  caspase-independent  mitochondrial  apoptosis  in  HeLa  cells.  Caspase-
independent  apoptosis  involved  the  release  of  AIF  from  mitochondria  and  its 
translocation to the nucleus (Article I:  Figure 11A-D). H20 2  also activated the Fas death 
receptor  pathway.  H20 2-induced  activation  of initiator  caspase-8  in  tum  resulted  in 
activation of caspase-2 (Article II: Figure 5A-D)., which is a novel finding of this study 
and to  our knowledge, is the first to point out the involvement of caspase-2 in apoptosis 
induced by H20 2. The results of  this study also show that mild exposure (15 to 50 f.!M, 15 
min) to H20 2 activates the ER stress response in HeLa cells, whereas longer exposure (1-
3 h) to H20 2 induced ER-mediated apoptosis. Treatment with pifithrin-a decreased both 181 
earlier and later events of apoptosis such as  mitochondrial Bax translocation, FasL up-
regulation,  activation  of  caspases-8,  -2,  -9  and  -3,  and  chromatin  condensation, 
confirming the role of p53  as  an upstream factor in the activation of death receptor- and 
mitochondrial-mediated apoptosis by H20 2.  Mild thermotolerance (  40°C, 3h) induced an 
increase in levels of several antioxidants (MnSOD, catalase, glutathione and y-GCS) and 
ER  stress  proteins  (PERK, p-PERK, eiF2a and  p-eiF2a). All  the  events  of the  death 
receptor, mitochondrial and ER pathway of apoptosis induced by H20 2 were found to be 
dîminished in  thermotolerant cells.  Mild thennotolerance even rendered HeLa resistant 
cells to cytotoxicity of  H20 2. 
H20 2 and cell death (Apoptosis vs Necrosis) 
H20 2  is  considered  as  an  important  signalling  molecule  based  on  its  umque 
biochemical properties:  H20 2  has  a relatively long half-life,  and  is  soluble in  aqueous 
media  (Droge,  2002).  Thus,  it  easily  diffuses  to  its  cellular  targets,  triggering  cell 
signalling pathways. The main way that H20 2 affects cell signalling pathways is through 
oxidation of specifie target molecules.  If the concentration of H20 2  is  high, then these 
oxidation processes may lead to  irreversible damage, followed by cell death, which can 
occur by either apoptosis or necrosis (Saito et al, 2006; Pletjushkina et al, 2006; Kroemer 
et al,  1998).  The mode of death occurs generally depends on the severity of the insult 
(Golstein  and  Kroemer,  2007).  For  many  years,  necrosis  has  been  considered  as  an 
accidentai mode of cell death that is unregulated. The morphological changes associated 
with  necrosis  include  cytoplasmic  swelling,  organelle  breakdown  and  irreversible 
membrane  rupture,  which  lead  to  release  of  intracellular  contents  that  promote 
inflammation in surrounding tissues  (Fulda et  al, 2010; Van  Herreweghe et  al, 2010). 
Necrosis does not usually involve caspase activation. Necrosis can be induced by stress 
stimuli such as ischemia-reperfusion, inflammation, ROS and glutamate excitotoxicity. 182 
Recent  evidence  suggests  that  necrosis  is  also  a  regulated  process  involving  several 
signaling  pathways  (Vanlangenakker  et  al,  2008;  Hitomi  et  al,  2008;  Golstein  and 
Kroemer, 2007; Duprez et al, 2009). Death receptors such as Fas, TNF-R1  and Toll-like 
receptors are  able to  trigger necrosis, in particular in the presence of caspase inhibitors 
(Vanlangenakker et al,  2008). The serine/threonine kinase RIP1  is an essential mediator 
of necrosis, in the case of death  receptors (Meylan and  Tschopp, 2005; Festjens et  al, 
2007).  Necrostatin-1 (Nec-1)  can  block the kinase  activity of RIP1  and  inhibit  TNF-
induced necrosis (Degterev et al, 2008). However, the mechanisms involved in activation 
ofRIP1 and the propagation ofnecrotic signaling have not been clearly elucidated. It was 
suggested  that  RIP1  may  be  activated  in  response  to  metabolic  changes  involving 
decreases  in levels of ATP  and NAD, or by decreases in intracellular pH  arising from 
lactate production during ischemia (Van Herreweghe et al, 2010).Jn vivo, necrosis occurs 
mainly after ischemia-reperfusion in the heart and  brain.  Therefore, necrosis inhibitors 
such as  necrostatins could be potential therapeutic tools for treating human diseases that 
involve ischemia-reperfusion damage, such as  cardiac infarction, stroke, traumatic brain 
injury and organ transplantation. 
The results of this  study show that HeLa cells treated with higher concentrations of 
H20 2 underwent  necrosis  whereas,  lower  concentrations  induced  apoptotic  cell  death 
(Article 1: Figure 9).  This switch between apoptosis and necrosis could be explained by 
two possible mechanisms: 1) the inactivation of caspases due to oxidation/S-nitrosylation 
oftheir active site thiol groups by ROS (Samali et al, 1999; Melion et al, 1997; Hampton 
et al, 1997); and 2)  a drop in cellular levels of ATP  due to  the failure of mitochondrial 
energy production by oxidants (Leist et al, 1999). Several studies have shown that H20 2 
induces apoptosis in different cell types (Son et al, 2010; Siu et al, 2009; Takeyama et al, 
2002;  Blanco  et  al,  2005;  Matsura et  al,  1999;  Ramachandran  et  al,  1998),  but the 
mechanisms involved are not completely understood. 183 
Induction of the mitochondrial pathway of apoptosis by H20 2 
Stimulation  of  the  intrinsic  mitochondrial  apoptotic  pathway  by  ROS  and 
mitochondrial  DNA  damage promote outer membrane permeabilization  and  release  of 
mitochondrial inner membrane proteins into the cytosol, leading to the activation ofboth 
caspase-dependent  and  -independent mitochondrial  apoptosis  (Ryter  et  al,  2007).  The 
induction of  mitochondrial apoptosis by H20 2 is well established in the literature and was 
reported in different cellular models such as pancreatic beta cells (Sampson et al  201 0), 
human keratinocytes (Wang et al, 2010), neuronal PC12 cells (Crispo et al,  2010; Cai et 
al,  2008),  H9c2  (rat  cardiomyocyte)  cells  (Eguchi  et  al,  2008),  and  a  human  retinal 
pigment epithelial cellline, ARPE-19 (Kim et al, 2003). This was apparent by a decrease 
in  mitochondrial  membrane  potential,  release  of  cytochrome  c,  caspase-9  and  -3 
activation,  P  ARP  cleavage  and  DNA  fragmentation.  However,  the  detailed  signaling 
mechanisms involved are not completely understood. 
An important finding from this study is that H20 2 caused both caspase-dependent and 
caspase-independent  mitochondrial  apoptosis  in  HeLa  cells.  Activation  of caspase-
dependent  mitochondrial  apoptosis  by  H20 2  was  evident  by  Bax  translocation  to 
mitochondria, loss of mitochondrial membrane potential, cytochrome c release into the 
cytosol,  activation  of  caspase-9  and  -3,  PARP  cleavage  and  nuclear  chromatin 
condensation.  For  caspase-independent  apoptosis,  H20 2  caused  AIF  release  from 
mitochondria into  the  cytosol, and  its  translocation to  the nucleus  after short exposure 
times  (1  h)  (Article  I:  Figure  11A-D).  It  was  reported  that  AIF,  embedded  in  the 
mitochondrial inner membrane, has to be cleaved from this membrane in order to become 
a soluble, apoptotic protein that can be released from  mitochondria (Otera et  al,  2005). 
This cleavage can be mediated by the activation of cysteine proteases such as calpain and 
cathepsins (Yuste et al, 2005).  Our observations are consistent with these studies since 
AIF release and calpain activation both occurred during a 1 h treatment with H20 2. Thus, 
mitochondrial  proteins  released  by  H20 2  can  trigger  apoptosis  through  both  caspase-184 
dependent  and  caspase-independent mechanisms  in  HeLa cells. Transfection  and  gene 
knockdown  using  SiRNA  directed  against  AIF  and  studying  H20 2-induced  apoptosis 
(Hoechst  staining  for  chromatin  condensation)  in  both  knockdown  and  control  cells 
would  provide  a  strong  evidence  for  the  role  of AIF  in  H20 2-induced  caspase-
independent apoptosis. H20 2-induced AIF release from mitochondria and its translocation 
to  the  nucleus  were  also  reported  in  other  cell  lines  such  as  human  retinal  pigment 
epithelial (ARPE 19) cells (Ho et al, 2006), mouse differentiated C2C12 myotubes (Siu et 
al, 2009) and human microglial cells (Braun et al, 2002). 
Induction of death receptor pathway of apoptosis by H20 2 
In the literature, very few studies have shown the induction of apoptosis through death 
receptors in cells exposed to oxidative stress. Furthermore, the mechanisms are not weil 
defined and are dependent on cell type.  Another novel contribution of this study is that 
the exposure of HeLa cells to H202 induced Fas-mediated death receptor apoptosis. This 
was  evident by increased expression of the death ligand FasL, translocation of adaptor 
protein F  ADD to  the plasma membrane and the activation of caspase-8. Once activated, 
the  initiator  caspase-8  in  tum  processed  caspase-2.  The  activation  of caspase-2  by 
oxidative stress  is  another novel  finding  of this  study.  Pre-treatment with  a caspase-8 
inhibitor reduced the enzymatic activity of caspase-2, confirming the role of caspase-8 in 
the  activation  of caspase-2  during  oxidative  stress.  Once  procaspases-8  and  2  are 
activated,  they  can  induce  a  cross-talk  pathway  between  the  death  receptor  and 
mitochondrial pathways, through the cleavage of Bid (Y oule and  Strasser, 2008; Lavrik 
et al,  2006). H20 2 also  induced Bid  cleavage and  t-Bid  translocation  to  mitochondria. 
Cleavage of Bid  and mitochondrial t-bid translocation  were completely suppressed by 
caspase-8 and -2 inhibitors. This suggests that both caspase-8 and caspase-2 can process 
Bid  and  contribute to  the  mitochondrial  amplification  of  H20 2-induced  cell  death  by 
apoptosis. 185 
One of the  important strategies to  assess the contribution of specifie caspases  to a 
given apoptotic signaling pathway is to treat the cells with their respective inhibitors that 
are  commercially available.  A number of specifie and broad spectrum peptide caspase 
inhibitors have been developed based upon substrate specificity profiles for the caspases 
(Berger et al, 2006; Callus and Vaux, 2007). These inhibitors act as pseudosubstrates for 
caspases.  Irreversible binding of these inhibitors to  the  caspase  active  sites, results  in 
inhibition of enzyme activity thus preventing apoptosis (Callus and Vaux, 2007). A study 
determining  the  specificity  of peptide-based  inhibitors  using  a  variety  of sequences 
revealed that sorne of the inhibitors were able to inhibit more than one caspase, with little 
selectivity (Garcia-Calvo et al, 1998). Problems of specificity have also been reported by 
other studies  (Berger et  al, 2006a; Berger et al, 2006b; McStay et  al, 2008).  For such 
reasons, using peptide-based inhibitors may lead to  flawed  conclusions as  they may not 
target  a single  caspase in an  environment where multiple caspases  exit.  Several  other 
approaches  in  addition  to  inhibitors  such  as,  the  use  of RNA  interference,  caspase-
deficient  cells  from  knockout mice, and  variants  of cell  lines  lacking caspases  can be 
used, which pro vides stronger evidence in determining the role of  individual caspases. 
In  companson  to  caspase-8,  little  is  known  about  the  activation  and  function  of 
caspase-2, which is controversial. The role of caspase-2 in cell death pathways appears to 
depend on both the apoptotic stimulus and cell type (Bergeron et al, 1998). The activation 
of  caspase-2 has been demonstrated in apoptosis induced by different stresses such as UV 
irradiation,  trophic  factor  withdrawal,  anti-Fas,  cytokine  deprivation,  P-amyloid, 
etoposide, and other stress stimuli (Zhivotovsky and Orrenius, 2005).  Studies show that 
activation of caspase-2 can occur either by the PIDDosome (Tinel et al, 2007; Tine1  and 
Tschopp, 2004) or the DISC (through caspase-8) (Olsson et al, 2009; Manzl et al, 2009). 
It was reported that dawn-regulation of caspase-2 in human leukemic cells significantly 
prevents Bid cleavage and abolishes cytochrome c release and caspase-3  activation after 
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cytochrome  c  release  and  apoptosis  was  also  shown  in  mouse  embryonic  fibroblasts 
(MEFs)  exposed  to  heat  shock  (Bonzon  et  al,  2006).  Bid-null  MEFs  were  relatively 
resistant to  apoptosis  induced by active  caspase-2.  Our observations  are  in  agreement 
with these studies where a caspase-2 inhibitor decreased Bid cleavage, t-Bid translocation 
to  mitochondria and  chromatin  condensation,  confirming  its  involvement in  apoptosis 
induced by H20 2 in HeLa cells. Together, these studies suggest that activation of  caspase-
2 occurs upstream of mitochondrial outer membrane permeabilization (MOMP). A more 
recent study shows that cleavage of  Bid by caspase-2 also acts as a cross-talk between ER 
stress and mitochondrial apoptosis, where ER stress inducers caused caspase-2-mediated 
cleavage of t-Bid, followed by MOMP and  cytochrome c release  (Upton et al,  2008). 
Various  studies  have  reported  the  involvement  of caspase-2  in  apoptosis  induced  by 
chemotherapeutic drugs (Panaretakis et al,  2005; Vakifahmetoglu et al, 2006).  Silencing 
of caspase-2  by  siRNA  was  reported  to  inhibit  cisplatin-induced  Bax  activation  and 
apoptosis (Cao et al,  2008), while dawn-regulation of caspase-2 to  inhibited etoposide-
induced  death  (Lassus  et al,  2002;  Robertson et  al,  2002). The neurons  derived  from 
caspase-2-null mice showed resistance to  ~ -amyloid-mediated death, also suggesting its 
role in neuronal death (Troy et al, 2000). 
Our  results  also  show  that  H20 2-induced  death  receptor  apoptosis  was  mediated 
through  Fas,  since  H20 2-induced  caspase-8,  -2  and  -9  activation  and  chromatin 
condensation were inhibited by the Fas/FasL antagonist (Kp7-6). The inhibition ofH20 2-
induced  FasL up-regulation  and  caspase-8  activation  by the  antioxidant  PEG-catalase 
confirms the role ofH20 2 in FasL induction and activation of  the death receptor pathway. 
H20 2-induced apoptosis through death receptors was shown in  a few  other studies, but 
generally at higher pro-oxidant concentrations and longer exposure times than those in 
HeLa cells.  Up-regulation of FasL and  Fas by H20 2  was  shown in human endothelial 
cells (HUVEC) and murine intestinal epithelial cells (Denning et al, 2002; Suhara et al, 
1998). In human leukemia (HL-60) cells, H20 2 activated a caspase-8 mediated signalling ,-------
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pathway leading to  caspase-3 activation (Zhuang et al,  2000). Taken together, the results 
from  these studies indicate that the mechanisms of H20 2-induced apoptosis are  clearly 
dependent on cell type. 
ROS also play a role in TNF-a and TRAIL-induced apoptosis (Shen et al, 2006; Lee et 
al, 2002). Exposure of cells to TNF-a caused an increase in intracellular ROS levels. The 
source of ROS generation was mitochondria and appeared to be mediated by JNK (Shen 
et al, 2006). Although the mechanism of  mitochondrial ROS generation mediated by JNK 
is  not well  established,  one  possible  source of intracellular ROS  in TNF-a-stimulated 
cells  was  considered to  be the mitochondrial ETC  (Goossens et al,  1999).  In  a mouse 
fibrosarcoma cell line (L929), TNF-a induced a caspase-independent, necrosis-like cell 
death,  which  was  dependent  on  both  ROS  and  mitochondria  (Gossens  et  al,  1995; 
Vercammen  et  al,  1998).  Furthermore,  antioxidants  such  as  N-acetylcysteine  (NAC), 
SOD  and  thioredoxin  afforded  protection  against  TNF-a-induced  cytotoxicity. 
Scavenging  of ROS  by  antioxidants  also  abrogated  caspase  activation  and  apoptosis 
induced by TRAIL (Shen et  al,  2006).  Interactions between ROS  and  TRAIL-mediated 
apoptosis have implications for several human disease states.  Oxidative stress has been 
implicated  in  several  pathological  conditions  such  as  cancer  and  neurodegenerative 
disorders. Damaging effects of ROS,  such as  protein oxidation  and  lipid peroxidation, 
have  been reported within specifie  brain regions  in patients  with Alzheimer's disease, 
Parkinson's  disease  and  amyotrophie  lateral  sclerosis  (ALS)  (Andersen,  2004). 
Furthermore, P-Amyloid has been shown to  produce H20 2 in cultured cells (Behl et al, 
1994). H20 2  sensitized human astroglial cells to  TRAIL-induced apoptosis through up-
regulation ofDR5 expression (Kwon et al, 2008). Several types oftumors are resistant to 
TRAIL-induced  cytotoxicity.  In human  malignant  astrocytoma  cells,  ligation  of the 
TRAIL  receptor  led  to  generation  of intracellular  ROS  through  caspase-dependent 
proteolytic activation of protein kinase C delta (PKCdelta)  and subsequent activation of 
the NADPH oxidase 4 (NOX4) complex (Choi et al, 2010).  Caspase-dependent cell death 188 
induced by TRAIL ligation was  inhibited by oxidative modification of the  active  site 
thiol of caspase-3, leading to resistance to TRAIL-mediated apoptosis. 
Role of H20 2 in ER stress and ER-mediated apoptosis 
The  activation  of the  UPR by mild  stress  appears  to  be an  adaptive  response  to 
maintain cell survival and function. However, more severe or prolonged stress causes cell 
dysfunction and death, resulting in tissue damage that can contribute to the development 
and  progression  of human  diseases  such  as  diabetes,  atherosclerosis  and  neurological 
disorders (Malhotra and Kaufman; 2007). 
Unlike the cytosol, the ER has a unique oxidizing environment that promotes protein 
folding and  the formation of disulphide bonds (Gorlach et  al,  2006).  lt was  suggested 
that protein folding and generation of ROS  as  a by-product of protein oxidation in the 
ER  are  closely  linked  events,  since  they  both  cause  ER  stress-mediated  cell  death 
(Malhotra  and  Kaufman, 2007).  ER stress  and  oxidative  stress  appear  to  be  closely 
related  events,  although  the molecular pathways  that  link  these processes  are  poorly 
understood. 
This  study shows that H20 2  induced both ER  stress  and  ER-mediated  apoptosis  in 
HeLa cells. A short exposure (15 min) of cells to oxidative stress (15-50 )lM H20 2) led to 
activation of  the UPR, shown by increased expression ofp-PERK, p-eiF2a, p-IRE1a, and 
ATF6 cleavage (Article III:  Figure 5, 6, 7, 8). However, longer exposure (1-3  h) to H20 2 
induced ER-mediated apoptosis, which was  evident by increased expression of CHOP, 
and the activation of calpain, caspase-7, -4, -12 and -3  (Article III: Figure 10, 12, 13, 14, 
15). Calcium, calpain and caspase-7 were shown to be upstream factors in the activation 
of ER-mediated  apoptosis  by H20 2  (Article  III:  Figure  15).  The results  of this  study 
provide evidence for the involvement  of the  ER in  oxidative stress-induced apoptosis. 
H20 2-induced activation of the UPR and apoptosis was also reported in other cell lines. 
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Bip/GRP78, CHOP, and caused cleavage of  caspase-4 (Min et al, 2008). The oxidant tert-
butylhydroperoxide caused up-regulation of CHOP  and  Bip/GRP78  in  retinal  pigment 
epithelial  cells  (He  et  al,  2008).  In  hepatocytes,  tert-butylhydroperoxide  induced 
activation of caspase-7 and caspase-12, which were implicated in  apoptosis through the 
ER (Haidara et al, 2008).  The results of our study demonstrate that H20 2-induced both 
ER  stress  and  ER-mediated  apoptosis  in  HeLa  cells.  Activation  of ER  stress  (UPR) 
occurred during earlier time periods i.e.  during shorter exposure times (15  min) to H20 2 
whereas ER-mediated apoptosis was observed during longer exposure times to H20 2 (1-3 
h).  Inhibition  of caspase-4  and  -12  activity  by  calcium  chelator  (BAPTA-AM)  and 
inhibitors  of calpain  and  caspase-7  confirms  their roles  as  upstream  initiating  factors 
leading to caspase-4 and -12 activation. 
Both ER stress and ROS  can stimulate Ca
2
+ release from  the ER lumen (Gorlach et 
al,  2006).  The  close  proximity of the  ER  and  mitochondria  leads  to  mitochondrial 
calcium  accumulation,  further  increasing  mitochondrial  ROS  production  through  the 
ETC,  leading  to  opening  of the  permeability  transition  pore  and  the  release  of 
mitochondrial  inner membrane proteins  (Jacobson  et  al,  2002).  The  other important 
consequence of deregulation  of intracellular calcium  homeostasis  is  the  activation of 
nitric oxide synthase, which increases nitric oxide generation. It was reported that nitric 
oxide can induce apoptosis involving CHOP in  microglial cells through the ER  stress 
pathway  (Kawahara  et  al,  2001 ).  In  addition,  pancreatic  islets  and  peritoneal 
macrophages  from  CHOP-knockout mice showed increased resistance to  NO-induced 
apoptosis (Oyadomari et al, 2001; Gotoh et al, 2002). Peroxynitrite, a by product of the 
reaction between superoxide and nitric oxide, caused ER stress in cultured endothelial 
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Role of p53 in pathways of apoptosis induced by oxidative stress 
Different stress conditions, including ROS  and chemical DNA-damaging agents, can 
up-regulate  and  (or)  activate p53  through  phosphorylation.  Phosphorylation of p53  at 
ser15  and  ser20  can  lead  to  its  stabilization  and  activation  (Liu  et  al,  2008).  Recent 
studies show that phosphorylation of p53  on Ser46 following DNA damage is important 
for  preferential transactivation of proapoptotic genes  (Kodama et  al,  2010;  Saito  et al, 
2002). Activated p53 protein can induce cellular pathways leading to  cell cycle arrest in 
the  G 1 phase,  or  to  apoptosis  dependent  on  the  cell  type  and  in  jury,  via differentiai 
activation of target genes (Y oshida and Miki 201 0; Liu et al, 2008). At the transcriptional 
level,  phosphorylated p53  induces transcription of pro-apoptotic proteins  such  as  Bax, 
Bid,  Puma,  Noxa,  Apaf-1  and  FasL,  and  it  suppresses  the  activity  of anti-apoptotic 
proteins such as  Bcl-2 and lAPs (Yoshida and Miki, 2010; Yu  and Zhang, 2008; Muller 
et  al,  1998).  Several  recent  observations  also  suggest  a  role  for  p53  in  caspase-2 
activation (Zhivotovsky and  Orrenius, 2005). Activation of caspase-2 can in  tum induce 
the mitochondria-mediated apoptotic pathway. A new finding from  this study is  that, in 
HeLa cells, induction of apoptosis by H20 2 was mediated by p53  as  an upstream factor. 
This study clearly demonstrates that H20 2  causes phosphorylation of p53  at  Ser15  and 
Ser46,  leading  to  its  activation.  The  activation,  of p53  was  further  confirmed  by 
inhibition  of  the  expression  of  p53  target  proteins,  FasL  and  PUMA,  and  Bax 
translocation to mitochondria by the p53 inhibitor, pifithrin-a. H20 2-induced activation of 
caspase-8, -2, -9 and -3, and chromatin condensation was also decreased by p53 inhibitor 
pifithrin-a. Furthermore, the fmdings  using pifithrin-a indicate that p53  is  an up-stream 
factor leading to the activation of death receptor and mitochondria-mediated apoptosis in 
H20 2-treated HeLa cells.  Rat neural AF5  cells and  glioma cells treated with H20 2  also 
showed increased protein expression of p53, phosphorylated p53  at  Ser15, Puma, Noxa 
and Bax (McNeill-Blue et al, 2006; Datta et al, 2002). p53  expression was also shown to 
be induced during apoptosis mediated by nitric oxide (Messmer et al, 1994). 191 
The  chemical  inhibitor of p53,  pifithrin  was  isolated  for  its  ability  to  block  p53-
dependent transcriptional  activation (Komarov  et al,  1999). Studies  show  that pifithrin 
suppress  transactivation of p53-responsive  genes  encoding p21, Mdm2, cyclin  G,  and 
Bax (Komarov et  al, 1999; Tamagno et al, 2003; Nakaso et al, 2004; Duan et al, 2002; 
Dagher,  2004;  Kelly et  al,  2003).  ln vitro  and  In  vivo  studies  also  show  that pifithrin 
protect different cell  types  against p53-dependent apoptosis  induced by a multitude of 
stimuli (Camphausen et al,  2003;  Culmsee et  al,  2001 ; Schafer et al, 2003;  Leker et al, 
2004;  Kuo  et  al, 2004; Walton et al, 2005; Fraser et  al, 2006). Antiapoptotic effect of 
pifithrin was found to be p53-dependent and involved suppression of caspase activation. 
ln  neuronal  cells,  caspase  inhibition  by pifithrin  was  associated  with  suppression  of 
mitochondrial dysfunction (Nakaso et al, 2004; Duan et al, 2002). A direct inhibition of 
p53  translocation to  mitochondria was  observed  in  kidney cells  as  a result of pifithrin 
action (Dagher, 2004;  Kelly et al,  2003).  DNA  damage studies  show that the levels of 
nuclear but not those of cytoplasmic p53  protein, were found to be lowered by pifithrin 
(Komarov et  al, 1999; Lorenzo et  al, 2002; Liu  et  al, 2004; Dagher, 2004; Kelly et al, 
2003; Schafer et al, 2003) suggesting that pifithrin might modulate the nuclear import or 
export  (or  both)  of p53  or  decrease  stability  of nuclear  p53.  Besides  p53  dependent 
effects,  pifithrin  can  also  suppress  heat  shock  and  glucocorticoid  receptor  signaling 
(Komarova  et  al,  2003).  Recent  studies  do  show  that  pifithrin,  can  also  target  other 
proteins such  as  the aryl hydrocarbon receptor (AhR)  (Hoagland et  al, 2005), ICAM-1 
(Gorgoulis et al, 2003), androgen receptor (Cronauer et al, 2004), and CD95  (Lorenzo et 
al,  2002).  These  studies  suggest  that  pifithrin  effects  are  not  limited  to  p53  and 
downstream  components  of p53  pathway but involve other cellular factors and  signal 
transduction pathways. It is, therefore, extremely important to  include  controls of p53 
specificity for accurate interpretation of experimental results. Altematively other types of 
inhibitors  such  as  gene  knockouts  or  knockdowns  using  siRNA  would  be useful  for 
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Interactions between p53, ROS  and antioxidants are complex and not well understood 
(Liu  et  al,  2008).  During  apoptosis  induced  by  tumor  promoter  12-0 
tetradecanoylphorbol-13-aectate, p53 underwent translocation to  mitochondria, where  it 
directly  bound  and  inhibited  MnSOD  (Zhao  et  al,  2005).  p53-mediated  MnSOD 
inactivation led to  subsequent activation of p53  transcriptional activity and induction of 
pro-apoptotic target genes such as Bax. Translocation of  p53 to the nucleus and induction 
of Bax protein were blocked by a  SOD  mimetic (MnTE-2-PyP
5+).  Over-expression of 
catalase protected HepG2 cells against apoptosis induced by DNA-damaging agents (Bai 
and  Cederbaum,  2003).  The  protective  effect  was  associated  with  decreased  p53 
phosphorylation and accelerated proteasomal degradation of  p53  protein. p53 is a redox-
sensitive  protein,  which  undergoes  oxidation  at  cysteine  residues  that  contain  redox-
sensitive  thiol  groups  (Liu  et  al,  2008).  During  oxidative  stress,  p53  undergoes  S-
glutathionylation, which inhibits DNA binding activity ofp53. This process was reversed 
when GSH levels were increased by the antioxidant NAC. 
Studies  show that p53  target gene Tp53-induced  glycolysis and  apoptosis regulator 
(TIGAR)  regulates  intracellular ROS  levels  by modulation  of the  glycolytic pathway 
(Bensaad  et  al,  2006).  By  decreasing  the  glycolytic  rate  and  redirecting  glycolytic 
intermediates to the oxidative branch of the pentose phosphate pathway, TIGAR caused 
an increase in NAD  PH production, which allows for scavenging of intracellular ROS by 
reduced  glutathione.  Thus,  TIGAR reduces  the  sensitivity  of cells  to  p53-dependent 
apoptosis induced by oxidative stress (Bensaad et al, 2006). 
H202 and Cancer 
Oxidative deamination of polyamines by amine oxidases results in the generation of 
H20 2  and  aldehydes  such  as  acrolein  (Toninello  et  al,  2006; Agostinelli  et  al,  2004; 
Averill-Bates et al, 1994; Lord-Fontaine et al, 2001). The naturally occurring polyamines 
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differentiation (Wallace et al, 2003). Tumour cells express high levels of  polyamines and 
depletion of polyamines leads to  inhibition of tumour growth (Heby and Persson, 1990; 
Bachrach, 2004).  The oxidation products such as  H20 2 and acrolein were shown to  be 
responsible for cytotoxicity and  caspase-mediated apoptosis induced by amine oxidase 
and spermine in mouse melanoma cells (Averill-Bates et al, 2008). To take advantage of 
higher levels of polyamines in tumor versus normal tissues, toxic products such as H20 2 
and  acrolein  could be generated in situ,  by delivering  amine oxidases  into  tumors  to 
induce cytotoxicity (Averill-Bates et al, 2005). Thus, generation oftoxic products such as 
H20 2 and acrolein by amine oxidases could be a promising new tool in cancer treatment. 
The results  of our study demonstrate the  signalling mechanisms  implicated  in  H20 2-
induced apoptosis. 
Mild  heat-pre-conditioning  causes  resistance  of  cells  to  apoptosis  induced  by 
oxidative stress 
Oxidative stress plays a major role in various pathological conditions such as  cancer, 
diabetes,  cardiovascular  disease,  Parkinson's  and  Alzheimer's  disease  (neurological 
disorders), ischemia-reperfusion and ageing (reviewed by Valko et al, 2007). The results 
of this study show that mild heat (  40°C) pre-conditioning protects cells against oxidative 
stress-induced apoptosis. An important new result is that mild thermotolerance increased 
the expression of major antioxidants (MnSOD, catalase, glutathione and y-GCS) as well 
as ER stress proteins (p-PERK, p-eiF2a).  It is well established that mild thermotolerance 
induces the expression of Hsps (Przybytkowski et al, 1986; Bettaieb and Averill-Bates, 
2005). Ail of the events in the mitochondrial, death receptor and ER-mediated pathways 
of apoptosis were found to be diminished in thermotolerant cells. These protective effects 
could be attributed to  the ROS  scavengers, ER stress proteins and Hsps  (  discussed in 
articles  1,  2  and 3). Hsps (Beere,  2004)  and ROS  scavengers are known to  have anti-
apoptotic  properties  (Portt  et  al,  2011).  Mild  thermotolerance  even  rendered  cells 
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results  from  this  study  suggest  that  mild  heat  pre-conditioning  at  40°C  plays  a 
cytoprotective role by up-regulating anti-apoptotic genes. 
Hsps are expressed at increased levels in a wide range of tumors (Calderwood et  al, 
2006).  Other  anti-apoptotic  molecules  that  are  up-regulated  in  tumors  include  ROS 
scavengers (reviewed in Portt et al, 2011). Mild thermotolerant HeLa cells with increased 
expression of Hsps  and  ROS  scavengers  are resistant to  H20 2-induced  apoptosis.  This 
suggests that tumors that over-express anti-apoptotic molecules could exhibit resistance 
to  therapeutic agents, such as  radiation and oxidant-generating drugs, which kill  cancer 
cells via oxidative stress. 
0 2 ·-, H20 2 and OH" are produced during ischemia-reperfusion through metabolism of 
xanthine  and  hypoxanthine  by  xanthine  oxidase  (Szocs  et  al,  2004).  The  massive 
production of ROS  during  ischemia/reperfusion  leads  to  tissue  injury  and  death,  thus 
causing serious complications in organ transplantation, stroke and myocardial infarction 
(Kasparova et  al,  2005).  Ischemie pre-conditioning (IPC) and post-conditioning (IPOC) 
have been shown to protect the heart against ischemia-reperfusion (1/R) injury (reviewed 
by Portt et al, 2011; Murry et al,  1986; Zhao et al,  2003). Activation of kinases such as 
ERK and Akt (Portt et  al,  2011), Hsps (Yellon  and  Latchman,  1992)  and antioxidants 
(Hoshida  et  al,  1993)  were  found  to  be  involved  in  the  cardio-protective  effects  of 
ischemie pre- and post-conditioning. Over-expression of anti-apoptotic protein IAP-2 in 
transgenic mice was shown to render the heart more resistant to apoptosis and 1/R injury 
(Chua  et  al,  2007).  The pre-conditioning with  ER stress-inducing  conditions  such  as 
ischemia or tunicamycin protected cultured neurons or cardiomyocytes from  subsequent 
oxidative stress and 1/R injury (Hayashi et al, 2003; Zhang et al, 2004; Liu et al, 2008). 
Antioxidants  are  able  to  protect  cells  against  the  nocive  effects  of  severa} 
environmental toxins. Mitochondrial SOD was shown to protect S accharomyces 195 
cerevlslae  cells against stresses such as  high osmolarity, heat and  metalloid stress 
(Dziadkowiec et al, 2007). The protective role of NAC against lead-induced cytotoxicity 
and oxidative stress was reported in human liver carcinoma (HepG2) cells (Yedjou and 
Tchounwou,  2007).  Recent  studies  also  demonstrated  protective  roles  of vitamin  E 
against  nickel- and/or  chromium-induced toxicity (Rao  et  al, 2009)  and  ascorbic  acid 
(vitamin  C)  against  lead  toxicity  (Bhattacharjee  et  al,  2003)  in  mouse  ovary  and 
erythrocytes.  A  protective  role  of glutathione  and  metallothioneins  against  cadmium 
toxicity was reported in Chinese hamster cells (Ochi et al, 1988; Park et al, 2001). Studies 
showed  that  over-expression  of antioxidants  such  as  SOD  or  glutathione  peroxidase 
protected  against  the  combined  paraquat  and  maneb-induced  Parkinson  disease 
phenotype (Thiruchalvam et al, 2005). 
Together,  these  studies  indicate  that  increased  expressiOn  of anti-apoptotic  genes 
(ROS  scavengers  and  Hsps)  could  serve to  delay or prevent cell  death  in  response  to 
different  stress  stimuli.  Pre-conditioning-mediated  stimulation  of  endogenous  anti-
apoptosis proteins might have therapeutic potential in limiting apoptosis in neurological 
diseases  such  as  Parkinson's,  Alzheimer's or  stroke  (Portt  et  al,  2011),  and  against 
toxicity of  environmental pollutants. 
FUTURE PERSPECTIVES 
Different stress conditions such as  hypoxia, nutrient starvation, hormonal imbalance 
and  oxidative stress can  also  induce  autophagy.  Autophagy is  rapidly activated  as  an 
adaptive  catabolic process  in response  to  the  above metabolic  stresses, whereby  cells 
eliminate  damaged  cytoplasmic  components  (mitochondria,  ER).  The  cytoplasmic 
contents are sequestered within double-membrane vacuoles (autophagosomes)  and then 
delivered  to  lysosomes  for  degradation  (Kroemer  et  al,  2010;  Portt  et  al,  2011). 
Degradation of cytoplasmic contents generates free fatty acids and amino acids that can 196 
be recycled and used for de novo synthesis of proteins and in maintaining mitochondrial 
energy (ATP) production and thereby promote cell survival (Levine and Kroemer, 2009). 
Under  most  circumstances,  autophagy  constitutes  a  stress  adaption  pathway  that 
promotes  cell  survival  during  nutrient  limitation  (starvation)  or  acts  as  a  defence 
mechanism against different environmental stresses. 
Under conditions of  prolonged stress, autophagy may also serve as an alternative form 
of regulated non-apoptotic (type II)  cell death (Portt et al,  2011). The autophagy related 
genes  (atg),  Beclin-1  and  the  mammalian  target  of rapamycin  (rn-TOR)  signalling 
pathway mediate autophagy. Autophagy is  also linked to apoptotic cell death, indicating 
the  existence of a  'molecular switch'  between these two  processes.  Studies report that 
apoptosis  and  autophagy may be interconnected and  even  regulated  simultaneously by 
the  same  trigger  (Liu  et  al,  2009;  Cheng  et  al,  2009). ROS  and  Ca
2
+  may provide  a 
common link between cellular stress signais and  the initiation of autophagy, since ROS 
(specifically,  H20 2)  accumulation  bas  been  reported  to  result  in  inactivation  of the 
cysteine protease A  TG4. This leads to  accumulation of the A  TG8-phosphoethanolamine, 
which initiates autophagosome formation  (Scherz-Shouval et al,  2007).  Ca
2
+ -stimulated 
cal pain activation con  tri butes to induction of  both autophagy (Demarchi et al, 2006) and 
apoptosis (Y ousefi et al, 2006). Calpain-mediated cleavage of  Atg5, to a 24kDa fragment, 
switches  autophagy  to  apoptosis,  where  the  truncated  fragment  translocates  from  the 
cytosol to mitochondria, mediating cytochrome c release and caspase activation (Y ousefi 
et al, 2006).  ER stress bas also been shown to act as a mediator connecting apoptosis and 
autophagy.  Activation of the PERK-eiF2a or IRE1-JNK pathways promotes autophagy 
through  facilitating  or stimulating light chain 3 (LC3)  conversions and  autophagosome 
formation  (Moretti  et  al,  2007).  In  addition,  studies  show  that  p53  can  transactivate 
damage regulated autophagy modulator (DRAM), a lysosomal protein that can stimulate 
the accumulation of  autophagie vacuoles during autophagy (Crighton et al, 2006). 197 
The  above  studies  show  that  regulators  such  as  ROS,  calpain,  ER  stress  and  p53, 
which play a major role in apoptosis induction, can  also induce autophagy. As  a future 
perspective, it would be interesting to determine the role of ROS (H20 2)  in the induction 
of autophagie cell death. The results of the present study show that the exposure of cells 
to  a mild H20 2 stress activates the ER  stress pathway as  an  adaptive survival response 
(article III). We can therefore hypothesize that H20 2  could also induce autophagy as  an 
adaptive survival mechanism at lower doses and  trigger cell death by autophagy and/or 
apoptosis at higher doses. It would also be interesting to  understand the molecular links 
between autophagy and  apoptosis that should improve our knowledge about cell  death 
pathways, which in  tum may lead to  the development of new strategies for therapeutic 
induction or inhibition of cell death.  Targeting autophagie signalling pathways could be 
an alternative way of  inducing cell death in cancer cells that show resistance to apoptosis. 
However, in neurodegenerative disorders such as  Alzheimer's and Parkinson's diseases, 
autophagy could  play a  cyto-protective role by maintaining  neuronal  homeostasis  and 
protein quality control. 
In conclusion,  improved understanding of mechanisms  of adaption  to  stressful  and 
extreme  environments  provides  the  basis  for  understanding  environmental  health 
problems, performing toxicological risk assessment and in clinical  applications against 
many disease states. APPENDIXA 
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Acrolein is  .1  highly reactive.  a .~-un sa rurared aldehyde rh ar is an omnipresent environmenral  pollut.lllt. 
Hu  mans .ue exposed  ro  .lCrolein in  food, vapors of overheated cooking oil.  cig.uertl'"  srnoke .md  by 
combustion of org.mic  producrs.  Acrolein  is  .'1  roxic by-product  of lipid peroxid.nion  resulring  from 
oxidative  stress,  which is implic. Hed  in pulmonary,  c<trdiac and  n eurodege nN~H ive dise.1ses. Low dose 
exposure  ro  roxic compounds  c hen  teads  ro  adaprive  responses.  If  the  .Jdaptive  response does  nor 
counre racr the  adverse exposure. dea th processes such as Jpoptosis will eliminare  the cell.  This  study 
investigates the .lctivarion of ,1nriapoprosis surviv.11 factors in relation ro  the induction of cel\  de.nh by 
apoptosis. following exposure ro  low doses of .1cro\ein. in A549  hu man Jung ce lis.  Exposure to acrolein 
(< 15 j..LM. 30 min) activa red the survival  factor AKT. which led ro phosphorylation of Bad and induction of 
anri.1poprosis proreins ciAPl/2. Acrolein ( 1 0- 50 j..LM, 30-60 min} increased  reJctive oxygen species "1nd 
caused mitochondri.almembld ne hyperpola risarion. lnhibirion by the anrioxidants caralasl", polyethyle ne 
glycol-c.at.llase, sodium pyruv,ne .1nd  MnTBAP showed  th.n .1cro\ein-induced  re.1ctive oxygen species 
we re  responsible  for  mitochondrial  membr.tne  hyperpolarisation.  Acrolein  (3- 27 ~M .  30-60 min) 
.1nivated earl y  s r~1ge processes in the  mi(()chondriat pathway of apoprosis.  such .1s  B.tx  rr.:mslocarion  ro 
mirochondri.t, cytochrome c release. caspase-9 activation. and translocation of apoprosis-inducing facror 
to  the  nucleus. Acrolein (10-SOjJ.M) triggcrcd  l.ater  stage processes such  as  activation  of caspases-3. 
-7 .and -6.  phospharidylscrinc exrernaliz,uion and cleavagc of poly(ADP)ribose JX)Iymerase afrer longer 
times (2 h). Thesc events  were  inhibircd by polyethylene  glycol-c.aralase, showing  r11ar  .1poprosis  w.1s 
mediated  by  overproducrion  of  re.activc  oxygcn  spccics  by acrolcin. The  novel  findings  show  thar 
anriapoptosis  proccsses domina te .n  low doS<'  ( <  15 J..LM)/shorter cxposure times ro  acrolein. where.as 
proapoptoric  processes dominate  at  higher dose ( 10-50 J..LM )/Ionger exposure  rimes. Acrolein induced 
.1poprosis rhrough the mirochondrial parhway thar wc~s mediared  by reactive oxygen sjX'cics. 
Abbrf'viorions:  AIF,  .apopros i s~ inducing  facror:  AKT.  protein  kinase  B: 
Apaf-1.  apoprosis  prorC'dse  clctivating  factor-1 :  B..1x.  Bcl-associated  X  pro-
rein:  Bcl-2,  B-cells  lymphoma  2:  Bel-Xl.  Bcl-associ.ued  X long  protein:  Bid. 
BH'l-inter.lcring domain  dearh .agonisr:  BSA,  bovinc serum  ~l l b u m in ;  CHAPS,  l-
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cellular  inhibitors  of apoptosis:  COPD. chronic  obstructive  pulrnonJI)' discase: 
DMEM.  Dulbccco's  modification  of  Eaglc's  medium:  EDTA.  Nhylene  diamine 
tcrraacetic  acid: EGTA.  N hylcne  glycol tetra,lCeric  ,lcid: F,ls.  fibroblasr-associ.n<'d 
I '<'CCptor:  F <tsL  Fas  ligand:  FACS.  fluorescence  acrivarcd  œil  sorter:  FBS.  ferai 
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rnorpholino)-propane  sulfonic  acid:  NADH.  nicotinamide  adenine  dinucleotide: 
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buffcrcd  saline:  PL propidium  iodide:  P1 3K.  phosphatidylinositol 3-kinase: PVD F. 
polyvinylidenc  difluoridc:  Rho123.  rhodamine  123:  RR.  relative  fluorescence 
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polyacrylamide g<'l electrophoresis: tBid. truncated Bid. 
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1.  Introduction 
Acro lein  is an  Cl.j3-unsaturated aldehyde. which is an  ubiqui-
tous environmenta l pollurant Ill.  lt is generated as a product of the 
incomplete combustion du ring forest and  hou  se  fi res. combustion 
of plastics.  cooking of food  and  motor vehicle emissions.  A major 
source of acrolein is cigarette smoke. which generates 50-90 ppm 
of acrolein per cigarette. Acrolein is mainly utilized as a biocide. as 
weil as an  intermediate in the production of acrylic acid and  Dl-
methionine. and as  a starting material for aCiylate polymers and 
nu merous other agents [21 . Acrolein  is a  Iso produced  in  si ru. dur-
ing the  nonna l intermediary catabolism ofvarious ami  no acids and 
polyamines  1 3], and  as  a metabolite of .1llylic alcohol or the ami-
cancer drug cyclophosphamide 1 41 .  An important source of acrolein 
is as  a by-product  of cellular lipid  peroxidarion associared  wirh 
oxidative stress 1 21. 
Acro lein  is a highly reactive compound  wirh an  elecrrophilic 
nature  [SI. which permits it to bind  and  deplete cellular nucle-200 
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opililes.  Acrolein  couses  ropid  depletion  of  the  ,mtioxidont 
glutathione and  is oble to initiote Jipid peroxidation (2 (. Further-
more. acrolein binds  ro  nucleophilic sires in DNA ond  forms DNA 
odducts (2]. lt is mutagenic and genotoxic to hu man cells (2 ). •nd 
was shown ro decrease the proliferation of hum•n Jung rorrinoma 
cell !ines  (6)  .  .1\crolein can  also fonn  protein adducrs and  couses 
severe conform,ltional  c.h.mges in proteins (7 ]. Given rh.lt inhola-
tion  is che major roure of exposure, etcroJein has  been  associ,ued 
with many  Jung discases  such  os asthm.1  (8).  d1ronic  obstruc-
tive J WilllOil.lry diseose  (COPD) 19). wilich often includes cilronic 
bronchiris ond  emj)hysema llO).  cystic fibrosis (8) and  Jung cai-
cinogenesis (Il]. However, the biochemical pothways  invo lved in 
acrolein-incl uced  cellular responses  ond  roxiciry  are not  entirely 
understood. 
Low  dose  chronic  exposure  to  toxic  compounds  con  ofren 
leod  to odaptive  responses (12]. Ad,1ptive  responses ,11low  cells 
and  organisms  to  contintie  normal  funnion  in  the  foce  of  an 
adverse stimulus. These  responses  often involve changes 111  gene 
and  prorein  expression. including  the  induction  of defenses  to 
enable  rhe  cell  to  survive  113].  Organisms  have  cleveloped  on 
el.•borare  system  oi defense  molecules  (  e.g.  annoxid,1nts.  Iwo! 
shock pro teins (HSP;. anriapoptosis proteins (lAPs) and deroxifying 
enzymes) ond survival sign.!ling pathways (e.g.  phospharidylinos-
itol 3-kinose (PI3K)jAKT. Rasimitogen-activared protein kinase) to 
c.oumeroct vaiious toxic and environ men rai stresses. If the adap-
tive  response  does not  coumeran  the  adverse  exposurC".  then 
the cell will be climinared by death  processes such as apoprosis 
113(. 
A  po  ptosis  is  essenriat for normal developmcnr and m<1intcnancr 
of tissues.  but  also  plays ,,  role in  the elimination of damaged 
relis.  lt  has distinct  morpholog.ic,ll and  biochemical  alterations 
such as DNA  fr,lgmemar.ion inw 180- 200 pb.  phosphariclylserine 
exrcrnalization and  cellular fragmentation into opoptotir  bOdieS 
114). The mitochomlriol pathway of apoptosis is activ.1ted by var-
lous clcwlopmental eues or cytotoxic insults. su  ch os DNA damage. 
oxidative stress. he  ar shock and exposure w a variery of toxic com-
pounds. This pathway is strictly controlled  by the Bcl-2  family of 
proreins (15]. Activotion of proapoptotic members of thiS family. 
such .as  B.:lx or trunc.:Hed Bid (tBid ). indures  permeabiliz.ttion of 
the outer mirochondrial membrane.  w hich  releases  soluble pro-
teins from the intermembr,Hle sp.1œ into the cyrosol. where they 
promore c.aspasc activar.ion and œil dear.h 1  16]. The best swdied 
of th esc  proreins is cyrochrome c.  which binds ro ,,poptosis  pro-
tcase activ.uing facto r-I (Apaf- 1) and  lcads to the assembly of ,lll 
apoprosome CûlllJ)iex. The ,woptosome can bind proc,,sp.•se-9 ,1nd 
cause its auto-(Ktiv\'ltion thmugh a c.onformationt11  ch< 1nge  114.161 . 
Upon acrivation, caspase-9 prop.1gares the cas pa se cascade through 
activation of  effecror casposes-3 and -7( 16). Casposc-3 in ru  rn acti-
vates cospase-6 and can a  iso participote in a feedbock ampliftcatiOll 
loop w further process caSJ)ose-9( 1 7,18]. Th us. acrivated caspase-9 
can rapidly omplify the de,1th signal. Furrhermore. prot<' ins.  such 
as endonuclease Gand opoprosis-inducing factor (AIF), w hich nor-
mally reside 1n rhe mitochondria.are a  Iso rele  ..  ~ sc d  dunngapoptosJ s. 
Thrse proteins translor.rtre from mitochontiria tothr nuclrus. whrrr 
they induœ DNA îr.1gmentation in .1  caspast' -independent mann er 
[ 1 8]. 
Th1s  swdy  invest1gates  whether exposure  to  J ow  doses  of 
acrolr in (<50 J l M)  can  inclure  ontiapoprosis ccli su iv  ivoi  factors 
such as AKT  and  lAPs.  in relation to the induction  of cell death 
by apoprosis through the mirochondriol pothway. Sin ce one of the 
mojor routes of exposure to acrcM in is the  Jung via inhai.Hion. the 
A549 cell line was chosen for this swdydue toits hu mon pulmonary 
origin. lmproving our undcrstanding of acrolcin-induced CC'Ilul.u 
responses is important given the widespread chronic cxposure of 
humans ro low doses of this taxie agent and its porentiol adverse 
efiects on human health. 
2.  Materials and methods 
2.1.  Ce/1  w lwre 
A549 hu mon Jung cells (ATCC #CCL- 185) were grown in mono-
layer in Dulbecco's modified  E.1glc's medium (lnvitrogen Canada. 
Burlingron, ON, Canada) containing  10% fetal bovine  serum (FBS) 
( lnvitrogen (Jn,1da ). 2 mM L -glutaminr. 3.7 g{J sodium bicarbonate, 
1.0 mM sodium pyruv,ne and 1%  penicillin (SOUjml)-streptomycin 
(50J.Lgi ml) (Flow  l.\ bo r.~ton e s .  Mississ.l ug,,, ON. Canad,1).  in ris-
sue ctili<m·  flasks (SMstedt.  S c.  L.1urent.  QC.  Canada). The  C<'IIS 
were  grown to ne.ar  confluence  anet then harvesred using 0.25% 
(wjv) ny psin-0.02%(wiv) EDTAsolurion. w,Jsilecl bycemrifugarion 
( 1000 x g. 3 min) ond resuspended in  minimum essemial medium 
alpho (u MEM) plus 10%  FBS for experimental studieS  1  19.20]. 
2.2. Tremmem wirll  acro l ~:·m 
Ce  lis ( l0°jml) were  incubated  w ith acrolein  (Sigmo-Aidrich 
CaiJ.ld,!, ON. L 111.1da) ( 1- 1000  ~ .M ) for different rimes ranging from 
30 min to 24 1 1  at 37 •c. Cc lis were pretrcated for 1 h wirh 25 J .LM of 
the PI3K/AKT inhibitors LV294002 or 50 nM  Wortm,mnin. 1 0 1-1-M 
AKT  inhibiror 1.  50 J .lM  Mn(lll)tcrrakis(4-benzo•c  acid)porphyrin 
chio  ride (MnTBAP).  JO  J .l M oî the gene  roi caspase  inhibitor Z-VAD 
(Calbiochem. Lajo  llo. CA. USA). for 3 h with 300 U/ml of the antiOX-
idanr polyethylene glycol-cot.1 lase  (PEG-catalase) or 2.4 mM PEG 
MW 5000 (equivalem amounr of PEG in PEG-cotolase (300U/ml)). 
and  for 5 min witll  1 mM  soditllll pyru vote or 300 U/ml c.atalase 
(Sigma- Aldrich. Can.1d,1 ),  wherc illdic.1ted. Cells were washed  by 
cenrrifug.llion ( 1000 > g. 3min) ro rcmove ,lcrolein. and til  en .111.11 -
ysed for apoptotic sign< lling. 
1.3.  Cmalase aCf!\'lCY 
Following  incubation  with 300Uj ml  PEG-caralase  or 2.4 mM 
PEG  for  3 il. A549 ce  lis (5 < 106)  were  suspended  in  500 J .cl  of 
PBS.  The cel!  suspension was thcn sonicated  n-vice  for 20s each 
(Vibra Ccli. Sonics & Moterials. Jnc  ..  D,mbury. CT) and  centrifuged 
( 12 000 x g. 15 min) to obtain a clear exttoct (21  ]. Carolase activiry 
was derermined at 25 •c  according ro Claiborne 1 22). The decompo-
S ition ofhydrogen peroxidc by c,lt,1lase w,\5 followed by ultraviolet 
spectrosropy M  240 nm.  Thr dosetgcwas  pcrformed using  ct  soJu[ion 
of 19 ml\11 hydrogen prroxidr containing th<"  cl <"ar cc ll u lii r ex [r~K r in 
a final volume of 3 ml at 25•C.  One unit was  defi nec!  as  J .cmol  of 
peroxide consunwdi 111ill/ 10° CL' lis. 
2.4.  C/ouogenir cell surviva! 
A549  cells  ( 105/ml)  were  pretreated  with  or  w it l10ut  PEG-
c.aralase (300 U/ml) or  2.4mM  PEG for 3 h. or DMSO Oi  Z-VAD 
( 1 0 Jl.IVI) for 1  h  .•  md thenexposed toacrole•n (0-1000 Jl.M)for 1 hat 
37 ''C ina final volume of 1.0 ml, in tt-MEM cont.1ining 10%  FBS .After 
theappropriate rime. the cellswere washed three tinwsby centrifu-
gation ( 1 000 x g. 2 min) to stop the incubation(21  ]. The cells w ere 
resuspended in culture medium. dilutrd to the .1ppropriare concen-
tration and pla  red in tissue culturedislws(60 mm x  J5mm). w hich 
were incuba red  at 37 •c ill '"'  annosphere of 5% C01  for JO  days. 
The dishes W<' re thcn ;va shed with PBS. fixed with 95%  ethanol and 
stained with methylene blue bef  on~ counting macroscopic. colonies 
(>50 cells). Cyroroxiciry w.1s ex pres s~ d os tlw  mean  number of 
c .olonies  obrained relat1ve to the mean numbC'rof  colonie-s obrained 
in the control. Two hu  nd red cells were seeded in the control plates. 
but w here rhere was a J oss of  cc li suiv ivol, ce lis were plared ar sev-
era! different dcnsitics ro ens  ure thar cou nt able colonies wou id be 
obtained. and the results wc  re correcred accordingly. Wc have pre-
viously demonsrrated th,1t. in this system. tl1ere is lineariry berween 201 
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th~ number of cells pla  red ancl  colonies  formed over the range of 
JO-JO" [23 ]. 
2.5.  Flow cywmeiTy analysis cif"miroclwndriul memiJran <' 
potenria! 
A549 cells ( 1 x 10°) were  precreared  with or  w ithour  1  mM 
sodium pyruvare for 5 min, 50 f.LM MnTBAP for 1 h, 300 Ui ml cata-
l.lse for 5 min. 300 Ui ml PEG-catalase  or 2.4 mM PEG for 3 h, and 
then exposed  to acrolein or to 5 J .LM p-crifiuoromethoxy-phenyl-
hydrazone (FCCP; positive conrrol), in a final volume of 1.0 ml ,1r 
37 •C. Then, 21.LM  rhodamine  123 (Rho l23) was added  for 30min 
,Jt 37 ' C in the darlc Changes in fluorescence (mirochondrial mem-
brane porential) on the FL-1 derector in lOOOO cells were measured 
by flow  cyromen y  using a FACScan equipped with an argon  laser 
(488 nm) and analysed using Lysis Il software (Becton  Dickinson. 
Oxford. UK) [24]. 
2.6.  R OS generation 
Th<'  generation of pro-oxidanrs was measured as described by 
Denning et al. [25 ]. wirh modifications. A549 œlls wc re pn•treated 
with or without 300Ui ml PEG-cat.Jiase for 3 h .11HI th  en exposed ro 
acrolein  . .Ils a positive conrrol, ce lis were rre.Jted witb ! mM hydro-
gen pe roxid ~ (H20 2 ). Then. 10 J .LM 2'7'-dihydrodichlorofluorescein 
diacerare (H2DCFDA) was added.  Levels of pro-oxidants in 10000 
relis were derermined by flow cyromerry using the FL- 1 dNector. 
2.7.  Prepararion ofwlwle cel/ lysa  tes 
Cr  lis were  prerreated  w irh or w ithout  25 J.LM  of LY294002 for 
1  h. 50 nl'vl Wortmannin, 10 p.M AKT inhibiror 1  for 30 min, 300 U/ml 
PEG-C .Jtolase or 2.4 1111\11  PEG for 3 h and  then exposed to acrolein. 
Cells WNC then washed by centrifugation( 1000 x g.3 min) in buffer 
A ( 100 mM  sun ·ose,  1 mM EGTA, 20 mM MOPS,  pH ï .4) [26].  The 
supernatantwasdiscarded, pellered cc lis were resuspended 1 11 lysis 
buffer B [buffer A plus 5% Percoll, 0.01% digironin and a cocktail of 
protcas<:' inhibiw rs; 1 0 J.LMaprotinin. JO  J.LM pcpstarinA, JO  J .tl'vl lcu-
peptin. 25 J .LM  calpain inhibiror 1  and  1  mM  phenylmrrhylsulfonyl 
fluoride (PMSF)] and incubared on ice  for 1 h.  Then, by  .1  IOmin 
centrifugation  step ar  2500 :-..g  ro  remove  nuclei  and  unbrokcn 
cells, the proteins of  w ho le celllys.Jtes wert'  isolared in the super-
natant for the  immunodetecrion of AKT, phospho-AKT (ser473). 
Bad, phospho-Bad (ser l36). ciAPI/2 and PARP. 
2.8.  P repararion of subcelllllar.fmcnons 
Ce lis were u eared  w irh acrolein and  chen subcellular fractions 
were prep.1red <lS previously described [26]. Ct'lls were washecl  in 
buffer A and  resuspendecl  in buffer B containing 0.1 mM dithio-
rhreitol (DTT). Following a 30 mm incub.Jtion on ice. lysa  res werc 
homogenised usinga ha nd potter (Komes g l~ ss CO. Du<lll22, Fisher. 
QC . Can <~ d <~ ) a n d centrifugedat2500 x g fori O min. The supernatam 
was cenuifuged at 2500 x g for10 min ro isolate rhenucleorfr.Jction 
in the pellet. w hilt> the supernat<lnt w~ s used to isolate mirochon-
dria and cytosol (sec bdow). The nuclear fraction was purifted by 
resuspending  the pellet in an  equal volume of a buffer  cont,lin-
ing20mM HEPES-KOH (pH 7.9) at 4' C, :!5%  glycerol. 420mM N<1Cl. 
0.2 mM PMSF. 1.5 mM MgCI2• 0.5 mM EDT. >\. 1 mM DTT and 1%  cock-
tail of prote<1se inhibitors [27]. Samples were incuba  red on ice for 
20 min ,1ncl rhcnuclcar fractionwas isolated from thecellulardebris 
by centrifugation ar 15 000 x g. for 5 min. This fraction was used for 
detection of  AJF in the nuciN IS. 
The • supcmarantfrom the 2500 x g cemrifugation step was cen-
rrifuged ar 15 000 xg, 15 min. The subsequent pellet was washed 
with buffer A and centrifugcd .Jt  15000 >:g for 15 min.  The final 
pellet  containing  thl•  purified  mitochondrial  froction  was  rhen 
resuspenderl inlysis butler B îor the detection oî Bax, cyrochrome c 
and A  IF. Tl!e supern.Jt<lnt was th  en ce ntrifuged at 1 00000 x ,g for 1 h. 
The resulting  supe rn<~ ta nrwas  designa red as the cyrosolic fraction. 
w hich was used for the detection of  cytochrome r and AIF. 
2.9.  /nmlunoderectlon 
SDS-polyacrylamide gel elecrrophoresis (SD5-PAGE)(10%; PARP. 
cJ API/2. AIF. AKT. phospho-AKT (ser4ï3);  15%:  cyrochrome c. Bax, 
B<ld, phospho-Bad  (serl 36)) of  cellular  protcins was  carried  om 
accordingro Laemmli [28]. Proteins( 40 1 1g)w<:'re quamified <lccord-
ing to Bradford  [29] and th  en solubilizecl  in Laemmli S<lmple buffer. 
Elecrrophoresis  was carriecl  out  ar  a  constant vo ltage  of  125 V. 
Cellul-u proteins werr  rransferred  to a  polyvinylidene clifluoricle 
(PVDF) membr,lne using ,1  MilliBlor Graphite Elecrroblotrer 1  appa-
ratus (Milli-pore. Bedford.  MA. USA) [30]. The blots w ere probed 
with  the  prinMry  .1nribodies:  ,1nri-PARP.  anri-ci.AP  1/2.  <lnti-AIF. 
<Hlti-cytochrome r. ,liHi-Bax, anri-Bacl. anti-phospho-Ba< l (ser136). 
,1nti-GAPDH (Sama Cn1z  Biotechnology. Sant,l  Cruz. CA. USA). and 
anti-AKT.  anri-phospbo-AKT (ser473)  (Srressgen. San  Diego,  CA. 
USA) in Tris-buffe  red  saline (50 mM Tris base. ISO  mM N <~ Cl. 0.1% 
Twecn-20) (TBS-T) conraining 1%  bovine serum albumin (BS.>\)  for 
1  hat room temper.Jture. l'vlembr<1ncs wcrl' washecl and incubated 
for  1 h ar room  tcmpcrawre with horseradish peroxidas<'  (HRP)-
conjugared  .Jmi-mouse.  anti-rJbbir.  or anri-goat lgG  (Biosourcc. 
C1marillo. CA.  USA)  diluted in TBS-T containing 5% milk  powder. 
Proreins were detecrcd using the ECL plus chemiluminescence kir 
(Pt' rl:inElmer. Boston. MA. USA).  Prorein expression was ,Jnalysed 
using a s c~1nn i ng  l ~l ser densirometer (MOJ ('cui.H· Dynamics, Sunny-
vale. CA. USA), relative ro GAPDH. 
2. 10.  Flow cymmetry mwlysis of lllrmce/lular expression qf" Bax. 
Bc/-2 and  s urvn ~m 
Ce lis were  tre<lted  with acrolein and  then  fixed  in  1.0 ml of 
freshly  macle cold  0.25% par,1formaldehyde for  1 h on  ire. After 
w,•shing,  cc lis were  penm~ b iliz e d in  1 ml of PBS- 1% FBS-0.05% 
Tween-20 for  15 min at  37 "C.  Ce ils were then  l~be l ed with ami-
Bax,anti-Bcl-2 oranri-SLIIVivin monoclonal antibodies (5 J.LI per106 
cells)  ( Sam~ Cruz Biotechnology) for 30min ar room temperature. 
Afterwasbing. Jabeled ce lis w ere incubated for 30 min at  room tem-
perawre in the dark witb a seconda1 y  ATC-Iabeled anti-mouse or 
anti-rabbit anribody (jackson  lmmunoResearch Laborarori<'S  lnc.. 
West Grave. PA. USA). Ce  lis ( 10000) were analysed by flow cyrome-
try on the FL- 1 derector. The specificity of the secondary ami  bodies 
was  resred  by  labeling cells. w ith or withour acrolein treatmem . 
with just  the second,Jry  fluorescent antibod1es witlwut prim,l ry 
antibody [3 1.32]. 
2. 11.  Dererrnirwtion o(  cospase ocrivity /Jy jluoresren c~ 
specrroscopy 
The activiry of caspases was mcasured as previously describecl 
by  H<lmpton  and  0 1wnius [33 ]. w ith  minor modifications.  Cells 
were prctreated  with or w ithout  300  Uj ml  PEG-caralas<'  for 3 h 
and th<'n <>xposed to acrolein. Afrer incubation, cells were washed. 
resuspended  .md  lys  rd  at  - 80 o c for 30 min.  Th<'  kin  eric  reac-
rion was  followed  for  30 min  afrer addition  of the  appropria  tt' 
caspase substrares at 37 •c [30] using a Specrr,, Max Gemini spec-
rrofluorimeter (Molecular Deviees. Sunnyv,l lc. CA. USA). Casp.Jse-9 
<lctivity  was  measured  by  cleavage  of the  nuorogenic  peptide 
substrate  Ac-Leu-Giu-His-Asp-AFC.  For caspase-3.  tllC'  subsrrate 
was Ac-Asp-Giu-Vai-Asp-AMC, MCA-Vai-Asp-Gin-Val-Giy-Trp-Lys-
(DNP)-NH2 was the substrare for caspase-7 and for caspase-G.  the 
substrote was Ac-Vai-Glu-lle-Asp-.1\MC (C<llbiochem). 202 
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2.12.  Ce/1  cycle mwlysis 
Following  tr~atmenr with an olein. cells were  washed. resus-
pended  in  l ml  of cold  PBS-1% FBS and  then 3 ml of co  id  100% 
ethanol were adcled drop by dropwith agitation. Ce lis were fixed at 
- 20•C for 1 h. Cells were resuspended in 500 j.LI of cell cycle solu-
tion (0.05mg/ml of propidium iodide (Pl) and 0.5 p.gjml of RNase 
.A.  in PBSl  and  incub,ued  at  4 "(  for 24 h  in the  clark  [34).  Ce lis 
( 10000) were  analyse cl  by flow  cytomeuy on the FL-2. FL2-.A. and 
FL2-W derecrors and analysed using ModFit soft\'li.>re (Verity Soft-
ware House. Topsham. ME, USA) to determine the percemage  of 
ce lis in apoptosis, GO/G 1 phase, S phase and G2/M phase. 
2.1 3.  Del"erminari.on of pl10sp/wcidvlserine (1'5) exrernaluarion by 
.~n n ex in V-FITC sraining 
.A.549  ce lis  ( 106/ml)  were  pretreated  w ith  or  w ithout  PEG-
caralase (300 U/ml) or PEG (2.4mM) for 3 h, or Z-VAD ( 10 tLM) for 
1  h, and  th  en  exposed  ro  acrolein (0- 14 tLIVI) for  2 h. Ce lis were 
washed with PBSand rcsuspended in 1 ml of binding bu!Ter( 10 mM 
HEPES/NaOH, pH 7.5, 140 mM NaCI.  .>nd 2.5 mM CaC/2).  .A. volume 
of  500 f.t.l of  ce  il suspension was incuiJared wirh 5 f.tl of  Annexin V-
FITC (BD Biosciences C.1nad,1, Mississ.w ga, ON. C.m~ d a ) ,1nd  10 f.LI 
of 1 >ropidium iodide (Pl) for  10 min ar room  t em p e r~t u re in the 
clark [35).  (l'Ils (10000) were then ,1nalysed  by  flow  cyromNry 
[36). Annexin V-FITC fluorescence \.vas derecred on  th ~ Fl -1  derce-
tor and Pl  fl uorescence on  the FL-3 derer tor.  Four popul.>rions of 
ce  lis w ere analysed: live control œlls (Annexin V-/Pl-): early stag< ' 
~ po pto ti c cells (.A.nnexin v•jPI- ); la testage apoproric cells( Anncxin 
v•jpJ • ): necrotic ce Ils (Annexin v-tpr• ). The results are reporred as 
the fi"<lC!ion of rotai apoprotic cells (carly and lare srage apoptosis) 
and necrotic cells. 
2.14.  Starisrics 
Dar,l represent  means± SEM  from ar leasr  rhree  independent 
experiments perfonned in duplicate. When nor shawn. error bars 
lie  within  symbols.  Compa1isons among  multiple  groups  were 
made by one-way ANOVA, \Nhich measures tht• linear contrasr of 
means. The Bonferroni- Holmes adjustment  was used  to contro l 
for the family-wise error rate at a desired leve! (a - 5% ).  Software 
used was JMP Statistical Discovery 4.0 (SAS lnstitute lnc.. Cary. NC). 
For significanr differences. (')P< 0.05. ( ..  )P< 0.01 or ( '" )1'<0.001 
for .>crolein-treatment compart'd with control (0 p.M); (O)P< 0.05. 
(00)1'< 0.01 or (OOU)P<O .OOI  for cells with or w irhout rreatment 
w ith sodium pyruvate. MnTBAP. catalase, PEG-catalase, PEG,Z-VAD. 
Worrmannin, AKT inhibir.or 1  or LY294002, at the sa mc concentra-
tion of  acrolein. 
3.  Results 
3.1.  Acrivarion of  Sllrvivalfacrors and anriapoptosis proteins by 
acrolein  in A549 l1111g ce  lis 
Exposure ro  toxic compounds. under  Jess severe stress  condi-
tions. can ofren inducecellulardefensesto ena ble rhe ce li to survive. 
Therefore. wc will derennine wherhcr ,Krolein can acrivare su1vival 
factors such as AKT (protein kinase B) and  B.Jd. and anti.>poptosis 
proteins such as c-lAP and suwivin. 
3. 1.1.  1\cralem acHvated Af(f 
We beg,1n investig,1ting whethcr acrolein cou  id activat!' the sig-
naling parhways involw d in ce li su1 vival. AKT is generally involved 
in ccli  suivival  signaling  pathways and  is  acrivarcd  in  rcsponse 
to many different growth factors, hormones. and exrernal stresses 
su  ch as he  ar shock and osmolarity [37]. We ev,1luated the capacityof 
acrolein to regula  re the expression of AKT and its phosphorylation 
in A549 cclls (Fig. l A and  B). lndeed, acrolein (3- 14 tLM)  causcd 
a significant increase  in the rotai cellul,1r exprt'ssion of both .A.KT 
and phospho-AKT (st'r473). after a shorr t'xposure ti me of 30 min. 
in relation ro untreare<l cells. 
.3.1.2.  Aaolrin-inriuœd plwsplwry/alion of Bac/ 
The  proapoptotic  Bcl-2  family  prorein  Bad  regul,l te s.  apop-
tosis upstrea m  of mirochondrial-mediated  casp,1se-9  ,1Ctivarion. 
Activation  of AKT  by  phospholy lation  plays a  survival  rolt'  by 
prev!'ming the pro.w optotic action of  Bad  through its phospho-
rylarion ar  SerD6p  [38).  We thert'fore detNmined  th<:  ability of 
acrolein  ro  modulare  til<:  expression of Bad  and  its pilosphoiy-
larion in A549 relis (Fig. 1C- G). Exposure to acrolein (3- 14 tLM) 
for 30min caused  a significant incre.>sc (58-77%) in total cellular 
expression of phospho-B,1d (ser 1 36). The  re  w.1s ,1J so a small increase 
in wral  ce ll ul <~r  expression  of  Bad  in  cells u eared  wirh  14t.LI\i1 
acrolein  . .A.crolein-induced phosphoiy larion of Bad was inhibired 
significantly IJy tht' PI3K/AKT inhibiror LY294002 (Fig. 1  C-E), w hich 
suggests thar tllis response  could be mediated by  PI3K and AKT. 
Howt'Vl"r. LY294002 is known ro  IJind rt'vcrsillly to Pl3K, bur it can 
a  iso inhibit the kinase activity of mTOR at a similar concentration 
to that used  for PI3K inhibition [39). Facect  with this possible J ack 
of  l Y294002 spccificiry. wc a  iso employect  a direct inhibitor of  AKT. 
designar!'d AKT inhibiror 1. which ~ c r s by competitive/y binding the 
AI<T plecksrrin homology domain of the kinase 1 40). AKT inhibitor 
1  ( 10-40 tLmol/1 ) w.1s shown to suppress AKT phospiloryl,1tion in a 
dost•-dependent mamwr, yet it exerred no cffect on mTOR signal-
ing in cells wirh .md without ,1crivated AKT 141]. ln A549 ce lis. AKT 
inhibiror 1  inhibited significamly acrolein-induced Bad pi!Osphory-
larion (Fig.  1  F  and G). 
To confirm fu1ther the implication of  PI3K/.A."'T in Bad plw spho-
rylation, we used another well-lmown PI3K iniliiJitor. Wortrnannin. 
ln contrast ro LY294002 and .A.KT inllibitor 1 , Wortmannin is cffec-
tiw at low nanomolar doses. which suggests that it may be more 
specifie than rht'other rwo inhibitors 140). Wortnhllllllll binds irre-
versibly to  PI3K.  Although Wortmannin can  also  have  off-target 
effecrs. tbcre appear ro be effective concentrations (i.e.,  lOOnMj 
.1t which the inhibitor is PI3K selective [39). lndeed.  Wortmannin 
inhibited Bad phosphorylation in acrolein rreated ce  lis (Fig. ·1  F and 
G). Together, the findings witb the three inhibirorsLY294002, Wort-
mannn and AKT inhibitor 1  suggesr thar Bad  phosphorylarion was 
mediated by PI3K/ .A.KT (Fig. 1). 
3.1.3.  J\crolcin lllcreased c/AI'I/2 expression in 1\549 œlls 
The expression of  cellul.1r inhibitors of  apoptosis proreins (elAPs) 
is also lmow n to be regulatccl  by the PI3K/A"'T patilway [42,43). 
The clAP proreins fu ncrion as imrinsic regulators of the caspasr 
cascade  [44).  W~  ev,1Juared  the  capacity  of acrolein  to  regu-
late rlle expression of ciAPl /2 in A549  cells (Fig.  :!A-D).  lndeed, 
acrolein (3- 14 p.M)  indu  ceci  an  increase  in wr, 11  cellular  expres-
sion of cJ.I\Pl /2, ranging from 37  to  84% ,1bove the comrol  leve!. 
Accordingly,  the  aldellyde-induced  incrcase  in  ciAPI/2  exprt's-
sion was inhibited by LY294002. AKT inhibitor 1  and Wortmannin. 
suggesting  that  this  rcsponse  was  mediated  by  the  PI3K/AKT 
parhway. 
SuJvivin, the only clAP to associatc w irh chromarin srructures 
[45],  plays a role in monitoring the success of chromosome rt'pli-
cation and the suppression of cas  pa  se ,1ctivity in rhe nucleus [44). 
However. acrolein (3-14 Jl.M ) dicl  not alter rhe expression of t.his 
anriapoprosis  1>rotein in A549 cc lis (data not shown). 
Together,  these  findings  show  rhar  exposurt'  to  low  doses 
of acrolein (< 15 tLM) activ<lted  survival responses in  A549  ce  lis 
(Figs.  1 and  2).  However, if sulVival  respons!'s  do not  succced 
in counteracr.ing a toxic insult.  then  the  cell will be eliminaœd 
by regulared death processes such as apoprosis. We subsequent/y 158  ). Roy ('ra:.;  Clu:m ico-B iQtogkal l rm.•,acnon . ~ 1SJ  f2009) 154-167 
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derermined the relation  berween  the activation  of antiapoptosis 
su1vival factors by acrolein and rhe induction oi apoprosis. 
3.2.  Acrolein induced apoptosis rh rougi!  t/ 1 ~ miroc!wndrial 
parhway in AS49 œll.s 
3.2. 1.  Acrolem încrrased mitocf!ondrial membrane poren cial and 
ROS production 
The potential ability of  ,1Crolein to induce apoptosis by rhe mito-
chond rial signaling  Jlathway was  derermined  in  1\549 Jung ccll s. 
Wt'  first evaluated  the effect of ,Krolt'in on  mitochondri.~l mem-
brane potential.  which is considered  a critiral cherlcpoint  in the 
c,1sradc of  events J eacling ra ccli death. Th(' exposure of ce lis to low 
concentrations of acrolcin ("J0-50 fLJ\il) caused  rapid (30-60 min) 
hypcrpolarisation of the mirorhondri,11 membrane (Fig. 31\- E). !\ft  er 
30 min. Rho 1 23 fluorescence increased by about 40-60% . compared 
to the untreated control, for 10-50  ~LM  aero le in (Fig. 31\). FCCP was 
uscd as a positive conrrol and  clecrcased membrane potential by 
about 60%  (Fig. 3A). 
Sinceacrolein increases mirochondrialmembranc porential, wc 
therefore investigated whcther this could aris"' from inrreased ROS 
production. Severa!  studies have )inl<ed mitorllOndrial membrane 
hyperpolarisation with ROS production [46-49]. lndt>cd. acrolein 
(10-50  J..LM) inrreased ROS production by about 20-46%  a  ft  er  30 
and 60 min in A549ct"lls. when compdl"ed ro unrreared ce lis  (Fig. 3F 
.1nd  G). Hydrogen peroxide was used as a positive control for ROS 
and increascd H2 DCFD!\ Ouorescenct' by a facrorof  about3.2 (Fig. 3F 
and G). Toconfirm wherherROSwere responsible formirochonclrial 
membrane hyperpolarisation, rhe ROS scavengers MnTBAP. sodium 
pyruvare, catalase and polyethylene glycol-ratalase (PEG-raralase) 
were  used (Fig. 3C and  D).  J'vlnTBAP detoxilies superoxide. Cata-
lase scavenges  hydrog('n peroxicle at th<:'  extracrllular levt'l, wh ile 
sodium pyruvate ,md PEG-r,1t.llasr deroxify peroxide ar tl1e  intr,l-
rellular levt"l  [211.  Pretreatment of relis wirh PEG-ratalase for 3 h 
increased cellular catalase acrivity by 37%  (Fig. 3B). An equivalent 
amoum of PEG atone was used  as  ,1  control and  did not increase 
caralasr  activiry  (Fig . .3B).  lndeed,  ali  of  the  antioxidants  sig-
nific.lntly arrenuated  acrolein-induced  mitochondrial membrane 
hyperpolarisarion (Fig. 3Cand D). suggesting thar membrane hyper-
polarisation was  mecliated  by  ROS.  Surprisingly.  PEG ,1Jone ,1Jso 
arrenuated this effect (Fig. 3D). 
3.2.2.  t\crol~in increased Bax levels at mirocliondria 
Si  nee the mitochondrial p.1rhway is strier!  y regulated bythc Bcl-
2 family proteins [ 1 61. wc derennined wherher acrolein cou id airer 
the proapoptoticamiapoprorir ratio of these proteins ar the mito-
chondrial memlJrane. When, A549 cc lis were exposcd to arrolcin 
(3- 1 4 t~M ) for 1 h, there was an  inrrease in Bax levels ar the mito-
chondria, relative ro  unrrcated  relis (Fig. 4A and  D).  There was  a 
correspondingderrease in Bax levcls in the ryrosolic fracrion afrer 
30 min  and  1  h (data nor shown). However.  rherE'  was  no ove rail 
change in roral cellular expression of Bax and Bcl-2 proteins,  or in 
the ratio of Bax/Bcl-2 (data not silown). The puriry of  cyrosolic a1Hl 
mirorhonclrial fractions is shown in Fig. 4E. 
3.2.3.  Acrolein ind11ced cywchromp c release and mspase 
nctivanon 
An important srep in the mitochondrial pathway is the releaseof 
cytochrome c  from mirorhondria inro the cytosol, where ir  can bi  nd 
Apaf-1 [50] and amplify theapoptoticrascade. 1\crolein (3- l4Jll'vl) 160  ). Roy !'i ai  .  .J Cllcm:co-Biologicallnccrnaions ISJ (20(1{1) J 54- 167 
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Fig. J. Acrolc-m c..luses mirochondrial mC'mbranc h}'pcrpola ris,nion .1nd incrNSt:'S ROS production.{.-\ anet C-G 1  A549 ccll.s ( 106/ml) Y.'Cœ mcubJt('d wirh .:tcrolcm (0-SOp.M) 
for30mm or 1  h Jt  ~Ï " (i n  u-MEM contJinmR 10%  FBS.Acrolcm-rrc.lt("d  n.~u s. rl'I<HIVC to untrcMcd conrrol cc  lis. wcrc~1na lyscd by flow cyromNry rort.::  .•  md E) Rhol23 (2~-tM ) . 
or(F and G) H~DCFDA  { 10 ~M ) tluorcscrmcc in channel Fll (note differenrvtrnc.ll sc ales roracrolcm .tnd H20;!). (8) C.1t.11asc act wiry was dctermmcd tn A549 cclls(5 x  106) 
fol\0\\'lnS:  mcub,uion wirh 300 U/ml  PEC-cau!J.sc· or 2.4 mM  PEG  ( ~·1W  5000) for l  h. The conrrol vJ.Iue of 0.0S72±0.002 unirs (l.tmol of pcrox1dc consumrd/min!1o' ecUs) 
was normalizcd ro 1.0. ((-0) A549 cc~  Ils (1Wiml) wc re prcrr<'.ltC'd \vi  rh  or ~··:ithout sochum pyruvare. MnTBAP,  c.1r~1 la se .  300 U/ml PEG-c.1ralasc or 2A mM PEG for 3 h. rhen 
cxpos('d to :.crolcin (0-50 p.M) for 30 min and an.1lysN1 by flow C}'tomcrry for Rha123. (E) Hlswg:r<un plors arc TC'prcS('ntMIVC rcsutrs of mnochondlial membrane porenri.tl 
in cc  lis cxposed for 1 Il to 0 MM ,tcmlein (fi  lied hnc) or 14jJ.M ,:,crolcm (-), orfor 5 min to S!J.M FCCP('  ·) ,,s posinvc con  n ol for mirochondri;\J membr.1 nc dcpol,tris.trion. (G) 
Representative hisrogr.tm plots ar<' shawn for ROS  production in C<' lls cxposed for 1 h to 011M (fillcrllmc). l4f.LM .Krolcin (- ). and to  lm1vl  HzO:! (  ) as a positive control 
for ROS. Data rcpr('scnr mc-ans ar1d  SEM of rcl.uive fluorcsccr.c.c intCIISity (RF! ) from rhrec inOcpendcnr cxperunems.  norm .l lî~ c d rv comrols( 1.0). P•: 0.05 (" ). P< 0.01  (  .. ~) or 
P< 0.001  ('•') mdicatcs <'1  s.r.ttistlcally s1 gnific.1nr diffNCI)CC  bctw~ ~<' ll rre,'ltm<'nt .,...-fth ,tcrolein ,'lnd rhc unrrrarC<I  control. P< 0.05 {0). P< 0.01  (IJO)  or P<O.OI  (Ut)Ü) Jndic.ucs 
a sra r istlc.liJ ~r Sl$,mificanr  difl'c:rcncC' bcnvccn C('IJS  exposee!  to acrolcm. with or \'\'ithour soc11Um  pyruvatc. MnTBAP.  c.at<tlasc. PEG f1:1W  5000 or PEG-<.lt.alasc. iit the  ~1 111<' 
conccmrat1 on of  dCrolcln. 
caused liberation of cy[Qchrome c imo  th ~ cytosol afœr 30 min  in 
A549 relis (Fig. 4C and D). Cyrochrome c levels decreased by abour 
40%  in the mitochondrial fractio n. relative to untreatecl ce lis (Fig. 4B 
,,nd D). Th<.>  bin clingof cyrochrome c to Apaf-1  leads to assembly of 
rhe.1poptosome. which promotes caspase-9 activation [16]. Expo-
sur<.>  of cells to acrolein ( 1-27 p.M) for 30min to 211  inc.rcasecl  rhe 
enzymaric acrivity of initiaror caspas<.>-9 (Fig. SA). 
Activation  of caspase-9  then  propagates the caspase  case<~cle 
rhrough activation ofeffecror caspases 118]. Todetennine rhe down-
strNm events from  ras(>.lse-9 in  thl•  apoprotic cascad..- initiated 1 
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30 mtn or 1 hdt 37 '·(  1n n-MEM cont.1inmg lOl FBS. (A and m lc\'l"ls ofB,\x (23 l:.Oa) 1n  nurochondrl.ll fr,\ctJons afccr  1 h wcœ .1nalyscd by W('stern blouing  <~nd densJtolllNr'J. 
r('l,uive w the unucatt."d  comrol (1.0). (B-D) lmmunodercrnon of cytochrome c (Ill:. O."  111  nurochondrial and cytosollc fr(lCfiOns o1ftcr  30 m111  was c.uricd om by Wcsrem 
blonin2-. ustng GAPOH ( 37 l:Oa) as lo.:1dmg. conrrol for rhc- cywsohc traction. DcnS1rornNnc ,,n,,lysc-s of lcvcls of(B) nutochondn.tl.lllc1 (Cl cyrosoltc cytochromc c  .1rc r c-Jarrvc co 
the- untrcatcd conrrol ( 1.0).(0 ) A rcprc'icnratiV<" blot is shown from thrcc indrpcndcm cxpc-rimcnrs. P< 0.03 (' ). P< 0.01 (.·)or P<  0.001 r· ••) mdicarcs a st.1rtmcally signific.1nr 
diffe-rence  bcrwe-cn  m:·.mncnr  wrrh  acrolrm  .and  rh<'  unrrc-.ucd conrr·ol. (E• A rC'prcscntJtivC'  bloc  is shown for  punty of s:ubœllulM  fr.~t:r i on s .  usmg !,mun  B.  glur.uhionr 
S-cr.msferasc (GST-'7:'1)  ~lnc1cycochrom c- oxrdasc (COX  IV) for nuci('.U, cyrosolic .1nc1  nutochondrk11  fracrrons. rt:'spccnvcly. 
by acrolein exposure. we Jooked at the enzymaric activity of  effec-
tor caspascs-3. -6 and -7. Caspasr-3 activiry increascd afre r  1 and 
2 h exposures w acrolein ( 1-JO p.M). when compared ro  un(reared 
cells (Fig. SB).  Acrolein ( I-7Jl.fV1) causee!  a very small inrrease in 
enzymatic activity of caspase-6 afrer 1 and 2 h (Fig. 50). Howcver. 
the re  was no increase in caspase-3 or c.1spase-6 activiry ,,r higher 
doses ( 14-27 J.LM). Furthermore,acrolein ( 1-27tl.M) also increased 
casp.~si"'-7 activiry (Fig. SC). To confirm the role of ROS in acrolein-
induced apoptosis. cells wc  re pretreated with PEG-caralase. Jndeed, 
the antioxidanr climinished significantly  acrolein-induced caspast'-
3 activation (Fig. SE). 
.3.2.4.  Acrolein induree/ AfF releuse from  muocl10ndrw and 
translocation ra  rl1r nucleus 
Another  factor  thar can  be  re1œscd  from  mitochondria  inro 
the cytosol clunng opoprosis is AIF.  which nonnally resides in the 
intermembrane sp.1ce [ 16]. A1F c.1n  rranslocatc w the nucleus and 
comril>lote to DNA dcgr,ldarion [51 ). ina caspase-indepenclem m,1n-
nt>r.  We suusequently investi  ga red whether acrolein cou id indu  ce 
transloc.~rion of  A1 F w the nucleus. There was a significanr incre,1se 
in AIF lt"'vels in the nuclear fraction (Fig.  GA and D). Fig.  4E shows 
the puricy of  the nuclear fraction. AIF 1cvels clecreased in the mito-
rhondrial (Fig. 6B) and cytosolic (Fig. GC) fractions. after exposure 207 
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Fig. S.  r.crol~in r< 'luses ,lctiv, ltJOn of initi.ltor c.aspase-9 .tnd  effector casp<'lscs-3. -6 .tnd -7. r549 cclls ( 106;' n1l j \VC'r<:'  mcubJf('d Y.'ith .Krolcm (0-2ï 11M) for 30 111111.  1 or 2 Il 
.;~t 3ï <>C in  (~-M8Vl com.uning 10%  FBS. Acrivlti<'S of (A) c.-.spa:s<'-9. (B .md  Ei casp.ls<--3. (D) caspase-6 Jnd {C) rasp.1sc-ï  111  ( Cl!  lys.ltcs wNe me.1surcd  ustng .lppropnatc · 
iluor~s("{·m  sttbsrr.1tC's. (E) Caspa5c-3  ~~n i viry in cc  ils thar ·.ven:- prccrc,ucd '.Vith or w ttho~H 300 Ufml  PEG-c .u~ l l . l sc for 3 h .1nd  rhcn cxposcd ro .l<rolcin (0-10 J.lM ) for 1 or 2 h. 
Casp.'!sc· .:tctiviry is :shown rci<Hivc ro untrcated contrOl!> ( 1.0). D~ua reprt:"scnt mc-.1ns and SEM from thrc-e indepc'ndenr cxpcnmc-nts p<'rforn)('c1 \vith mulriplc csttm.ltlons pC'r 
point  . .  4.-E) P<O .OS r}  or P< 0.01 r·)  mdic.ucs ,1  sr .m stk <~lly  signiftc,lntdiff("rcn( C' bNween trearmcnr wirh aero le  in ,1nd rhe untrc.H<'d control. (E) P<O.OS (ti) or P< 0.01  (Hi1) 
tndicatcs a stamrkally signific.:mt difference- bcnv('{'n cclls expv:>cd to acrolcm. with or withûut PEG-L"atal<'\sc. at the sa  me cont:entr  •  .mon of  aero  leut 
ro acrolein (3-l4J~ rvl) for 30,1Jid 60min. This indî e<~rc;-s thar acrolt"in 
incluced AIF release frommirochondri<l .1nd  irs tr<lnslocation ro the 
nucleus. via tilt> ryrosol. 
3.2.5.  Activarioll of che exeCI!rion phase of apoptosis by ucrolein 
After  establislling  thar  acrolein acriv<lted  the  mitochondri,11 
pathway in A549 cells. the execution phase of  apoptosis was anal-
ysed at the levet of cell cycle' changt'S (Fig. 7  A and B) and ck•avage 
of PARP (Fig. 7( and D ). Tht>  percentage of ce lis in the sub-GO/C 1 
population. corresponding to fragmenrt•d  DNA  in apoproric relis, 
increased up co 22%  in acrolein-treated ce lis, compared to untreated 
cells (Fig.  7A and B). The percentagc ·  of cells in the GO/Cl S.  and 
G2/M  phases of the ce li cycle did nor change afrer 24 h exposure 
ro  acrolt"in ( 1-27 f!M). The majority of cells were in GO/G!  pl1.1se 
( - 75%). w hereas - 19%  were in S phase and about 8%  were in G2/ l'v1. 
Funhermore, the DNA re  pair protein PARP underwent cleavage and 
expression of the cleavage fragment ( 85 kDa) increased by  7 1 ~; a  ft  er 
à 2 h  exposure ro acrolein (25-50  1J.I'v1.  Fig.  7C and D). To confirm 
the rote of  ROS in acrolein-induccd apoptosis. cc  lis were pretreated 
with the antîoxidant PEG-catalase.  lndeed.  PEG-cat,1lase  dimin-
ished significantly acrolein-indured cleavage of PARP (Fig. 7C and 
D). PEG was used as  a control and did nor significantly decrease 
PARP c  leavage. 
3.2.6.  Acrolein incl lices e. wenwl1zotion of pi!Os{J!I(Iriuylserine ÎI'S} 
The externalizarion of phosphatidylserine (PS) is à widely used 
mMker of apoprosis thar is consiclerecl to be an carly event in the 
execution phase. 1t  can  be revcaled  by Annexin v-mc labelling 
of exte-rn,11izecl  PS on the plasm,, membrane (Fig.  8). Pl  was used 
as a countersrain for necrosis (clara  not sllown). Tllere was a  14% 
incrcasc  in Annexin V-positive cells following a 2 11  exposure of 
A549 ce lis to aCJ·olein (7-14l.lM). comp,1red to the untre,1ted con-
trol. The role of ROS in this response Wàs confirmed by inhibition of 
acrolein-induced  PS exrernalization by  PEG-catalase. Surprisingly, 
acrolein-incluce-d  PS exrernalizarion was diminishecl by PEG atone 
as  control. ,11though  to ''  fesser extent than  PEC-catalase.  Under 
rhese conditions, levels of necrotic cells remàinecl low (  - 2%) and 
were not affected by PEG- e<~ralase or tlw general caspase inhibiror 
ZVAD(dara not shown). 
3.2.7.  Induction o.f cyroroxicity by acrolem 
Cyroroxici[y of acrolein w~ s assessed  by a clonogenic ce li sur-
vivat  ~s sày in A549  cells. Wc established  thar. concentrations of 
100 p,M ofacrolein and higher inctuced cytotoxicity afcer 1 h ( Fig. 9). 
A  concentration  of 100  1~M decreased  the  fraction  of surviving 
cells by 40? ~ .  Above 100 p.M, th  cre  was a  marked decline in  ce li 
survival. To  coniirm the role of ROS  in anolein-induced  cyrotox-208 
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Fig.  6.  Acrolcm induœs rc l ~. lSC' of AIF  from  mitochondria ~1nd rr.1nsloc,mon ro  the- nucleus. A549 œlls { 1i)6iml) wc re- C'xposcd  to acrolctn (~  14 MM) for '30 min or  1 h ~1r 
n ~c in  c~ -MEM  cont<~inmg IOX FBS. lmmunodNe<tton of mttochond rial. cytosolic ,1nd nue  leM AIF (5ï ).:0,1) was carned our by Western blotnng, usmg GAPDH (3ï kDa ) <1s 
J o.:1ding comrol for thecywsolic fr  act  mn. D('nsitomNncanalyses  for thr cxpresstonof.-\IF in (.-\) nuclcar. (B) mttochondric ll. ,1ndfCicyrosolic fr.Kttons M C'  rcl. mve to umrcarcd 
com ro l ~(  1.0).(0 ) .A. rcpresenr.nivc blot from thrce- indcp<'ndem('Xp('nmcnrs  is shawn for  CC'Jis cx.posC'd ro ~Kro lem  for 30 min. P< 0.05 (") or P<  0.0 1  ("' 11ndic,ucs  .1  s r~ms t iC.l ll y 
s Jgnificant differe neC'  bctWC('Il treatment with acrolem ,md the untrNtcd control. 
icity, cells were pretrc.Hecl  with PEG-catalase or PEG. lndeccl. the 
anrioxidanr diminishc •d srgnificantly .lcrolein-incluced cyrowxicity. 
;vhereas  PEG  h.1d  no  effert.  The  role  of casp.1ses  in acrolein-
induced  cytotoxicity  w.1s  veritit•d  using  the  c<~sp <~se  inhibitor 
Z-VAD.  Acrolein-induced  cyrotoxiciry was  nor affected  by ZVAD 
(Fig. 9). indicating th<1t loss of clonogenic cell survival is nor medi-
ated by caspases. 
4.  Discussion 
4.1.  Acrolein  mduced an anriapoprosissn·ess respome mA549 
Jung cells 
4././_ Acrivarion ofAKTrmd plrosplwrylmion of Bad 
This study shows thar expostrr-e of A549 Jung cells to low doses 
of  .1crolein (  <1  5 JlM) caused induction of  the anriapoprosis survival 
factors,  AKT .1nd  lAPs.  AKT promotes  ccli survival by  excrting .1n 
anri.apoprosis  effecr against various srimuli  including growrh  fac-
tors. hormones and  exrernal srresses [37]. Acrolein inducecl  r<1pid 
(30min) activation of AKT, as  weil as  phosphorylarion of Bad~~ 
Ser116P , in A549  cells.  Acrolein  ~Iso  ~ c tiv~ ted AKT in CHO cells 
[52]. Bad  regul~re s ~poptosis upstream of  mitochondrial-mediated 
caspase-9 .lCtivation, by  binding ro  Bcl-2 and  Bel-XL.  rhus  neu-
tralizing their  anti,lpoptotic .Jctiviry [53!. However, when  Bad  is 
phosphorylared  ~r Ser136P by AKT acrivarion. it is sequestered  by 
the protein 14-3-3 for proteosomal degradation, which prevenrs irs 
proapopwric <rcrion [38]. 
4.1.2.  lncreased c/API/1 expression ill acroiein-creared 1\549 cel/s 
The  anti~poptosis proteins ciAP-1  <1ncl  ciAP-2  were  found  ro 
clirectly inhibit certain caspases.  in parricular c.lspases-9, -3 and 
-7.  by  ubiquitination  [44,54 ].  This  is  the  firsr  study  to  show 
that low  doses  (< ISi.J.MJ of ,1crolein  inclure upregulation of the 
ciAPI/2  proreins.  Severa!  studies  demonsrrared  ,,  link ben·veen 
clAP .1nd AKT. The enhanced rr, 111scnption .l!1d transi.Hion of ci.A.P-
2  was medi,1ted  by  activ.lted  A!Çf  [42].  The  overexpression  of 
AKT  resulted  in the upregularion of ciAP-1  expression [ 43j. These 
resulrs suggest a pivotai role of AKT  Hl  the regul,ltion of cell sur-
vivat rhrough rhe upregularion of a specifie IAP.  However  . .Jcrolein 
clid  nor  .1 11er expression  of the IAP survivin  in  .1\549  cells. Sur-
vivin is  resrricred ro expression ar rhe G2/M checkpoint in the cel! 
cycle  .•  1nd  is the only IAP  to  .1ssociare wirh chroma tin structures 
[  45j. The inililliwry rffecrs obrained trsing t11ree cliffeJenr PI3K/AKT 
inhibirors LY294002. Worrmannin <~nd .A.KT inhibitor 1. suggesr that 
this  survival response could be associared  wirh acrolein-induceô 
AKT actrvation. 
4.2.  1\crolein increosed ROS  genermion and ca11sed miroclwrrclrial 
opopcosis ill A549 ceils 
Ac.rolein  is  t>robably the most  roxic  <~ld ehyde l<nown. yet our 
tindings  indican~ thar lower doses can induce an anri,1poptosis sur-
vival response. The over.11l  f.Jre of the cell is <1  question of lk1lance 
bctween the pro- and  <~nti.wop tot ic signais.  Ofren, the fa te of the 
cel! is dctermined by rhe  re l <~tive speed of simultaneous survival 
.1nd  dearh processes.  <~nd by  rhe relative expression  of different 
anragonisrs of these indiviôual pathways [55j. ln this study. even 
though the .Hlliapoptosis proreins were upregu1.1ted, acrolein cou  id 
still activJte proapoproric signols and execu te death by apoprosis in 
A549 c<:>lls. ln fa ct, duringapoptosis, lAPs can be degradcd by certain 
caspases  [44]. which would neutralize their antiapoptosis  effect. 
Our finclings indicate thar Jntiapoptosis processes clomin.1te at low 209 
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Fig. 7.  Acciv~ltion of rhe execution phase  of apoptosis by  aero le-in. (A) A549 cc lis ( 106/ml) were incub.lted  with .1crolt'in (0-27 ~M ) for 24 h <tt  'f1 "(  m o:-MEM containing 
10%  FBS.  Using Pl  ~1s .1  marker for cC'll C}Kie,  10000 cells were then  analysed  by  flow cytometry ro derermine the percenrage of cells in each ph as<.'. Data represent mea ns 
é\nd  S EM  from  rhrce indepcndenr experimenrs.(B) Representative histograms of f! O\'V  cyromerry analysis for œil cycle  in channel Fl2-A are  shown  for untreated cclls and 
for thosc  trea red with 7 j..lM  of acrolcin. (C) lmmunodctt>ction of cle.wC'd  PARP (85 kDa) in w ho  le ccli  lys.u cs was cMried out by West<' rn  blotting. using GAPDH (37 k0 .1) as 
loading control. A549 ce lis ( tri/ ml) wcœ prerreated with or wirhout PE.G-caralase ( 300U/ml) or PEG (2.4 mM} for 3 h and then exposed to acrolcin (25 or 50 j.!.M) for 2 h in 
a-MEM containing 10%  FBS. Densirometric analyses of the expression of cleavcd PARParc relative rorhe unrrcated control ( 1.0). (D) A representative blot is shown from threc 
independcntexpcrimenrs.  P< 0.05 (·). P<  0.01 ( ·~ ) or P<  0.001 ( ..... ) indicares .1 shltisrically significam differe ne(' berween trc.1tmenr w ith .1crok"in dnd the untreatC'd control. 
P< 0.01 (08)or P<  0.01  (I}(Ht) indicatcs  ù slalistically signific.ml difference lx'rwcen cells exposed roacrolein, with orwirhout PEG-caralasc or PEG. ar th<' sa me conCC'ntr.uion of 
acrolein. 
dose ( <I5JLM)/shoJter exposure times to acrolein. whereas propa-
poptotic  processes  domina  te at higher dose  ( 10-50 J LM)/Ionger 
exposure times. 
4.2.1 .  Acrolein caused ROS media red mirochondrialmem/Jrane 
hyperpolarisarion 
This study establishes thar acrolein induced ROS overproduc-
rion in human pulmonary A549 ce lis and  thar cell dea  th occurred 
by apoptosis rather than necrosis. Acrolein was reported to stimu-
late ROS production and inflict mitochondrial dysfunction in PC- 12 
cells. but cell dea th occurred by necrosis [56]. ln addition. acrolein 
increased levelsofROS production and caused DNAdamage(8-oxo-
7,8-dihydro-2'-deoxyguanosine(8-oxodGuo) formation) in HepG2 
cells [57]. lncreased  ROS production cou id arise through acrolein-
induced depletion of the antioxidant glutathione (2]. 
Acrolein caused  hyperpolarisation of the mitochondrial mem-
brane in A549 cells. Apoptosis  has  been associated  traditionally 
with loss  of mitochondrial  membrane potential.  However.  more 
recent  studies  have  reported  a  transient  increase  in  mitochon-
drial  membrane  potential  (hyperpolarisation)  during  induction 
of apoptosis by a variety of stresses  (58]. These  stresses  include 
staurosporine [59], tributyltin [GO]. H202 , cisplatin, camptothecin. 
parathion.  and  )'-irradiation  [58].  ln  vascular  smooth  mus-
cle  cells.  high-glucose- and angiotensin-11-induced  mitochondrial 
membrane hyperpolarisation, which reflects impairment of mito-
chondrial electron  transfer  and  respiration,  enhanced  NAD(P)H 
oxidase acrivity (a major source  of  ROS generation) by increasing 
the cytosolic NADH: NAD+ ratio, which in tu rn induced upregulation 
of ROS production (48]. 
The mechanisms involved in membrane hyperpolarisation are 
currently unknown. However.  this study establishes for  the first 
ti me  thar acrolein causes  ROS  production, which in tu  rn caused 
mitochondrial  membrane  hyperpolarisation. The  role  of ROS  in 
acrolein-induced membrane hyperpolarisation was confirmed by 
the  inhibitory effects of different antioxidants such as  MnTBAP. 
sodium  pyruvate, catalase  and  PEG-catalase  in A549  cells.  Sur-
prisingly,  PEG  alone  also  inhibited  acrolein-induced  membrane 
hyperpolarisation.  However.  PEG  is a  known  membrane  repair 
agent. lt was reported thar PEG  does  not act as  a ROS  scavenger. 
but  instead.  it can  prevent ROS damage  by  repairing  disrupted 
plasma  membranes  and  protecting mirochondria through direct 
interaction (61,62]. PEG treatmenr suppressed  ROS elevation and 
lipid peroxidation  J evels in an  in virro  spinal cord injury model. 
The  inhibition of ROS  and  lipid peroxidation  was  attributed  to 
PEG-mediated membrane repair.lndeed, membrane repairby com-
pounds  such  as  PEG  could  be an  effective  means  for reducing 
ROS genesis  [61].  So  ir  would  appear  thar  PEG-catalase  could 
be  protective against  acrolein-induced  mitochondrial membrane 
hyperpolarisation. acting both as an antioxidant (catalase) and as a 
membrane prote ct  ive agent ( PEG). 
Severa! studies have reported thar acrolein induced mitochon-
drial dysfunction [ 56,63,64]. Acrolein (10- 1000 J.lM. 60 min) caused 
inhibition of NADH- and  succinate-linked mitochondrial  respira-
tion, change ofmitochondrial permeability transition, and enzyme 210 
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Fig.  8. Acrolcin  induccs  cxrcrnalization of  phosphatidylscrinc (PS).  A549 cells 
( J06fml) were  prctre.:~ tC'd with or wirhout PEG-l"atalase (300 U/ml) or PEG (2.4 mM) 
for 3 h. or Z-VAD (J O  JJ.M) for 1 h. and rhcn exposcd to acrolcin (0-1 4 JJ.M) for 2 h ar 
37°(  in a-MEM conraining 1 0%  FBS. (clis wcrc staincd for apoptosis wirh Anncxin 
V-FITC and  for nocrosis with Pl  (dar  a not shown). Colis ( 10000) wc  re analyscd by 
now cytomerry wderermine the percentagcs of Ann"xin V-positive and Pl-positivc 
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perccntages arc relative ro the unrrearcd  control. P<O.OOI r··) indic.ltcs ,, sr.uis-
tic.l lly signific.1nr  difference bcrween trearmcm with  acrolein  .md  rhe umre ~1 ted 
concrol.  P< 0.01 (09). P<  0.001 (9ê9) indicates a staristic.:tlly significa nt difference 
bcrwecn cclls exposed ro acrolcin. with or wirhout PEG-catal.lS C. or PEG  .•  n the s.1me 
conccrHration of acrolein. 
inhibition of mitochondrial complex 1 , Il, pyruvate dehydrogenase, 
and alpha-ketoglutarate dehydrogenase,  in isolated  mitochondria 
[64). Acrolein (75 J.lM, 24 h) caused a decrease in membrane poten-
tial, and  decreased activities of mitochond1ial complexes 1 . Il. and 
V and dehydrogenases, in a hu man retinal pigment epithelial (RPE) 
cellline [63 ]. 
1000 ~-------------------------------. 
200  400  600  800  1000 
Acroleln (I'M) 
Fig. 9.  Induction of cytotoxicicy  by acrolein. Cytotoxicity was assessed by a cio no-
genie  ce  li  survival  assay. A549  ce lis (lOs/ml) wc re  pretreared  wirh  or  1 Nithout 
PEG-catalasc (300Ufml) or PEG  (2.4 mM)  for 3 h, or DMSO  or Z-VAD ( 10 J.lM) for 
1 h, and  then exposed to acrolein for  1  hat 37 °(  in  1  ml of a-MEM containing 10% 
FBS. Acrolcin was thcn  rcmove<t.  and  cells were dilured and  incubatcd in culture 
dishes for 10 days to allow the  formation of macroscopic  colonies (sec  Section  2). 
The control value represcnts tOS cc  lis  and was  normalizcd to rcprescnt IOO!tccll sur-
vival. P<  0.001 ("' ..  ) indic~ues a starisrically significantdiffcrencc betwecn rrcatment 
with acrolcin and the untrc.Jtcd conrrol. P< 0.01 (98). P< 0.001 (996) indicares a sta-
ri stically sign ificant difference bcrwecn cells exposed ro acrolcin, with  or wirhout 
PEG-catalase. at the sa rnc conC<'ntration of acrolein 
4.2.2.  Acrolein aCJivatecl rl1e milocl10nclrial parliway of apoptosis 
in A549 ce/ls 
The mitochondrial  membrane potential has  been reported  ta 
decrease,  increase  or  not  change.  during  cytocl1rome  c  release 
[65). Some authors demonstrated  thar cytochrome  r release  was 
upstream ofcaspaseactivation and that lossofmitochondrial mem-
brane potential was not  required  for its release.  suggesting that 
depolarisation was a consequence of  caspase activotion .111d not the 
cause of it ]49,66]. Cytochrome c release can also  be explained by 
formation of a pore in the outer mitochondrial membrane,  com-
posed of tBid/Bax ] 1 6]. which would not  involve  opening of the 
mitochondrial permeability transition pore or loss ofmitochondrial 
membrane  potential.  Consequently,  acrolein-induced  activation 
of the mitochondrial pathway  of apoptosis  does  not necessarily 
depend  on opening of the  mitochondrial  permeability transition 
pore. 
ln most ln vitro studies, proapoptosis prote  in Bax shows a differ-
ent intracellulardistribution beforeand after  apoptotic stimuli ]16]. 
BH3-only  proteins such as Bid  (full length and protease-cleaved, 
tBid. for  ms) havebeen shown to provoke conformational changes in 
Bax, and insertion of Bax into the outer mitochondrial membrane, 
which triggers cytochrome c release  ]67.68]. Acrolein (3-14 JLM) 
stimulated Bax translocation to mitochondria in A549 cells,  with-
out changing the cellular ratio between Bax and Bcl-2 proteins, as 
weil as liberation of cytochrome c into the cytosol.  Our findings 
suggest that acrolein induces cytochrome c release by mechanisms 
which appear to involve  proapoptosis Bcl-2 proteins.  rather than 
loss ofMMP. 
4.2.3.  Acrolein acrivarecl caspases and rlle execution phase  of 
apoprosis 
At  the post-mitochondrial  level,  cytochrome c is  an  essential 
component of the cytosolic apoptosome complex, along with Apaf-
1 and  procaspase-9. which  then  propagate  the caspase  cascade 
[ 16.  1 8]. Our results show that acrolein caused activation of initiator 
caspase-9 and effector caspases-3. -7 and -6. Caspase activation by 
acrolein appears to be cell type dependent. Acrolein also induced 
caspase-9  and  caspase-7  activation  in  CHO  cells  [30).  whereas 
caspase-9 inhibition occurred  in murine FL5.12  proB lymphocytes 
]69]. Acrolein activated  caspase-3  in  A549  cells  and  in rat  hip-
pocampal neurons [70). whereas caspase-3  was  inhibited  in CHO 
ce lis [30). PC- 12 cells [71  ]. lymphocytes ]69). and  neutrophils [72]. 
lt was suggested thar the weak activation of certain caspases  may 
arise from a partial inhibition of the  ir active site cysteine residue 
through direct alkylation by acrolein [69]. lt appears that acrolein 
can  simultaneously activate and  inhibit certain  casp.1ses  and  the 
final  outcome (activation or inhibition) is  the  net  result of these 
two processes [30]. 
Activation of the execution phase  of apoptosis by  acrolein  in 
A549 ce ils was confirmed by PARP cleavage and  externalization of 
PSafter2 h,and DNA fragmentationafter24 h. However, quenching 
of ROS by the antioxidant PEG-catalase inhibited acrolein-induced 
caspase-3 activation, PARP cleavageand PS  externalization. indicat-
ing a role for ROS in these processes. PARP cleavage does not involve 
membrane damage, and accordingly, pretreatment of  ce lis with PEG 
did not inhibit cleavage. However, PEG inhibited PS  externalization, 
and could be acting by preventing or repai1ing plasma  membrane 
damage  [61]. Acrolein (25 J.lM,  24 h) induced  apoptosis in other 
cell types  including hu man alveolar  macrophages  [73 ).  branchial 
epithelial ce ils ]74], and aftershorter times (<50  ~J.,M ,  1-2 h) in CHO 
cells  [30]. Higherdosesofacrolein(>SO J.lM)caused massive disrup-
tionof  cellular  structure and function [2,69). and ce il  dea th occurred 
by necrosis [30,56,71,73.74). 211 
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4.2.4.  Acrolein indu  ceci Alf releasc from mlmchondria and 
rmns/omrion ro rlle nucleus 
AfF normally resides in the mirochond ,;,,1 inrermembrane spa ce 
.and  can  ~ct as  ,~  ROS sc  ..  :tvengt'r, enablîng  cells  to  cop('  more 
effectively  with oxid,ltiw stress.  But once AfF is relc.1sed  during 
apoptosis. it translocates to the nucleus where it in duces cell death 
by  binding DNA. srimulating DNAse activity, niggering chromatin 
condensation and  DNA  fr,lgmentation.  in  a caspase-independenr 
manner [75]. This swdy shows,  for the first time,  thar low doses 
(<  ISJ~M) of ,1crolein induced AfF uanslocation from mitochondria 
w the nucleus in A549 cellsafte.r short exposure times (30-60 min ). 
Thus.  it appe<1rs thot mirochondriol proteins released  by acrolein 
con  uigger .Jpoptosis  by  both  caspase-dependent and  caspase-
independenr mechonisms. 
ln conclusion, the  novel findings show  thM  exposure to low 
doses of ,1CJnlein  (<15J1M) induced a rapid (30 mi n) antiapopro-
sis celluiM stress  response  rhrough  the activation of AKT. whtch 
led to phosphoryl<1tion of B.'d and upregulotion of clAP 1/2, in A549 
hu man lungcells.Acrolein( 10-50 J.lM. 30- GO min)triggererl a rapid 
incrcase in  ROS production  and  mitocltondriol  cl1angcs.  such  os 
membrane hyperpoldl'iSdtion and tl1e  release of cyrochrome c ancl 
AfF.  However. the execution events of ,;poptosis, such <1s activation 
of executorcaspasesond PARPcleavage. occurred a ft er longerexpo-
sure times ( 1-2 h) to higher doses of acrolein ( 10-50  f~M ) .  These 
findings are relevant  ro  the  roxicicy  of ocrolein in  multiple con-
texts,  including the )Jhann.Kological action and/or sîde effects of 
the antiranccr agC'nt cyclophosphamide, which has acrolein as Oll(' 
of irs mer.1bolites. the regulation of cellular proliferation and tu mor 
growth by  poly,;mincs.  Alzheimer's. Jung and  cardiovoscular dis-
e ~l ses. as weil as  the roxicicy of environmentêll  exposur('s  to low 
doses of acrolein. Ncvertheless.  funher swdies arc  neccss,;ry  ro 
incrcasl' our knowlcdge on the taxie mcrhanisms of this oiMhyde. 
which  h<1s important repercussions for hu man health. 
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Acrolein induces apoptosis through the death 
receptor pathway in A549 lung cells: role of p531 
Julie Roy, Pragathi Pallepati, Ahmed Bettaieb, and Diana A. Averiii-Bates 
AbstJ·:.lrt:  Acrokin,  <î  highty  reactive a . ~-u n S-a!luatcd < lldchyde. is an omnipr("liCnt  cnvironmental pollut< mt.  Chronic :md 
iiCute  hu man exposu re~ OCCltr  thro u ~h cxo~enou s and endogenous source:-,.  including food, vapor' of ovct heatcd cooking 
oil.  housc. and forest fires. ciga.rcae  smokt:. and au10mobilc  exh;ntst.  Acrok in  j,  ot  toxic hyproduct of lipid peroxid<:Hion. 
which  h(l :::  becn irnplic:ucd in  pulmonnry,  c<1rdiac.  and  llt~ lll"üdcgc ne mti vc di!->C:t:-c!'!.  This study  ;\hows thnt p53 is an initim-
ing factor in acrolein-induced dea rh rcceptor activation durin!!  npoptosis in A:'49 hu mon  Jun _f!  cel! .;;;.  E xp o!<~urc of cclls  to 
ncrolein W-50 J.nnoUL)  mainly cm1sed apoptosis. which  wns  m~.mifeqed by execution ph:1se  ~vem!'  such a'  conde!ll\ution of 
nuclear chromatin. pho.s:phutldylsclinc cxtcrnalization.  nml  po i~· (A DP-ri lx>sc) polymcr:t'l-C  lPARP) clea\'ag:c. Lcvd s  of nc-
n osis t -5%) wer(: low. Acrolein  t r î gg~rcd the  dc.ath  rcccplor  p<Hhw:ty of <~popwsi ::-. .  cau co:ing dcv:ltion of F~1 :0  ligand  (Fa~ L l 
and  mmslocmion of adaptor protcin  F::ts-:t%oci:ucd dt;ath domain to  the  pl:t o;:m:t  mcmbran<'.  Acrolcin  c:.nbcd nctivmion  of 
c~tspasc-8 .  Ci:IS J.laSe-2. caspasc.-7. :1nd  the cros  ... -talk  pathwHy  mcdi ;;ucd  by  Bid  c lca va~c. A ctiv~t t i o u of p53 < tnd  increa$.:d ex-
pression of p53-upregubtcd  modulator of apoptosis <PUMA) <Knun·d in  re!<>pOlhC 1 0  Hcrok in. FasL  uprcg.ulat ion and cas· 
pa::-e-8 activation  werc dccrcascd by  p53  inhibitor  pifithrin-a  ~m d antioxidant  polycth y k ~ n ~ ~Jy,·o l  cntab.st·.  Thco;;c  finding::. 
incrensc our knowledge about the inducliun of cell  de:.Hh  pat h way~ by acrolein. which  h.as imponanl  implications  fur  hu-
tnan heahh. 
Kev H'orâs:  m::roJcin.  apoprosis. dcath  rcccptor, ca..;pa  .  .,.e.  p53. oxi<.httiv<.·  s tr~ s~  ..  .z\549 ccli. Fas  ligand. 
Rl:..;umt :  L"acroléine. un  nldéhyclc ct.j{-insaturé très réactif. c-a un polluant  omniprésent  dan:::  !"environnement.  Les hu-
mains s'CX);X)SCnl de  flu~ ~on '-'hroniquc el  aiguë.  .î  cet tlgtnl  par de  ...  sources exogc!ncJ'  ct  endogène:-. par c.xcmpk l"alimen-
tation. les vapeur!'! d'huîlù de  <:U Î\1\0 11  ~ u rdm uff(:(",  les  feux de  forêt ct dï1nbitation.  la  t'uméc de  c i ~w rctt c ct  ks gal 
(.!"éclmppcmc.·nt  des automobiles.  L" a~ ro lf inc c.·st un  ~ou :.-prod uit toxique cl (.·  ln  pcroxyckttion de:'  lipides. qui (tété impliquée 
dmu;  diverse~ nwladies pulmon< drc),. cardiaques  ct ncurndêgénérativt:s. La  préscmc étude  nw nH'('  q u t~ ps:; est un  f<.~c t cur dé-
clencheur dans l"aci.ÎV<IIion des réccpl~ lll...,  de  mort  indui!C  par  J" ncroJéint "!  dur.:u\1  J"apoptOSC  chez, les cellules  pu lm o n a ire~ 
humaines AS49.  L'.:xposition  d~o>::-.  cellule..,  ü l""croléinc t0-50  ,umol!L) <1  induit  l"<tpopto..,c  par d~;s phases d"t;xécution 
comme la condcnsai'Îon  de  la chromatine  nucléaire. l' cxtcrnali,";Jlion  de  la  phosphatid.vbérine ct le  cli vag~ de  PARP. Les 
tnux de mort  par nécrose ont  ëté  f;;liblt::-:  ! -5%  }.  L"  :1croléine a  activé la voie  apop to tiqu t~ des  réct:ptcur:-;  de mort. cau.,am 
une augment.'ltion d'expression du  ligand  Fa~ (F.tsL} et ln  translocation, ft la membrane  plasmatique. de  la  protéine udapta-
trîœ <JSsociée au  domaine ùc  mort de Fa:-..  L '~ tcroléinc ~ dc.!clcnché  !"activation de' Cih jX I St~-8 .  -:!ct -7. cl  la voie de di,llo-
guc (cross-ralk) induite  par le  clivage de  1:1  protéine  Bid.  L'acroléine a aussi causé l" acti\'ation de p55 ct  l"augmentarion 
de  !"expression du  gèn<~ PUMA.  L"aup:mellltllion  d "cx prc~sio n de Fas ct  l':lrtiv;Hion de  la  c:-.~pase-8 om été diminuées  p~1r 
l'inhibiteur de  p53. pifithrinc. ct l·antioxydant.  polyéthylënc glycol cat:llasc.  Cc:-.  résultms améliorcm  no..,  conn:tissanccs 
sm  l'inducrion  des  vole:-:  apop10tique:-.  p.:1r  l"<tcroléinc. qui .:1  de' répc rc u s~ ion s importante sur la  "ll111é  humaine. 
Mois-clés : ncroléi_ nc. apoptosc, récepteur de mon. caspasc, p53.  s t rc"~ oxydmif.  cellule A549. ligo: -u1d  F: . ~. 
!.Traduit  par l.a  Rédaction] 
Introduction 
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wide  varicty  <'f  "''ntcxls  IWHO  2(lll2:  USEPA  200.1 ).  lt  îs 
rdl!::bt;d  n ~Hllf :t ll y tfi the  H I OlO 'i p h t· r~ ;1 :-- ~ ~  product of  f~ rmc n­
tation and  ripc nin ~.  Ac rolcin  j;-,  !!t: n cra t ~.: d durin g- forest  <.Hld 
hou ~~ lire:...  A major source of acrolcin  cx p <•~ lll 'è  is.  ~ i ~~m.: .u c 
smokc.  Acrolein  i;  found  in  food  and  drink  (\'/ HU  2002). 
and  in  vapors of ovcrhcatt:d  cooking  oil.  whcn:  lnxir  cxpo-
sure' have OCCliiTt:d  !Beauchamp cl al.  1985l.  ln addition to 
cxogc n ou ~  ~ourccs of cxpt)sun;. ac.rokin is  produccd  in situ 
durine,  th  ...  ~  llOflllai  ÎlltCI'Illcdiarv  catallofism or  v arÎOU ~ aminü 
acicb-•uxl polymninc>  and  alsZ)  when allylic  akolwb or the 
anti-cancc:r  drus,  cydop h o~ phami d c is  m~ t aho li 1.eJ (Slevcn:--
and  fv1nîer  2008t.  Furthcrmorc. ncrolcin  i:-.  both  ::.  byproduct 
and  an  inili:nor  of  lîpid  r(:roxidatinn  1  Kchrcr and  Bi l'>W;.ll 
20(Xl) arising  from oxîcbti vc  stress.  which  ha, hccn  împli-
ca t~d in  pulmonary. cardiac.  and  neut\)dcgL:nerativc  di:-.ea~cs. 
Th~  levcl  of acrnlèin  in  human  serum  i ~  t:stimatcd  to 
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normally rang,, as hi ~ h m; 50 J .HnoVL (S:uoh ct al.  1 \19'1) and  to 
rcach KO pmoi/L  in fluid• lining the rc>piratory  trat'l ur •mok-
crs !Eis.:1 ich et al.  1995).  ln  patients wilh Alzheimer·,. :1t·1 nk in 
lcvcb  1 1.\llgcd  from 50  10  100  pmoi/L  in  some  hruin  regi'"" 
(Lovell  el  al.  ~(Xl i ).  A  bkl(ld  levcl  or  12'J  pme > !  IL  acmkin 
wa  ..  <i  achicv\.!d in a patient  who dicd of acrolcin-indm:cd arull: 
c;m.liotoxicity aflcr oral ingc..\\Lion of lh0 herbicide ally! alcohol 
(Tocnncs cl al.  ~0021. 
Acrolcin is a highly sd cct.ivc  airway loxicanl  tAranyi ct al. 
1  %6) that  can inducc rcspiratory tract lesion> !13cauchamp cl 
al.  1  9X 5J. Th,·rcforc.  aero kin CX fXlSUI'<'  '""  hccn as-;oci:ucd 
with  lung dis,::tScs such as asthma (Samct and  C h e n~ 1  9'14 l. 
d11\ mic ('hstnld Îvc  pulmonary  d i~~ t t....;e  (Hogg 200 1  ).  L" hro n i ~_· 
hronchitis. cmphyscma (Saclla  1 9'JLJ). cystic lïhn> ' i'  (\Vit>chi 
ct al.  199ï). and  lung carcinogenesis (Fcng ct al.  2(XJ 6). 
The  mode of ccli  dea1h inducecl  by  acrokin  i,  d;> sc- and 
ed f  lypc-tkpcmlcnl.  Acrokin  concentrations  c x cccdi n ~ 
50  ~t m o l /L t'ausc  massive  disruption  tll  lhc  ~ tru c lllrr  :.md 
hll>ction of cclls  t Kchrcr  and  Biswal 20Uil).  which  di<'  '" 
nccrosi,  (l i cl al.  I<J97; Tancl  and  Avcriii-Batc' 20051.  Nc-
crosis  is.  characterizcd  hy  irreversible  pla ...,ma  m~m h ra n r 
damag:.l.:. which lcad.;;  lll  lcakagc of cdlular Ctlllll' lll ..;  into  t h ~ 
cxtraccllubr  cnvironmcnt.  oftcn  rcsuhing  in  inllamm:llory 
reac Li o n ~ .  Howcvër.  at  d os~ s  l es~ than 50  umul/l. :I L"I'Okin 
d~ L :reas._:d  r:wo li f~ rat . ion of  human  Jung  c ~ tr~ i n om a cd!  l i n ~ -., 
(RuJra  and  Krokan  19Y 9J and  induccd  apoptosi;.  in  "·veral 
('d f  types.  stKh  as  alvcolar  macrophage> (li ct  al.  1  '197 1 . 
bronchial  epithel ial cclb  fNardini  ~~  al.  ~ ! X l2 J.  allll  Chines.: 
h:un'icr  <>Val)'  (CHOI  ccli'  <Tancl and Avcriii-B:uc' :'0051. 
Acrolcin  inhihitecl  llJX> ptosis  in  nculrnphif,  c FinkclSIL 'in  cl 
al.  20011  ;md incluccd oncnsis :tllll (or) ncc rcosis iu  pr<>B lvm-
phocytcs  1  Kcrn  '"'" Kehrcr "002). 
A  majnr  fOlllt.:  or  human  cxpoSUI\'  IO  .acrolcin  j,  th rou,gh 
lnng  inhalation.  Th~ rc fon. :: .  the  A54~ cdl  linc  \\ a~  c: ho~c n 
for  thi ~  stu <.ly  ht;c:wsc  of  its  human  puhnou ar~  o n ~ · i 11 .  Thi :-. 
Stlld)  invc.  t i g ~l tcs  potcntial  initiating:  factor!-..  SlH..'h  a  ...  p:S~ 
and rem:1 ive  oxygcn ;;pecics  (ROS\.  in  the activ:uinn ,,r  the 
ckath  r-ec~pt o r  pathway  of  apoptosi -.  hy  ac.:rolcin.  Givcn  rlll· 
w id l: s pr~ ad  CX f :X>SUrC ol'  hUill i..t ll ~  1 0  hn\· do:-,l;;-.  t) ('  acrok in. 
this  rcscarch  is  i mponant  for  i mprov ing  our  k nowkd~ c 
ahout thé acli v:ninn or ccli  dcath pathway;;  h)  an nlcin. 
Materials and  methods 
Ccli  t·ulturc 
A5-l9 hu man lung ccl  b (A TCC No. CCL-1851 "cl\' )! l'<>wn 
in a mf•nolaycr in  Dulhccco-s modiliccl  Eagfc·, medium (ln-
vltrog:en.  Rurlington. Canada).  <..:Ontaini ng  1  oc-<  f'ctal  hovinl! 
:-.crum  tFBSJ  (lnvili\H!Cil  CanaJa),  ~  mm• JI!L  L-tdutaminc. 
3.7  g/L sodium  hicarhonatc.  1.0  mmoi/L  sodium' pyruvatc. 
and  1  ',1  pen  ici  fl in  (50  U/ml)  - Si rcptomycin  (50  ~l,: iml) 
(Flow  Laborat  rie·.  Mississauga. Canada).  in  tissu  culi n  l '<' 
flasks  (Sarstcdl.  Saint-burent.  Canada ).  The  ccli'  "Cil ' 
g.rnwn  t(• n..::ar  conflucm .:c.  and  th~ 11  h a rvc~a ed using 0.25t;; 
lw/1·1 lrypsin- 0.020i  (w/P) EDTA 'olution. washcd hy  c~ n ­
lrifugalinn (JOOOg. 3  min). and rcsuspcmkd  in minimal  c'-
scnt ial medium  a  laMEM 1 ph"  100i  FBS  for experimental 
sludics IHorton cl al.  1  9\JYI. 
T rc:atmcnt with anolcin 
A54'1  ~clb ( f(J6iml) wcrc exposcd ln acmkin !Sigma-Aldrich. 
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o,,k,·iflc.  Canada) concclllrali<lll'  'a ry in~  fi·nm  1 Ill 50 > llllc )I/L 
( r..:prt~sc nt in!!  in  ' ' ÎV(~  va lu ~.: !-.)  for timc  ...  rangmp  frum  :;o min  t\l 
4 h. at  :iï ~c. \\'here  ind it.:~l l t.:LI.  cdl ~  w~n~  pr ..: t rc~ l cd for  3  h 
wilh  10 > 1moi/L pilithrin-a. a  p5~ inhihitor (Calhinchcm.  La 
Joli'!.  USA 1 or 300 UimL polvcthyknc gly.:ol .:alala'" (PEG 
rllal'"c).  an  anl in, idanl  (SI_;!ma-Aidrirh).  Ccli'  wcrc 
wa~ h cd by lTillrifugation ( HXX>g  . .  l  min ) Ill rcm<wc  acrnlein. 
:md 1  hL·n  j_ n a l y~c J for apoptntic  , j ~ n a lin l! . 
Preparation  of whniL•-t:l'll  l~ ·~att- ~ 
Aflcr lrcatmclll  with  acrokin. cd ls  wcrc  w ~ s h ,, cl  hy  ('Cil-
lri J'c, ~ a li n n ( J(J\l(k ~ min) in  buffcr A  ( 100 mme >  I ll  sucro,c, 
1 mmoi/L  EGTA,  20  cnmoi!L  ~ - (N-m nrph n lin o ) pro pa nc su l ­
l,liHC acid  (MOI'S),  pH  7.-l) tSamali  cl al.  19Y'I I.  The supcr-
n ~H a nt  wa, -,  discardcd.  ;mJ pclktcd  ~c l b  w...:r...:  rcsuspcnJ..:d  in 
lysi;.  huiT.:r  B  rhull.:r A  plus  5'1(  Pcrcoll. 0.0 1  'li  digitonin. 
and  a  ~oc k l a il  of  prokns..:  Îllhihitor'\:  10  pmoi/L  aprutinin. 
lU pmoi/L pcp,t:ltiu A.  10 >unoi/L lcupcptin.  25  pmoi/L cal-
pain  inhihitnr  1.  and  1 mmni/L  phcnylmcthylsull'nnvl  rtuo-
ride  (PMSF)J  und  incuhalcù  0 11  iœ  for  1 h. Thcn.  after  a 
f(J  min c.:ntrifugalion  stcr  al  ~.5 ! X lg lll  rcmow  nud ci  and 
unbrokcn  c~ ll ~.  the  protcin :-.  or whnk-çd l  Jy, a t ~'i  wcrc  iso-
b t~d  in  the  supcrnalanl  for  the  immunodc!C('tion  of  p53. 
p5.'  Scr1 5P.  p5~ - uprc g u btcd  mcK iul :~ to r  of  a po pt ~) li Ï :-. 
fi'UMAI.  Fa,  rcccplor  (FasR).  and  pt>ly(ADf'-libo>c 1 pol  y-
mc rase (PARPJ. 
Pn·para1ictn  of S1Jhl'l·llular fral·ticm s 
Subt:cllu b.r  fra ~: t ium .  wen.·  prt.!f XHcd  a:-.  prev i o u s l ~  dc-
scrihcd iSamali  cl al.  19<J':I:  G tnne t . -A n ~t · l 3! s '""' Cidlnwski 
~()(J f ).  A  fier  t r~: ll mc ul  with  atTnlt:in. ce lis  \\Wt'  \\'a,hed  in 
huiler  A  and  thcn  lv,uspcndcd  in  hulïi:r  B  cont ;~ in ing 
O. 1 nunni/L  d ithi c>thr~it n l  !DlT 1.  Ahcr a  ~ ()  min  iucubatinn 
on  ire..:.  l y~~H t,;~  w TC  homogcnit.cd  ll " i ll~  a  ha nd  pol! cr 
1  Konks  1'"'"·  Du:dl  22:  Fi,hcr.  Montreal.  Canada 1.  :md 
tilcn  cc nt ri fu ~e d al 25!Xlg  for  10  mm. The SUJ Xrnatant  wns 
ce nt r i fu g ~ ( l  agai 11  al  1:1 (XXl..t;  rl) l'  30 min. TIH .:  pc lk~ t  <.'l)lltain-
ing  th ~.:  mit c..K hondrial  fractitm  "'~" then  re~u s rx: nd c d in  l y :-, i ~ 
hufli.:r  B  for  till'  detection of truncakd  Bd-2  h< > mvlogy  :> 
!BH ' ) - int c rac t in ~ domain dcmh  a~o ni s 1  ltBid /.  The supcrna-
tant  was  ccntrif'ugcd  al  J(XJOOOg  fur  1  h.  The  rc,uliing 
:-.UfX:Illatant  w :1 ~  d l.! :-. i g n ~ttl:d  a  ...  the cyt•Jsolic  fraction.  which 
\\'HS  used  lor  (.lctc..:ctiou  or  F i.t:"\-a:-.:-.o L: ia t ~d  dc..:ath  lh.llllaÎil 
1  FADDJ.  Bid. 11nd  rcccplor-inlcmcli ng prow in  !RlP)  ki na;;ç, 
Th ~,;  pdk:l  \\ ~~ n.:.su  ... pl.!ndt·d  in  ly"t :-.  h u lï~ r Band  (.h:. ... igrwtçd 
~p;,  t.hc  mi t: ro~om al  rra~ t ion.  \\ hi  rh  \\' ~ !\  u ~cd  l\1  ch.:tcct  th e..: 
lr:u" loc:ll i<>ll  or  FADD  and  RI  l' IO the  "'"""" membrane. 
Purit;  of  ('~l oso li c .  mitochondri:d.  and  micr<lsornal fr.:K tÎOil' 
W:.l:-.  dctcrmincd  hy  \Vc:-.tcrn  hloHing.  u-.ing  glutaL hionc 
S- t ran ~ ft.! r~ 1 sc fGST--:t  1 ).  rytPchrom(:  oxid:J:-.c.  ~1 nd cai1H.::xin. 
rcsr>cctivdy  lJaîa nol  ~how n ). The micro:-.nmal  t..::xiract:-;.  con-
tainrd  pin m;t  membranes  (G.Jmçz-Angclats  and  Cidlowski 
2tXI Jl. 
lmrnunndctl-di4m 
SDS- PAGE  (I!V·i  for  RIP.  p5~. p5:l  Scri 5P.  and  PARP: 
15'K  for  PUM A_  FasR. FADD.  Bid.  and  1BidJ of  cc.:llular 
proteins  w a ~  \.·arricù  nul  accnrd îng  to  Lhc  mcthods  or 
Lacmmli  ( 1970).  Prolein> 140 pg·J wcrç quantificd according 
ln  Br.1drord  t l9ï6i and lhçn "'luhiliœd  in  L H.:mmli ' ""'Pk 
buller.  Ek c llu p h o rc~ i !-.  wa ~ t'(lrric<.l  out.  at  a conslanl  voilage. 
Public:hed  b}'  NRC  Rescarch  Pn:"' Roy et al. 
of 125  V.  Cellular prot,.:ins wcrc transfcrred  1 r1  a polyvinyli-
dene  clilluoride  (PVDFJ  membrane  by  using  a  Mi lliBiot 
graphite  electrohloucr  1  apparatu>  (Millipo.orc.  Bedrord. 
USA) (Tancl and Avcriii-Bates 2005\. The hlots w~rc  proh ~d 
wi th  the primary  antibudies  anli-p53. ami-PUMA. ami-FasR. 
anti-FADD.  anti-RIP.  anti-B icl.  anti-GAPDH  (Sam:•  C111z 
Binlcchnology.  Sama  Crut..  USA ).  anli-tBid.  and  llllti-pS ~ 
Scri 5P tStrcssg"n.  San  Diego,  USA)  in Tri,-bulkred "'li  ne 
(50 mmoi/L  T~ is b:1sc.  !50 -mmolll NaCI,  and  O.I S1  Tw~cn 
20) (TBS-T) eontaining 1  'A · hcwinc serum albumin lBS  A) l'<>r 
1 h ::u  n.lom  h .:mpcraturc. ~1 t.!mbranes wen::  \vashcd and  in ~.: u­
bat<xl  for  1 h  at  room  temperat ure  with  h l) r st: r~\d i s h  p~! rox i ­
das<.:  (HR P)-c.:onjugalcd  :11ltÎ-m(lliSC.  ~mti-r.:i hhit .  or  ~n t i-gnat 
]gG  Œiosourcc.  C nnarillo.  LISA)  di iULcd  in  TBS-T cnnlain-
ing 59é milk  po\vder.  Pro l.I.::În~  \Vere  dctectcd  u s in~ th <.:  ECL 
Plus  chemilumincsccnœ  kit  (PcrkinEimcr,  Boslon.  LISA ). 
Pmwin  expression was  analyst.::d  with a scmmi ng  b ~c r <.h:n :-,i-
lomclcr  and  cxprcsscd  rclaiiVc'  ln  GAPDH  (Molcndar 
Dynamics. Sunnyvalc.  USAl. 
Flow cyt.omet.ric analysis nf FasR and FasL  <'Xprcssion 
Al'ter  lrcaimcnt  wilh  acrolcin.  1 x  1()6  cclb  wcrc  incu-
bated  wilh  c ith ~ r  20  flgimL  lluorcsct:in  isolhiocyanal.o 
(FITC)-Iahcllcd  an1i-FasR  (Cil'c>nc el  al.  199.:1)  or 20  f!;!lml 
phycocrylhrin  IPEl-labclled ami-F:tsL (Kayaimki cL  al.  1 1195) 
(CallaQ  L tboraiOrie>.  Burlin ~a mc. LISA) for 30  min  al  room 
L cmpc;·arurc in  ille dark and lhcn wnshcd (Filic>n cl al. 2004). 
Cclb  (10000)  wcrc  analys..:ll  by  llow  cy t\ llll<~ U)  usint'  li 
FACScan  tAvc•iii-Batcs cl al.  2005) cquippcd with  an  argon 
laser  (-18~  tlln)  and  analyscd  wi th  Cc:il()ucst  so.Jftwarc 
(Bcclon  Dickinson.  Oxford.  UKL  Th <.>  cxlracd lubr expres-
sion of Fa,R ancl  F:t, L was w mparo.!d with  thal  or untrcatcd 
ccli >.  To  conlrol  for  nonspccific  hinding.  A5.:1'.J  œ lls  w..:r,· 
lahdlcd wi1h  appn.>priatc·  isolypc con!I\Jis  for FITC :tnd  PE. 
No signifïcanl  dillcrcm;cs  wcrc  round  cnmparcd  wi1h  unla-
hdlccl  cel ls !data  nol  shown). 
For 1 01al  FasL  cx p r~ss i o n.  ccJis  wc r~  prclrcatcd  wilh  or 
wilhmu  :100  U/mL  PEG  c:ualasc  or  10  pmoi/L  pilïthriu-a 
fo.Jr 3 h and  lhcn  ~xposed lo acro.llein.  C:<è.lls  w~ re ihen  iïxcd 
wilh  l'k  1 \mnaldehyde  for  20  miu  ~t nd  permcahili z<.>d  wilh 
,aponin  buller  (20  mmoi/L  H ep'~'- IJX  mmoi/L  KCI. 
..!  mmol/ L  l 'vlgC1 2.  0.2  mg/ mL saponin.  1  lf?  ho  vi ne  ~cnun al-
bum  in. 1 mmolll A  TP. and  :<  mmoi/L phalloidin) for 1 min. 
Ccl ls  wcre  washc:ù  in  sapunin-frce  buller nnd  labcllcd  lùr 
1 h  at  4  ''C  with  20  u ~/mL PE-Iabcllcd  ami-FasL  !Ca h ~t~ 
Laboratorics).  Total  c~p-rcss io n of Fr.sL in  101100 œ lls  wa~ 
analyscd by FACScan  (Vitriol  ct al.  2(Xl7J. 
Uctcnninatiun of caspasc  Hct ivit~  by tluor·es(·cnn· 
spcctrns<·<  'l'Y 
Caspasc  ac t.ivîty  wa.."  mcasured  a~  tle~cri hcd  d SI.!\\·hen.:· 
(Hamplon and  On·cnius  1997).  wilh minor modificatimb. Aftcr 
Ln:almenl  with  acrolcin. cclls  wcre  washcd.  rcsuspcndcd.  and 
lysed al --SO o c ror  ~0 min  ITanel  and  AY.,IÎ II-B:"cs 2005). The 
kinclic rcaclion  wa'  l(lllowcd  for  3{1  min.  aftcr addition of 1hc 
appropriatc  caspase  substmtcs al  17  C.  usin);  a  S1X!.::lra  Max 
Gcmini  SIX:clronuorimctcr  tMolo.:cubr  Deviees.  Sunnyvalc. 
USA). Caspasc-2 aclivity w~s  m~asu rc xl  by ckavagc of 111~ nun-
rogcnic  pt:pticlc  substrate  Z-Vai-Asp-Vai-Aia-Asp-AFC.  For 
caspase-8.  th~ substrat(• was  Z-1 1\>-Giu-Thr-Asr-AFC:  lùr ca>-
pasc- 10.  it  was  Ala-Giu-Vai-Asp-A FC:  and  f i1r  caspa'<l·-7.  it 
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"'"' MCA-Vai-Asp-Gin-Vai-GI)-Trp-Lys-i DNP)-NH1  ICalbio-
c·hcml. 
Flow  c~ · tumdry n11alysis of miioduJIIdrialmcmbrant• 
poicnlial 
A54'1  ..:cils  ( 1  1  06)  \VO.:I ·  cxposc:d  to  ac roh.: in  or  10 
:i  ~um , lfL p-lrilluot "o.lm..:llh'XYPhcnylhydrai.Clnc  (FCCP:  po>i-
tivc  m nll\>11 in  a  fi na l volume  of  l.lJ  mL al  ~7  C.  Then. 
2 umoi/L rhod:Hnine  12'\  !Rhcl l23)  "''" adckd for  ~Il  min  at 
.;7  ''C  in  ilw  clark.  C ltc•n ~..:'  in  llu o.>rcsccncc  (mitodK'ndrial 
membrane  pmcnti:dJ on  the  FL-1  clctc·ctor  (~ rcc n  rluore'-
..:cn..:cJ  in  10000  œ il'  wcrc  mc•hurcd  by  flo"  ..:y10mctry 
and  an:dy,cd  '"in;;  Ly' i'  Il  softwar..:  (Tand  and  A vcrill-
Bato.:<.  2(X)5t. 
Ddcnnluntiou of phosph a tid ylst~ r-itH ~  4:~ tt>rnali zaf iou by 
annl·xin V - FITC staining 
Aftcr  trcalmcnt  with  acrolcin.  cclls  (1 Y  10"/mL)  wcrc 
wa&hcd  with  PBS and  re,uspcnckd in  1 mL of binding huiler 
(10  mmolll Hcp ·,_N:tUH (pH 7.5).  140 mmolll NaCI. and 
2.5  mmolll CaCI11.  A volume of )(Xl fiL  of cdl suspension 
was incubai cd wilh 5 pl  (Ir :mncxin V- FITC ŒD Bioscicn-
cc·s.  1vli" i,sauga.  C:mada)  and  10  pL or pt-,•pidium  iodidc 
tPIJ for  10  min  al  rc,om lcmpcraturL '  in  the:  clark 1  van  En ge-
land cl al.  IIJIJXJ.  Ccl ls 110000) wcrc ihcn a n al)' ~cd hy flow 
..:ylnmctry (AI'criii-Jh L cs cl cd. ~005) .  Aun..:xin V- FITC llu-
nt\:SCCtll'c  wa~ dc:tc:ctcd ou FL-1. and Pl fluorescence \lll FL-) 
lrcd  lluorcsccncL'  dctccl\1 1'1.  F(> Ur  populaLiOih  or cclb  wcrc 
ana l v~L.:d :  li ve  conlrnl  ccli <\  (anncxin V-/ PI-J.  <;arlv-sta !!C 
apol;lntic·  ccli,  1:111ncx in V+  i Pl-).  lak-sla!'c  a po pto ti~ œ Ïis 
(anncxin V+ / PI+J. and  nccrotic  cc lis  launcxin V-/ Pl+).  The 
rcsuli s  arc  rcp<>r!cd '" ille  rracli,,n  or ltllal  apopl<lli c  cclb 
1  t:;)rly- and  l ::tt~ .:: -·;;t~l g L'  ~l['Xlpl o, i s  ). 
i'vlorphological  aœ1lysis of apnptnsis 
Cclls trcatcd  with  acrolci n wcrc wa,hcd.  and thcn Hocchst 
~:; 25~ (60  ~tg/mL J "''" acldcd  r,,. 15  min!(>  stain  apopwtic 
..:clis.  Pl  (50  pg/mL) "''"  :tddcd  ln  slain  l'or  nc..:rolic  cclls. 
Im ag e~  i'lbl< lin c..:d  hy  fluon:s<.:~ n c~  tnÎl'rosrop;  <Carl  Z..: i s~ . 
Montreal.  C:an:tdai  \\ cre  analy"·d by Nonhcrn  Eclipse  >ofl-
w~ r..:.  and  picwrcs wcrc  takcn  with  ::i digital camcrn  (cament 
3CCD.  Sony  DXC-IJSO P:  Empix lmag ing.  l'vli ss i s,a u ~a .  C~tn­
adu)  (/\vcriii-Bmc,  cl  :tL  2005).  Cc li> wcrc  d ~«.>ilîed  ac-
cording  "'  ihc  l'ollnwing  cri1cria:  live  cclls  !pale:  hluc 
c hrom ~u in  with  organized  ..  stnlcturcJ.  apoptotir  cclls  fbriglll 
blue·  nmdcn>o.·d ''" fra!! mcntc:d chrommi n). anJ  nccroli c·  cd ls 
1  red  l'lllorcsccncc).  Tl1 c  frac  li nn ~  of  apOJ 1lntic  ~1 nd  ll(!C t'OIÎ <.: 
ccli  ....  v  .  .:t.:rc  dctL.:.rmincd  rclativ'-·  lO  lotal  ccli"  toh1aincd  u s in ~ 
hriuhL-IÏcld  illumitt<ttion).  A  minimum  or  200  œ lis  w;" 
cm;ntcd  iT and  anJ J\\'criii-Ratc>  2005 ). 
ROS generation 
The  ~cncration or pro-oxicl:ulls was  IHC:ISUrcd a'  ckscribcd 
cl scwh c r~  r Dc n n in~ Cl al.  200~ ) .  wilh  modification:,, Cc lls 
wcrc  cxposcd  10  a~ro l c in. and  thcn  10 pmolll 2'7'-clihydro-
dichlorolluorcsec:in  dia..:ctaie  fH,DCFDA)  (Molcc ular 
Probô .  Eugcnc.  USA!  was  added.  H2DCFDA  produces  a 
green  fluorescence  whcn  it  hccnmcs  oxiclizcd  in  Lhc  prc>-
cnœ  of hydrO;!Cil  pcrnxidc. LcYel'  or hydrogcn  pcmxic l<.!  in 
10000 c;dls  wcr,·  o.kl<:rmincd  hy  llo\\  cylom,,try  us in ~  the: 
FL-1 dct.:ctor. 
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Fig. 1. Acrolein  induces activation of p53 { Uld increases PUJviA  cxpre:;;sion. A549 ceiJ .;:  (106/mL) '""·cre  prctrci.ltcd  with or witholll  10  ~mol!L 
piiitluî.n-a  for 3 h nnd  thcn inn1bmed for 30 min or 1 h al Jï "C with acrolcin  ((}-50  ~un oi/L )  in  c dv1Etvl  containing  1  O t;~ ;  FBS.  Immunodc-
tcction of p53. p53  Sct'l5P.  nnd  PUMA in whole-cc ll  lysa tc' wn ~ c::trricd out  u-,ing GAPDH  (37  k.Da) :tf'  lomling comrol.  Dc n ~ it om c lri c 
mw  lyses of  IIH~ expression of (A) p53 and p53 Ser15P and (CJ PUMA ar('  rdativc to  untrc<lh ::d controh  ( 1.01.  Representative  bJor, from 
3 indepcndent  expt..'Timcnts arc shown ior the expression of (C) p53 and p5.."  Scr15P tJO  min) und  for the  cx p rc~s ion of cDJ PUr..1A il lu. 
*. Sig-nitknnt  m p < 0.05. **. p < (LOI. and *::::!:. p < 0.()()1  v ~.  untrc< ncd control:  t . p < 0.05  nnd tt . p < (1.01  v ~. çorrcsponding  t. ~e ll :-;  withom 
pifithrin-u. PUMA. p53-upreguhued  modulator of ~tpop to s i s :  a MEM. minimal  Ci>!<>Cntinl mGdium a: FBS.  ù~ t al  bo , · in <.~  -.crum. 
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Stntistks 
Daia  rc pn .: ~ l! nl  m ~a n :-.  ±  SE  frurn  at  lc:1st  ~  i  nd c pe nd~.:nt 
,,xpcrimcnts  pcrfonncd  in duplicale. Whcn nol  shown.  crr\!r 
hnrs  lie  within  symhols.  Comp ari son ~  ~un nn g  multiple 
group ">  wcre  m ad~  by  OJH:-way  ANOVA.  which  lll (!a ~ un.;~ 
the  linc:~r contrast  of means.  The  Bonfcrroni-Holme, adju,t-
mcnt  w:t ~  u~~d to control for the Family-wisc c n \l l'  rat ~ at a 
clcsircd  levet  ill =  5C,t 1.  Soft wal\·  us..:d  wa; JMP  Stati,tical 
Discovcry 4.0 (SAS  lnstitutc.  Cary. USA). 
Results 
At:rolcin indnœd at·tivation nf p5:l:ond incrcas< ·d  PUiVL'\ 
cxpn·ssinn in  A549 cclls 
p53  i ~ a trans\.·ription factor  ~1 s weil  as  a tumor supprcssor 
and  is  an  imponam  r~gu l n t o r  or :tp<>plosi,.  Onœ  activatcd 
throuf!h  phosphoryl:ilîon  or  acctylalion.  p5~ nm  tra n ~a<: ti ­
valc  gene;;  involvcd  in  apoptosis.  such  a> Bid.  Bax.  Bcl-7.. 
FasL.  and  PUMA  {Mcndozn-R<xlrigucz  and  C:crbôu  2001: 
S:tx eL  al.  2002).  ln  addition, p5:1  cnn inducc  apoptosi;,  m~di­
atçd  hy aclivation of casrase-2 lf'vlai uri  cl  al.  20071.  To  de-
termine  \- vhether acrnkin can  activa1c  p53.  A54Y  cells  wcn: 
cxposcd  L t.'  low  cnncentnllio n ~  llf  :.tcn.)k in  (3-ï J  .. unoi!LJ  for 
c 
•  1 h D 1 h + Pifithrin 
2.0 
<  ::;:  **  ::J  T 
~ 1.5 
1i  . 
T 
::  t  t  <ii  1.0  c 
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0.0 
0  10  25  50 
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JO min. Acrokin  (7  ~unoi/U  imlucd a  s i~n ifï canL incrcasc 
t- 22'# 1 in  total  cellular cxprc"ion  of p53  and  p53  Scr15P 
!Fig,.  1  A.  lB). Suhscqucnll). the  ahi lit'  of "erok:in  hl  in-
duct.:  th ~  t::xprcs:-.inn  of  thr  p5 ~  l::trg..:!t  .PUIVIA  wa ~  invcsti-
gatcd.  lndc:cd.  a~ rok: i n  (10-:iO  J .unoi/Ll  signilïcantly 
incrcased  the  total  œ llubr  cx prc"ion  nf  PUMA  hy  up  to 
59'11  (Figs.  IC:.  ID1.  Prct n::almcnl  of cclb with  pilïLhrin-11.  a 
rçvcrsihlc  inhibitor or p5.1. ' i.'!nilicanll)  hlockcd  the  induc-
tion of PU IVIA expression. Sulhv:qucnl l). tlw 1 u k  or p5~ as 
an  iuitiatîng  fach)l'  in  the  activation  of  the  dcath  r~cepttll' 
pathway of  apoptn~ î s hy acrolein  was evaluatcd. 
Rolt· of p53 in adivation  nf tht· d<·ath  rt·ccptnr pathway 
by tu.:rolein in A5.J.9  t :cll~ 
Activation of the  dcath  receptor  Fas during apnplosis can 
he initiatcd  hy th-.:  Cllt!:.tgcmcnt  or its  ligand  (FasLJ to ih c:x-
t ra~ c llular domain. which triggcrs  the juxtaposition  of  Îh  in-
tracdluhu  domains (G uicciardi and Gore, 2003:  Malhi  cL  al. 
2006).  Tn  determine  thv·  pntt·mial  for  toxicit)  of acrokin 
lhrcmgh  th ·  Fas dealh  rcccptor  palhway  in  A549  œ lb.  the 
exprc"inn of FasR and  Fasl  w'" c\·aluated  hy llow c-vtom-
cLry  (Figs.  2A-2Cl.  C:omparcd  vvith  the  untrcalcd  control. 
thcrc  wa~ a signifi..:ant 90{-220(  incrcase  in  Fm;L cxprt!ss i()fl 
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Fig. 2.  Acroldn increases  expression of FasL:  inhibitiOJl  hy pi!ithrin-a. A5..J.9  ceHs (l{)Ô/mL)  werc  irwub~ ted for  1 hat 37  C  with acrole.in 
(()-27  ~tmoi/L )  in  a:MEM  containing  IO(:i  FBS. (A) C\!ll c;  were nnalyscd  by  flcw; cytomctry  for  thcir  cxtcrnal  expression of FasR nnd  Fl,C)L. 
Dat.:1  arc mcnns ±SE from 3 indepcndt:nt cxperimenb  nnd  arc relative 1 0  lhc umremcd conU'OI ( 1.0).  The  hi '\togram plot' arc  rcprc o;;cmmivc 
results of  ~:<.press i on of FasR  ffi) or FasL 1C) in  control c<>IL "'  10  ~unoVL ac:wlcinJ  with  or  without  < 1ntibody or  ccJJ" tre:Hed  with  14  ~n1o liL 
acrolein. (0 ) lmmunodetecrion of FasR (48 kDa)  in  wholc-cell  lysales Î'\  shown using GAPDH (37 kDa) a;;  lo:~di n g control. A  representa-
Live  blot for  F:.tsR is shown from 3  indepcndenL  ~x~rimcnt~.  Dcn~itomeuic :malysc  ...  of Fa~R  e~prc~s10n arc  rdatÎ\'C to  Lhc comrol  ( l 00%). 
1El  Ce ll~ pretrcmcd  with  or  without  10  pmoi/L  pifithrin-a:  for  3 h :tnd  thcn  an.alyscd  by t1o\\  cyiOmctry  ror  lhcir total  expression of FasL. 
*. Signilïc;:tnl  ill l'< 0.05. **. p < 0.01. and ***. fl  < 0.001 v ....  untrcatcd  control:+. p < 0.05  \"'·  con\~"po ndin!! celh \\- Îthout  pifithrin-o.. 
Fas:L. Fas ligand:  FasR. Fas receptor. 
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at  the cxtraccllular qu'face  of the  plasma  mcmhrauc aftcr a 
1  h  cxposur •  to  acrolcin  ( 1-27  ~mol/Ll  ( Fi ~  s.  2A.  1C). 
linder  till'  sanw  conditions.  r.xlraçdJular  F'"R  c::qm·"inn 
decrca>ed  , i ~ nilï cant l y (2 1  ' :1 --.!:~ ' lt ) compan:d  with  tllltrc:llcd 
ccli'  (Figs.  2A.  1B).  Thcrcfore.  wc  rurthcr  invc"i!!:tlcd 
\\·IH.!ther tiH.:rc \l'ère changes in  IOlal  CXJ'I'èSsion or this rcc~p­
lOr.  lmmunodet..:clion  in  A5.:i9 whok-ccll  lvsalc< aftcr  1 h nf 
exposurc  10  acrokin  {3-14  ~unoi/L )  showcd  '"' , ignifïcam 
changes in  total  expression  or FasR fFig.  201. The dccn:a'c 
in  ~x trace llul ar  Fa:-.R  cxpt\.::-,sion  (Fig.  2A)  ~u uld  he  ex-
plaincd  hy  the  hinding of FasL  lo  the  extracellular  surface 
ol'  lht·  n.:ccptor.  Tht• acrolein-induœd  incrcase  in  Fasl cx-
pres~ i o n  wa~ significantly  inhibitcd  by  pilïthrin-et.  suggesl-
ing thHL  thi ~ n:sponsc  wa:-.  mt:diatcd  by p5.i  (Fig. 2[). 
Acr·oldn c·anscd  transloc·atiun nf adaptor prutcirh FADD 
and RIP  lo the plasma membrane 
Onçc  clcath  rcœp1 or sign:1ling  is  initiaiCd,  1hc  dc:llh  do-
muiw, of FusR lhcn  rccruil adapt.or protcins  FADD  "'"' tor) 
RIP  l<>  the  reccrlor comrlcx  al  the  cytoplasmic  ,;d,· of the 
D 
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Acrolein (~m oi/L) 
plasma mcmbr:mc (J;;;;udèi  and  Lci' t 200:'\).  lndœd. acrolcin 
(<::i  ).lmoi/L)  induccd the•  tmnsl,,c:Ui('n or FADO and  RIP tn 
th ~ A:i49  ccli  membrane·  (Fi!!'·  ~A .  3C. -lA. and 4C'I.  which 
rcsuiLI.!J  in  a  co rrcspo nd in~  r~d u c ti tm in  Lhcir  t\::-.pccti vc cy-
IOM>Iic levcJ, !Fig,.  ~B. 3C.  -lB.  and -ICi. The  maximum  in-
c r~as -..· :o.  in  p i ~L"illl~l  m~mbran c  Lr:ms l <l~::HI O il  for  FADO  and 
RIP  cx.:currcd  aCl~.:r  1 h of'  r.::x po~un. ~  to  acrl)h::in.  rch:tti vc  to 
untreatcd  c:0ntrob. 
Acr·olein  induœd activation of initiator c:asp:h~ - l) 
and caspaSl'· 2 in  A34\l  c·clls 
The initi:uor  p ro(· a spa;,c-~ and  procaspasc-10 ar<'  rccruiLcd 
hy  ad< lptnr  pro L~o:.in s and  act:urnubtc  at  t h ~.!  membrane  death-
inducing  s i~nalin p  co mplc ~ (DISC:).  r~su lti n )!  in  thcir  spon-
lc1ncous  activation  h)  auloprotcolytic:  clcaYagc.  which  ini-
tiaLes  3J X'plolic  signaling  (Guiœ iardi  and  Gore;  2003: 
IVI c>llincdo  and  GajUIL'  ~006!. CaspU>l'-2  is  also  an  init.ialor 
c:tspa~c. but  ih  m cc h an i ~m :o\  arc  not  weil  dcfin t.::d.  Expo" ur~ 
of A54<J  cc lis to acrul..:in  (2: 1 ~l llhJI!L )  for  ~0 min  tn 2 h kd 
to  ~ignifïcant  activation  of init i ~uor caspa~e-2 fFig. 5A) and 
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Fi~. 3. Acrokin  cause~ tran..slùenlion of adaptor proiein FADO to 
the.  pla:-mn  membrane. A549 ccli ..::  (I 06imL) wcrc  incubatcd  for 
30 min or  1 h at  37  .::c with  < J crolein (0-14 pmol/L).  (mmunode-
lcction  of FADD (30 kD<t)  in  microsomal  and cytosolîc  fraction  . ... 
was cnn·ied out using GAPDH  (37 kDa) as  londing control  for  tht ~ 
cy t o~o l.ic  fraclion.  Dt!nsitomctric  analy~es of the expression of 
(A) membrane  FADD and  (B) cytosolic  FADD arc  relative  tc)  the 
tmtre.<ned  controL  tC)  A representadve blot  for  f ADD expression 
( 1 h) is shown  from  3 indepcndcnt  cxperimems.  *. Significant  at 
p  < 0.05. **. p < 0.01,  o md  :t:+-*. p <  O.CXJJ  vs.  untrc;Jtcd control. 
FADD. Fas-associ.:ltcd clcath domnin. 
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caspasc-S iFig.  5B).  CaspiiSe· IO uct.ivitv  incrcascd  slightl). 
but.  this ctTcct  w:t< not  significant  !Fig. SC l. Th<!  increasc  in 
cnzymatic activily  was  mor<:  prnnounccd  for caspase-8  than 
for casp:osc-2.  tFif!S.  5A. 5B).  The acrokin-induœd  incrcasc 
in  caspa.st'-g  activity w:h signific:mtly inhibited  by pilïthrin-
ct.  "uggcsting  lhat  lhis  n.:"ponse  wa:-..  medhttcd  hy  p53 
iFig. 5DL 
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Gan.  J. Physiol.  Phannacol. Vol. 88. 2010 
Fig  .  ..t. Translocation of ncbptor protein  RIP  tc~ the pla;.;ma  mem-
brane  in  c lcrolcin-trcatC<"I  ~c ll s.  A549 c:ells t i06/mL) wcre  incub 01ted 
for  1 h or 2 h a1  37 "C with  ocrolein  (0-50 1-llllDI/L) in  uMEM con-
wining  JO % FB S.  lmmunodcte-ctîon of RI P (74  kDaJ  in  mîcrosomal 
< md  cytosolic fractions wns  canicd  out  using GAPDH (37  kDa)  ns 
lo.:lding  control  for the cy10solic fraction.  Densitometrk:  <lll :-t i~'Ses of 
the expression of (Al mcïnhnmc  RIP < md <8) cyL osolic RlP are  re-
kui ve  to the untreated comroL  (C) A  represcnwtivc- blot  for RIP 
expression ( l  h)  jo.,  ' hown from 3  indcpcndclll  cxpcrimcnh. *. Sif!-
ni fi c..1nt  al  p < 0.05 v  ....  un tr~ 1l cd control.  RlP. reccptor-intcracling 
protein. 
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Adimtinn nf till" crnss-t.alk pathway hy acrnlein 
Once  initiator  caspasc·2.  c:"pasc·S.  and  (or)  caspa>c-10 
arc  activULt,;d.  they can  inducc  a cross-talk  pathway  hctwecn 
the dca!h  rcccplor and  mitochondrial palhways throu)!h  thcir 
abi lily  10  l'icaw  Bid  (Fan cl  al.  2005:  Lovrik  ct  al.  2006). 
Expo,;ure  or  A54Y  cclb  to  anolcin  (7-14  pmoi/LJ  for 
:10  min  led  to  a  signi fïcant  i m.T~! iSC  in  cy tc~so l i c cxprc')sion 
or l'ull-lcnf!lh  Bid  hy  approximalcly  1.5-lold  rGiativc  [1)  the 
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Fig. 5.  Ao'Olcin incluccs  activation  of iniliator cm•ptl'  .. t-:!  and  ca...,pa..::c-8.  A54Y cclls t 106/rnLJ  werc pn::trcatcd with  or wirhout  10  ~tm o l /L 
pifithrin-cx_  for  J h and  then incuh<Hcd  for  30 min.  1 h,  or~ h at  37  C:  with  acrolcin  (~27 pmoi/L).  (A) Ca'!p< l'c-2.  CC)  caspa:-:e-10.  and 
Œ.  D) C ilsp"se-8 :1ctivities  were  mcasured  in  celllysme<>  using the fluorescent  s ub~ lrate ~ Z-VDVAD-AFC. Ac.:-1ETD-AFC.  ~md Z-IETD-
AFC, respectivcly.  Ca:.:pasc acliviry  w:1 ~ exp res~ed relati\·c  to the  untreatcd  comrol.  Dma arc  n'lctms :!::  SE from  3 indcpendent  cxpcriments 
performcd  with  multiple  estimations pcr  point.  li" .  Sip:niflc;uH  at  fl  < 0.05.  :a:*· /)< 0.01. and **:;'·!'< (1.001  V\. Ulltrcatct.l control: tt+·f• < 
0.001  ""· corrc,rmnding cc  JI .;:  without  pifithrin-u. 
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lllllr~a t cd comml  f Fi ~s.  68. 60). Titi,  UJm:~ lll ati o n of  Bid 
was  significuntly inhibiwd  hy pifïthrin-ct. implicm inf  p5 :1  in 
thi ~ cfJ'ccl.  The  inm:ascd cytosolic  Bid  ~.x pr~ ;,, i ou ,,(l;;crvcd 
aflcr  :10  min  r..:turncd  1 0  control  k"els  aft..:r  1 h (Fic. 6B). 
and  lh(:r" was a cnn·cspondinf!  in ~ r~:.t~i.:  in  lev --1 ,  or  :~eavcd 
fragment tBid  in  the  mitochondrial  ft~K"tion (Ftgs.  11A.  6(). 
Alter 2 h. cvtosolic  Bid  leve!'  dcct~a~cd siunilïcantl\'  aftcr 
cxpo,urc to :tcn>lein  ( F i~ .  68 ).  Uncc clc;wcù-.  tB id  in;cns it-
sell'  111  the  mitochnndrial  membrane.  whirh can  lcad  h> the 
activation of the mitochundrial  pathway  of apopl< >,i <,  (Fan ct 
al.  20051.  lnd<.!cd.  annkin C :Hhcd  chang's lu  mit.ochnndria. 
manifcstcd  il' hypcrpolariL .ation of the  mitochondrial  mcm-
hr;;nc  (Fig.  7).  This dlect  was signifïcantly  inhihitcu  hy pi-
lithrin-u.  suggt:stin,g  thal  p5 ~ \vn;;  in vn lvcd.  FCCP w:l s  U !o\~d 
a;-,  ::t  positi vt.:  Cl..)lltrol for  m~ m bra n ~..:  dq.x>larit.alion. 
Acth·ati(lll  of tht· <·xt>cntion phase nf apuptusi< hy •w•·oldn 
Once  activatcd.  initiator  ~asp:.Iscs can  prnccss  d O\\ n ~trcam 
cffcclor ca" pa. ~.;c~. which arc resrxmsihk:  fnr  th ~ ch::nvagc  and 
dcgrndation of many  crucial  cellular  protcins (c.g ..  !amin  A. 
c  D 30 min  •  1 h  D  2 h 
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nc1 in, fodrinl  ~ n d J (,r the  c·xc~ uti n n nf œil ckath  ( F~n ct al. 
2(Xl5:  Guicciardi  and  Gor<.!s  200.,1. Il  \\'os r.::poncd  !hat ;lcro-
lcill  inhibit' c"> f':l~c-:1  activitv in  CHU cclls and nc1Hrophib 
C l'<lncl and  Awrill-13atcs  2005:  Finkcl,tcin  ct al.  2(XI I l.  Th,· 
initiator  ca,pa~ ..: -2 and  c~ls pa ~...:-X  arc  hoth  knrm n L n acti vatc 
the  cffcctnr  c a, pa s~-7 C H,,  cl  al.  2tl05't.  lndœd.  cnzy nwtir 
acti v it~  of cas pas..:-Î  w a ~  inc r~as.:d :-.ignilican tl y whcn A5-l9 
ccli'  werc·  CXJ 'l<hcd  ln al'J "<>kin ( l-2ï ~mo i /L) for 31l  min to 
::!  h.  comparcd "ith  umrcatcd  controls  ( Fi~. 8A 1.  The  m:lxi-
mum  incrcasc  in  activit  wa.;  4-Rf; . which  w!ls  r~ac h cd aftcr 
2 h. 
Subscqucntly. the cxccuticm  rhas · of apnptosis  was ana-
lyscd  to  Jcterminc  lhl'  uhim;H t  < 1UI.come  of acrobn  in ~ uh 
on  the  intcgrity  of  the  ccli.  This  was cvaluated  hy  PARI' 
clcava~c.  h)  ;~ nncx in \'-FI  TC  labclling  of  cxtcrnalizcd 
ph<>sphatidybcrinc  fPS)  nn  the  plasmt•  mcmbr:Ull' 
(Fig>.  ~ D-8 Fi .  and  h)  Hocchst  ~3 25 !;  ( hlu~-g rœn  lluoln -
ccncc).  whi ch  l abel~  condcnscd  nudcar  chrom:.ttin 
(Figs.  ~G .  8H) (i'vlalhi  Cl  al.  2006). Pl  wns  uscd as a cnuntcr-
stain  J'or nccrosis.  The DNA  rcpair protcin  l'ARP  undcrwcnl 
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Fig. 6.  Cle11vage of Bid  to  tBid  by t1 crolcin.  A5...J.9  ecUs  (106/mL) wcre  pn.:treatcd  wîth  or withoul  10 pmol/L pifithrin-o:  for~ h and the:n 
cxposcd to acrolein  (0-14 ~tmo l/L) for 30 min to 2  h. lmrnunodetcction of cyto:-:olic  Bid  ( ~2 k_Dn) and  mitochoudrial tB id  ( 1::;  kDa) was 
carried  out  using GAPDH (3ï kDrd  a:-:  loading control for rhc cyiO"-olic  fraction.  Dcnsitomctnc  analyse:-.  of the  cxprc~:-. i on of (Al mitochon-
dria.l  rBid :md  (B) cytosolic Bid arc relative  tO untrcaœd conrrols.  Repn.:::-cntntive  b l ot ~  from ~ indcpcndcnt  ex periment.::  :trc shown for ex-
pression  of (C) tB  id tl  h ) :111d  Bid  (2 hj and  tD)  Bid  t30 min) wilh  or  wi1hou1  pifilhrin-a. *. Signifinml  <tl l' < 0.05 and **. f' < O.f\J  vs. 
untremcd control:  ++.p < 0.01  and +++. r>  < 0.001  vs. con·esponding cciJ,  without  pitithrin·u. Bid. BH3-irncrnctinf!  domnin dc.1th  agoni~ t ~ 
tBid. 1runcaled  Bid; ND. nol detennined. 
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(22kDa)  ~ 
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c h.:av~gl.! .  and c.xprèssion nf  th e.::  cl cavag~ fragment  (85  k  Da) 
incrca.":>cd  sig nilï~a nll y  (:16 </~ J  afler  ~l  2  h exposun.:  to  :u.:ru-
lcin  (25-50 !lmoi!L)  fFig,.  RB.  SC).  During  the  ~Xc( ' llli<lll 
phase or apoptosis. c;L5pases ~au :.è PARP-1  cka va~ c and inaç-
tivation.  PARP  ck:ava~c hao hccn  uscd  as a clas.,ic hi<1dlcll1 i-
cal  hallmark  of  aptl J~os i s.  T< '  eoniïm1  the  r< lk  ,,,- p:i ~  in 
acrol c in-induc~d  PARP  ckavagc,  œlls  wcrc  prcm:atcd  with 
pilïthrin-a.  ln,fècd.  pilïthrin-a  signiiÏc;tntly  diminishcd  acro-
lein-induccd  c kav a~c·  of PARP  (Figs.  ~ B. XC). Therc  "'"' a 
signifi -:·anl  3.1 - to 3.  7-fold  inc r~a ~c in  anncxill V-positive  c ~...· ll ~ 
a l'ter  a 4 h ex po, ure of A549 cdls to acrolcin ( !-2ï lttnoi!U 
(Figs.  SD,  8F)  compnrcd  with  the  umrcmcd  comrol 
(Figs.  8D. 8El.  A  sirni lar  :\-fold  inncasc:  in  apoplotic  œ lls 
was  obtaim.·d  with  Hocchst  staining  after  cxposun;  to 
14  pmol/L  acrolcin  comparcd  with  the  comrol  (Fig;,.  8G. 
RH).  Onder  1hcse  conditions.  lt-vels  of  necrotic  cdls  r~ ­
maincd  low t- 5%1 rFigs.  SD. 8E. and 8H). 
Rolc of ROS generation in  p53 adiv:ttion  by acrolt:in 
Our fîndings  sug·f!cst  thal  p5:1 plays  an  upstrcarn  rok:  111 
activat ion  of  the  dc:1th  rcccptor  pathway  by  acrnlcin  in 
A549 cclls.  Subscqucntly. we dct<.;rmincd whcthcr ROS gen-
eration  hy  açrolein  i"  invnlvcd  iu  the  activalion  of  p5.'. 
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Aero kin ( 1  0-~5 lllllol/Li causcd  a  ,i~ ni lï c an l  25'ft  incrcasc 
in  ROS  production  afin  1 h.  manifestcd  as  an  innea>c  in 
H:DCFDA  fl unr..:scc:ncc  1\:lati vc  to  lhc  untrc::ttcd  control 
(Fi!!.  9A). Thc  incrcasc  in  H2DCFDA  lluort" ccnet:  was in-
hihitcd  h1· PEG  catalasc.  a  wcll-known  ROS ' c<tvcnœ r that 
d.:: t ox i lic ~ hvdrogcn  p~ n>x iJ ,,  (data  not  shnwn).  Prc tr~ .a lm~ nl 
c>f  A:'i4')  ~db with  3CXJ lJ/mL  PEG  cat;tlasc  for  ~  h  in-
(:ft:a:-.cd  catabsc  ac ti v i t ~  h)  37t.~  (da t ~l  not  shown).  lnJt:L:d. 
anolcin-induccd  p53  ;~t'li Y atÎ<llt  wa;  signilicanlly  inhibited 
by  PEG  catalasc·  (Fi <''· 'JB.  9C:). which  sug~cs t;;  thal  ROS 
play  "  l't>k  in  r5:'1  acliV :tlion  in  A54')  cclls.  Funhcrmorc. 
:lC rolcin-indu c~d f{( > S production  w:t'  signi licantl y inhibitcd 
by rifitltrin-u. indic:tting a roic:  lor p5.i  in  ROS  gt·ncration. 
Roi~ of ROS in m-rolcin-induœd adiYation of th  .. death 
rc<·eptor  pathway 
The  suh  ... cqucm  slcp  wa ~.;  tn  tk l \! rmin~  whd hcr acrokin-
induccd  ROS  G ill  activatc  the  < k ath  rcccptor  pathway  in 
A549  cclb.  Accordingly,  acrolc:in-induc.::d  upregul;nion  of 
FasL (Fig.  101\).  ca,pase-R activation  (Fig.  lOB ). and  mito-
chondrial  mcmhram!  hypcrpolarization  (Fig.  IIIC1 wcrc  ail 
attcnuatcd signilic;mtly by PEG  catalasc.  Togcthcr. our  lind-
lll g~  sugf cst  thal  p53  acüvation  :111d  ROS  g~..mcraliO II  arc 
Published by  NRC Rose arch P1~ S' Roy et al. 
Fig. 7.  Acrolcîn  coms~ mitochondriaJ  membrane hyp<"IJX>ii'lriz.:liion: 
inhibil"ion  by pifirhrin-u. A549 ecUs (J06imL} wcrt~ prctrcatc.d  v ·.·ith or 
withoul  J 0 pmol/L pifilhriu-o.  for 3 h and th en  exposee!  to acrolein 
((~~') 1-lmoi/L) for 30 min. Acrolcin-m~at ed cd]s, rclmjvt':  tu un-
trc<Jted  control ccl b. wcr~ mwlysed by flow cytonH!try  for rhodamine 
123  ('2  ~mol/L } fluorescence  in  ch~mnd FL-1.  FCCP (5  ~uno lfL) \vus 
addcd for 5 min to ccli .:.;  not  cxpœcd to <KTolein as a  po:'itîvc control 
for  mitochondrial  rncmbmne depolariz.·uion. Daw :m;:  means ± SE of 
RA  from 3 indcpcndcnt  cxp~imcn t s .  normalizcd  t0  r..onn·o]s.  >~~: .  Sig-
nific:.mt al p < 0.05 :md ***. p < 0.001  v::...  untrcated control: .;.tt. p < 
0.01  vs.  cotTCSJKmding:  cclls without  pilithrin-u. FCCP. p-trifluoro-
m(:lhoxyphcnylhydrnzonc: RH. relmivc fluorescence  îm cn ~ î1 y. 
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intcrconncctcd  and  that  bollt  art•  invoh·cd  ,.,  initiating  t'ac-
lü!:-.  in  al'rolein-induced  J~ath  reccptor  adivation  in  A)-+9 
ccli s. 
Discussion 
Upstrcam <'YL·nts  iuvolwd in  dt'nth  n·ccptor at:timtion by 
acrolciu in A:'4'1  eclls 
Acroleiu indrtced aclil'atiou of' p53 aod incrca.<cd  PUMA 
( 'Xpre~•siuu 
Tht.;  ini1iating  l'ac1or.;;  thal triggcr  apoptosi~ whcn  crlb an; 
cx1 x·,,cd  1<\  the  toxic  lipid  pcroxidation  hypr<xluct  acrolcin 
ure  not  weil  UJHicrsloulL  tvlany  cn\'ironmcntal  stimuli.  in-
cluding  ROS anJ chemical  DN A - cb ma gi n ~ agem;,.  c m  up-
negulatc  and  ton activatc  p55  Lhrnugh  phosphorylation (Xu 
2fXB:  lvlcndoz:t-Rodrigucz  and  Ccrht1n  2001:  Sax  ct  al. 
2fXJ2).  Acrolcin  ;,  known  to  cau,;c  DNA damage  (Stevens 
and  Mai er 2008).  and  at  lo\\  do.  ~s C0.-7 pmol!Ll.  it  indced 
induced  t ~t pid  (~() min )  uprcg.ulatjon ami < •etival ion of p5 ~ in 
A54<J  cells.  This  is  th ~ lirst , tudv to show  thal  acrnkin illllu-
ces p53-dcpcndcnl  uprcgulation  ~Jf PUMA. a BH3-only  Bel-~ 
fami ly prmein and an  esscnLial mediator of DNA damagc-in-
duccd  apoptosi,.  The  post-lranslation:tl  modi1 Ïn1lion  of p53 
al  Serl5P also nccurn::d  in  CHO  cclls  that  wcrc  cxposcd  ln 
acrolcin  (50  ft mol/U  for  l  h  ( J'ancl  and  Averili-Hatcs. 
2<X>7b).  ln  A549  cel l,,  henzo/aJpyrcnc·-induccd  p53  DNA 
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binding  and  aclivily  wcrc  inhihi~c.. :d  hy  acrukin  (.)()  fmoll 
cdl. 30 mÎilJ (Bis\.val  ct  ~ 1\.  200:1).  l-knv~.: v..: r.  ~h .: nJ k: in  ~l lont 
did  not  affect  lcYds  of p53  or  Scri 5P-p53  !Biswal  ct.  ni. 
2003!. This difkrcnœ  from our swdy cnuld  he cx pl:linctl  hy 
lh t.:ir  usf..:  of  a  diffcn.:nt  in t.:tJhalinn  medium.  ::.crum-frcè 
Dulbccw's modilicd Eafle·, medium (DMEM l.  whcrca' our 
study tl'cd  s.:.nml-('Ontninin1!  aMEM.  Givcn thal acrokin cnn 
reac:! with  nndeophilic substances. n·llular rcsponscs ln aero-
kin  an..:  hi ~ hl y dcpt.;ndcnt  on culture  nH:dîa  çnmposi tinn and 
the presence ami  (orl concentration of :-.t:nun  fThomp:-.on  and 
Burch:1m  ~OOX). ln  our  study.  A5.J9  ccli,  Wei\'  n tlturcd  and 
thcn  t.::X()(bt..:d to  al.T~lh; ~ i n in  :-:..:nlln-c:oma inin ~ nH.:dia  1 ~'  a v~) id 
impn\Îng  tlw  ~ ln...:s:-.  nf  protl·in  withdrawal  on  cdb.  whid1 
cause'  :-.evc...:rc  cd lular  dama,gc  and  lh.!t:rotir  pn H...·t.:,~~:..  dc-
tcctcd  as  Pl uptak"  (data not  shown).  How.,,·cr.  a  limitation 
of th,·  currctll  study is thal  1  ()'.(  FBS  is not phvsiologic:tl. 
Rolc of  p53 Il.\  1111  iuitiaiÎIIf! ./(le/or iu  dcath receplor 
aciÎ•'aiÎf,, by acrolein 
To  adva n ~c knowlcdgc  about  the  m~c h a ni sm ~  În\·nlvt.!-d  in 
ac.:rnkin-induccd  a popt ~1~ i s.  wc..:  ~v ;:lluat t.::d whr..:thcr  tht:  tumor 
supprcs:--or  p53  is  ~111  up stn..:~m  tri gg....:r of dcath  n..:ccptor acti-
vmi( 11l. The twvcl fimling in  this study io;  thal  Fasl  uprcgub-
LÏ\111  ~md ca." JXLS\.:-0  a(·tivation  WCI\.:  dccrc::L'cd  b ~  pi lithrin-a. 
..;uggt..:st.ing  that  p5:i  is  an  init iatin~  f~ 1 t t or  in  acrolcin-induccd 
d~ tth  rcccptor  m.:ti\·ation  during  : 1poph )s i ~  in  A549  cdls 
(Fig.  Il ).  llu. kcd. p53  i~ known h.' nh:diat....:  th !.!  uctivution or gent.'~ 
such '" fit< and  FasL during a1 x1pwsi'  (tvlcndclw-Rudrigucz und 
CcrhAn 200 1:  Sax Cl al. 20021.  ~·l o rcov .;r. the U C LIV :llion or  c.xecu-
tion  phase  cn:nts  of  apopt ( "~s i r...  hy  acrok~ in.  such  as  PARP 
~ li..:avagc .  \'- ./ ~l e; also dependent  on p53. 
Roh• of ROS in p53-mediated dea th  n ·cepfur actil,mion by 
acroleiu 
S uh sc qt~c.mt l ).  WC'  dek:rmincd  v.:hcthl.!r  p53  i:-.  a(:ti vatcd  hy 
ROS. lndeed. < lllr  findings shm,·  thal  low apoptosis-inducing 
d\1>c'  ,,f  <ternie in  ( l  (J-~5  ~unul/L J  induccd  ROS  :tc~ unHtiH­
Iinn  and  ROS-dependent  a.:tivmi <>n  of  p5 ~  in  A54lJ  œ lls. 
i\nokin ( 1-100  ftmol/L.  ~4 h)  was  r~ ro rt cd to  e<H!Sc  ROS 
:tecumulntion  in  PC-12 cc Ils:  howcvcr.  ccli  ckath  <>ccurrcd 
by  necnlSis  (Ltlll  ct  al.  200~  ).  l n c 1\: u s~d  ROS  production 
could  a ri ~t.·  thrmtf!h  :Jl."h> h.:in-indm.:....:d dc..:pktion of Lht.:  aniin.x-
idant'  g lut athion~ (Kdm'r nnd  Bisw<tl 2(X )0) and thiorcdoxin 
(YnM  ct  al.  200.1).  ln  A549  cclls.  the •  nntinxidant  PEG 
catul::sc  inhibitcd  ucrolcin-indurcd  uprcgulation  of  F:"L 
protcin.  c:t"!pasc-S  activalion.  and  mit oc hondr i~ll  mcmhranc 
hypcrpolaritation.  This  suggcsb  thal  in  additilm  t0  p53. 
ROS  arc·  an  up s t r~am  initi ;uin ~  facltlr  in  acrolcin-incluced 
dca th  rcc<::ptür  activatic>n  du ring  apupto' i'  IFig.  li ).  ROS 
wcrc  shown  10  inducc  Fasl  cxrrôsion  IWang  cl  al.  2008! 
and cau rcgulate the ••cli\'ali\)11  of' caspasc-X  durin~ apoptosi~ 
IPcrcz-Cruz ct al.  2(Xl7 J. 
Tlw  novel  lïndin!!s  in  thi;  stud)  :trc  thal  hoth  p5:>  and 
ROS  arc  initiating  factors  in  acrolcin-mcdiatcd  dcath  rcccp-
tor activation  (F i ~.  I l).  ROS  ge nc r~ 1ti on was inhibitl!d  by pi-
lithrin-a.  and  p53  nctivmion  was  inhibitcd  by  c:ualasc. 
suggcsting  that  acr~>lein- in d u ~cd  RC >S  gen t~ rm ion  and  p5J 
::tctivation  arc  linkt.::d.  Prcvio u ~  rq'lorh.  indicatc  thal  ROS 
can  act  both  upqream  and  down..;.trcam  or  p5.:;  activation 
(IVkNciii-Bluc'  ~~  al.  20)6:  Xu  ~003).  Furthcrmorc.  it  ap-
pcars thal  kvels of p5 ~ can control rcdox  lcvels withi n ccli;, 
Publi~hed hy NRC Rcse:trch  P~ n ~S ,------- - ------
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Ft;;;.  8.  Acrolcin acti va.tcs the  cx~c ulion phase of npoptosis. A549 cclb (1 06/mL)  wcrc  inct1batcd  for  JO min.  1 h. 2 h, or 4 h at  37 "C with 
ncrolein (0-27  ~tmo l/L )  in a MEM comaining  10% FBS. (A) Ca:-;pase-7 acti\'ity was mem:urcd in ccli  lysate:- using.  the  flu on:~ccnt  ~u b s trate 
!vi  CA-VDQVDG\\FJ\.(DNP)-NH2 and  \VilS  expresscd rd ativc  to the untrcntcd comrol.  Data mc  meilns ± SE  ti·om 3 indcpcndcnt  cxpcrimcnts 
pcrformed  with multiple  es t im <~ t ion s pcr point. (B) A549 cells ( 10°/mL) wcrc prctreatcd with or wirhout  pifïthri n-a  and  thcn cxpoi'\cd  to 
acrolein  (25 or 50  pmol/LJ for 2 h in o.MEM containing  10% FBS.  lnununock ::tc:ction  of  cl c .:~ v r..cl  PARP (S5  kDa;  in  wholc-ccll  lyslltcs  was 
carried  out  b~ ·  \llcstcm blollîn g:. using GAPDH c37  kD;l) as  lo.rtding controL  Dcn~ ito rnc tric , tn a l y~c!- of the  ~.. ~x pn. ~ ·' " i o n of clca\'Cd  PARP arc 
relative  to  the  umreated  control.  (C) A  repruscntmive  blot  is shown  from  ~  in d ~ pc n d ~ nt cxpcrimenb. (D ) A540 cc:IJ:.:  wert:  staintd  îor apop· 
1 osis with anncxin V- FITC and for  nccro s i ~ wilh PL  Cdls (10(00) wcrc :malyscd by 1low cytomccry  to determine the pcrccmages  of 
annexin V-po)o:it ive and  Pl-positive cel b. Representative.  dot blots arc  for  ~mn cx in V- und  Pl-swined  ccJJ ..;  nftcT cxposure  lO  0  pmoi/L l E) and 
14  J.Unoi/L acro lcin (FJ for 4  h.  D.atn  m·e menns  ± SE  from  3 indcpendcnt  expcriment'  and the pcrccmag.;:: ...  arc  relative to the  untrcated 
control. Morphological  imaly ~ is of apopro::::is is shown in (G ) untJcatc:d  A.'\4-l) cells  and  <H) cells cxposcd  lo  14  pmoi/L ttcro lcin  for 4  h. 
Ccll.,;  wcre staincd  with  Hocchst  33258 and  PJ and '"'cre vio;;ualizcd by fluorc,ccncû  microscopy (mag:nili c.ation  x 320).  Photogr< tph'  :1re 
rcpn.:.scnl.'lfiv<: of 5  indepcndcnt cxperiments .""'.  Si~ nif i c< ln t  at /}< 0.05 and **. p < 0.01 v,, corrcspondin!!  untn.:mcd  ~.:om ro l:  t. p < 0.05  and 
t+. p < 0.01  vs. corrcsponding cclb  without pifithrin-a.  PARP, poJ y(ADP-tihu.\c)  polymt:rasc: FITC. flllorc,ccin  i so th i ocy~uH t h::  Pl. propi-
dium iodide. 
rror  rcvi..:w.  sœ  Grocecr  ct  al.  2009!.  Thus.  low  k vc\,  or 
p5:;  c:tn  suppress  ROS  within  cclls.  while  highcr  Jcvcls or 
p).' can promote  ROS  accumulation.  Inhibition ()r  aerolcin-
induc<!d  H.OS generation  by·  pilïthrin-a  would  be  consist<:nt 
with  thi,. ln  LoVo  and  HC:TI I(\  cancer ccl b. th <.:t\·  "J'P'-'"'·cd 
to  he  a  f"ecdhacl;  signaling  loor  in vol v in~ p2lfROS/p53  in 
apnplntic  resr<>nsc.< rlnouc ct al.  2009). Hmvevcr.  the ,·nm-
plex rcb tionship betwccn  p5:;  :md ROS  1 \!main'  a matter or 
<k:hatL'. 
Downstrcam ev(·nt.;;  in acrolciu-indtu.:t•d  dt·ath n:t.·ep1or 
adivatiou in  r\.:;49  cells 
A.crnlein induced trauslocaliou  t ~F  adaptor proleÎJt.\  FA IJIJ 
and RI!' lo  the pla.ww membrane 
E xposurc  or A549  ~d i s  (\)  acrok in  led  1{1  n  (.h .  .:(.. Tt! a ~~  in 
the  expression  of f asR  at  the  cxtr:Jccllul:tr  surracc  or the 
plasma  membrane.  whik'  tlltal  cellub r  content  or FasR  re-
mainccl  stable. Thcsc  rcsults suggcst  !hat  i ncrcascd  FasL ex-
pression  at.  the  cx1raœ llul:tr  membrane  cnctnnbcl'- FasR by 
specifie  binding.  thcrchy  prcvcntin;:  ils  dct<.:ction  hy  tlw 
FITC-bhcllcd  anti-F:1 sR ;111tibody. The  dccrcasc  in  FasR  at 
the cxtracd lular membrane could a\;;q he cxpbincd hy intcr-
nalization of the FasL-FasR  clustcr al"lcr rcccptor activation 
(Hcnklcr ct al.  2005 1.  Acrolcin causee!  Fas clcath  rcccptor ac-
ti vation  in  hamster  ccli,.  which  was  manircstcd  bv FADD 
t ra n~ l oca ti o n .  casrasc-8 aclivation.  and  Bid  clc.!HVagr.:  (Tand 
and  Avcriii-Batcs.  200/a).  Howcvcr.  the  upstn.:am  mccha-
nisms invoh·cd îu death rcccp10r acti vation w t..:r\.:  llù t  invcsti-
gatcd. 
The  complexit.y  of dc:1th  reccptor-induccd  cd !  stt rvi v:d. 
apoptosis. and  n0crosis  signaling  nctwo rk!'.  JlOW  l.:X ~<.:~d ~ .  hy 
far. thal  of th,·  simple lincar pathwav originally  s u ~gcs tcd hy 
the  discovcry  or  the  rcccrtor-triggcrcd  casra<.i(.'  cascade 
Oüiittdii  ami Lcist 2003). lt b  wc Ji c,stahlishcd  t h ~11  dcath  rc-
ccp lo r- n l<.:di;~tcd ccJI  dcath  can takc the r,,,.,n of cithcr apop-
tosi,  or nccrosis < Laster et al.  198  : H< 'llcr et al.  :2000).  The 
adapter protcins  FADD  and  RlP appcar to  be  key  dctcnni-
nanl$ or whcthcr ck:ath  rcccptors triggcr t\W :lJ X)plotic or lll'-
<:rolic  pathway  (Festjens  el  al.  ~006 ) .  FADD  i,  usually 
associall·d  ""ith apop10sis.  whcrcas RIP  :1ppc:u·, to  be a cen-
tral initiator of nccrosi,. Howcvcr.  RIP can  pla)  a dual  rok 
and  is ahk  to  initiale  pro-survival  a:-.  \vell  = 1 s death-iuducing 
pathways.  n lth t'~ug: h  lh ...: ~~..~  oppnsing  function  . ....  arc  not  wdl 
und ~ r S l\lOd (Ft...::-.tjl.:n:-.  t::l al.  2CX16 l.  ln  A)-4<)  cclls. th t.:  l'\.lnccn-
lrations t.\- 5(1  pnw\/L.)  of acrolcin  thal cau;,cJ m..:mbranc rc-
crui tmcnt  or FADD  and  RIP indm:cd  mnrphological chang..:s 
asso<.:iah..:d  with  <~ p0 pt o!-. i ~  rather  lhan  ncc ·ro:-.i\.  Undcr  Lh cs1,. ~ 
condition:-..  RI P appcar..;  tn  play  a  rok  :t' :.t  d ~o: ~ tlh  induct.:r. 
~ i v in f!  rîsc.·  lt'  apopto s i ~ .  Givcn  lh t.·  low  lcvd  of  n ~o: c ros i ~ 
(-)',i) in  A540  œ lk thc>C  lïndings  indicatc  thal  dcath  rc-
ceptor activation triggL"rcd  npo p t o~ i ~  rat h~ r than  the  n~e ros î s 
~ i g n : tlin ~ nctwnrk. 
r1crolciu activared iuithaor ca. \'fHtse-8 und cas·pase-1 and 
the cm .< s-talk pallnray:  mie· '~r  p53 
Caspa,;c-o  h<>comc, activatcd aftcr recruitmcnt  to Fi\[)[) at 
t h~  mcmhran ~.:  rt:cL'ptnr  and  is  cnn s id c r~d tu  he  :ln  impn rtant 
initiator caspcbl'  in  dcath  recc pt o r - rncd i~t ed apoptüsi:;  <Curtin 
and  Cottcr 2003). Acrobn (1 -2ï pmoi/LJ  <.:.:IUSc"<-1 p53-< Jcpcndcnt 
casi"Xt«:-k activat ion  in  A5-N  cclls. ln hamster cc lls. low doses 
or acrolcin  ( 10-50 pmoi/LJ induœd c:t,pasc-X activation and 
apoptosis (Tancl and Avcriii-B:uc;,. 200Ï a). Lowcr dos.:s ( l-
lO pmni/L) ,,r acrolciu  causcd  .:aspa;,c-K ckavagc  in .lurkat 
T  (type  Il l ccl b.  wh.: rea> high..:r do>CS  (> JO ).llllOI/U  wc re 
inhibitor)  in  bnth  .lurkat  and  B  lymphoblastnid  S  K W6.-l 
uyp <.:  1  J ccll. s  !Hristova  cl  al.  200ï J.  Hnwcvcr.  cxp< •>ure  10 
acrolcin  (5-\0  pmol/LJ ror 12  a1t<l 2-1  h inhi hitcd cosp:tsc-8 
activity  in murilll"  FL5. 12 proB lymphocytes. and  cdl < k ath 
<>Ccurrcd  hy  on,·osi;,  :u1d  \Ot)  nccrm.is  iK,,rn  and  Kchrcr 
1001).  The mod..:  or atrolcin-induccd cd l dcath i> cel\  rylw-
~.kpc ndc nt . 
Caspasl.'-:2  wa"  al :\t.)  0\(.:lÎ\':.H cd  by  h'w  l.'<)nc:cntrations  of 
acrolci n  ( 1-7  ~ 11n o l.~"l  in  A:i49  ccli s.  The  activation  or 
c: l spa s~ -2  h)  acrolcin  has  nol  h~... · cn  rcportcd  p 1 '1.. ' viou s l ~. 
Cornrared  with  c ~-·~ Jla S\.~ - R .  th ~.:  m o lccuhlr  lllC\.:hani-.;ms  or 
<.:aspa ~~..:-2  activalion  are  not  weil  dcfim:d  ~m u.  in  rncl.  ar~ 
controvcrsial.  lt  wa:-.  n.:porh:d  that  DNA damag:L:  cnn  :lcti vall· 
caspasc-2  in  a  multi nuclcar  complcx  lPIDDo,ome)  thal 
i n vo lv c~  th~  p:"3-induccd  protcin  wilh  a  dcalh  domnin 
CPL DD) and  tlw  RLP-associatcù  pmtcin with a dcath domain 
1  RAID Dl (Mc o iuri  ct al.  2007: Tine! d  al.  2007). Oth ''"'have 
rcponcd  thal  the  clcath  domain or  RIP  can  bind  tc>  thl'  Fa' 
rcccptm  and  rcnuit  RAIDD  and  caspasc-2  to  Fa'  rcceptor 
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aggrcgatcs  (Cunin  and  Coller  200~ ).  ln  severa!  œil  lincs. 
procaspase-2  was founcl  at  the  Fas  DIS  and  was  acti vated 
on  Fas  stimulation.  At  the  samc  time.  it  was  rcp011cJ  that 
procaspasc-2  could  not  initiale  cell  dcath  in  the  ahscncc  of 
procaspasc-8.  which  suggcsts  thal  caspasc-2  is  acti vatcd  at 
the  DISC. but  does not necessarily  prime  Fas-induced  apop-
tosi'  (Lavrik  ct al.  2006). 
lltcre  was  mpid  (:10  min)  p5 ~-mcdiatcd upn:gulation  of  Bid 
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Fig. 9.  Rolt:'  of ROS gcncrmion in p53 activation by acrolcin. A549 
cc  Ils ( IOilJmL) wcrc prclrcatcd \VÎih  or withollt  300 U/mL PEG  cal-
a Jase or  10  ~trno l/L pifithrin-o:  for 3 h and 1hcn c:o:po,.ccl  to acrolcin 
(C)-25  pmoi/L)  îor 30  min or  1 h. (A )  Lcvcls oî ROS in  10000 
cells wcre  analy!.e.:d  for H.2DCFDA fluoresce11ce hy fl ow cytometry. 
(8 ) Immunodctcction of p53 Scr15P in  wholc-ccll  lysmc::.  was car-
ried  out  usin p:  GAPDH  (37  kDoti  as  lmtding control. Dcnsitomctric 
:mnl yse~ of the expres:sion of p53 Seri5P arc rdmivc 1 0  tmtremed 
control:-..  ((;) Repre  ... e.ntativ  bJoLS  from 3 indepcndent cxpcrimcnb 
arc shown for cxprt:-!'l..,ion of p53  SerlSP (30  min ) wilh or wilhout 
PEG catalasc:.  **, Significant al p < 0.01  and  **:t, p <  U.  01  v ~ . 
untrcated ('Ontrol; t . p < 0.05 and tt"·. JI< 0.001  vs. cd l-.  with(llll 
PEG  cawlnsc  or pifîthrin-a ut the samc .::oncentration of acrolcin. 
ROS. rcartiv('  oxygen  ~pccic s :  PEG. polyethylene glycol. 
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Fig.  10.  Rok of ROS production hy acrolein in de:nh  receptür ~tc t i­
vation. :\549 c-c lis ( 1  on/ml ) wcrc prctn::mcd  with or without 
300 U/mL  PEG  c aral ~t'e for  3 h und  thcn cxposcd ro  acrolcin 
(0-50  ~tmol/L) for JO min.  1 h. or:::!  h. (A}  To t ~li  expression of 
F:t-.L.  rcl:uivc  to  untrc:ncd control  cclls. wa" :uulyscd by flow 
cytomctry.  (8 ) Ci!:-.p<.l..,c-8 ilCii\·ity  wa' mcn:-urc{l  in ccll  lpatc' 
using  tlu orc~cc nt sul.,srmtc Z-IETD-AFC.  Datil  arc rcl;uivc to  the 
11ntrc..1rcd controls and arc  mennf'  ± SE from 3 mdependcnt cxpcri-
mcnts  performed  wilh  mulliplc  c~ tilfl alion :-:  pcr point.  tCI tv1 Jlo-
t.:hondrial  mcmb~mc potelllial  in  10000 cdJ:..  wa" an;llyscll  for 
rhod;unine  123  lluoresccncc by  llow cytometry.  *. Si,:ulificant al 
p < 0.05. **,  /) < 0.0 1.  < md  ·""**.  l' < 0.001  w. corresponc.ling 
untretttcd  conrrol: t. p < 0.05.  1  .. . p < 0.01. tultJ  t+t. p < 0.001 V\. 
fO!Tcsponding cclls withoul PEG  cw.aJa,c. 
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Fig.  Il. Schematic  diagram summarizing  the  pathways initÎiltcd  by  acrolcin cxposurc. ( 1) Acrolcin  cxposurc  incrcascs  lcvcls of  ROS and 
activatcs p53  in  A549  Jung cells.  (2) ROS  and  p53  arc  both  upstream  factors  in  acrolein-induced apoptosis.  lncreascd  ROS  lcvels nre  de-
pendent on p53. and  p53 acti vation is dependent  on ROS. (3) Acrolein induces  binding of FusL  and  FasR.  thus triggering the death receptor 
pathway. which involvcs translocation of adapter protcins FADD and  RlP  to the plasma  membrane.  ROS arc  involvcd in  incrcascd  expres-
sion of FasL and caspase-8 activation.  si  nee these events  are  inhibited by PEG  catalusc. p53 activation lcads to (4) caspase-8 activation and 
increased  expression of  FasL and  (5) PUMA, si  nee  these everlls arc  inhibîted by  pifithrin-a.  (6) Acrolcin activatcs the cross-taJk  pathway 
involving caspase-8 mediated  clcavagc of B id and  U<lnsloca tion of tB id  to  rnitochondria. Bid cleavagc  and  hypcrpolariza tion of the  mîto-
chondlial membrane  are  downstream  events  from  p53 activation. ROS nlso contributc to mitochondlial mcmbnmc  hypcrpoli 1li z~Hi o n . 
{7)  Acrolcin causes  acti vation of caspasc-9 and  caspasc-7. (8) Caspasc-7. an  effcctor cuspasc involvcd  in  the execution phase  of apoptosis. 
is able  10  clcave PARP and  cause chromatin condensation. Phosphatidylserinc  (PS) externalisation il\  also  involved  in  the execution  phase. 
PARP clcavage is dependent  on p53. si  nee it  is  in hibited  by pilïthrin-a. 
cxprcssio11  aflcr  cxpostm. ::  lo  low  closes  Ll f  acrolcin  (7-
tO ~m o l li...)  in  A549 cclls. p53 can  mediate  apoptosis by  up-
rcgutati ng  proapoptotic  genes. such as Bid (Sax ct al.  2002). 
1  n  addition to  an  initial  uprcgulation  or Bid in  A549  ccli s. 
acrolcin  causcd Bid  clcavagc  to  tB id. which accumulatcd  at 
the  mitochondrial  membrane.  Thc r~fo rc.  cytosolic  lcvcls  of 
Bid appcar  to  rcprcscnl  a  balanec hclwccn  induclion  by  p5:1 
and  d ec re~t~cd levcls duc  l\l cleavage. 
The  molecule  Bid  is  a  well-known cleavage  substrale  of 
caspa!-ic-8.  hut  it  is also  a  substratc  of caspasc-2  (Guo  .;t  al. 
2002).  Thcrcfore.  both  c a s p as~:-2 and  e<tsp<"c-8  can  Lriggcr 
Bid-mcdiatcd  acti vation  of  the  mitochondrial  pathway  of 
apoptosis (Lavrik  ct al.  2006). Our  fïndings show thal acro-
lcin  causes  milochonclrial  changes  (membrane  hypcrpolari-
zation)  in  A549  cclls.  which  arise  from  dcath  rcccplor 
signali ng through the cross-talk pathway. mcdiatcd  by clcav-
age of Bid. involving caspase-2 and  caspasc-8.  In hibition by 
pifithrin-cr  suggests  !hal  p53  is  an  upstream  factor  in  thcse 
events (Fig.  1  1  ). 
Activation of  tite execution phase of  apoptosis by acrolein 
in A549 cells 
Acrolein  induced  execution  phase events  or 3iXJPIOsis  in 
A549 cclls.  such as caspasc-7 activation. PS  cxtcrnalization. 
PARP clcavagc.  and  nucl..:ar chromatin  condcnsmion. PARP 
cleavagc was inhibitcd by pilïthrin-cr. conlïnning thal execu-
tion phase event> arc also dependent  on p53. Caspase-7 was 
activated  by  acrotein  in  hamster  cd ls  (Tand  and  Averill-
Batcs  2005).  is  able  to  clcavc  many  pr01ci n  substratcs that 
an.:  comnlon  lo  ~.,;a s pasc- 3 .  and  can  inducc  chromatin  con-
densation  (Dcgtcrcv ct al.  2003).  Acrolcin  stimulatcd  execu-
tion  phase  event s.  such  ns  DNA  fragmentation,  chrornatin 
condensation.  and  PS  t!XternaliLati on during apoplosis in  iso-
laicd  human  alvcolar  macrophages (Li  ~~  al.  1997). hamster 
cclls (Tancl and Avcrill-Balcs 2005). and  HBEI hu man  Jung 
epithelial cclts (Nardini  ct a l.  2(XJ2). 
Conclusions 
The  novel contribution to knowledge ahoul  acrolein  toxic-
ily  is 1ha1  p5:1  and  ROS are  upstrcam factors  involvcd in  ac-
livation  of  ihc  death  reccptor  pathway  of  apoptosis  hy  low 
concentrations  of  acrolcin  (<50  ~moi/L )  in  A549  human 
pulmonary  cclls.  Thcsc  llndings arc  relevant  to  the  toxicity 
of acrotcin  in  many  contexts. including  the  phannacological 
action  and  (or)  sidc  cffccts  of  the  anlicanccr  agent  cyclo-
phosphamide.  which  has  acrolcin  as  one  of  ils  metabolites_ 
and  the  regulation of ccli  proli femtion and  tumor growth  by 
Published  by  NRC Research Press 366 
po l yam i n ~ s.  Anokin  is  of  intcrcsl  from  a  publi,·  hcalth 
pcr spt~  tivc. sin  ... ·c  long-lerm  cxposurc  to  chro n i ~ .  low  closes 
of Lhi;  rcacLi\'c  aldchyd<·  occur from both eXü!!cnous and  cn-
dog ...:llt.)U."l  soun.:es. 
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